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ABSTRACT 
J J HAGAN 
This thesis is ~oncerned with lysine vasopressin's (LVP's) 
behavioural activity. Chapter One describes vasopressin's synthesis, 
secretion, metabolism, pressor, antidiuretic and putative corticotrophic 
functions with emphasis on behaviourally significant aspects. Chapter 
Two reviews behavioural data showing that manipulations of endogenous 
vasopressin levels alter subsequent avoidance performance. Although 
these data have predominantly been interpreted in favour of vasopressin 
altering memory formation (consolidation) results reported from an 
experiment combining response prevention trials and vasopressin injec-
tions failed to support the consolidation hypotheis. Chapter Three 
reviews the response prevention literature and confirms the feasibility 
of using prevention trials with automated shuttle box training 
(Experiment One).- LVP (I IJg/rat) injected immediately after training 
increased subsequent extinction responding (Experiment Two). Experiment 
Three showed that LVP (I IJg/rat) increased responding when injected 
immediately after prevention trials but decreased extinction responding 
when injected after 30 minutes of post training retention in the home 
cage or 30 extinction trials. LVP injections 30 minutes after training 
and immediately after prevention trials increased suppression of con-
current lever press responding 24 hours later (Experiwent Four). Mani-
pulating the training-injection interval after automated training 
yielded maximal response reductions with a 60 minute interval (Experiment 
Five) with indications of a negative dose response curve for higher 
(2-4 IJg/rat) doses (Experiment Six). Manual shuttle box tests showed 
that with a 30 minute training-injection interval subsequent extinction 
responding varied as an inverted "U" shaped function of the LVP dose 
(Experiment Seven). Opposite effects of 0.11 1Jg/rat and 2.97 IJg/rat 
were confirmed with higher training shock levels (Experiment Nine). A 
further experiment (Experiment Eight) revealed a complex interaction 
between dose and injection interval. Extinction responding was also 
reduced by some doses of DG-LVP (Experiment Ten),· P.ost training mani-
pulation of cholinergic activity did not alter LVP's response reducing 
effects in well trained rats (Experiment Ele~en) although some choliner-
gic involvement was indicated (Experiment Fourteen) in the response 
increasing effects of LVP (I 1Jg/rat) injected 30 minutes after training 
in poor avoidance learners (Experiments Twelve and Thirteen). Tests on 
the suitability of appetitive responding for exploring vasopressin's 
behavioural effects showed that both a variable interval (60 seconds) 
schedule and differential reinforcement of low response rates (DRL) 
schedule were sensitive to high LVP doses (3-4 1Jg/rat). The implications 
of these data for our understanding of vasopressin's behavioural effects 
are discussed. 
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ABSTRACT 
This thesis is concerned with lysine vasopressin's (LVP's) 
behavioural activity. Chapter One describes vasopressin's synthesis, 
secretion, metabolism, pressor, antidiuretic and putative corticotrophic 
functions with emphasis on behaviourally significant aspects. Chapter 
Two reviews behavioural data showing that manipulations of endogenous 
vasopressin levels alter subsequent avoidance performance, Although 
these data have predominantly been interpreted in favour of vasopressin 
altering memory formation (consolidation) results reported from an 
experiment combining response prevention trials and vasopressin injec-
tions failed to support the consolidation hypotheis. Chapter Three 
reviews the response prevention literature and confirms the feasibility 
of using prevention trials with automated shuttle box training 
(Experiment One), LVP (I ~g/rat) injected immediately after training 
increased subsequent extinction responding (Experiment Two). Experiment 
Three showed that LVP (I ~g/rat) increased responding when injected 
immediately after prevention trials but decreased extinction responding 
when injected after 30 minutes of post tra1ning retention in the home 
cage or 30 extinction trials. LVP injections 30 minutes after training 
and immediately after prevention trials increased suppression of con-
current lever press responding 24 hours later (Experi~ent Four). Mani-
pulating the training-injection interval after automated training 
yielded maximal response reductions with a 60 minute interval (Experiment 
Five) with indications of a negative dose response curve for higher 
(2-4 ~g/rat) doses (Experiment Six). Manual shuttle box tests showed 
that with a 30 minute training-injection interval subsequent extinction 
responding varied as an inverted "U" shaped function of the LVP dose 
(Experiment Seven). Opposite effects of 0.1 I ~g/rat and 2.97 ~g/rat 
were confirmed with higher training shock levels (Experiment Nine). A 
further experiment (Experiment Eight) revealed a complex interaction 
between dose and injection interval. Extinction responding was also 
reduced by some doses of DG-LVP (Experiment Ten). Post training mani-
pulation of cholinergic activity did not alter LVP's response reducing 
effects in well trained rats (Experiment Eleven) although some choliner-
gic involvement was indicated (Experiment Fourteen) in the response 
increasing effects of LVP (I ~g/rat) injected 30 minutes after training 
in poor avoidance learners (Experiments Twelve and Thirteen). Tests on 
the suitability of appetiti've responding for exploring vasopressin's 
behavioural effects showed that both a variable interval (60 seconds) 
schedule and differential reinforcement of low response rates (DRL) 
schedule were sensitive to high LVP doses (3-4 ~g/rat). The implications 
of these data for our understanding of vasopressin's behavioural effects 
are discussed. 
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INTRODUCTION 
An important development 1n our understanding of the relationship 
between brain and behaviour in the last two decades has been the 
realization that peptide hormones play an important role in regulating 
physiological and behavioural processes. Current biological and physio-
logical research in this area depends heavily on recent technical 
developments; however, much of the initial impetus came from the 
behavioural studies of de Wied and his colleagues. They showed that 
both adrenocorticotrophic hormone (ACTH) and melanocyte stimulating 
hormone (MSH) could alter levels of conditioned avoidance responding in 
adenohypophysectomised, hypophysectomised and intact rats independently 
of endocrine target organ effects (see de Wied and Gispen (1977) for 
review). They also produced extensive evidence implicating vasopressin 
in behavioural processes independent of its pressor and antidiuretic 
functions (see Chapter Two). In addition recent evidence implicates 
oxytocin (Schulz et al 1974; Bohus et al 1978a) endorphins and enhe-
phalins in modulating avoidance extinction rates (de Wied et al 1978). 
Psychological theories and constructs have been used extensively 
to explain these findings, and it has been argued that as behavioural 
procedures are not only sensitive to,but can differentiate pharmaco-
logical responses from structurally related peptides, these are 
necessarily affecting different mechanisms. These results have clearly 
stimulated expectations that peptide hormones will prove useful in the 
treatment of mental illness; ACTH and MSH appear to affect memory 
(Flood, Jarvik, Bennet and Orme 1976; Rigter, Jansenns-Elbertse and 
van Reizen 1976) and attention processes in rats (Champney, Sahley and 
Sandman 1976; Beckwith; Sandman and Kastin 1976), normal adult males 
(~!iller, van Reizen and Kastin 1976; Dornbush and Nikolovski 1976), 
mentally retarded adult males (Sandman, George, Walker, Nolan and Kastin 
1976) and the elderly (Ferris et al 1976). The fragment des-tyrosine-
gamma-endorphin may prove therapeutic in treatment of schizophrenia 
(de Wied 1979) and vasopressin has been tested with amnestic patients 
(Legros et al 1978, Oliveros et al 1978) and may prove beneficial in 
treating lesh-nyhans disease (Anderson et al 1979). 
Discussionsin this thesis focus on vasopressins and the widely 
accepted hypothesis that these peptides play a physiological role in 
regulating memory formation (consolidation). Attention has been 
focussed on vasopr~ssins, rather than comparing different classes of 
peptides as is common in the literature, in order to avoid the methodo-
logical difficulties inherent, though rarely discussed, in the latter 
vii 
approach. These problems are particularly acute with systemic injections. 
Multiple sites may be involved with differential accessibility; blood/ 
brain barrier permeability, metabolic and behavioural half life and 
susceptibility to enzymatic degradation will vary between peptides. In 
addition, each peptide will activate central and peripheral endocrine 
target organs differentially, altering ·the animal's physiological con-
ditions and triggering compensatory mechanisms. 
The behavioural effects of vasopressins form part of a wider 
spectrum of pharmacological responses, some of which are thought to 
reflect physiological roles for the endogenous peptide. Chapter One 
briefly describes aspects of vasopressin's synthesis in the anterior 
hypothalamus, transport along the hypothalamo-hypophyseal tract, 
secretion into the periphery and evidence suggesting direct secretory 
routes into the cerebrospinal fluid (CSF) and blood vessels supplying 
the anterior lobe of the pituitary gland. Several aspects of the data, 
including peripheral metabolism rates, secretion under stress, presence 
of vasopressin in the CSF, its putative role as corticotropin releasing 
factor (CRF) and capacity, at least in high doses, to stimulate the 
pituitary-adrenal axis bear directly on the peptide's involvement in 
behavioural regulation. 
The hypothesis that vasopressin plays a physiological role in the 
formation of memory (consolidation) derives from experiments which show 
that manipulations of endogenous vasopressin levels and post training 
pharmacological challenge with exogenous vasopressin result in altered 
performance levels when responding is subsequently tested in the absence 
of reinforcement (extinction). These data, with supportive evidence from 
experiments using amnestic treatments and studies which explore the 
neuroanatomical and neurochemical for vasopressin's behavioural effects, 
are reviewed in Chapter Two. 
A result which appears to contradict the consolidation hypothesis 
was reported by King and de Wied (1974) using vasopressin injections 
coupled with response prevention trials, a behavioural procedure which 
reduces avoidance responding in extinction. This important negative 
result forms the basis of some of the experiments described in later 
chapters; therefore a brief review of the response prevention literature, 
highlighting important variables, together with an experiment demon-
strating the feasibility of using prevention trials after shuttle box 
avoidance responding in a delayed testing procedure is presented in 
Chapter Three. 
In subsequent chapters a number of experiments are reported, all 
using post training injections, some with and some without response 
Vl.l.l. 
prevention trials, which show that, although vasopressin quite clearly 
alters the status of an aversively conditioned stimulus, as measured by 
both avoidance extinction and suppression of a concurrent operant base-
line, the effects appear to be independent of any "informational" or 
"associational" changes. In addition, as both magnitude and direction 
of performance changes in extinction varied as a function of peptide 
dose and the interval between training and injection, it was concluded 
that the data could not be explained by the consolidation hypothesis 
alone. 
l.X 
CHAPTER ONE 
THE VASOPRESSINS: ANATOMICAL, FUNCTIONAL. PHYSIOLOGICAL AND 
PHARMACOLOGICAL CONSIDERATIONS 
This chapter describes aspects of the structure, synthesis and 
secretion of vasopressin; additional consideration is given to factors 
which affect secretion, neurochemical control of secretion, effects of 
the peptide on target organs and the role which vasopressin plays in 
activating the pituitary adrenal axis. 
I. I Structures and Evolution of Posterior Lobe Peptide Hormones 
The vasopressins are classified as octapeptides or nonapeptides 
and are formed by a ring of six and tail of three amino acids linked by 
peptide bonds (Bennett and Freiden 1972). This structure is illustrated 
in Figure One, a disulphide bond between the two cystei~e residues in 
positions one and six produce the characteristic ring of the structure 
(Conn and Stump£ 1972). 
Figure One: Structure of Arginine Vasopressin (AVP) 
/ 
4. GLN - NH2 
3. PHE 
~ 
s. ASN 
N~~ 
6. CYS 
~ 
disulphide 7' 
bond 
I. CYS 
/ 
2. TYR 
PR0-8. ARG--9. GLY-NH2 
The pressor effects of bovine pituitary extract were first dis-
covered by Oliver and Schafer (1895) but it remained for Du Vigneaud 
(1955) to identify the molecular structure of the active principle. 
Vertebrate neurohypophyseal extracts have yielded seven biologically 
active octapeptides, three of which exhibit strong antidiuretic and 
pressor action (Sawyer 1967). These three are arginine vasotocin (AVT), 
arginine vasopressin (AVP; cf Figure One) and lysine vasopressin (LVP). 
The four remaining posterior lobe peptides are oxytocin, mesotocin, 
isotocin and glumotocin. These exhibit low antidiuretic and pressor 
action (Walter et al 1967). Oxytocin is secreted from the mammalian 
pituitary and stimulates milk ejection, from the mammary glands, and 
uterine contractions (Bennett and Frieden 1972). The amino acid 
sequences of these peptides are presented in Figure Two. 
Figure Two: The amino acid sequences of posterior lobe peptide hormones 
(I) Arginine Vasotocin (AVT) 
* 
Cys Tyr Ile Gln Asn Cys Pro Arg Gly (NH 2) 
(2) Arginine VasoEressin (AVP) 
Cys Tyr Phe Gln Asn Cys Pro Arg Gly (NH2) 
(3) L:z:sine VasoEressin (LVP) 
Cys Tyr Phe Gln Asn Cys Pro Lys Gly (NH 2) 
(4) Ox;ttocin 
Cys Tyr Ile Gln Asn Cys Pro Leu Gly (NH2) 
(5) Isotocin 
Cys Tyr Ile Ser Asn Cys Pro Ile Gly (NH 2) 
(6) Mesotocin 
Cys Tyr Ile Gln Asn Cys Pro !le Gly (NH2) 
(7) Glumitocin 
Cys Tyr Ile Ser Asn Cys Pro Gln Gly (NH 2) 
* denotes ring structure 
2 
AVT has been found in all major non-mammalian vertebrates including 
reptiles, amphibians, teleost fish, cyclostomes and birds. Structural 
variation from AVT does not appear until the mammals, indicating struc-
tural and functional stability over some four hundred million years of 
evolutionary development (Sawyer 1967). Most vertebrates have two 
neurohypophyseal hormones, one in the vasopressin series (cf structures 
1-3, Figure Two) and one in the oxytocin series (cf structures 4-7, 
Figure Two). These two separate series may have developed as a result 
of doubling the gene controlling AVT synthesis (Sawyer 1964), The 
common predecessor hypothesis is supported by comparisons of biological 
potency between the peptides. AVT, the proposed predecessor, is prin-
cipally found in non-mammalian vertebrates although reports also suggest 
it to be present in foetal mammalian neurohypophyses (Viszolyi and Perks 
1969) and in pineal tissue from rats (Rosenbloom and Fisher 1975). AVT 
is equipotent on uterine, mammary, pressor and antidiuretic activity 
(Walter et al 1967). In contrast oxytocin and the vasopressins, which 
are found in the mammals, show greater specificity of action with vaso-
pressins showing high activity on the antidiuretic and pressor assays 
and low activity on the uterine and mammary assays whilst oxytocin 
exhibits high activity on the mammary and uterine assays but low activity 
on antidiuretic and pressor assays (Walter et al 1967). 
Comparing within the vasopressin series, AVP appears to be more 
potent than LVP in both pressor and antidiuretic action. These peptides 
also have different distributions. AVP is far more widespread than LVP 
in the mammals, this latter being specific to members of the Suina 
including the wild boar (sus scrofa), wart hog (phacochoerus aethiopicus), 
bush pig (potomochoerus porcus) and hippopotamus (hippopotamus amphibius) 
(Ferguson and Heller 1965). Evidence of AVP has been found in the wild 
boar, the probable ancestor of the domestic pig, suggesting that the 
capacity to synthesise AVP may have been lost as a result of selective 
breeding (Sawyer 1967). 
1.2 Synthesis 
The evidence available suggests that although vasopressin and 
oxytocin are secreted from the posterior lobe of the pituitary gland 
(neurohypophysis/pars nervosa) this is not the site of synthesis. Two 
remote production sites have been identified, the supraoptic and para-
ventricular nuclei in the anterior hypothalamus. The peptide is 
actively transported between these sites of synthesis and secretion. 
Evidence on these points ~ill be considered in the following three 
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subsections. The key structures and anatomica l r e lationships ar e des-
cribed in Figure Three . 
Figure Three: Simplified schematic recons truction of the hypothalamic-
hypophyseal ner ve tracts and as soci a ted pi t uitary 
s truct ur es 
SUPRAOPTIC N . 
OPTIC: CHIASM 
superior 
hypophysial 
a rtery 
ANTERIOR---
LOBE 
I . 2 . I The site of biosynthesis 
PARAVENTRICULAR 
NUCLEUS 
MAMM ILLARY BODY 
·neurosecretory 
material . 
A wealth of evidence supports the existence of a fibre tract 
connecting the supraop t ic nucleus in the anterior hypothalamus with the 
posterior lobe of the pituitary gland (Magoun and Ranson 1939, cited ~n 
Melville and Hare 1945) . Silver staining clearly distinguishes the 
tract (Melville and Hare 1945) and pituitary stalk transection leads t o 
fibre degeneration at sites distal to the lesion, posterior lobe atrophy 
and degener ation of 80-957. of supraoptic nuclei neur ons . 
The supraoptic neurons were evidently involved in the secretion of 
antidiuretic hormone (ADH) (Scharrer and Scharrer 1945 , cited in 
Melville and Hare 1.945). Indeed Melville and Hare (1945) confirmed that 
the supraoptic neurons contained ADH equivalent to 1. 5-5 units of 
pituitrin (crude extract from the posterior pituitary) . In addition 
hypophysectomy and pituitary stalk transection induced a degeneration 
of the supraoptic nuclei accompanied by loss of the antidiuretic prin-
ciple (Melville and Hare 1945). This evidence , coupled with the view 
expressed by O'Connor (1947) (cited in Bargmann and Scharrer 1951) that 
the cells 1n the pars nervosa have little in common with secretory cells 
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elsewhere in the body, led to the suggestion that production sites for 
the posterior lobe hormones were remote from the secretion sites in the 
posterior pituitary. The evidence reviewed by Bargmann and Scharrer 
(1951) suggested that the synthesis of ADH was restricted to the supra-
optic and paraventricular nuclei in the anterior hypothalamus. 
Furthermore, Mirsky, Stein and Paulisch (1954a) found that ADH 
secretion occurred in the absence of the neurohypophysis. It was 
apparent that the supraoptic and paraventricular nuclei, not the neuro-
hypophysis were the source of ADH. These nuclei are formed by the cell 
bodies of neurons whose axons form the hypothalamo-hypophyseal tract and 
terminate in the posterior pituitary gland where they act as storage 
vessels for ADH and from which release occurs on demand (Scharrer and 
Scharrer 1954; Sachs 1967). Vasopressin cells are principally found Ln 
the ventral and caudal supraoptic nucleus whilst oxytocin containing 
cells predominate in the dorsal, medial and caudal areas (Antunes and 
Zimmerman 1978). Cytoarchitectural studies, using a Golgi-Cox staining 
method, have revealed three cell types in the supraoptic nucleus -
long multipolar neurons, bipolar neurons and smaller interneurone 
(Felten and Cashner 1979). These latter are probably not involved Ln 
neurosecretion. Oxytocin and vasopressin cells could not be distin-
guished structurally (Felten and Cashner 1979). 
Dense granular structures are found within the cells of the hypo-
thalamo-hypophyseal tract. Evidence for the active transport of neuro-
secretory granules (NSG) aggregated into neurosecretory·material (NSM) 
was first provided by Hild (1951, cited in Bargmann and Scharrer 1951). 
Transection of the frog pituitary stalk resulted in a marked accumula-
tion of NSM in the tract between the lesion and the nucleus preopticus. 
The relationship between ADH and NSM is supported by observations of a 
good correlation between the amount of stained NSM in the tract and the 
animal's state of hydration. Dehydration induces high plasma ADH levels 
and depletion of NSM within the tract, conversely hydrated rats have 
low plasma ADH levels and an accumulation of NSM in the tract (Bargmann 
and Scharrer 1951). These data suggest that cytoplasm bearing ADH flows 
from the cell bodies of the supraoptic nucleus along the axons in the 
supraopticohypophyseal fibre tract to the posterior pituitary. As a 
note of caution, Sachs (1967) points out that NSM stainability may not 
accurately reflect ADH levels in the posterior pituitary gland. Indeed, 
Krisch (1979) has recently visualised a form of vasopressin in the rough 
endoplasmic reticulum of the supraoptic perikarya and in the inter-
cellular clefts of immobilisation stressed rats. Krisch (1979) suggests 
that under stressful conditions vasopressin may be rapidly released in a 
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more soluble and freely available form than that which is granule bound. 
In summary, ADH is synthesised in the cells of the supraoptic and 
paraventricular nuclei and transported to the posterior pituitary by 
axonal flow in association with NSM. This conclusion is supported by 
observations that NSG are formed by golgi bodies in the anterior hypo-
thalamic nuclei, in keeping with the role of golgi bodies in other 
secretory tissues, eg pancreas (Sachs 1967). In addition, lesions to 
the supraopticohypophyseal tract results in diabetes insipidus (DI), 
the severity of which is directly related to the degree of interruption 
inflicted upon the tract (Ranson and Magoun 1939). DI is characterised 
by primary polyuria and secondary polydipsia due to abnormally low ADH 
levels resulting from nephrogenic or neurogenic failure, or from 
genetic inability to synthesise vasopressin (see Section 1.10.1). 
I. 2. 2 The process of biosynthesis 
Recent work by Sachs and his colleagues (Sachs 1967; Gainer et al 
1977a) has clarified the steps involved in vasopressin synthesis with 
radioactive tracer techniques. These authors used radioactively 
labelled cysteine, ~dministered by various routes, allowing the experi-
menter to monitor incorporation of the label into pituitary peptides and 
proteins. Cysteine, one of the amino acids, is widely distributed in 
peptides and proteins. In particular it occupies positions one and six 
~n the vasopressin structure. 
Ventricular infusion of c35sJ cysteine into dogs followed by 
centrifugation of hypophyseal tissue did not reveal radioactive vaso-
pressin in association with the ribosome rich fractions, as would be 
expected if nucleic acids within the ribosom~s were involved in syn-
thesis. Two interpretations seemed likely; either nucleic acids were 
not involved in synthesis or synthesis did involve nucleic acids and the 
product was not vasopressin but an inert precursor molecule. If an 
inert precursor was involved then there should be a considerable time 
lag between the infusion of labelled cysteine and the emergence of 
labelled vasopressin. Sachs and Takabatake (1964) infused radioactive 
amino acid into dogs and observed that no radioactive vasopressin 
emerged within 1.5 hours of infusion; however, if the dogs were spared 
for an additional 4.5 hours then substantial amounts of radioactive 
vasopressin were detectable. They hypothesised that if an inert pre-
cursor was involved and its synthesis was nucleic acid dependent then 
puromycin, a protein synthesis inhibitor, should inhibit vasopressin 
synthesis. Additional infusion experiments revealed that vasopressin 
was not synthesised when puromycin was present from the start of 
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infusion; however, if puromycin presence was restricted to the post 
infusion period then radioactive vasopressin was synthesised. 
The ventricular infusion technique involves difficulties in inter-
pretation. The amino acid used is ubiquitous in brain proteins and 
peptides; it is difficult to determine the degree of cysteine uptake 
into brain tissue or to what extent breakdown of the amino acid struc-
ture occurred, thereby releasing the radioactive label and allowing 
incorporation into other structures. These objections are to some 
extent answered by reports that identical results are found following 
bilateral ~njection of c35sJ cysteine into the supraoptic nucleus of 
ether anaesthetised cats (Gainer et al 1977b) and using in vitro pre-
parations (Sachs 1967). 
The data suggested that c35 sJ cysteine was initially incorporated 
into an inert precursor molecule, the synthesis of which was probably 
dependent upon RNA in the ribosomes. This stage involves protein syn-
thesis and is puromycin sensitive. After synthesis the inert precursor 
is bound into secretory granules, probably by the golgi bodies (Sachs 
1967). The subsequent elaboration into vasopressin appears not to 
involve further protein synthesis, as indicated by the lack of puromycin 
sensitivity. Inert prohormone synthesis may be restricted to the peri-
karya of the cells. Leclerc and Pelletier (1974) used an immunohisto-
chemical technique and found that vasopressin was restricted to the 
axons of the cells in the supraoptic and paraventricular nuclei; no 
reaction was found in the perikarya. However, Krisch (1979) has found 
evidence of vasopressin in the endoplasmic reticulum of neurosecretory 
perikarya. 
Labelling techniques have also yielded data on axonal transport 
following elaboration into NSM. Gainer et al (1977b) injected C35sJ 
cysteine bilaterally into the supraoptic nuclei of ether anaesthetised 
rats and then killed the animals at various times after injection to 
elucidate the time course of labelled proteins emerging at the supra-
optic nucleus, median eminence and posterior pituitary gland. Incorpor-
ation at the supraoptic nucleus was very rapid, appearing 30 minutes 
after injection. Substantial incorporation appeared at the median 
eminence after one hour, rapidly increased between one and two hours and 
slowly reached a peak after twelve hours. Labelled proteins were not 
detected at the posterior pituitary until two hours after injection. 
Thereafter incorporation increased steadily to a peak at twelve hours. 
For all areas the detection of labelled proteins was maximal twelve 
hours after injection and was maintained until the final test 24 hours 
after injection, confirming that proteins are synthesised in the 
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supraoptic nucleus and transported to the posterior pituitary in the 
hypothalamo-hypophyseal tract which traverses the'median eminence (cf 
Figure Three) (Gainer et al 1977b). The rate of detection following 
injection is consistent with the original hypothesis proposed by 
Bargmann and Scharrer (1951) that transportation from the site of syn-
thesis to the site of secretion in the posterior pituitary is by axonal 
flow. 
1.2.3 Neurophysins 
Vasopressin is found in close association with specific proteins, 
neurophysins which have a molecular weight of approximately 20,000. 
Kurtzman and Boonjarern (1975) and Zimmerman et al (1973b) provide 
evidence for two such proteins. In contrast, Burford and Pickering 
(1972) found three neurophysins in the rat hypothalamo-hypophyseal tract 
and only one of these appeared in association with vasopressin. Gainer 
et al (1977a), however, could not confirm the presence of three neuro-
physins using an identical technique. Neurophysin is distributed 
throughout the neurons of the tract and in the supraoptic and paraven-
tricular nuclei (Zimmerman et al 1973b). 
The close association between vasopressin and at least one species 
of neurophysin has been taken to indicate that neurophysin and vaso-
pressin are bound together possibly for the purposes of transport along 
the axons (Kurtzman et al 1975; Wimersma et al 1977). This is uncertain 
in view of findings that the neurohypophyseal vasopressin content does 
not always bear a constant relationship to the neurophysin content as 
would be expected if neurophysins acted solely as transport molecules 
in a one to one relationship with vasopressin (Bakker et al 1975). 
Results obtained with radioactive labelling techniques suggest the 
presence of four neurohypophyseal ho~mones in addition to vasoprssin 
and oxytocin (Gainer et al 1977a). These authors argue for the existence 
of a precursor which is common to neurophysin and the other neurohypo-
physeal hormones. Following the suggestion of Sachs (1967) that an 
inert precursor molecule is produced by translation from RNA at the 
ribosomes and elaborated into NSG they proposed that the precursor may 
be cleaved in the NSG to produce oxytocin, vasopressin, neurophysin and 
possibly the four other peptides which have been detected. This is an 
attractive hypothesis of considerable biological economy, a common 
precursor protein undergoes post translational cleavage within the trans-
port granule whilst in transit in the hypothalamo-hypophyseal tract. 
The peptide which is produced would depend upon the particular combina-
tion of proteolytic enzymes packaged with the precursor. 
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I. 2. 4 Summary 
Vasopressin synthesis starts in the supraoptic and paraventricular 
nuclei of the anterior hypothalamus. The peptide is transported to the 
posterior pituitary gland via the axons of the cells which constitute 
the hypothalamo-hypophyseal tract. Synthesis may occur during the pro-
cess of transport within the neurosecretory granule deriving vasopressin 
and/or other peptides from a common protein precursor. 
1.3 Secretion 
The secretory process is described and evidence for vasopressin's 
primary peripheral route of secretion is briefly presented. Evidence 
for two additional routes of secretion, to the hypophyseal portal blood 
supply and to the cerebrospinal fluid (CSF) is discussed. These two 
routes are important in considering the behavioural effects of vaso-
pressins as the hypophyseal portal blood supply provides access to the 
adenohypophysis, and may serve as a route through which vasopressin 
affects the release of behaviourally active adrenocorticotrophic hormone 
(ACTH) and corticosteroids. Furthermore, if vasopressin is secreted 
into the CSF, then the peptide may be acting directly on central nervous 
system (CNS) structures using the CSF as the transport medium. 
I. 3. I Exocytosis 
Through the mechanism of axoplasmic flow (Bargmann and Scharrer 
1951; Gainer et al 1977b) granules (NSM) stream down the hypothalamo-
hypophyseal tract into the posterior pituitary and are released into 
the capillary blood supply by exocytosis (Rolmes and Ball 1974). 
During this process the enclosing membrane of each granule fuses 
with the cell membrane simultaneously rupturing to exude the granule 
contents into the perivascular space and from there into the capillary 
blood supply. Surplus membrane fragments may persist in the peri-
vascular space or be digested by the lysosomes which are evident in the 
posterior pituitary nerve endings (Whitaker, Labella and Sanwal 1970). 
In vitro vasopressin release can be stimulated by potassium (K+) and 
calcium (Ca++) ions (Douglas 1963). The release mechanism may involve 
. . . . . ++ the destruct~on of b~nd~ng between vasopress~n and neurophys~n by Ca 
following its entry into the cell after depolarisation (Holmes and Ball 
1974). Vasopressin is secreted into the capillary blood supply and 
through this route affects its physiological role of water reabsorption 
in the kidney (Rydin and Verney 1938; Verney 1947). 
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I. 3. 2 Secretion into the hypophyseal portal blood vessels 
In view of the close association between vasopressin and neuro-
physin (Section 1.3.3) the presence of neurophysin in a structure may 
indicate the presence of vasopressin. Neurophysin has been found in the 
supraoptic and paraventricular nuclei, in the axons of the supraoptico 
hypophyseal tract and in the external layer of the median eminence 
(Zimmerman 1973a,b). The axons of the tract pass close to the wall of 
the third ventricle in the region of the median eminence (see Figure 
Two , Section 1.3) and a small number of axons appear to terminate in 
this area (Zimmerman 1973a,b). Considered together, these findings 
provide circumstantial evidence for a secretory route from the supra-
optic nucleus to the median eminence, an area from which capillary blood 
vessels drain into the portal blood vessel. 
In order to test this hypothesis, Zimmerman et al (1973a) can-
nulated monkey portal veins to collect hypophyseal portal blood for 
comparison with systemic venous blood. Neurophysin and vasopressin 
concentrations were measured using a radioimmunoassay. The portal blood 
contained an average neurophysin level of 61.5 ng/ml compared with 2.5 
ng/ml in the systemic blood; the mean portal blood level for vasopressin 
was 13,000 pg/ml compared to 42 pg/ml in the systemic blood. The authors 
suggested that the source of the higher vasopressin and neurophysin 
levels was probably the axons of the supraoptico hypophyseal tract 
terminating in the median eminence and draining into the portal blood 
vessels. Zimmerman et al (1975) confirmed these observations and ~n 
addition reported that electron microscopy of the median eminence area 
revealed large osmophillic granules (Herring bodies) in the perivascular 
space, granules which are typically found in the supraopticohypophyseal 
neurons (see Section 1.2.1). These data are compatible with the hypo-
thesis that vasopressin and indeed neurophysin gain access to the 
anterior lobe of the pituitary gland and its behaviourally active 
hormones via the portal blood supply. 
I • 3. 3 Secretion into the cerebrospinal fluid (CSF) 
Anatomical evidence supports the existence of a secretory link 
between the cells of the supraoptic and paraventricular nuclei and the 
CSF. Rodriguez (1970) has observed that many of the neurons in the 
ventral preoptic nucleus of the toad are bipolar. Short ventricular 
processes terminate on the ependymal lining of the preoptic recess 
giving direct access to the ventricular fluid. However, an examination 
of 200 of these endings, using gomori stain, revealed no evidence of 
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neurosecretory material which would be expected if these processes act as 
secretory routes. In contrast, the ventricular processes in the trout 
are rich in neurosecretory material (Muller 1969). These data indicate 
one possible mode of access to the CSF. Felten and Cashner (1979) have 
reported bipolar and multipolar neurons in the supraoptic nucleus of an 
adult rabbit. Axons of the nultipolar neurons were seen to course 
towards the median eminence, supporting the hypothesis that neurons of 
the hypothalamo hypophyseal tract terminate in the median eminence 
(Section 1.3.2). Robinson and Zimmerman (1973) have suggested that 
neurophysin and vasopressin first gain access to the CSF via axons 
terminating in the median eminence and from there are taken by the 
tanycytes of the ependymal layer in the infundibular recess back to the 
hypophyseal portal blood system. This single route could explain the 
presence of vasopressin in the portal system and ~n the CSF. Involvement 
of the tanycytes is a recent suggestion, but the idea that secretion 
into the CSF occurs via the infundibular recess has a long history. The 
hypothesis was first suggested by Herring (1908, cited in Cushing 1931) 
who observed that secretory granules moved towards and into the infundi-
bular recess, indicated by the presence of hyaline bodies (Herring 
bodies) which he believed to be secretory products. The hypothesis has 
recently been supported by data from Wittowski (1968). Electron micro-
scopy confirmed that axons from the supraoptico-hypophyseal tract ter-
minated in the infundibular recess of the third ventricle; these were 
rich in neurosecretory material which appeared to egress into the ven-
tricular fluid. Furthermore, Rodriguez (1970), using electron micro-
scopy, has confirmed the presence of neurosecretory granules (1,300-
1,500 A0 diameter) in the ependymal layer of the infundibular recess in 
toads. Therefore posterior lobe peptides may gain access to the CSF by 
two routes, via short ventricular processes into the preoptic recess -
this route has little supportive evidence - or into the infundibular 
recess via the median eminance - this route is well supported by the 
evidence. 
The evidence for a secretory route for vasopressin into the CSF 
must meet three criteria. The first has been discussed and demands 
sufficient anatomical evidence for the route; the second is that the 
CSF contains vasopressin; the third and most difficult to satisfy is 
that CSF vasopressin originates by direct secretion and not by "leakage" 
across the blood/CSF barrier or by other means of indirect access 
(Rodriguez 1970). 
~!any experiments between 1915 and 1930 (Cushing 1931) indicate 
the presence of vasopressin in the CSF but Van Dyke et al (1929) argued 
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that these findings were artefacts of a non-specific assay technique. 
More recently Heller et al (1968) found that CSF, withdrawn by cisternal 
puncture from experimental rabbits, inhibited diuresis in assay rats 
following stimulation of the vagal nerve under pentabarbitone anaes-
thesia, or treatment with pentabarbitone anaesthesia alone. Both these 
treatments stimulate the release of vasopressin (Ginsburg and Brown 
1956). In contrast the inhibition was not seen after a local anaesthetic. 
The assay was performed using ethanol anaesthetised hydrated rats, a 
preparation in which endogenous vasopressin release is blocked in the 
assay rat. The destruction of antidiuretic activity in the CSF of vagal 
and pentabarbitione stimulated rabbits by incubation with trypsin or 
sodium thioglycollate confirmed that the antidiuretic activity was due 
to vasopressin and was not a non-specific effect. The data indicate 
that CSF contains vasopressin following the stimulation of endogenous 
secretion, assay levels were greater following pentabarbitone anaes-
thesia than following local anaesthesia and were also higher in vagal 
stimulated pentabarbitone rats than·in non-vagal stimulated pentabarbi-
tone anaesthetised controls. The source of vasopressin.in either case 
could be direct secretion into the CSF or leakage from the plasma across 
the plasma/CSF barrier; this could occur naturally or be caused by 
pentabarbitone distorting the normal barrier permeability. The vaso-
pressin stimulating effect of pentabarbitone may be restricted to the 
period immediately after injection as Heller et al (1968) found that the 
barbiturate increased both peripheral and CSF levels of vasopressin when 
samples were taken two to three minutes after anaesthetic, but when 
Vorherret al (1968) delayed the collection of samples for half an hour 
after anaesthetisation only very low levels of plasma and CSF vaso-
pressin were found, In both studies rabbits were used; the assay pre-
parations were similar and the dose of pentabarbitone was identical (30 
mg/kg), Vorherr et al (1968) confirmed that haemorrhage massively 
increased plasma vasopressin levels (Ginsburg and Brown 1956), and also 
increased CSF vasopressin, although these never exceeded 25% of plasma 
levels. The specificity of the CSF antidiuretic principle was confirmed 
by destruction of antidiuretic activity following incubation with vaso-
pressinase from human pregnancy plasma; however, the source of vaso-
pressin was not specified. 
Determining the source of CSF vasopressin involves measuring to 
what extent the blood/CSF barrier is permeable to vasopressin and similar 
peptides. If the barrier is 'impermeable then the source of CSF vaso-
pressin is more likely to be a direct secretory pathway. These studies 
have used peripheral administration followed by examination of the CSF 
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to determine whether or not vasopressin levels have increased after 
administering the exogenous peptide. This approach is complicated by 
the fact that uptake of vasopressin by the kidney is rapid and efficient 
even for large exogenous doses (Section 1.8. 1). If a small dose does 
not change CSF vasopressin levels this may be due to peripheral enzyma-
tic degradation preventing sufficiently high concentrations from 
reaching the blood CSF barrier. If on the other hand the dose is in 
excess of the normal physiological range, then the subsequent changes 
of vasopressin levels in the CSF may be due to distortion of normal 
barrier permeability brought about by the increase in blood pressure 
which characteristically accompanies large vasopressin doses (Section 
1.8.2). Thus Heller et al (1968) found that CSF vasopressin levels 
increased in response to a non-physiological dose of 50 mu of AVP/kg 
within two minutes of the peripheral injection. In contrast Vorherr et 
al (1968) used a constant infusion of AVP (5 mu/min) for 40 minutes, or 
25 mu/min for two hours; neither affected CSF vasopressin levels. 
However, these tests by Vorherr et al (1968) were run after animals had 
previously been subjected to haemorrhage which itself may have distorted 
barrier permeability. More recently, Zaidi and Heller (1974) injected 
radioactively labelled oxytocin (3H oxytocin) or vasopressin (3H lysine 
vasopressin) intravenously into urethane anaesthetised rats and studied 
the appearance of radioactivity in plasma and CSF sampled by cannula-
tion and cisterna! puncture. In oxytocin treated rats the subsequent 
plasma radioactivity count (849 counts/ml/min) was far in excess of the 
CSF level (22 counts/ml/min) and the plasma count for vasopressin 
treated rats (1753 counts/ml/min) was far in excess of the CSF level 
(35.5 counts/ml/min). The authors concluded that barrier permeability 
for the peptides was low, supporting the hypothesis that the high CSF 
levels seen after the stimulation of endogenous secretion (Vorherr et 
al 1968; Heller et al 1968) originated from direct secretion into the 
CSF and not from the plasma. However, Zaidi et al (1974) had also used 
a non-physiological dose of 117 mu of labelled vasopressin, which may 
have distorted barrier permeability. A further possibility is that 
enzymes degraded the structure of labelled vasopressin very rapidly but 
released the breakdown products, including the tritium label back into 
the plasma, in which case the radioactive counts do not necessarily 
reflect the fate of the exogenous peptide or its capacity to cross the 
barrier. Similar objections may apply to the study by Greenberg et al 
(1976) who reported that, following intracarotid injection of labelled 
vasopressin ( 14o AVP), radioactivity was detected, after IS seconds and 
ten minutes, in all major brain areas, including the cerebral cortex, 
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hypothalamus, caudate nucleus, brain stem and cerebellum in roughly 
equal proportions. The pineal and pituitary glands exhibited levels 
ranging from 5x to 8x that found in other areas. Binding appeared to 
be non-specific and passive, the increased levels observed for the 
pituitary and pineal glands may reflect increased binding at these 
sites or the fact that the glands are located outside the blood brain 
barrier. Alternatively, the labelled peptide may have been rapidly 
degraded or synthesised in which case the distribution of radioactivity 
after injection_ may not reflect the distribution of peptide uptake but 
simply the distribution of amino acids or their fragments following 
degradation. 
1.3.4 Extrahrpothalamic vasopressinergic pathways 
The development and widespread application of microdissection 
techniques coupled with the use of sensitive radioimmunoassays have 
revealed the presence of peptide hormones in brain tissue remote from 
the hypothalamus. The earliest evidence for this was published by 
Barry (1963), using Gomori stain which was incapable of distinguishing 
individual peptides. The presence of vasopressin and oxytocin in the 
supraoptic and paraventricular nuclei has been confirmed (George and 
Jacobowitz 1975; Dogterom et al 1978). Fibres coursing from the supra-
optic nucleus to the posterior pituitary were found to contain large 
amounts of vasopressin in the region of the median eminence (see Figure 
Three) (George and Jacobowitz 1975). Vasopressin levels were higher in 
the retrochiasmatic nucleus, lying adjacent to the supraoptic nucleus, 
than in the supraoptic nucleus itself which may indicate transformation 
of the peptide in transit to a form recognisable to the vasopressin 
antibody (George and Jacobowitz 1975). This confirms the suggestion by 
Gainer et al (1977) that synthesis is completed in transit (see Section 
1.2.3 for discussion). 
A number of fibres emanate from the paraventricular nucleus and 
enter the dorsal hippocampus and subiculum after traversing the ventral 
fornix commissure (Buijs 1978). These fibres pass close to the sub-
fornical organ which contains vasopressin fibres (Buijs 1978) and vaso-
pressin (Summy-Long 1978) and continue to the ventral hippocampus via 
the fimbria (Buijs 1978). Dogterom et al (1978) have confirmed the 
presence of vasopressin in the anterior and dorsal hippocampus. 
Additional fibres originating in the paraventricular nucleus course 
rostrally to the medial and lateral septum. Dogterom et al (1978) have 
confirmed the presence of vasopressin in the septum. From the para-
ventricular nucleus two pathways course to the substantia nigra, one 
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via the infundibular recess and arcuate nucleus and the other caudally 
through the substantia nigra to the medulla oblongata (Buijs 1978). 
Finally, a series of fibres pass via the stria terminalis to the nuclei 
of the amygdala (Buijs 1978), the presence of vasopressin in the amyg-
dala has been confirmed by Dogterom et al (1978). The hypothalamus has 
long been considered to be the highest centre of autonomic control, 
mediated via its anatomical connections with the lower brain stem. 
Recent evidence from experiments using the horseradish peroxidase tech-
nique to track individual neurons has challenged this concept by demon-
strating the existence of a direct pathway from segments 7 and 9 of the 
rat spinal cord to the paraventricular nucleus (Ono et al 1978). 
Another fibre system, characterised by its fine fibres (Sofroniew 
and Weindl 1978, originates in the suprachiasmatic nucleus and projects 
to the lateral septum (Sofroniew and Weindl 1978; Buijs 1978), medial 
dorsal thalamus and solitary tract (Sofroniew and Weindl 1978). 
Finally these authors described a pathway to the lateral habenular 
nucleus which coursed under the ependyma of the third ventricle. In 
the projection areas described the fibres make numerous axosomatic con-
tacts and do not appear to contact the capillary blood vessels suggesting 
that their primary function in these brain areas is not secretory 
(Sofroniew and Weindl 1978; Krisch 1978). Furthermore the vasopressin 
pathways are absent in rats with a genetical absence of vasopressin 
(Sofroniew and Weindl 1978; Buijs 1978) (see Section 1.10 for discus-
sion of genetic DI). The functional significance of these pathways 
remains to be established. 
1.3.5 Summary 
The primary route for vasopressin secretion, from the posterior 
pituitary gland into the circulation is well established. Evidence has 
been presented supporting the hypothesis that vasopressin is secreted 
into the hypophyseal portal blood supply and from there to the anterior 
lobe of the pituitary. Anatomical evidence supports the existence of a 
fibre tract linking the cells of the supraoptic and paraventricular 
nuclei with the CSF via the median eminence and the infundibular recess. 
In support of the direct secretory route, observations confirm the 
presence of vasopressin in the CSF using a specific assay technique. 
However, it has not been unequivocally demonstrated that the source of 
CSF vasopressin is not plasma borne peptide crossing the blood/CSF 
barrier. Recent studies have shown vasopressin to be present in 
numerous extrahypothalamic pathway originating from the paraventricular 
and suprachiasmatic nuclei. 
IS 
1.4 Neurotransmitter Control of Vasopressin Secretion 
Evidence is presented which indicates that adrenergic, cholinergic 
and histaminergic neurons play integrated roles in regulating vaso-
pressin secretion. 
I • 4. I Adrenergic involvement 
Histological studies have indicated that noradrenergic fibres are 
present in structures which are involved in vasopressin secretion. 
Carlsson et al ( 1962) reported that the supraoptic, paravent·ricular and 
periventricular but not the pars nervosa stained heavily for noradrena-
line; later Shute and Lewis (1966) confirmed these observations. 
Furthermore, Fuxe and Hokfelt (1970) reported that fibres which stained 
for noradrenaline in the supraoptic and paraventricular nuclei were 
activated by hypo-osmotic and hyperosmotic stimuli, which are known to 
affect vasopressin release (Section 1.6.1). 
Early physiological experiments had suggested adrenergic involve-
ment in vasopressin secretion. O'Connor and Verney (1945) reported 
that intravenous injections of adrenaline (20 ug) prevented the anti-
diuretic response normally induced by mild shock in dogs when given 
before but not after shock, adrenaline was ineffective when posterior 
pituitary extract was used instead of shock to induce antidiuresis. 
Adrenaline did not mediate its effects by altering arterial blood 
pressure and Verney (1947) suggested adrenergic involvement in ADH 
secretion. Additional support for this hypothesis was provided in a 
study by Abrahams and Pickford (1956) who found that 200 ug of acetyl-
choline blocked diuresis in hydrated bitches when injected into the 
carotid artery. The effect of acetylcholine was in turn blocked by 
pretreatment with 2 ug of adrenaline and occasionally by I ug or 0.5 ug 
provided that adrenaline pretreatment preceded the acetylcholine injec-
tion by not more than 45 seconds and not less than eight seconds~ Doses 
of 3 ug, 4 ug and 5 ug of adrenaline were found to be less effective 
than the lower doses and 10 ug was completely inactive. In a later 
study, Mills and Wang (1964b) elicited vasopressin secretion by elec-
trically stimulating the ulnar and vagal nerves and areas in the 
medulla, pons and midbrains of anaesthetised dogs. Low doses of hyder-
gine (hydrogenated ergot alkaloids) and phenoxybenzamine, an a adrenergic 
blocker which inhibits noradrenaline reuptake, blocked vasopressin 
secretion elicited by ulnar but not vagal stimulation (Mills and Wang 
1964a). Higher doses of phenoxybenzamine and hydergine reduced the 
effects of vagal stimulation and prevented vasopressin secretion 
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following electrical stimulation of the central tegmental tract. High 
doses were required in order to block secretion following stimulation 
of the pons or medulla. More recently Guzek et al (1978) used severe 
dehydration, extending over four days, to deplete vasopressin levels and 
found that depletion was partially prevented by pretreatment with phe-
noxybenzamine. Although these studies suggest that blocking a adrenergic 
activity prevents vasopressin secretion following a variety of stimuli, 
there is contradictory evidence from Corson (19 ) who reported that 
ephidrine, an adrenergic mimetic, inhibited vasopressin secretion in 
hydrated bitches, indicated by increased urine volume and decreased 
urine osmolality. This apparent conflict may be resolved by studies 
reported by Kulsrethra et al (1976) who examined the effects of injecting 
adrenergic, cholinergic, dopaminergic, tryptaminergic and histaminergic 
drugs on urine flow, and plasma vasopressin levels in the jugular vein 
of anaesthetised dogs when injected introcerebroventricularly. The a 
adrenergic agonists phenylephrine and noradrenaline (10-200 ug) decreased 
urine flow and increased plasma vasopressin levels, the log dose response 
curves were linear and the response was blocked by pretreatment with 
phenoxybenzamine. In contrast the S adrenergic mimetic isoprenaline 
increased urine flow and decreased plasma vasopressin levels; this res-
ponse was blocked by pretreatment with propanolol, a S blocker. Urano 
and Kobayashi (1978) have reported similar results following micro-
injections of phenoxybenzamine and dichlorisoproterenol (S adrenergic 
blocker) into the supraoptic nucleus of hydrated rats. Therefore 
increased a adrenergic activity appears to be associated with facili-
tated vasopressin release whereas increased S adrenergic activity 
inhibited release. Bi-directional effects were reported with adrenaline, 
low doses (1-5 ug), increased urine flow and decreased plasma vaso-
pressin whereas large doses (50-500 ug) had the opposite effects 
(Kulsrethra et al 1976); this dual effect appears to be due to the 
sensitivity of S adrenoreceptors to low doses of adrenaline as phe-
noxybenzamine reversed the antidiuretic response to large adrenaline 
doses without altering the diuretic response to low doses (Kulsrethra 
et al 1976). Furthermore the diuretic response seen after blocking the 
effect of high adrenaline doses with phenoxybenzamine was itself blocked 
by pretreating the animals with the S adrenergic blocker propanolol. 
Therefore, vasopressin secretion appears to be under dual control with 
a adrenergic neurons involved 1n facilitating whilst S adrenergic 
neurons inhibit release. 
The hypothesis of 'dual control' proposed by Kulsrethra et al 
(1976) may explain why Mills and Wang (1964a) found that various doses 
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of phenoxybenzamine blocked vasopressin secretion following electrical 
stimulation of brain areas. Furthermore the differential sensitivity 
of a receptors to low doses of adrenaline may explain why O'Connor and 
Verney (1945) found that 20 ug of adrenaline blocked the antidiuretic 
response to mild shock if it is assumed that use of the intravenous 
route would have permitted peripheral uptake, degradation and binding to 
effectively reduce the concentration of adrenaline at the receptor site 
to the range reported by Kulsrethra et al (1976) to stimulate a adreno-
receptors following intracerebroventricular injections. In addition to 
its role in the regulation of secretion adrenaline has been reported to 
produce short term diuresis probably mediated by changes in renal blood 
flow (Pickford 1939; O'Connor and Verney 1945; Abrahams and Pickford 
19 56). 
I. 4. 2 Cholinergic involvement 
The results from histochemical studies indicate that cholinergic 
neurons are found in those areas which are associated with vasopressin 
secretion. Feldberg and Vogt(1948) reported that the level of acetylo-
choline synthesis in the supraoptic nucleus was considerably higher 
than in the neural lobe. Similarly, Abrahams et al (1957) detected the 
presence of acetylcholinesterase in the supraoptic nucleus and in the 
supraoptico-hypophyseal tract but not in the neural lobe. Acetylcholin-
esterase is present in the cell bodies but not the axons of cells con-
stituting the supraoptic and paraventricular nuclei (Shute and Lewis 
1966). Tracing the degeneration which followed thermal lesions revealed 
a cholinergic pathway which originated in the ventral tegmental area, 
traversed the lateral preoptic area and terminated in the supraoptic 
nucleus (Shute and Lewis 1966). More recently Ratter et al (1979) have 
described an autoradiographic technique for localising the distribution 
of muscarinic receptors using [3H] propylbenzilycholine mustard, a 
potent and irreversible muscarinic antagonist, they reported high grain 
counts in the supraoptic nucleus, indicating a dense muscarinic receptor 
distribution. 
A large number of studies have shown that acetylcholine stimulates 
the release of vasopressin. Molitor and Pick (1924, cited in Pickford 
1939) reported that diuresis was inhibited by treatment with choline; 
later Pickford (1939) found that intravenous acetylcholine induced dose 
dependent antidiuresis in hyd.rated dogs, beginning approximately five 
minutes after treatment. Large doses also induced muscular weakness, 
panting and paling of the lips and vulva; however, these effects were 
absent with smaller doses which still induced considerable antidiuresis, 
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suggesting that the antidiuretic response was not secondary to the peri-
pheral effects of the drug. Furthermore, the antidiuretic response was 
blocked by posterior lobectomy, indicating pituitary involvement 
(Pickford 1939). Antidiuresis was also seen after direct injection of 
acetylcholine or the acetylcholinesterases physostigmine and diisopropyl-
fluoride into the supraoptic nucleus and this too was abolished by 
posterior lobectomy (Pickford 1947). More recently Kulsrethra et al 
(1976) reported an antidiuretic response after intracerebroventricular 
injections of acetylcholine in anaesthetised dogs and Urano et al (1978) 
found antidiuresis following microinjections into the supraoptic 
nucleus. In vitro studies have confirmed that acetylcholine stimulates 
the release of vasopressin but not from the isolated neural lobe. In 
addition microiontophoretic application of acetylcholine was found to 
accelerate the electrical activity of cells in the supraoptic nucleus 
(Barker et al 1971). 
Although there is strong supportive evidence that acetylcholine 
stimulates vasopressin secretion, the evidence from experiments which 
use cholinergic blocking agents is contradictory. A number of authors 
have found these not to be effective in preventing secretion. Pickford 
(1939) reported that atropine did not block the antidiuretic response to 
acetylcholine; similarly Mills and Wang (1964a) found that neither 
atropine or ethylbenztropine blocked vasopressin secretion in response 
to electrical stimulation of the ulnar or vagal nerves and the central 
tegmental pathway. No effect was found using crystalline atropine 
implanted in the hypothalamus (Hedge and de Wied 1971) and intracerebro-
ventricular atropine was only weakly effective in blocking the anti-
diuretic response to acetylcholine (Kulsrethra et al 1976). In contrast 
Bridges and Thorn (1970) successfully used atropine to block the release 
of vasopressin in response to a hypertonic solution; this was recently 
confirmed by Sobczak (1978). In addition Urano et al (1978) reported 
that the antidiuretic response to acetylcholine injected directly into 
the supraoptic nucleus was blocked by pretreatment with 20 ug of 
atropine. Finally in a paper published by Guzek et al (1978) atropine 
was found to partially prevent the severe depletion of vasopressin seen 
when rats were dehydrated for four days; however, vasopressin was signi-
ficantly depleted by atropine itself when given to non-dehydrated rats. 
The contradictory results from these experiments may partly 
reflect the wide range of experimental procedures used. In addition 
recent data from Sladek and Joynt (1979a,b) suggest that cholinergic 
control of vasopressin secretion is nicotinic rather than muscarinic. 
Atropine, which is a muscarinic antagonist, did not block secretion in 
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response to acetylcholine (Sladek and Joynt 1979a) and osmotic stimula-
tion (Sladek and Joynt 1979b); this agrees with many of the results 
previously discussed. However, the nicotinic antagonists hexamethonium, 
tetraethylammonium chloride and trimethaphan successfully blocked 
release in response to both stimuli. Furthermore Rotter et al (1979) 
have described an autoradiographic technique which revealed high density 
muscarinic recaptor distribution in the supraoptic nucleus. Failure to 
block secretion with atropine may in some cases reflect the nicotinic 
nature of the pathways involved. 
In summary, data from histochemical, physiological and pharma-
cological experiments strongly implicate cholinergic neurons in the 
regulation of vasopressin secretion. Furthermore, Kulsrethra et al 
(1976) reported that secretion of vasopressin in response to acetyl-
choline could be blocked with an a-adrenergic blocker, suggesting a 
functional relationship between adrenergic and cholinergic neurons; 
this is discussed in more detail in Section 1.4.4. 
I. 4. 3 Histaminergic involvement 
The evidence which suggests a role for histaminergic neurons in 
regulating vasopressin secretion comes mainly from pharmacological 
experiments. Early observations from Dale and Laidlaw (1910, cited in 
Blackmore and Cherry 1955) suggested considerable parallelism between 
reduced urine flow and decreased arterial blood pressure following an 
intravenous injection of histamine. This observation was confirmed by 
Blackmore et al (1953) using an intravenous infusion of histamine (2.5 
ug/kgbw/min) over a two hour test period. The antidiuretic response 
was apparently mediated by vasopressin and was not secondary to blood 
pressure changes as Mirsky et al (1954a) found that histamine (I mg/ 
100 gbwiP) induced peak plasma vasopressin levels after five minutes 
gradually declining to control levels after 30 minutes. In addition 
prolonged intravenous histamine infusion reduced the urine flow in 
control group hydrated bitches but not in those suffering from diabetes 
insipidus induced by neurohypophysectomy (Blackmore and Cherry 1955) 
and finally De Wied (1960) reported that carotid artery plasma ADH 
levels were significantly elevated over control levels after an IP 
injection of histamine (5 mg/IOOgbw). 
Although these data indicate that histamine induced antidiuresis 
due-to facilitated vasopressin secretion the physiological importance of 
this mechanism is uncertain. Kulsrethra et al (1976) reported variable 
results with intracerebroventricular injections of histamine in compara-
tively low doses (1-20 mg). In contrast, doses in the range from 
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25-500 ug increased plasma vasopressin levels and decreased urine flow; 
the poor response to low doses suggests that the response to histamine 
may be of pharmacological and not of physiological importance. 
One interesting possibility is that histamine induced antidiuresis 
is mediated by catecholaminergic neurons (Kulsrethra et al 1976). These 
authors reported that the specific antihistamine mepyramine blocked the 
antidiuretic response to intracerebtoventricular histamine (400 ug); 
however, the response was also blocked by pretreatment with tetrabena-
zine (3 mg/kgiP) but not atropine (2 mg). Furthermore, the a-adrenergic 
blocker phenoxybenzamine (2 mg) converted the histamine induced anti-
diuresis to diuresis and this response could itself be blocked by pro-
panolol (S-adrenergic blocker). These data suggest that histamine 
induced antidiuresis requires the participation of central adrenergic 
pathways. 
I. 4. 4 Neurotransmitter integration in the control of vasopressin 
secretion 
Evidence for the involvement of other putative neurotransmitter& 
~n regulating vasopressin secretion is conflicting. Bridges et al (1975) 
reported that intraventricular injections of Y-aminobutyric acid 
elicited antidiuresis when a low dose (5 ug) was used but not when the 
doses were higher (10-100 ug). Dopamine, delivered by the same route, 
elicited vasopressin secretion and pronounced antidiuresis (Bridges et 
al 1975). The effect of dopamine was confirmed by Urano et al (1978) 
using microinjectiqns into the supraoptic nucleus (10-20 ug) but could 
not be confirmed by Kulsrethra et al (1976) using a wide range of doses 
(10-100 ug) injected directly into the cerebral ventricles. Similarly 
Kulsrethra et al (1976) reported that 5-hydroxytryptamine (100-500 ug) 
did not induce antidiuresis when injected intracerebroventricularly but 
Urano et al (1978) reported antidiuresis after microinjections of 5-
hydroxytryptamine directly into the supraoptic nucleus when much lower 
doses were-used (5-15 ug). Clearly these data allow no firm conclusions 
as to the involvement of dopaminergic or serotonergic neurons in 
regulating vasopressin secretion. 
The data discussed in the preceding sections implicate cholinergic, 
a-adrenergic and histaminergic pathways in regulating the secretion of 
vasopressin. Kulsrethra et al (1976) have proposed a model for inte-
grating the pharmacological data from their experiments suggesting 
multiple control of secretion. Principally secretion is facilitated 
by a-adrenoceptive neurons and inhibited by S-adrenoceptive neurons. 
As the antidiuretic responses 
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to histamine and acetylcholine could be blocked by f'h."No-r~yb•N~A~(a blocker) 
a-adrenergic neurons appear to be the final excitatory neurotransmitter 
link although these must also be cholinoceptive. This would explain 
the absence of acetylcholine in the cells of the neural lobe (Feldberg 
and Vogt 1948; Abrahams et al 1957) and why direct stimulation of the 
neural lobe with acetylcholine failed to stimulate vasopressin secre-
tion (Douglas and Poisner 1964). Furthermore Mills and Wang (1964a) 
reported that subthreshold doses of adrenergic antagonists potentiated 
the diuretic action of subthreshold doses of a muscarinic antagonist, 
suggesting a functional relationship between the two systems. Kulsrethra 
et al (1976) argued that the cholinoceptive cells were muscarinic on the 
basis of the partial blocking of antidiuresis seen after atropine; 
however, more recent data from Slobek et al (1979a,b) suggest that these 
neurons may be nicotinic. 
1.5 Feedback in the Control of Vasopressin Secretion 
Feedback control refers to a mechanism whereby vasopressin may 
regulate its own secretion in response to circulating levels. There is 
little direct evidence for such a mechanism operating in the case of 
peripheral vasopressin levels and in view of the findings discussed in 
section 1.8. I indicating removal rate at the kidney to be approximately 
equal to secretion rate at the pituitary; such a mechanism would appear 
superfluous. Evidence against the existence of a feedback loop was 
reported by Bakker et al (1975). They injected 0.5 IU of vasopressin 
or control vehicle into rats over a period of eight days and although 
this dose raised urine osmolality and reduced water intake bioassays of 
the posterior pituitary revealed no changes in the vasopressin or oxy-
tocin levels. However, three neurophysins were significantly increased 
as a result of treatment. Although the evidence does not favour the 
existence of a feedback loop, the authors pointed out that the result 
could be explained by postulating an inhibition of secretion from the 
lobe followed by less rapid breakdown of the neurophysins. 
Contradictory evidence has been reported by Kulsrethra et al (1976) 
using a pharmacological preparation. Graded doses of vasopressin 
(0.001-1 IU) injected directly into the ventricles of hydrated dogs 
under a-chloralose anaesthesia increased urine flow and decreased plasma 
vasopressin levels. This response could be blocked by pretreating the 
animals with tetrabenazine (30 mg/kg) or propanolol (2 mg) but not by 
a-adrenergic blockers or atropine. These data indicated the existence 
of feedback loop mediated via the CSF and involving 8-adrenergic 
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inhibitory neurons. 
1.6 Factors Affecting the Secretion of Vasopressin 
A number of physiological factors affect the secretion of vaso-
pressin, including dehydration, blood volume, sexual stimulation, angio-
tensin and stress. These factors must be considered when evaluating 
data from behavioural experiments involving procedures which may 
directly or indirectly stimulate vasopressin secretion. 
I • 6. I Dehydration 
Vasopressin plays an essential role in maintaining the organism's 
fluid balance (Section 1.8. I) by stimulating water reabsorption at the 
kidney and is sensitive to changes in the animal's state of hydration. 
Increased antidiuretic activity in the urine of dehydrated rats was 
reported by Gilman and Goodman (1937). Later Mirsky et al (1954a) 
found that plasma antidiuret'ic levels in rats following 24 hours of 
water deprivation were 29.7 mu/100 ml compared to 18.4 mu/100 ml in 
control rats maintained on ad lib water. Furthermore, Little and 
Radford (1964) have observed that sustained dehydration for one to three 
days significantly increased vasopressin levels. Czackes, Kleeman and 
Koenig (1964a) have confirmed that three days of dehydration increased 
the plasma concentration of vasopressin and the turnover rate. Conversely, 
three days of overhydration decreased the turnover rate and reduced the 
plasma concentration to zero (below the lower sensitivity level of the 
assay). Czackes et al (1964b) confirmed these observations and reported 
that dehydration increased disposal rates at the kidney. Therefore the 
build-up of plasma vasopressin levels following dehydration was due to 
increased secretion, not decreased elimination, at the kidney (Sawyer etal 
1966). More recently it has been confirmed that severe dehydration 
leads to depletion of neurohypophyseal vasopressin levels as measured by 
bioassay (Guzek et al 1978) and radioimmunoassay (Rougoun-Rapuzzi et al 
1978). Clearly an animal's state of hydration is a critical factor in 
determining the level of vasopressin secretion. Furthermore the regula-
tion of secretion is mediated by changes in plasma osmolality. Verney 
(1947) used 40 min carotid infusions of hypertonic saline or dextrose 
to demonstrate that the liberation of vasopressin was affected by the 
osmotic pressure of the extracellular fluid. These observations were 
confirmed by Kovacs et al (1951) and by Zuidema et al (1956) who found 
that isotonic saline did not invoke the response. De Wied (1960) has 
also reported increased plasma vasopressin following intracarotid 
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administration of hypertonic saline. The osmoreceptors which monitor 
osmolality changes may be located in the internal carotid arteries 
(Jewell and Verney 1947) although more recent observations from Hayward 
and Vincent (1970) suggest a location within I mm of the supraoptic 
nucleus in the perinuclear zone. Osmoreceptor sensitivity is such that 
a 2% change in the plasma osmotic pressure is sufficient to stimulate 
. vasopressin release. Recording from single cells in the supraoptic 
nucleus of rats, Bennet (1973) has observed increased firing rates 
following 23.5 hours of water deprivation. In addition, intragastric 
water infusion sufficient to induce a 3% decrease in plasma osmolality 
decreased the firing rates observed in water deprived rats. Conversely, 
intracarotid injection of 16% saline solution induced a 3% increase in 
plasma osmolality plus a significant increase in the firing rates of 
supraoptic neurons, corresponding well to the threshold values required 
to stimulate vasopressin secretion (Verney 1947). Furthermore, the 
electrophysiological response to intracarotid saline was biphasic; the 
·author suggested that the initial increase in firing rates were the 
result of painful stimulation caused by the hypertonic saline whereas 
the secondary response corresponded to the osmolality changes. Wakerley 
et al (1978) have also confirmed that supraoptic neuron firing rates 
increase in response to dehydration. The evidence suggests that firing 
rates of supraoptic cells are responsive to the same changes in condi-
tions which excite and inhibit vasopressin secretion. However, data 
from Kannan and Yagi (1978) suggest that the situation may be consider-
ably more complex. A carotid injection of hypertonic Locke's solution 
reduced the firing rates of only two antidromically identified neuro-
secretory neurons. In contrast, 32 such neurons showed increased 
firing rates. Of these 32 neurons, 23 showed a monophasic excitatory 
response whilst the remaining nine exhibited a biphasic response in 
which an excitatory phase was followed by an inhibitory phase during 
which firing rates were reduced. The physiological significance of 
these different populations of neurosecretory cells is not clear; 
however, it is clear that changes in plasma osmolality such as those 
induced by dehydration or overhydration affect the firing rates of 
neurosecretory cells and the secretion of vasopressin from the posterior 
pituitary gland. 
Much recent research has indicated the presence of vasopressin in 
brain structures which are structurally and functionally remote from the 
pituitary gland (see Section 1.2.4). Summy-Long et al (1978) have 
reported that vasopressin levels in the sub-fornical organ and the 
hippocampal commissure-fornix were increased following dehydration 
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whereas the levels in the anterior commissure and fornix were unaffected. 
The functional significance of vasopressin in these structures is 
unknown. 
Little attention has been paid to processes associated with 
~ehydration. Recently Rougoun-Rappuzzi et al (1978) have reported that 
increased vasopressin levels in the posterior lobe of the pituitary are 
evident after one minute of drinking; levels increased to a maximum IS 
minutes then again three hours later. 
1.6.2 Angiotensin and renin 
Angiotensin plays a vital role in the regulation of fluid balance. 
In response to a drop in blood volume, pressure or a decrease in sodium 
ion concentration the kidney liberates renin which is converted to 
angiotensin and finally angiotensin II in the liver. This peptide 
causes a constriction in blood vessels thereby compensating for pressure 
loss. In addition the peptide stimulates the release of aldosterone 
from the adrenal glands which in turn stimulates the reabsorption of 
sodium in the kidney, and prevents further sodium loss (Myers 1974). 
Furthermore, both angiotensin II and renin have dipsogenic effects 
following intracranial injection (Fitzsimmons 1971). Thus both renin/ 
angiotensin and vasopressin are involved in the regulation of fluid 
balance. A number of experiments suggest that centrally administered 
angiotensin II may stimulate the release of vasopressin. Malvin (1971) 
used peripheral intravenous infusions of 10 ng/kg/min into unanaes-
thetised dogs and observed an increase in plasma vasopressin levels 30 
minutes after the onset of infusion. A lower infusion concentration of 
(5 ng/kg/min) angiotensin was ineffective. The effect could have been 
the artifactual result of angiotensin increasing blood pressure; however, 
a ventriculocisternal perfusion elevated plasma vasopressin levels in 
the absence of a pressor response, or changes in plasma osmolality. 
Yamamoto, Share and Schade (1978) have confirmed that ventriculo 
cisternal perfusion (19 ng/min) of angiotensin II increased plasma 
vasopressin levels. The site at which angiotensin II evokes vasopressin 
release is not well understood; Nicholl and Barker (1971) reported that 
the iontophoretic application to single neurons in the cat supraoptic 
nucleus resulted in rapid increases in the firing rate of these cells. 
On the basis of this result and considering previous indications that 
angiotensin stimulated the release of vasopressin, Myers (1974) has 
suggested that the activation of these cells by angiotensin may result 
in the release of vasopressin. However, this seems unlikely in view of 
the fact that Nicoll et al (1971) could not find any change in firing 
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rates of antidromically identified supraoptic neurosecretory neurons in 
response to the systemic administration of angiotensin II. In addition 
Malvin (1976) has reported that angiotensin II failed to stimulate vaso-
pressin release in isolated posterior lobes. In a review of the 
relationships between vasopressin and the angiotensin-renin systems, 
Share (1979) has concluded that although centrally administered angio-
tensin stimulates vasopressin secretion the physiological significance 
of the effect is uncertain. Furthermore, although vasopressin may 
inhibit renin secretion from the kidney at levels likely to be achieved 
physiologically there appears to be little correlation between levels 
of vasopressin and renin under a variety of conditions known to affect 
both systems. 
The E series prostaglandins are endogenous to the CNS (Barker 
1977) and may be involved in mediating dipsogenic activity following 
intraventricular angiotensin (Epstein and Kennedy 1976). In addition, 
Andersson and Leksell (1975) and Yamamoto et al (1976) ~ited in Yamamoto 
et al 1978) reported that ventriculocisternal perfusion with E series 
prostoglandins increased the plasma vasopressin titer. When indomethacin, 
an inhibitor of prostaglandin synthesis, was infused, vasopressin 
release was partially inhibited although indomethacin alone was 
incapable of affecting the vasopressin plasma levels. These data may 
suggest that the E series prostaglandins are involved in mediating the 
effects of angiotensin on vasopressin secretion (Barker 1977). However, 
when prostaglandin El was injected directly into the lateral ventricle 
of the rat brain it was found to exert powerful antidipsogenic effects 
blocking the dipsogenic activity of angiotensin II, carbachol and poly-
ethylene glycol (Kenney and Epstein 1978). These findings preclude a 
straightforward conclusion as to the physiological role which prosto-
glandins play directly or with angiotensin in mediating vasopressin 
regulation. 
1.6.3 Changes in blood volume 
Reductions in blood volume stimulate vasopressin secretion (Heller 
et al 1968). Ginsburg and Heller (1953) examined variations in the ADH 
potency of rat plasma as a function of the volume of blood withdrawn 
from the external jugular vein or from the common carotid artery. In 
both cases the plasma ADH potency depended upon the amount of blood with-
drawn. The 5th ml of venous plasma (approximately 30% of the total 
circulating plasma had been withdrawn) contained 3.6 mu/ml plasma, 
representing approximately 20 x the level of ADH present in the 1st ml 
withdrawn. Similarly the 6th ml of arterial plasma contained I mu/ml, 
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approximately 20 x the level found in the 1st ml withdrawn. At a com-
parable stage of haemorrhage the ratio of ADH potency between the venous 
and arterial samples varied from between 4:1 to 8:1. De Wied (1960) 
has confirmed these results using a different assay technique. Further-
more Noble and Taylor (1953) found similar effects in humans following 
fainting induced by venesection. In order to reduce the confounding 
effects of massive blood withdrawal, Share (1967) used gradual small 
changes in the extracellular fluid volume and found that a IS% reduction 
in the fluid volume induced a 6 x increase in the blood ADH titer des-
pite the maintenance of constant blood pressure. However, the method 
used to reduce extracellular fluid and maintain blood pressure (intra-
peritoneal dialysis) also increases plasma osmotic pressure thereby 
possibly stimulating ADH secretion (Sawyer et al 1966) (also cf Section 
1.6.1). The posterior pituitary origin of the activity was confirmed 
by Moll and De Wied (1962) who observed that the effects of haemorrhage 
on ADH secretion could be blocked by posterior lobectomy. 
Neurosecretory neurons also receive inputs from baroreceptors; 
Kannan et al (1978) found that antidromically identified neurosecretory 
neurons in the posterior pituitary responded to carotid occlusion or a 
pressure pulse with reduced firing rates. Similar results were reported 
by Yamashita and Koizumi (1979) who found a linear relationship between 
sinus pressure and the level of inhibition observed in the firing rates 
of neurons in the supraoptic nuclei of anaesthetised cats. This inhi-
bitory effect was accompanied by decreased blood pressure and the supra-
optic neurons appeared to be extremely sensitive to baroreceptor 
excitation; the authors argued that the cells of the supraoptic nucleus 
played a physiological role in the barostatic reflex. The pressor 
effects of vasopressin are discussed in more detail in Section 1.8.2 
I. 6. 4 Stress 
A number of early studies in the literature suggest that vaso-
pressin is secreted under stressful conditions; indeed procedures such 
as handling, exposure to footshock, loud noises, strange environments 
and anaesthetics, eg ether, have commonly been used to stress animals 
and elevate plasma vasopressin levels. Mild electrical stimulation 
applied "until the animal (dog) showed signs of annoyance" produced 
antidiuresis (Verney 1947) which was diminished by posterior lobectomy 
(O'Connor and Verney 1942). Similarly Dempster and Joekes (1955) con-
firmed the antidiuretic response to electrical stimulation in dogs with 
denervated kidneys. The plasma vasopressin response to extended foot-
shock (120 secs) was found to be maximal five minutes later, returning 
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to normal after 15 minutes (Mirsky et al 1954a). Histological changes 
have been reported following painful stimulation. Rothballer (1953) 
reported evidence for three phases of neurohypophyseal change in rats 
in response to pinpricks to the tail. Within two minutes vasodilation 
occurred and NSM moved towards the capillary vessels, between four and 
six mins there was considerable loss of NSM, presumed into the dilated 
capillary vessels. Restoration of NSM, although evident after one hour, 
was not complete until three hours after stimulation. Similar changes 
were apparent in the pituitary ~talk and median eminence. Antidiuresis 
has been reported to occur during the extreme stress of bladder canula-
tion and exposing the jugular vein in rats (De Wied 1960) and in res-
ponse to ischaemic forearm muscle pain in humans (Kelsall 1949). Mirsky 
et al (1954a) reported that loud noises elevated plasma vasopressin 
levels but not to the extent seen after footshock. Furthermore, although 
one minute of handling or exposure to an unfamiliar environment was 
ineffective, a marked elevation of plasma vasopressin levels was seen in 
response to longer periods of stimulation (Mirsky et al 1954a). The 
studies suggest that vasopressin is secreted during stress; this con-
clusion is supported by a number of experiments described in Section 1.9 
These studies relied exclusively on indirect measures of vaso-
pressin release (antidiuresis) and bioassays; the concensus achieved 
with these methods has been challenged by more recent studies using 
radioimmunoassay& to directly measure plasma vasopressin levels. Keil 
and Severs (1977) found that ether exposure for one minute did not 
affect subsequent plasma vasopressin levels in normal rats. When basal 
levels were elevated by dehydration ether exposure resulted in signi-
ficant declines in plasma levels. Similarly centrifugation for periods 
up to two hours did not alter plasma vasopressin levels in normal rats 
but dehydrated rats responded to the longest period of stress with a 
decline in plasma vasopressin levels. The absence of any effect in 
normal rats under ether has been confirmed by Huzain et al (1979). In 
addition these authors reported that forced exercise, swimming, con-
tinuous loud noise and restraint in a strange environment did not 
elevate plasma vasopressin levels. Only electric shock (45 secs, 58 v), 
mild manual restraint for three minutes or body compression for 60 secs 
significantly elevated plasma AVP. Resting levels were in the region 
of 1.69 pg/ml rising to 42.4 pg/ml under restraint and 283 pg/ml after 
compression. Impaired breathing, associated hypoxia or hemodynamic 
changes during compression may account for the increases in AVP. 
Regardless of the actual mechanism the negative results obtained after 
the stress of ether, forced exercise, swimming and centrifugation 
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suggest that stress per se does not stimulate AVP secretion. The con-
flict between these and earlier studies may be due to a number of 
factors, bioassays and indirect measures may be influenced by non-
specific factors; excessive manual restraint may have been used prior to 
decapitation to hold animals excited·by stressful procedures, an anti-
diuretic substance other than vasopressin may be released during stress 
or finally the radioimmunoassays used may be insensitive to the form of 
vasopressin secreted during stress. 
1.6.5 Sexual stimulation 
Circumstantial evidence sugge.sts that sexual stimulation may 
excite vasopressin secretion. A slight but significant decrease in the 
volume of urine voided by hydrated male rats following copulation has 
been reported by Eranko et al (1953). This effect did not appear in 
females; one hour after copulation the voiding rates of both male and 
female subjects were higher than controls. Friberg (1953) observed a 
significant reduction in· the urine flow following coitus in humans. 
Neither experiment assayed directly for vasopressin. Stronger evidence 
comes from Peeters et al (1963) who reported antidiuresis in sexually 
mature hydrates rams following massage of the seminal vesicles and 
ampullae or coitus with oestrous ewes. The antidiuresis was accompanied 
by increased urinary K+, Na+ and Cl-. In addition, the time course and 
form of the antidiuresis were identical to that obtained with physio-
logical doses of pitressin (2-4 mu) suggesting posterior pituitary 
origin. 
I. 6. 6 Summary 
The principle factors affecting the rate of vasopressin secretion 
have been described. Many experiments have demonstrated that water 
conservation during dehydration is mediated by increased vasopressin 
secretion increasing the level of water reabsorption at the kidney. 
Small changes in plasma osmolality trigger this mechanism. Angiotensin 
and renin also play important roles in the conservation of body salts 
during dehydration and although some experimental evidence suggests 
that vasopressin may inhibit the release of renin from the kidney and 
angiotensin II may stimulate vasopressin secretion the physiological 
significance of this relationship is uncertain. Changes in blood volume 
and.pressure stimulates vasopressin secretion and recent electrophysio-
logical evidence implicates cells of the supraoptic nucleus in the bare-
static reflex. Copulation and sexual stimulation may also increase 
vasopressin secretion. 
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Finally Hayward and Jennings (1973) suggest that the population 
of vasopressin secreting neurons in the supraoptic nucleus may be dif-
ferentiated in terms of their baseline activity levels reflecting 
functional differentiation. They have identified three types of neurons, 
silent neurons showed no activity, continuously active neurons showed 
rhythmic activity during slow wave sleep which changed to irregular 
discharges during the waking hours and burster cells which were charac-
terised by 5-10 seconds of discharge followed by 7-12 seconds of silence. 
Furthermore, an intracarotid infusion of hypertonic saline or noxious 
stimuli disrupted this pattern of responding. The role of hypertonic 
saline in stimulating the release of vasopressin has been discussed; 
the possibility that noxious stimuli are also effective in this respect 
is discussed in Chapter Two. The authors reported that the noxious 
stimuli (pin pricks) appeared to be capable of stimulating cell activity 
in a manner similar to a conditioning effect, ie performing the actions 
leading up to pin pricking was sufficient to effect the electrical res-
ponses of these cells. 
1.7 Physiological Levels of Vasopressin in the Plasma 
This section examines the normal physiological range of vaso-
pressin plasma concentration. These data are important for assessing 
physiological significance of the behavioural effects discussed in the 
following chapter. Accurate estimates of baseline levels may often be 
confounded by stimulating secretion during the collection of samples, 
either by handling (Hu ain et al 1979) or other stressors (Huzain et al 
1979; Keil and Severs 1979). Furthermore, the advent of radioimmuno-
assay techniques with increased sensitivity suggest that earlier 
estimations based on bioassays may have been too high. 
The earliest reports were from Shannon (1942) who infused pitui-
tary lobe extract into the ear vein of freely moving diabetes insipidus 
dogs (10-15 kg) and found graded antidiuresis with infusion rates in the 
range of 1-5 mu (pressor assay) per hour; this was verified in normal 
dehydrated dogs. In addition Verney (1947) found that a 1% rise in the 
arterial blood osmotic pressure stimulated vasopressin secretion equi-
valent to 3.6 mu/hour of posterior lobe extract. Lauson (1967) has 
estimated the rate of vasopressin liberation to lie in the range of 
7.5-50 mu/hour for a normal 70 kg man. When calculated according to 
body weights, these estimates agree well. The data on vasopressin 
levels in men under varying states of hydration has been reviewed by 
Sawyer and Mills (1966). Subjects with DI (Yoshida et al 1963) and 
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normal subjects with induced watery diuresis (Sawyer, cited in Sawyer 
and Mills 1966) registered no blood vasopressin using an assay technique 
in which the lower sensitivity level was I ~g/ml of blood. Normal 
hydration (Yoshida et al 1963) produced a mean value of 1.9 ~g/ml (range 
1-2.7) whereas overnight thirsting produced mean values of 6.5 mu/ml 
(Yoshida et al 1963) and 6.0 mu/ml (Sawyer, cited in Sawyer and Mills 
1966). These values compare well with the minimal predicted anti-
diuretic limits from Lauson (1960) of 1-5 ~g/ml. On the basis of these 
estimates Lauson (1967) has suggested that the secretion rate in a 
normal man after overnight thirsting should be approximately 800 ~g/min 
(48 mu/hour). In the normal long evans rat, Miller and Moses (1971), 
using a radioimmunoassay technique, have estimated the normal rate of 
vasopressin secretion to be approximately 4.5 mu/24 hours in rats with 
ad lib access to food and water. In contrast, rats which were hetero-
zygotic for genetic vasopressin deficiency (brattleboro strain; cf 
Section 1.9.2) yielded a secretion rate of 2.3 mu/24 hours and those 
homozygous for the strain yielded 0.16 mu/24 hours. In response to 
four days of dehydration, normal rats responded with peak values of 
18.2 mu/24 hours, heterozygotic brattleboros responded with peak values 
of 5.5 mu/24 hours and homozygotes exhibited no change. Laszlo and 
De Wied (1966) reported urinary vasopressin levels of 0.46 mu/24 hours 
increasing by a factor of 14 in response to hypertonic saline. The dif-
ferences between the absolute levels reported by Laszloet al (1966) and 
Miller et al (1971) probably reflects the use of different extraction 
and assay procedures. More recently, Huzain et al (1979) have estimated 
basal plasma levels to be approximately 1.69 pg/ml (plasma); this agrees 
well with estimates from a number of authors (see Huzain et al 1979) and 
confirms the data from Keil and Severs (1976). Direct measurements of 
hormone levels by the radioimmunoassay technique eliminates the influence 
of non-specific factors inherent in bioassays and measurement of the 
antidiuretic response. 
The rate of irreversible removal of vasopressin by all routes 
(~g/ml) is proportional to the arterial plasma concentration of vaso-
pressin ()Jg/ml) (Lauson 1967). "Clearance" may therefore be defined as 
follows: 
Cl ( 1 ) Total rate of vasopressin removal (~g/min) earance m s = • . Plasma vasopress1n concentrat1on (~g/ml) 
Under steady state conditions, ie when no changes occur in the plasma 
vasopressin concentration, the rate of clearance equals the rate of 
secretion or infusion. Using infusions of vasopressin in the physio-
logical range Czaczkes et al (1964a) estimated a total clearance of 
31 
8.5 ml/min/kg; one quarter of the total vasopressin content of the 
plasma was irreversibly removed every minute. The estimated half life 
for vasopressin under these conditions was 2.77 minutes. For higher 
concentrations of AVP Sawyer (1963) (cited in Lauson 1967) calculated a 
much higher total clearance of 52 ml/min/kg, yielding a half life of 
45 seconds for vasopressin; under· these conditions the total plasma 
vasopressin contentwascleared nearly three times every two minutes. 
These figures emphasise the point made by Lauson (1967) that large doses 
of LVP are removed with great efficiency from the circulation. This 
author found that high concentrations of vasopressin had a clearance of 
21 ml/min/kg and a half life of 1.10 minutes. Thus well over half of 
the total vasopressin in the plasma was removed every minute. The 
higher clearance found with AVP (Sawyer 1963) compared to LVP (Lauson 
1967) may reflect the role of the former as being the natural anti-
diuretic principle in rats which were also used for the assay. 
Estimates for the half life of intravenously administered AVP in 
ethanol anaesthetised hydrated rats (Czaczkes et al 1964b; Smith et al 
1965b, cited in Lauson 1967) yield values of 1.5 mins, 1.92 mins, 3.46 
mins and I. I mins. In the rat virtually all clearance occurs at the 
kidney (Ginsburg and Heller (1953). These half life estimates have 
important implications for understanding the behavioural effects of vaso-
pressin following peripheral injections (Chapter Two). In view of the 
rapid elimination of the peptide it is clear that behavioural effects 
do not stem from the long term presence of abnormally high peptide con-
centrations. 
1.8 Target Organ Effects 
Vasopressin derives its name from its effect on the peripheral 
blood vessels and plays a role in mediating pressor responses. In 
addition the peptide plays a key role in regulating water reabsorption 
at the kidney. 
I. 8. I Regulation of water reabsorption 
Early observations indicated that the isolated perfused dog kidney 
excreted a large volume of dilute urine which could be reduced either 
by adding posterior pituitary extract to the perfusate or by passing the 
perfusate through an isolated dog's head containing an intact pituitary 
(Verney 1926). A time lag of 15 mintues was observed between the onset 
of maximum hydration and the onset of maximal antidiuresis. Verney 
argued that this was the time required to reduce the secretion of 
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antidiuretic principle from the posterior pituitary and remove i!t from 
the blood. Vemey ( 1947) demonstrated that osmotic pressure controlled 
the release of ADH and matched the response thus e'licited with the res-
ponse ·to posterior pituitary extract. 
The mammalian kidney, with its myriads of microscopic nephrons, 
presents a formidable organ for study; the technical problems have 
forced researchers to examine similarly responsive but not more acces-
si!ble tissues, eg the toad bladder. This organ regulates fluid balance 
in a similar manner to the distal convoluted tubu·le in the kidney (Leaf 
1967). Vasopressin, when applied to the serosa'l surface, increases the 
permeability of the isolated toad bladder in the absence of an osmotic 
gradient. Linear increases in the-osmotic. gradient in the presence of 
the hormone produces a linear increase in the nett water flux (Leaf 
1967). Therefore, when applied to the serosal but not to the mucosal 
(urinary) surface of the-membrane the peptide alters permeability with 
a resultant change in the rate of water flux across the membrane. 
Koefoed-Johnsert and Ussing (1953) argued that this effect is mediated 
by increasing the pore sizes in the membra[le. Rays et al (1971) favour 
an explanation in terms of an increase in membrane diffusion permeability.· 
Elements of ~oth expl!anations may be correct (Leaf 196 7) , He has 
suggested that the membrane is composed of two layers in which a porous 
membrane is overlaid by a diffusion barrier. 
The toad bl"adder actively pumps Na + from the urinary to ,the body 
fluids against a concentration gradient. This action is stimulated by 
applying pitressin to the serosal -surface of the bladder,_ is highly 
specific to Na+ and requires energy_, as demonstrated by the increased 
oxygen consumption seen after simultaneous appiication of Na+ to the 
mucosa•l and vasopressin to the serosa•l surface of the membrane, 
Evidence suggests that thes_e effects are mediated by 3' 5' cycl:i!c 
amp (cAMP) (Orloff and Handler 1967) which has been found to mimick 
the effects of vasopressin on water flow. Furthermore, Takahailhi et al 
(1966) have found excreted 3"5' cAMP in the urine following antidiuresis 
induced by exogenous vasopressin. Homozygous DI rats have reduced 
excretory 3'5' cAMP and Johnsen and Nielsen (1978) have reported that 
arginine vasotocin, the frog antidiuretic principle increased cAMP 
leveis in isolated frog epithelia. These data implicate cAMP in 
mediating vasopressin '·s membrane effects, Orloff and Hand•ler ( 1·96 7) 
have suggested• that the peptide increases the conversion of adenosine 
triphosphate (ATP) to 3''5' cAMP by increasing adenyl cycl'ase, Dousa 
(i973) reviewed the evidence that peptide receptors associated with 
adenyl:ate cyclase were located on the basilar and lateral plasma 
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membranes (serosal) whilst the barrier controlling water and solute 
permeability were located on the luminal or mucosal surface. Adenylate 
cyclase is activated by vasopressin analogues. The mechanism by which 
cAMP may affect membrane changes is unknown but could involve varying 
the pore size. The administration of cAMP is associated with an increase 
in the mechanical deformability of the membrane and Dousa (1973) has 
suggested that 3'5' cAMP may affect a reversible modification of 
specific membrane proteins. 
Evidence has accumulated suggesting that the E series prosta-
glandins play a role in regulating the intracellular effects of vaso-
pressin in the toad bladder (for review see Orloff and Zusman 1978). 
Prostaglandin El blocks the action of vasopressin but not cAMP at the 
toad bladder and prevents vasopressin induced accumulation of cAMP. 
Furthermore, indomethacin, a prostaglandin synthesis inhibitor, has been 
reported to enhance the effects of vasopressin in rats, dogs and men 
(see Orloff and Zusman 1978 for references). Thus vasopressin appears 
to increase water permeability by increasing cAMP synthesis and simul-
taneously trigger increased synthesis of prostaglandin E which then 
diminishes adenylate cyclase activity thereby diminishing the response 
to vasopressin. 
I. 8. 2 Effects on blood pressure 
Much of the earliest research and clinical usage of posterior lobe 
extracts was related to their capacity to induce transient increases in 
arterial blood pressure (Oliver and Schafer 1895; see also Erwald and 
Weichel 1978 for references). Changes in blood pressure have been 
reported in response to peripheral injections with vasopressin or 
posterior lobe extracts in excess of that required to produce anti-
diuresis. Statt and Chenoweth (1966) demonstrated a triphasic pressor 
response following intravenous injections of vasopressin (300 mu/kg) 
into rats anaesthetised with pentabarbitone, which is known to stimulate 
vasopressin secretion (Ginsburg and Brown 1956). Blood pressure 
reached a maximum of 180 mm Hg compared to the pretreatment mean of 123 
mm Hg. Pressure increases were accompanied by increased catecholamine 
release into the cavernous sinus and occlusion of the CNS circulation 
removed the source of catecholamines and either diminished or eliminated 
the pressor response. These data suggested a relationship between vaso-
pressin and catecholamines in mediating the pressor response to large 
vasopressin doses. Chenoweth et al (1958) reported a synergistic 
relationship between vasopressin and catecholamines in eliciting the 
pressor response, they reported that pretreatment with L norepinephrine, 
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dopamine or hydroxyamphetamine potentiated the pressor effects of vaso-
pressin. Experiments with lower doses (10 mu/kg) have successfully 
elicited the pressor response in rats with isolated and denervated 
carotid sinuses; furthermore, the response was blocked by pretreatment 
with phentolamine (2 mg/kg) or phenoxybenzamine (5 mg/kg) (Traber et al 
1968). 
Vasopressin levels in the physiological range have variable effects 
on blood pressure. Traber et al (1968) reported that endogenous vaso-
pressin secreted in response to intra-carotid injections of hypertonic 
solutions did not affect arterial pressure in intact rats but increased 
pressure in rats with isolated and denervated carotid sinuses. Intra-
venous infusions of vasopressin at much lower doses (235-300 ~u/min) did 
not affect blood pressure but potentiated the pressor response to nore-
pinephrine and epinephrine in pithed rats (Bartelstone et al 1965). 
Pretreatment with 280 ~u/min doubled the pressor response to SO ng of 
norepinephrine. Infusion rates in excess of 500 ~u/min were required to 
elevate arterial blood pressure in the absence of norepinephrine treat-
ment. Potentiated pressor responses were affected within ten minutes 
of vasopressin application or withdrawal and were detectable in isolated 
aortic strips as well as in pithed rats. 
Intravenous infusions of LVP in men exert a dose dependent 
increase in systemic and arterial blood pressure with peak values 
occurring approximately five minutes after the onset of infusion 
(Erwald and Wiechel 1978). Peak pressure occurred earlier after higher 
doses and was accompanied by bradycardia. In general, intact animals 
show much less sensitivity to the pressor effects of vasopressin than 
do isolated or denervated preparations; thus the predominant use of high 
doses to achieve effects. Cowley et al (1974) have argued that the 
baroreceptor reflex system plays a major role in buffering the pressor 
action of vasopressin. Mohring et al (1979) have extended this argument 
to account for their observations that plasma levels of AVP are strongly 
correlated with the severity of hypertension in spontaneously hyper-
tensive rats, by suggesting that in these animals there exist deficiencies 
in the reflex mediated buffering of the pressor response to vasopressin. 
A causal role for vasopressin in mediating chronic blood pressure eleva-
tion in these rats was suggested by the observation that systemic injec-
tions of anti-vasopressin serum reduced blood pressure temporarily. 
Angiotensin and renin do not appear to be involved in mediating chronic 
hypertension. The hypothesis is supported by Crofton et al (1979) who 
have found that vasopressin plays an essential role as a pressor agent 
in mediating and maintaining DOC salt (deoxycorticosterone) hypertension. 
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They demonstrated that unilateral nephrectomy followed by DOC salt and 
maintenance on salinated drinking water induced hypertension in normal 
long evans rats but not in rats with a hereditary lack of vasopressin 
(HO-DI; see Section 1.9.2). Furthermore, blood pressure was reduced by 
vasopressin analogues which block the pressor response, indicating the 
specificity of vasopressin as the pressor agent. 
An additional role for vasopressin in cardiovascular regulation 
has been proposed by Bohus (1980). Intravenous LVP was found to reduce 
the pressor response to posterior hypothalamic stimulation, reaching 
its maximum inhibitory effect approximately 60 minutes after the onset 
of infusion, long after the initial pressor response had disappeared 
(Bohus 1974). Dose dependent reductions in the magnitude of the pressor 
response to stimulation of the mesencephalic reticular formation have 
been confirmed by Versteeg et al (1979) following intracerebroventricular 
injections of nanogram quantities of AVP. This apparently central 
effect may be mediated by exciting central noradrenergic mechanisms 
involved in the regulation of cardiovascular function. Centrally 
administered vasopressin has been found to increase noradrenaline turn-
over in specific brain regions, particularly the nucleus tractus 
solitari, which appear to be involved in regulating cardiovascular 
functions (Tanaka et al 1977; see Section 2.6.1). 
1.9 Vasopressin Involvement 1n the Release of Adrenocorticotrophic 
Hormone (ACTH) 
It was suggested by Harris (1955) that ACTH secretion was regulated 
by a humoral agent released into the portal blood vessels. Saffran 
coined the term corticotrophin releasing factor (CRF) the identity of 
which has remained elusive despite extensive research. Many authors 
have proposed that vasopressin is the CRF but the evidence for this is 
contradictory. In order to interpret the behavioural effects of vaso-
pressin it is necessary to consider the extent to which treatment with 
the peptide is likely to stimulate the secretion of behaviourally active 
ACTH. 
I. 9. I Preliminary evidence 
Early experiments relied extensively on indirect measures of ACTH 
secretion. Nagareda and Gaunt (1951) monitored changes in adrenal 
ascorbic acid (AAA) following injections of pitressin (IP) 1n intact rat 
and reported that although 5 mu elicited antidiuresis without changing 
AAA levels, both 100 mu and 400 mu depleted AAA suggesting that pitressin 
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activated the adrenal gland. In addition a number of studies claim to 
have demonstrated simultaneous increases in ACTH and vasopressin during 
stress; however, the reliability of these observations has recently been 
questioned (see Section 1.6.4 for discussion). Surgical lesions of the 
supraopticohypophyseal tract at the level of the median eminence dis-
rupted both vasopressin and ACTH secretion and the severity of secondary 
polydipsia was inversely proportional to depletion of plasma ACTH and 
AAA (McCann and Brobeck 1954); in addition AAA levels were not affected 
by the acute stresses of surgery, histamine or epinephrine. 
The results from Nagareda and Gaunt (1951) and McCann and Brobeck 
(1954) suggest that vasopressin may stimulate ACTH release thereby 
affecting AAA levels. There are three principle difficulties with this 
interpretation. Pitressin is a crude extract from the posterior lobe 
of the pituitary and may be contaminated with genuine CRF from surroun-
ding tissue. Second, increased ACTH secretion, as measured by AAA 
changes, was achieved only at very high doses. Thirdly, ACTH was not 
directly assayed; changes in secretion were inferred from AAA levels. 
In a review of the literature concerning the role of vasopressin 
Ln ACTH secretion, Nicholls (1961) listed 25 experiments using dif-
ferent preparations and measures which demonstrated that the adrenal 
system was activated by vasopressin or posterior lobe extracts. However, 
all the studies had used high doses and it was argued by Nicholls (1961), 
echoing the doubts of Nagareda and Gaunt (1951), that under normal 
physiological conditions the concentration of vasopressin was unlikely 
to reach the level required to stimulate ACTH secretion; in support of 
this argument Nicholls and Guillemin (1959) could find no correlation 
between diuresis and 17 hydroxycorticosteroid levels following stimula-
tion by hydration, hypertonic saline or vasopressin in low doses. Over 
a wide range of doses (10-300 mu/rat iv) Doepfner et al (1963) found a 
linear positive dose response relationship between plasma corticosteroid 
levels and the log of the vasopressin dose in rats treated with morphine 
to block endogenous secretion. 
Recent evidence suggests that the argument against vasopressin as 
the CRF based on its capacity to reach the required concentrations under 
physiological conditions is invalid. McCann et al (1954) has argued 
that the volume of blood in the portal vessels is very small and under 
these conditions vasopressin could attain local concentrations which in 
the-periphery would be considered pharmacological. Zimmerman et al 
(1973a) reported that vasopressin concentrations in the hypopyseal blood 
(13000 pg/ml) was approximately 300 times higher than in the systemic 
blood (42 pg/ml). 
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Interpretation of indirect measures of ACTH secretion is hampered 
by conflicting evidence on the capacity of vasopressin to directly 
stimulate the adrenal gland. Arimura (1955) has reported that even 
large doses of pitressin did not affect AAA levels in hypophysectomised 
rats; this was confirmed by Lipscombe et al ( 1960). However, ~;ilton et al 
(1959) reported elevated plasma hydroxycortisorie levels in the adrenal 
venous blood following infusion of the adrenals of pentabarbitone 
anaesthetised, hypophysectomised dogs with synthetic vasopressins in the 
dose range 0.001 - 0.4 pressor units/ml/min. The increase showed a 
degree of dose dependency and higher infusion doses induced longer res-
ponses. Furthermore Anderson and Egdahl (1964) reported that 17 hydroxy-
corticosteroid levels in the adrenal venous blood were increased by 25 
mu of vasopressin administered into the adrenal artery but not into the 
internal carotid artery. Much higher vasopressin doses were required 
to stimulate the adrenals via the internal carotid artery; 50 mu pro-
duced a response in 50% of the animals and 100 mu increased levels in 
all the animals. 
1.9.2 Deficient stress responses in Brattleboro rats 
The use of surgical procedures to induce a vasopressin deficit by 
lesioning the supraopticohypophyseal tract in rats (McCann and Brobeck 
1954) may leave some axons intact, thereby complicating interpretation 
of the effects of surgery. The discovery of a strain of rats which were 
genetically incapable of synthesising vasopressin (Valtin and Schroeder 
1964) stimulated many experiments aimed at determining the capacity of 
these animals to respond to stress and the importance of vasopressin in 
regulating pituitary adrenal functions. Diabetes Insipidus (DI) arose 
spontaneously in a colony of Long Evans rats maintained at Brattleboro, 
USA, and is characterised by polyuria, polydipsia decreased urine _ 
osmolality and body weight with increased Na+ and K+ content in the 
urine of animals homozygous for the defect (HO-DI). Urine character-
istics were not altered by dehydration, stress or hypertonic saline, 
but responded to treatment with vasopressin. Assays of pituitary and 
hypothalamic tissue from HO-DI rats revealed minimal pressor and anti-
diuretic activity and reduced oxytocic activity. Rats heterozygous for 
the strain (HE-DI) showed normal oxytocic activity but reduced pressor 
and antidiuretic activity compared to normal Long Evans adults (Valtin 
1967). The condition stems from autosomal recessive genes at a 
single pair of loci and is associated with a higher than normal frequency 
of runts, stillborns and newborn deaths (Valtin 1967). 
Many studies have since confirmed the absence of vasopressin in 
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HO-D! rats with a number of methods. Miller and Moses (1971) using a 
radioimmunoassay found secretion rates of 0.16 mu/24 hours in HO-D! rats 
compared to 2.3 mu/24 hours for HE-DI rats and 4.5 mu/hour for normal 
long evans stock. In response to four days of dehydration norma•l's res-
ponded with an increase to 18,2 mti/24 hours, HE-Di rats. increased to 
5.5 mu/24 hours and HO-D! rats failed to respond. Similar findings were 
r.eported by van Wimersma Gri!idanus et al (1974) and De Wied et 8'1 ( 1975a). 
Rosenbloom and Fisher ( 1975) and Chateau et al (1979). Furthermore, 
Leclerc et al (1974) used an immunohistochemical process and confirmed 
that the supraoptic nucleus, paraventricular nucleus, median eminence 
·and posterior pituitary of. HO-D! rats were deficient in NSMwhich is 
associated with vasopressin secretion (see Section 1.3) and gave ilo 
positive reactions to antivasopressin serum. 
In addition to the absence of vasopressin ilO-DI rats exhibit hypo-
kaiemia, rapid renal loss of K+ (~lohring et al 1972a,b) diminished extra-
cellular fluid volume (Harrington and Valtin 1968), reduced adrena•l res-
ponsiveness. to stress (see below) and ACTH aild a possible defect in 
growth hormone synthesis. The low levels of K+ and extra~cellular fluid 
suggest a preponderance of mineralocorticoids, as these and glucocorti-
coids derive from common precursors there may be deficient glucocorti-
coid synthesis therefore accounting for the deficient plasma cortico-
sterone response to mild stress reported for HO-D! rats (McCann et al 
1966; Arimura et al 1967; Wiley et al 1974), 
HO-D! rats respond to the stress of manual restraint and ether 
with lower plasma steroid levels than normal controls (McCann et a•l 
1966); after three minutes in an ether jar controls had steroid concen-
trations of 75 ug/100 ml compared to 55 ug/100 ml in HO-D! rats. 
Arimura et al (1967) could not confirm this finding using ether, hista-
mine, acetylcholine or nembutal as stressors, whils.t HO-DI rats gave 
consistently lower responses the differences were insignificant; 
however, the steroid response to epinephrine hydrochloride (0.02 mg/ 
1.00 mg) .or saline (0.2 ml, 0.9%) was significantly lower in HO-D! rats 
than controls, suggesting that these animals were deficient in their 
steroid response to stress as McCann et al (1966) had proposed. Further-
more, in the case of the ether experiment,.Arimura et al (1967) used 75 
seconds exposure, compared to three minutes in the McCann et al (1966) 
study, and found much lower baseline steroid levels in the control 
animals (32.5 ug/100 ml); therefore· the failure to replicate may be 
ascribed to .procedural differences, particularly in the severity of the 
ether stress. Some of these findings have been replicated by Wiley et 
. 
al (1974). Resting plasma corticosterone levels in HO-D! and HE-DI rats 
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were equivalent; furthermore, steroid responses to a low dose of hista-
mine (18 ug/100 gbw) were the same. In contrast a higher dose (36 ug/ 
100 gbw) injected through a jugular cannula differentiated the two 
groups; HO-DI rats responded wi.th significantly lower steroid levels 
than HE-DI rats. In addition the response to ether and haemorrhage and 
to the milder stresses of bell ringing and cage shaking resulted in 
lower steroid responses in HO-DI rats. 
The data suggest that the steroid response to stress in HO-DI 
rats although present is somewhat deficient, as these animals lack vaso-
pressin it appears that vasopressin plays a role in mediating the 
steroid response to stress. There are two difficulties with the hypo-
thesis that vasopressin is the CRF raised by the data. First, although 
the response is deficient it is present which would not be the case if 
vasopressin alone regulated ACTH secretion. Secondly, Wiley et al (1974) 
reported that HO-DI rats showed reduced steroid responsiveness to ACTH 
using studies in vivo and in vitro, a deficit which was reversed by 
long term replacement therapy with vasopressin starting at four days 
old. Therefore the deficient steroid response to stress may reflect 
reduced adrenal sensitivity to ACTH resulting from long term vasopressin 
depletion. 
Reduced adrenal sensitivity to ACTH following long term vasopressin 
depletion also poses problems for the hypothesis that vasopressin acts 
as CRF under limited conditions of mild stress. Smelik et al (1962) 
reported that handling and exposure to a strange environment depleted 
posterior lobe CRF activity; furthermore, mild electric shock produced 
an attenuated steroid response in posterior lobectomised rats compared 
to sham operated controls whereas the response to severe shock was the 
same in both groups. Similarly De Wied et al (196!) reported that 
posterior lobectomy attenuated the steroid response to loud noises, pain 
and exposure to a strange environment but did not alter the response to 
ether, histamine or nicotime tartrate. Five days of pitressin treatment 
alleviated the deficient response to mild stress. Similar results were 
found when vasopressin was depleted by maintaining the rats on 2.5% 
salinated drinking water for seven days; depletion was indicated by loss 
of NSM from the posterior lobe. The attenuated steroid responses 
observed during mild stress may reflect the lack of vasopressin exerting 
its role as CRF; alternatively it may reflect decreased adrenal sensi-
tivity resulting from vasopressin depletion accompanied by non-specific 
steroid release triggered by the application of severe footshock and the 
various drugs used. 
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I. 9. 3 Vasopressin as the CRF 
The identity of CRF has remained elusive; some of the data sug-
gesting a role for vasopressin in this respect has been described above. 
Animals with a genetical absence of vasopressin show deficient adrenal 
responses to stress and although a number of studies have shown that 
vasopressin, particularly in high doses, stimulates ACTH secretion, 
the evidence for this is conflicting. 
Arimura et al (1965) reported that neurohypophysectomised rats did 
not increase their blood corticosterone levels in response to LVP 
(100 mu/100 gip or 400 mu/100 giv), but did respond to posterior lobe 
extract. Moreover, Hedge et al (1966) found that relatively low doses 
of vasopressin (2 mu/100 gbw) did not stimulate ACTH secretion in rats 
treated with dexamethasone and morphine whereas pituitary extract did. 
Similar results have recently been reported by Yasuda and Greer (1976). 
Using an in vitro system of cultured adenohypophyseal cells followed by 
direct measurements of ACTH levels by radioimmunoassay they found that 
synthetic LVP or AVP neither stimulated ACTH secretion nor potentiated 
the action of CRF contained in hypothalamic extract even in doses up to 
4 ug/ml. Furthermore, using a potent bioassay for CRF, Krieger et al 
(1977) found the highest concentrations of CRF to be in the median 
eminence. Very small amounts of activity were found in the supraoptic 
or paraventricular nuclei, which would not be the case if vasopressin 
was the CRF. In addition HO-DI rats had reduced but distinct CRF 
activity in the median eminence. Pearlmutter et al (1980) have confirmed 
the presence of CRF like activity in the median eminences of HO-DI rats 
although these rats are known to lack AVP and its associated neurophysins. 
The CRF potency of HO-DI stalk median eminence extract was over 95% of 
normal rats and Pearlmutter et al (1980) argued that the structure of 
CRF was closely related but not identical to vasopressin. They attri-
buted the reduced CRF activity reported for HO-DI stalk median eminence 
extract by Gillies and Lowry (1979; 1980) and Krieger et al (1977) to 
the use of a dispersed pituitary cell assay system. The argument that 
CRF may be structurally similar to AVP gains some support from much 
earlier experiments. Saffran et al (1955) reported that whilst chroma-
tographically identified vasopressin increased ACTH secretion in vitro 
they were also able to isolate a vasopressin free preparation from the 
posterior lobe capable of stimulating ACTH secretion. Furthermore, 
Schally and Guillemin (1963) identified a CRF which was composed of all 
the amino acid groups of vasopressin plus serine and histidine. 
On the other hand, Yates et al (1971) argued that vasopressin 
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potentiates the CRF. They reported that a dose of AVP or LVP, not by 
itself capable of stimulating ACTH secretion, potentiated the ACTH 
response to crude pituitary extract in intact rats; a similar effect was 
found when endogenous AVP levels were increased by dehydration. 
The argument has been reversed by Gillies and Lowry (1979) who 
found that the major peak of CRF activity in chromatographed stalk 
median eminence extract from normal male rats is identical to AVP 
chromatographically, immunologically and biologically in a dispersed 
pituitary cell assay system. In addition, they have reported ACTH 
secretion in response to low doses of AVP (100 pg/ml). Two smaller 
CRF peaks were also identified (Gillies and Lowry 1979) which potentiated 
the ACTH agonist properties of the AVP peak to yield the full biological 
activity characteristic of stalk median eminence extract and on the 
basis of this finding they suggested that AVP is the CRF but that its 
activity is modulated by synergistic factors with reduced CRF activity. 
In support of this argument, Gillies and Lowry (1980) reported that 
stalk median eminences from HO-DI rats lacked AVP after chromatography 
but contained approximately 20% normal CRF activity and the two syn-
ergistic peaks of the chromatogram. Full agonist activity was restored 
by adding small amounts of AVP. Although these data strongly support 
the hypothesis that vasopressin is the CRF, they clearly conflict with 
the reports discussed earlier and a concensus remains to be achieved on 
this question. 
I. 10 Electrophysiological Characteristics of Vasopressin Secreting 
Cells and Electrophysiological Effects of Vasopressin 
In vitro studies of the electrical activity of cells from the 
supraoptic nucleus revealed the presence of units which maintained 
spontaneous discharge in the presence of synaptic blockade (Gahwiler 
and Dreifuss 1979). A number of authors have linked the activity of 
such pacemaker cells to the tonic regulation of vasopressin secretion 
(see Gahwiler and Dreifuss 1979 for references). 
Microelectrophoretic application of LVP to cells of the supraoptic 
nucleus inhibited firing rates in 80% of cases (Nicholl and Barker 1971) 
and the authors suggested that vasopressin mediated inhibition of its 
own release. In support of this hypothesis, Vincent and Arnauld (1975) 
reported that when injected into the carotid artery of monkeys vaso-
pressin (5 x 10 - 9 moles) decreased the firing rates of cells in the 
supraoptic nucleus which had been identified as responsive to osmotic 
stimuli. Inhibition lasted IS to 20 seconds after intracarotid 
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injection but intravenously injected LVP was inactive even in doses four 
times as high. Chronic dehydration also inhibited firing rates and was 
accompanied by the characteristic rise in plasma osmotic pressure. 
However, after five days of dehydration firing resumed its normal rate, 
which the authors suggested reflected chronic vasopressin depletion. 
Barker (1976) has suggested that presynaptic vasopressin receptors could 
modulate the electrical activity of supraoptic neurons by altering the 
release of excitatory or inhibitory transmitters involved in regulating 
secretion (see Section 1.5). Indeed some of the pharmacological evidence 
discussed in Section 1.5 suggests that vasopressin secretion is regu-
lated by a negative feedback loop. In contrast, Dreiffus et al (1974) 
reported recurrent inhibition in HO-DI rats. In this case AVP is 
unlikely to be the transmitter and suggests that in the case of micro-
electrophoretic (Nicholl and Barker 1971) and intracarotid application 
inhibition of firing rates may reflect membrane effects or effects 
mediated at sites distal to the supraoptic nucleus. 
In order to avoid the complexities inherent in trying to analyse 
peptide hormone effects in intact mammalian nervous systems a number of 
studies have used invertebrate systems. LVP, AVP, hemolysine vasopressin 
and oxytocin induce specific effects on an identified cell from the land 
snail (Otala lactea) (Barker and Gainer 1974). The responsive cell was 
inactive during the snail's dormant period and responded to acetyl-
choline with a typical transient depolarisation. In contrast, LVP and 
its analogs (I0-9 moles) rapidly induced bursting pacemaker activity 
from the cell extending long after the period of application. Four 
hours of washing was required to normalise electrical activity. Cell 
sensitivity was restricted to the axon hillock. The mechanism by which 
vasopressin analogues exerted their effects appears to differ from that 
of neurotransmitters. Exposure of the responsive cells to a peptide 
bath induced changes in the steady state properties of the membrane 
including the development of voltage dependent Na+ and K+ conductance 
whereas putative transmitters changes voltage independent conductance; 
the intact vasopressin molecule was required for the effects as des-
glycinamide analogs were inactive (Barker 1977). The data suggest that 
in the invertebrate nervous system vasopressin may modulate cell firing 
characteristics and in support of this hypothesis Ishfin et al (1975) 
has reported evidence indicating the presence of the hormone in Otala 
lac tea. 
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1.11 Summary 
The aim of this chapter has been to establish that the con-
sequences of treating intact animals with vasopressin are far reaching 
and involve many physiological systems, although this does not by itself 
establish physiological roles for the endogenous peptide. Increased 
vasopressin levels may stimulate water reabsorption accompanied by 
changes in osmotic pressure and ion concentrations; increase blood 
pressure with activation of the barostatic reflex; stimulate secretion 
of behaviourally active ACTH and corticosteroids and increase the 
transit of vasopressin across the blood/CSF barrier to gain direct 
access to CNS structures. Furthermore, experimental procedures commonly 
used in behavioural studies, eg handling, electric footshock and manual 
restraint whilst injecting the animals are liable to alter endogenous 
levels and trigger compensatory mechanisms in a number of systems. 
Finally pharmacological manipulations of neurotransmitter systems 
carried out for behavioural reasons are liable to interfere directly 
with neurochemical systems involved in controlling secretion, with con-
sequences for baseline secretion rates. 
44 
CHAPTER THO. 
THE EFFECTS OF \'.~SOPRESSIN ON BEHAVIOUR. 
2. 0 HITRODUCTIOH. 
Studies discussed in chapter one relate to aspects of 
vasopressin's synthesis , secretion and putative physiological and 
pharmacolor;ical roles ~~hich bear directly or indirectly on our 
understandin~ of behavioural roles for the peptide. Additional 
experimental evidence indicates distinct effects on conditioned 
behaviour and this chapter describes and discusses the evidence for 
this in detail. 
Hypotheses for explaining the behavioural activity of 
vasopressins refer to inferred processes such as memory , arousal 
fear etc rather than to the behavioural changes per se. This reflects 
preferences for concepts 1~hich provide unitary and parsimonious 
explanations of morphologically diverse behaviours. 
Despite extensive research 1~e sti 11 lack a coherent model 
of the physiological events presm~ed to underlie the behaviourally 
defined process of mefilory. In its absence the nost fruitful approach 
in the animal literature has been to operationalise definitions. The 
post training period is defined as the consolidation phase whilst 
subsequent tests measure retention (usually 24 to 4R hrs later.) The 
concept and terminolor;y derive fron models of human ner:~ory 1~hich 
postulate that inforfi\ation is first ~tared in short term labile 
stores then transferred or "consolidated" to long tern permanent 
store for subsequent retreival (:luller and Pilzecker 1900: llehb 1949). 
The theory explains aspects of human amnesia successfully (Russell 
and lJathan 1946 ; l-larrington and Heiskrantz 1973), Post traininr, 
treatment within the consolidation rhase ee. anoxia , concussion , 
drugs , electroconvulsive shock (ECS) etc., which alter subsequent 
retention are said to interact with consolirlation processes at the 
physiological level. When conbined with traininz procedures in which 
stimulus , response and reinforcement events are easily specified the 
moclel is a powerful analytical tool for studying the effects of ;>ost 
training treatments 1~ithout affecting sensory or 11otor capacities 
dnring training. Hm1ever without a well grounded pl1ysiologicnl 
theory of 171elaory there are no a iJriori criteria for establishin~; the 
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length of the consolidation phase. In addition there is considerable 
disagreement in estimates of the length of post training sensitivity, 
Using ECS different authors have reported the labile phase to be 
destructible up to a few seconds , 6 hours or 3 days (Deutsch 1973), 
Puromycin has yielded estimates varying from less than 1 hour up to 3 
weeks (John 1967). Furthermore on the basis of human 
neuropsychological data indicating that long term recall may remain 
intact when short term recall is disrupted (Warrington and Shallice 
1969; Shallice and Warrington 1970) it has been argued that 
consolidation failure is an inadequate explanation of the amnesic 
syndrome (Warrington and Weiskrantz 1973), Recall improvements seen 
after cueing suggested a role for retreival deficits. Application of 
the consolidation model to the analysis of animal experiments may 
therefore be misleading. Finally , in the case of the vasopressin 
literature the use of standardised behavioural procedures has 
increased the replicability of findings but the interaction between 
peptide and behavioural variables has remained relatively unexplored 
partially as a result of the wide acceptance of the consolidation 
hypothesis, 
In the experimental studies discussed below a number of 
main themes can be identified. First , attempts to establish that 
reduced avoidance responding in extinction following surgical 
manipulations of the endocrine system were in part due to vasopressin 
deficits • Second , attempts to demonstrate that intact rats showed 
increased extinction responding after 
corresponding to then current theories on 
storage. Third , attempts to show that 
physiological role for the endogenous 
vasopressin 
the nature 
these changes 
peptide and 
injections 
of memory 
reflect a 
are not 
pharmacological artifacts and finally to correlate vasopressin's 
behavioural effects first with specific brain regions and circuits 
and then with catecholaminergic neurotransmitter systems. 
2.1. Effects on Avoidance Responding. 
Removal of the posterior and intermediate lobes of the pituitary 
gland disrupts learning and extinction of two way shuttle box 
avoidance responding (de Wied 1965). One week after lobectomy rats 
were trained to avoid shock (40v 1.8 ma) preceded by 5 secs of buzzer 
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as the conditioned stimulus (CS) for 10 trials per day on 14 
successive days. Rats which failed to make 80% correct responses over 
t~ last 3 days were dropped from the experiment (0% lobectomised; 
17% shams). During 9 days of extinction testing in which shock was 
omitted the lobectomised rats made significantly fewer responses than 
shams, a deficit attributed to the absence of posterior and 
intermediate lobe hormones (de Wied 1965), ruling out general 
debilitation and gross sensory or motor deficits as a result of 
surgery on the basis that lobectomised rats did not differ 
significantly from shams during training to escape shocks of 
unspecified intensity in a runway. Furthermore, avoidance response 
rates in lobectomised rats were significantly increased by peripheral 
injections of pitressin tannate (crude posterior pituitary extract 1 
ml 10 IU ) 2 hours before test sessions on alternate days starting 
on the first day of training.Responding during extinction was 
maintained in excess of 90% and water intake was reduced to normal • 
In order to determine the behavioural activity of pitressins 
principal hormonal constituents ACTH in a zinc phosphate complex (0.5 
or 1.5 IU/48 hrs) ,MSH in zinc phosphate (2 ug or 6 ug/48/hrs) and 
LVP in zinc tannate (0.33 or 1 U/48 hrs) were tested in posterior 
lobectomised rats. All three peptides increased avoidance responding 
in extinction compared to their vehicle control groups. However only 
LVP normalised water intake suggesting that the behavioural deficit 
associated with posterior lobectomy is not due to abnormal water 
regulation. Increased responding in extinction after higher doses 
indicated a degree of dose dependency. Evidence from 
hypophysectomised rats, maintained on hormone replacement therapy of 
thyroxin, corticosterone and testosterone in order to counter the 
debilitating effects of surgery, showed that both LVP (1 U/48 hrs) 
and MSH (6ug/48 hrs) significantly increased avoidance responding in 
extinction compared to saline controls and this apparently was not 
due to stimulating the secretion of endogenous ACTH. Furthermore, 
adenohypophysectomised rats maintained on replacement therapy did not 
show acquisition or extinction · deficits compared to sham operated 
controls, suggesting again that endogenous ACTH deficits were not the 
cause of low avoidance response rates in posterior lobectomised rats. 
The data were interpreted as indicating a role for posterior 
lobe peptides in the maintenance of avoidance responding, independent 
of effects on water regulation, ACTH secretion or motor and sensory 
deficits (de Wied 1965).There are a number of difficulties withthis 
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interpretation. Escape responding is of doubtful value in detecting 
subtle motor or sensory defects. In laterexperiments (Bohus et al 1~73) 
much lower response rates were reported for hypophysectomised rats 
not maintained on hormone replacement therapy , in the absence of 
tests on intact rats a contributory role for replacement therapy cannot be 
excluded. Shamoperated controls were not tested for the effects of 
pitressin or peptides. 
In subsequent experiments some of these difficulties and the 
problems inherent in using surgical procedures to examine 
endocrinological effects on behaviour were overcome by using intact 
animals. De Wied and Bohus (1966) were the first to show an effect of 
pitressin on avoidance responding in intact rats and to distinguish 
the effects of pitressin (1 IU/rat) from a-MSH in zinc phosphate {10 
ug/rat) using the shuttle box procedure previously described. Rats 
were injected prior to and on alternate days during training. 
Responding in training was not affected by treatment but during 10 
trials of extinction on each of 14 consecutive days both placebo and 
a-MSH animals made significantly fewer responses than pitressin 
treated rats. When tested again 7 days later these differences were 
maintained, suggesting a long lasting effect of pitressin on 
avoidance responding. However , the behavioural requirements for the 
effect were uncertain as injections during training had elevated 
responding in extinction • Therefore in a subsequent experiment the 
peptides were injected on alternate days during 14 days of extinction 
testing. In this case placebo rats extinguished rapidly but both 
pitressin and a-MSH groups maintained high response rates (in excess 
of 90%). Treatment was discontinued and 21 days later 3 extinction 
sessions revealed that a-MSH rats responded at control levels but 
pitressin treated rats continued to make significantly more responses 
than control. Pitressin therefore exerted a long term effect on 
extinction responding whether injected during training or extinction. 
In contrast the effect of a-MSH was restricted to the period of 
treatment during extinction. The long term active component of 
pitressin was therefore notaMSH and probably not ACTH, earlier 
evidence (de Wied 1965) suggested a role for LVP. The long term 
nature of the effect led de Wied and Bohus (1966) to suggest the 
involvement of processes related to long term memory formation. 
The identity of vasopressin as the active constituent of 
pitressin was confirmed by de Wied (1971) using a pole jump avoidance 
task. Intact rats were trained to avoid shock (0.2 ma) preceded by a 
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light as the CS .for 10 trials per day on 3 consecutive days. Those 
rats which made more than 10 correct responses were then given 10 
extinction trials , animals making 8 or more correct responses in the 
first extinction test were injected with either saline, ACTH 4-10 
(100 ug) or LVP (1 ug ;60 IU/mg) se. Extinction tests were repeated 
at 2,4,24,48 and 72 hrs. Saline controls extinguished rapidly , 
ceasing to respond after the 4 hr test, ACTH 4-10 increased 
extinction responding up to the 4 hr test. In contrast LVP maintained 
responding at 90% over all 5 tests. A number of other peptides were 
tested and found to be ineffective including oxytocin (1 ug;60 
IU/mg), angiotensin II (1 ug), insulin (1 ug) and growth hormone (1 
ug). Some aspects of the procedure may restrict the generality of the 
results, two behavioural criteria restricted the test population, in 
addition very small groups were used and no statistical tests were 
reported. Despite these points many subsequent experiments have 
confirmed the effects of both LVP and ACTR 4-10 on avoidance 
responding. More recent studies have shown that oxytocin affects 
avoidance extinction when injected peripherally (Schulz et al 1974 ) 
and directly into the ventricles of the brain (Bohus,Kovacs and de 
Wied 1978; Bohus,Urban,van Wimersma Greidanus and de Wied 1978). 
The behavioural activity of LVP in hypophysectomised rats 
(de Wied 1965) was confirmed by Bohus (1973) using the two way 
shuttle box avoidance task with 5 secs of buzzer as the CS and 0.12 
ma of shock, other aspects have been descibed (de Wied 1965, de Wied 
and Bohus 1966). During the first 7 days of training both LVP (1 
ug/rat) and ACTH 4-10 (20 ug/ml) significantly elevated response 
rates compared to saline. When treatment was discontinued on day 7 
the response rates of ACTH 4-10 treated rats declined to control 
levels but those of the LVP rats remained significantly higher. 
Hypophysectomised rats injected with saline had very low response 
rates, contrasting with the earlier report from de Wied (1965). The 
difference may be attributed to lower shock level, termination of 
shock after a maximum of 20 secs on each trial or the omission of 
hormone replacement therapy. Low response rates in control groups 
confound interpretation in terms of learning related processes , a 
problem found also in some early passive avoidance studies on the 
effects of vasopressin in intact rats (Ader et al 1972; Bohus et al 
1972; Wang 1972 ). In addition, increased inter-trial responding in 
hypophysectomised rats treated with LVP compared to saline (Bohus 
1973) suggest a relative lack of stimulus control when response rates 
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are elevated by vasopressin. 
The effect of vasopressin cannot be attributed to a general 
excitation as intact rats injected SC with LVP have increased 
re-entry latencies on a step through passive avoidance task (Ader and 
de Wied 1972). Rats were placed on an elevated, well illuminated 
platform and latencies to enter a dark chamber with a grid floor were 
recorded.!£ the sum of the latencies on 3 succesive trials did not 
exceed 30 secs then on entering the chamber on the 4th trial the rat 
received footshock for 2 secs,~ ma, 0.125 ma or 0.25 ma). Re entry 
latencies 24 and 48 hrs a~ter shock increased as a function of the 
training shock. LVP (0.3 ug/rat, 0.9 ug/rat 2.7 ug) or saline was 
injected immediately after shock.LVP significantly increased re-entry 
latencies 48 but not 24 hrs after training. Higher doses of LVP 
yielded higher re-entry latencies,indicating a dose dependent effect 
but this was not tested statistically. LVP did not affect responding 
after either 0 ma or 0.125 main control rats. Krejci and Kupkova 
(1978) have confirmed these findings using the step through passive 
avoidance task with 0.35 ma shock. LVP (1 ug) injected after the 
learning trial significantly increased re-entry latencies 2 and 3 but 
not 7 and 13 days after training. 
2.2. Time Dependent Effects. 
The effects of vasopressin on extinction responding 
diminish as the interval between the end of training,first extinction 
session or retention test increases. This was first shown by de Wied 
(1971) using pole jump avoidance responding (see sect. 2.1 for 
procedures and criterion). When LVP (1 ug) was injected immediately 
after the first extinction test response rates in extinction 24 and 
48 hrs later were significantly elevated. When treatment was delayed 
for 60 mins the effect was reduced but when delayed for 6 hrs 
response levels in extinction were comparable to saline controls. 
Subsequently it was shown that to be effective the 
injection may either follow or precede the first pole jump extinction 
session by up to 60 mins (de Wied 1973). Behavioural potency 
diminished as a function of increased intervals. Furthermore Bohus et 
al (1972) have shown that when LVP (1 ug) precedes the final training 
session of pole jump avoi~ance by 60 mins then extinction response 
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levels are significantly higher than saline controls 48 hrs but not 
24 hrs later, failure to observe an effect 24 hrs after injection is 
probably due to high baseline responding in saline controls in this 
test. When the injection preceded the final training session by 6 hrs 
LVP did no.t affect extinction • The results indicate that vasopressin 
increases extinction responding when injected within 60 mins .before 
or after training or the first extinction session. King and de Wied 
(1974) have· shown a time dependent LVP effect after a single correct 
avoidance response. Rats were removed from the apparatus after the 
first correct pole jump response and; returned to the home cage for 
injecting after the appropriate interval. During subsequent training 
session rats were give the balance oJ 30 training trials. LVP (lug) 
. increased responding in extinction 48 hrs later when injected 60 mina 
but not 6 hrs after the first correct response. In addition these 
authors have shown that under the influence of LVP classical 
conditioning trials alone are sufficient to act as behavioural 
substrate for the peptide's effects when followed by avoidance 
training and extinction (King and de Wied 1974). Time dependent 
decreases in behavioural potency , thought to reflect interactions 
with time dependent consolidation processes , coupled with numerous 
observations that effects persist long after the time of injection 
form the basis for interpreting vasopressin's behavioural effects in 
terms of consolidation. 
This explanation alone is insufficient however as a number 
of studies have shown that vasopressins increase passive avoidance 
re-entry latencies when injected one hour before the retention test 
(Ader and 'de Wied 1972; Rigter et al 19.74 ; 1975 ; Raemakers et al 
1977 Bo.okin and Pfeifer 1977; Pfeifer and Bookin 1978 see section 
2.4.2). Krejci and Kupkova (1978) have reported that DG LVP, DC DAVP 
an analog without sedative effects and DG-Trigly-LVP an analog with 
low pressor and antidiuretic activity were effective when injected 20 
but not 120 or 180 mins prior to the retention test,confirming that 
the effects of pre retention injections are also time dependent and 
do not appear to be mediated either by pressor and antidiuretic 
activity or by reduced mo.tor activity. However certain behaviourally 
active AVP analogs reduced mobility in open field tests in low doses 
(1-3 ug se) and produced sleep like immobility with higher doses 
( 10-30 ug se), Pre test injections may therefore exert subtle but 
·confounding influences on responding, thereby increasing the 
difficulties of interpretation. Bookin and Pfeifer (1977) have argued 
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that the effects of vasopressin on two apparently distinct mechanisms 
calls into question the validity of the two stage model , this 
reflects trends in the human literature , furthermore the extent to 
whi:ch animal procedures may be argued to distinguish these putative 
stages is doubtful. 
2.3. Structure Activity Studies. 
Previous experiments had shown that the behaviourally 
active sequence of ACTH was located in residues 4-10, neither the 
entire structure nor its endocrine effects were necessary for 
""cl G ISP~ tJ 
behavioural activity (de Wied A 1977 ) • A similar strategy has been 
applied to locate the behaviourally active sequence of vasopressin. 
Removal of glycinamide from position 9 of LVP or AVP produces 
des-glycinamide LVP (DG LVP) and DG AVP which retain 50% of the 
behavioural potency associated with the parent molecule but appear to 
lack endocrine activity. Lande et al (1971) showed that DG LVP (20 ug 
in zinc .phosphate) restored shuttle box avoidance responding in 
hypophysectomised rats. Subsequently de Wied et al (1972) confirmed 
the behavioural activity of DG LVP in intact rats. Ten training 
trials per day for 3 days were given on the pole jump avoidance task, 
5 secs of light as the CS preceded shock, rats which made more than 
10 CO•Yrect avoidances were injected with either LVP (12,36 or 108 mu) 
or DG LVP (0.1, 0.3 or 0.9 ug) immediately after training. Neither 
saline controls or non shock peptide controls were included and no 
statistical analysis was reported. Extinction responding was tested 
at 24, 48, 120 and 268 hrs after injection. The high dose of each 
peptide maintained responding in excess of 80% in all tests. 
Intermediate doses showed hi.gh response levels in the first test 
therafter declining to intermediate levels. The low doses showed high 
response levels in the first test declining to low levels in the 
second test and no subsequent data was reported. The results suggest 
a relationship between dose and both magnitude and duration of 
effects, however this conclusion is equivocal in the absence of the 
proper control groups and statistical tests. Furthermore, DG LVP 
showed very low activity when assayed for pressor, antidiuretic , 
oxytocic and CRF activity using bioassays. It was argued that removal 
of the glycinamide destroyed normal endocrine activity but retained 
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behavioural activity (de Wied et al 1972). indicating that 
vasopressin's behavioural effects are not mediated by its endocrine 
target organs. Krejci and Kupkova (1978) confirmed the effects of DG 
LVP on avoidance responding and also re_ported that another analog 
with low pressor and antidiuretic activity DG-Trigly-LVP increased 
passive avoidance retention latencies after post training injections. 
The behavioural potency of DG LVP has been confirmed by Wang (1972) 
in active and passive avoidance tasks. DG LVP (0.125 ug SC) injected 
after pole jump training increased responding to more than 75% on 
·extinction trials 24 and 72 hrs later compared to 10% for saline 
controls. However only 4 rats were used per group and no statistical 
tests were made, as in the de Wied et al (1972) study. Post training 
DG LVP injections (0.0625 ug ;0.25 ug SC) increased passive avoidance 
retention. However .only 5 rats were used per group and no statistical 
tests were made. If DG LVP retains behavioural activity in the 
absence of endocrine activity this may indicate functional 
disocciation for different parts of the vasopressin molecule (de Wied 
et al 1972). However Rigter (personal communication) has found that 
DG LVP (8 ug) administered over a number of days using either 
minipumps to acheive constant infusion or repeated injections reduces 
water intake and urine flow in DI rats suggesting that DG LVP retains 
endocrinological activity. 
The physiological significance of DG-analogs is uncertain ar.d 
largely speculative. Glass et al (1969) have isolated an enzyme from 
the toad bladder which cleaves glycinamide from AVP and LVP, a 
similar system may operate in the kidney. Lande et al (1971) isolated 
an octapeptide from hog pituitaries which they identified as DG LVP. 
This may have been an artifact of tryptic digestion used in the early 
stages of isolation although the authors argued that this was 
unlikely on the basis of high yields of ACTH and LVP from the same 
source despite their susceptibility to tryptic digestion. Many 
subsequent s_tudies (see below) support the conclusion that DG LVP is 
behaviourally active. 
The behavioura-l potency of smaller vasopressin fragments 
has been studied using the pole jump avoidance (de Wied et al 
1975;1976). Up to 5 ug of peptide were injected se after training in 
-order to establish the amount of each fragment required to elevate 
responding to 6 or more correct responses during the third and final 
extinction test. AVP and LVP were most potent and their DG analogs 
retained approximately 50% activity. The tail sequence (H-CYS PRO LEU 
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GLY NH2) showed no behavioural activity and Pressinoic acid, the ring 
structure (see figs 1,2) showed behavioural activity equal to 10% of 
theparent molecule. DeWiedet al(l975) suggested that the C terminal 
fragment may play a significant role in modulating the behavioural 
effects of vasopressin by protecting against enzymatic degradation 
after peripheral injections. This is supported by two types of 
observation. Direct injection of a small dose of AVP (25 pg) into the 
lateral ventricles of the brain significantly increased pole jump 
avoidance responding in extinction (de Wied 1976). Furthermore, 
pressinoic acid retained 50% activity and PRO ARG GLY, a tail 
structure analog, showed less than l% activity of the parent 
structure. The differences in potency when pressinoic acid was 
injected centrally and peripherally was attributed to reduced 
enzymatic breakdown associated with the central route and suggested 
that in the case of peripheral injections the tail fragment served a 
protective role (de Wied 1976). Krecji and Kupkova (1978) reported 
that behavioural activity was enhanced in vasopressin analogs which 
were resistant to various forms of enzymatic breakdown. Peptides were 
injected immediately after the learning trial in a step through 
passive avoidance test (0.35 ma). LVP (lug) increased re-entry 
latencies relative to saline when tested 2 and 3 but not 7 and 13 
days after injection. Analogs which were resistant to amino 
peptidases and re ducti ve ring cleavage, 
de-amino-6-carba-arginine-8-vasopressin, 
de-amino-6-carba-ornithine-8-vasopressin and an analog resistant to 
aminopeptidases and trypsin, de-amino-(8-D-arginine)-vasopressin all 
increased re-entry latencies up to 13 days after training. 
2.4. Effects of Vasopressin on Experimental Amnesia. 
Peripheral and centra~ injections of vasopressin and its 
analogs causes a long term elevation of response rates during active 
avoidance extinction, and increased re-entry latencies during passive 
avoidance tests. The peptides are most effective when injected within 
an hour of training or the first extinction test. Treatment is 
ineffective when delayed for 6 hrs. The long term time dependent 
elevation of response rates led de ~ied and Bohus (1966) to suggest 
that vasopressin affected mechanisms involved in memory formation 
. 
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independently of its endocrinological roles in antidiuresis and the 
pressor response (de Wied et al 1972). This hypothesis has been 
tested in a number of experiments using laboratory techniques to 
produce retrograde amnesia for learned responses. 
2 ~4 .1. Puromycin. 
Early theories of the mechanisms underlying memory formation 
suggested that protein synthesis played a central role. Puromycin is 
known t.o block protein synthesis for approximately 6 hrs after 
injection (John 1967) and to result in subsequent behavioural 
deficits resembling retrograde amnesia. 
Lande et al (1972) reported that vasopressin antagonised 
puromycin amnesia. Mice were trained to avoid shock in a Y maze by 
choosing the correct arm on successive trials. Response retention 
levels were calculated on the basis of trials required to re-achieve 
criterion a week later. Puromycin di-hydrochloride (90-129 'ug) 
injected intra-cerebrally one day after training resulted in total 
loss of retention.~fuen DG LVP (0.1 mg) was injected either 1,S or 20 
hrs before training the pooled data for all intervals showed 
significant savings in both trials and errors whilst re-acheiving 
criterion compared to puromycin treated controls. Similarly DG LVP 
(0.1 mg) improved retention when injected 12 hrs after training. 
Saline controls were omitted from both pre and post training 
injection ·experiments. Savings may therefore have been due either to 
peptide or a factor related to the injection routine. Recent evidence 
has shown that behavioural responses to drug treatments are modified 
by pre injection routines (Riffee,Wilcox and Smith 1979). When 
injection was delayed for 24 hrs after training DG LVP was 
ineffective. Lande et al (1972) suggested that DG LVP afforded 
protection of the response against puromycin amnesia. The absence of 
saline controls, pooling of dai:a across treatment intervals and the 
extremely high doses of DG LVP ,some 100x larger than the dose 
reported by de Wied (1971) to exert maximal behavioural effects in 
intact rats, renders this conclusion equivocal • These methodological 
problems have been overcome in more recent studies showing that AVP 
(0.07 uM) and LVP ( 0.2 uM) protect against puromycin amnesia when 
injected 1 but not 3 days prior to training; post training injections 
ss 
were effective with delays of 0 ,6 and 16 but not 24 hrs (Flexner et 
al 1978 ) • The period of pre and post training sensitivity in these 
studies is considerably longer than in intact rats (see section 2.2), 
no explanation was given for this discrepancy. The effectiveness of 
immediate post training injections was confirmed by Flexner et al 
(1978) who also showed that dose response functions were similar for 
AVP.,LVP and DG LVP although AVP was the most potent at low doses. 
Structure activity studies using identical training, 
treatment and test procedures confirmed that both AVP and LVP (0.1 
mg) injected se after training protected against the amnestic effects 
of puromycin (90 ug) injected 24 hrs after training (Walter et al 
1975). Pressinoic acid was ineffective, in contrast de Wied et al 
(1975) reported that pressinoic acid retained approximately 10% of 
the activity of the parent structure after peripheral injections in 
intact rats and 50% after central injections. In addition the C 
terminal fragment PRO-LEU-GLY-NH2 (PLG) and its analog 
PRO-LYS-GLY-NH2 protected against puromycin amnesia (Walter et al 
1975), In contrast de Wied et al (1975) found that the isolated tail 
fragment was inactive in intact non drugged rats. The C terminal 
dipeptide LEU-GLY-NH2 and its cyclic analog (CYCLO), derived from 
oxytocin, were extremely potent anti amnesics. Subsequent studies 
have demonstrated a positive significant correlation between the 
degree of protection afforded by cyclo against puromycin amnesia and 
the concentration of peptide present in synaptosomal fractions from 
mouse brain tissue (Rainbow et al 1979), 
The biochemical mechanisms underlying puromycin amnesia are 
not well understood, the role of protein synthesis blockade is not 
clear. Evidence suggests that the behavioural effects of puromycin 
may be mediated by the formation of peptidyl puromycin which persists 
in the synaptosomes long after injection (Gibbs and Hark 1973), In 
addition amnesia was reversed by saline injections (Gibbs and Mark 
1973), highlighting the importance of adequate saline control groups 
which were omitted in the Lande et al (1972) study. Furthermore 
there is conflicting evidence as to the onset of the puromycin 
sensitive stage of consolidation. Flexner et al (1963) reported 
sensitivity up to 3 weeks after training ,Davis and Agranoff (1966) 
reported amnesia when puromycin was injected immediately but not 60 
mins after training. In addition the period of susceptibility to 
puromycin was increased by up to 3 hrs by retaining the animals in 
the training environment for 3 hrs after training (Davis and Agranoff 
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1966.), Although this may suggest that environmental cues trigger the 
start of consolidation (John 1967) it is unlikely that protein 
synthesis inhibition is similarly triggered. 
2.4.2. Anoxia. 
Post training exposure to a carbon dioxide (C02 ) rich 
atmosphere results in respiratory arrest,anoxia and retrograde 
amnesia for the previously learned response (Rigter et al 1974;1975), 
Rats were trained in the step through passive avoidance task using 
0.35 ma of shock for 3 secs, then .removed from the training apparatus 
and placed in an enclosed chamber with a C02 atmosphere until 
respiratory arrest occurred, approximately 30-35 secs later. Passive 
avoidance of the shock compartment in the training apparatus was 
tested after 24 hrs, shocked animals which had short re-entry 
latencies after anoxia were ·considered amnesic for the passive 
avoidance response (Rigter et al 1974;1975), ACTH 4-10 reversed 
amnesia when injected 60 mins before the retention test but not 60 
mins before training. In contrast DG LVP (10 ug se) reversed amnesia 
when given 60 mins before training, retention testing or both (Rigter 
et al 1974), Re entry latencies for amnestic animals were higher than 
for non shocked controls indicating that the reversal of amnesia 
after DG LVP was partial. Rigter et al (1975) confirmed these 
findings and reported that the effect of DG LVP was time dependent. 
Amnesia was partially reversed when DG LVP (10 ug ) was injected 60 
mins but not 2,4 or ·6 hrs before training. The same dose partially 
reversed amnes_ia when injected up to 6 hrs before the retention test. 
However Rigter et al ( 1975) could not reverse C02 amnesia using post 
training injections of DG LVP. This contrasts with the results from 
many studies (see above) which did not use amnestic treatment and 
found that post training vasopressin injections increased subsequent 
extinction responding and with the results obtained with puromycin 
induced amnesia (see section 2.4.1) in which it has been generally 
found that post training vasopressin injections exert a powerful 
influence on subsequent responding. The differential time course for 
pre-acquisition 
interpreted as 
and pre 
indicating 
retention DG LVP effects on behaviour were 
that different biological mechanisms 
underlie the effects of vasopressin injections at these times (Rigter 
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et al 1975). Informal observations of rats injected after shuttle box 
avoidance training (expt One Chapter Five ) suggest that LVP treated 
rats are less active than saline controls an hour after injection. 
Similarly Krecji and Kupkova (1978) have reported reduced mobility in 
the open field following vasopressin analogs injected SC in the dose 
range 1-3 ug. Higher doses (10-30 ug) induced "sleep like" immobility 
in the absence of catalepsy or ataxia. These effects were noted up to 
4 hrs after injection. This may confound the interpretation of 
increased passive avoidance latencies in terms of antagonised 
amnesia, especially in view of the high dose of DG LVP used and 
indications that it may retain peripheral endocrinological effects 
(see sect 2.3). A further difficulty is the use of inappropriate 
control groups. Respiratory arrest takes up to 35 secs to develop. , 
by itself this constitutes a considerable stress. Control groups were 
confined in a normal atmosphere under no comparable stress. Therefore 
disrupted retention may not be unequivocally attributed to amnestic 
effects of anoxia, motivational and other non specific effects may be 
involved. Leukel and Quinton (1964) have shown that 60 secs of 
exposure to a C02 atmosphere acts as a negative reinforcer. 
The biological basis of CO~ amnesia is poorly understood. 
Leonard et al (1975) reported that hippocampal and brain stem 
serotonin levels were elevated after passive avoidance training 
whereas hippocampal noradrenaline decreased. When training was 
followed by C02 exposure serotonin levels remained unchanged and 
noradrenaline levels were increased. Rigter et al (1975) confirmed 
the results for serotonin but not for noradrenaline. Furthermore they 
reported that the effectiveness of the amnestic treatment decreased 
as a function of the interval between training and anoxia and this 
was paralleled by increasing serotonin levels in the hippocampus. 
Ramaekers et al (1977) confirmed the antiamnesic effects of DG-LVP 
injected prior to step through passive avoidance training and 
retention and confirmed that increased serotonin levels following 
footshock was prevented in C02 amnesia. Furthermore 
with DG-LVP (Sug/rat) elevated hippocampal serotonin 
pretreatment 
levels and 
prevented the decrease in serotonin levels associated with C02 
amnesia. Similar but less pronounced effects were reported for DG-LVP 
injected 23 hrs after training and 1 hr prior to decapitation, at the 
usual time for retention testing. Although the data show changes in 
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hippocampal serotonin and possibly noradrenaline following anoxia and 
of serotonin following DG-LVP the measurement of transmitter levels 
does not allow a conclusion as to the nature of synaptic changes 
involved,although increased serotonin was correlated with decreased 5 
Hydroxyindolacetic acid levels sugflesting effects on serotonin 
turnover (Leonard et al 1975). Furthermore the data sug3est a 
correlation but not a causal link between serotonin, ~oradrenaline 
and response retention. 
Post training injections of convulsive doses of 
pentylenetetrazol (SO mg/kg) have been reported to induce amnesia for 
the passive avoidance response which could be reversed by LVP (lug) 
injections one hour prior to either training or retention (Bookin and 
Pfeifer 1977). These findings have been confirmed by Conti and !lohus 
(personal communication).Pfeifer and Bookin (1978) have confirmed 
their results using ECS. 
2.5. Physiological SiRnificance of Vasopressin Effects on 
Avoidance RespondinB• 
Changes in active avoidance response rates and passive 
avoidance retention after vasopressin injections constitute one 
amongst onany phar:nacological responses to the peptides. Taken in 
isolation these effects rlo not prove that endogenous vasopressin. 
plays a physiological role in r:taintaining learned behaviour 
althou~h the presence of vasopressin in the perpiphery ,CSF and in 
extr'lhypothalamic pathuays coupled 1d th the behavioural potency of 
central injections (section 2.3) prolonged behavioural effects 
despite a short metabolic half life (section 1.7) and deficient 
responding in hypophysectomised rats sum~est that this oay be so. The 
studies discussed below have tackled this problem directly by 
quantifyinG vasopressin changes associated with behavioural chanr;es 
and behavioural changes associated with vasopressin deficits. 
2.5.1. Variations in Vasopressin Levels during Avoidance 
llespondino;. 
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Thomson and de Wied (1973) claimed to have found evidence 
that passive avoidance retention was directly related to plasma AVP 
levels. Twenty four hours after·a single shock ( 0,0.25 , 0.5 , 1 
ma for 3 secs ) in the step through passive avoidance apparatus (Ader 
et al 1972) rats were returned to the apparatus for retention testing 
and immediately after the test were anaesthetised with ether and 1-2 
m1 of eye plexus blood withdrawn. Antidiuretic activity of eye plexus 
blood was determined by bioassay. Vasopressin was confirmed as the 
antidiuretic principle using sodium thioglycol~ate. Non shocked 
control rats showed 0.34 mu/ml ADH activity, levels of 0.42 mu/ml, 
0.53 mu/ml and 0.63 mu/ml were found in rats given 0.25, 0.5 and 1 ma 
shock respectively. The differences between successive levels were 
significant. Re -entry latencies were not statistically analysed, the 
reported medians tended to increase as a function of shock but the 
reliability of these figures.is doubtful as the values at 0.5 and 1 
ma were considerably lower than in many-other reports using identical 
training parameters. Furthermore, exposure to ether is widely used in 
experiments to stimulate vasopressin secretion (see section 1.9.2) 
and therefore constitutes a source of uncontrolled artifact. 
Van IHI!'ersma Greidanus et al (1979) failed to confirm the findings 
of Thompson and de Wied (1973), no significant changes were found in 
AVP levels of trunk blood as measured by radioimmunoassay 
collected prior to pole jump avoidance training and extinction • In 
passive avoidance tests only rats trained with the highest shock 
level (1 ma) and showing the longest re-entry latencies (300 secs) 
had a slight but significant elevation of plasma AVP levels. In 
addition CSF was withdrawn via a polyethylene cannula inserted prior 
to experiments in the right lateral ventricle of the brain. Samples 
taken after passive avoidance retention showed that although basal 
AVP CSF levels were much higher than plasma levels ( )10.4) and 
re-entry latencies increased as a function of shock intensity in 
training there were no significant effects of training on AVP levels 
in the CSF. The results suggest that neither plasma nor CSF AVP 
levels bear a direct relationship to response retention as Thompson 
and de Wied (1973) suggested. 
The effect of pei-lpherally and centrally injected 
vasopressin is not therefore to enhance normal fluctuation in 
peripheral and CSF 
peripheral secretion 
evidence for direct 
vasopressin levels during behaviour even though 
is well established (section 1.2) and the 
secretion into the CSF is favourable (section 
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1.3.3). As endocrine target organ mechanisms had been ruled out on 
the basis of low endocrine activity in behaviourally active 
derivatives of vasopressin, particularly DG-LVP and DG-AVP (section 
2.3) these findings were interpreted as supporting a role for 
extrahypothalamic vassopressinergic pathways in mediating the 
behavioural response to exogenous AVP , assuming that access to the 
limbic region is via the CSF (van Wimersma Greidanus et al 1979) 
(see also section 1.3.4). There are three difficulties with the 
argument; DG LVP shows endocrine activity under certain test 
conditions peripheral mechanisms other than endocrine target organ 
effects have not been considered and there is no direct evidence to 
implicate 
regulation. 
2.5.2. 
extrahypothalamic vasopressin fibres in behavioural 
Behavioural Deficits in HO-DI rats. 
If endogenous vasopressin plays a physiological role in 
regulating learned responding then rats with a genetical absence of 
vasopressin (HO-DI) should show deficient avoidance responding. 
Experiments discussed below have tested this hypothesis. 
Characteristics of HD-DI rats have been described in section 1.9.2. 
These studies have established that HO-DI rats lack vasopressin. 
Behavioural experiments with these animals have produced 
conflicting results. Bohus et al (1975) have reported that both HO-DI 
and HE-DI rats maintain higher levels of ambulation, rearing and 
grooming than Wistar. controls in the open field test and make fewer 
faecal boli during the first test session • Bailey (1975) confirmed 
that HD-DI and HE-DI rats were not significantly different from each 
other but that both had lower ambulation scores and made fewer faecal 
boli than Long 6vans control rats. Bohus et al (1975) reported that 
HO-DI rats had a significantly higher threshold for eliciting 
flinches in response to footshock and both HO-DI and HE-DI rats had 
higher thresholds for eliciting jerking, jumping and running than 
!star controls. In contrast Celestian et al (1975) reported that 
HO-DI ,HE-DI and normal Long bvans control rats had identical shock 
sensitivity. The discrepancies may reflect the use of different 
control strains in different experiments and highlights the problems 
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of establishing reliable baselines for these endocrinologically 
abnormal rats. 
2.5.3. Passive Avoidance Responding in HO-D! rats. 
A number of experiments show that Ho-DI rats have 
deficient passive avoidance retention. De Wied et al (1975) trained 
normal wistars, HO-D! and HE-DI rats in the step through passive 
avoidance task using O, 0.25, 0.5 and 1 ma. Re-entry latencies were 
measured immediately, 3, 24, 48 and- 120 hrs after training. Median 
re-entry latencies for HE-DI rats increased as a function of the 
training shock, 1 ma caused total passive avoidance (300 secs) up to 
120 hrs after training. In contrast HO-D! rats passively avoided only 
immediately and 3 hrs after training, re-entry was rapid during 
subsequent tests. Even 1 ma was insufficient to increase latencies 
120 hrs after training. These findings were confirmed by Bohus et al 
(1975) ,HE-D1 rats showed passive avoidance after 3 secs of 1 ma 
shock at the immediate ,3 hr and 24 hr test. HO-D! rats showed 
significant avoidance when tested immediately, and after 3 hrs but 
not after 24 hrs. 
In contrast Bailey (1975) reported that HQ-D1 rats avoided 
on the first day of testing but not on subsequent days, whereas HE-D1 
rats maintained avoidance throughout testing. The results of testing 
24 hrs after training reported by de Wied et al (1975) and Bohus et 
al (1975) conflict with those of Bailey (1975), the decay in 
avoidance retention seen in HO-D1 rats may therefore be related to 
repeated testing. Reduced shock sensitivity in the HD-DI and HE-DI 
rats compared to wistar controls (Bohus et al 1975) may contribute to 
retention differences between these groups although this is clearly 
not the sole factor as HQ-D1 rats differed substantially from HE-DI 
rats on avoidance retention but differences in shock sensitivity were 
relatively small. 
The importance of shock levels during passive avoidance 
training is highlighted by additional data from Bailey (1975). When 
the shock level for passive avoidance training was reduced to 0.5 ma 
both HO-D1 and HE-D1 rats maintained avoidance responding when tested 
24 and 48 but not 72 or 96 hrs after training. Contrary to de Wied et 
al (1975) and Bohus et al (1975) the performance of these groups was 
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virtually indistinguishable. Furthermore daily pitressin (0.50) 
injections durin13 training an•i testing abolished the avoidance 
response in HO-Dl rats. Unfortunately Bailey (1975) did not establish 
the active component of pitressin and therefore the significance of 
this finding for assessing the hypothesis that endogenous vasopressin 
plays an essential role in naintaining responding is unclear. 
2.5.4.Active Avoidance Responding in· H0-!li rats. 
As in the passive avoidance studies the results of active 
avoidance tests using HO-Dl rats are conflicting. Bohus et al (1975) 
have reported consistent findings from pole jump and shuttle box 
avoidance tests. Rats t~ere trained to avoid shock (0.2 ma) preceded 
by 5 secs of CS (light) during 10 trial on each of 6 consecutive days 
in the pole jump apparatus. Wistar controls made significantly more 
responses in training than either HO or liE DI groups, hm~ever all 
rats made more than 75% correct responses after 6 days of training. 
During extinction !!0-DI rats made significantly fewer responses than 
HE-DI rats or wistar controls • HE-DI rats also nade significantly 
fewer responses than wistars. A similar pattern was found during 
shuttle box training ( 5 secs CS; 0.16 ma) and ex tine tion. ;·!iller et 
al (1976) repeaterl the Balms et al (1975) shuttle box experiment and 
confirmed poor learning in HO-Dl rats at 0.16 na but higher response 
levels at 0. 25 ma. Rats 1~ith greater than 18% correct responses in 
training were tested in extinction HO-DI rats made fe1-1er responses 
than HE-DI controls, this was attrihuterl to the absence of 
vasopressin anrl intermediate respondinf~ in HE-DI rats <·ras attributerl 
to abnorr.~ally low vasopressin levels (41% norr.ml; van \limersrna 
Greidanus et al 1977 1 Dogterom 1973). Reduced shock sensitivity in liE 
and 110 DI rats compared to 11istars (Balms et al 1975) tJas rulerl out 
as a significant factor on the basis that large differences in 
response levels between these p,roups <~ere parallelerl by snall 
differences in shock sensitivity. 
The results reported by !lobus et al (1975) and Hiller et al 
(1976) could not be confirmed by Bailey (1975) using the shuttle box. 
The CS (5 !lees 80 db tone ) 1Jas follmted by a 0.6 ma shoc!t, tnlinine 
continued for 10 trial per day until rats had made 80% correct 
responses on 3 consecutive days. Only 2 out of 8 110-DI rats anrl 5 out 
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·of 7 liE-D! r~tts ~tcheived this criterion but between these sroups 
there were no significant differences during trainin~. nuring 4 days 
of extinction testing all rats responded at criterion levels. The 
data sug3est that HO-DI rats can learn and ~aintain avoidance 
respor;~ding despite the absence of vasopressin. '10\Jever as the number 
of HO-DI rats acheivinr, criterion was lotJ this is a dificult result 
to interpret. 
Celestian et al (1975) have reported that HD-DI rats have 
higher response rates than controls during extinction of shuttle box 
responding. Those rats which made >BO% correct responses on the final 
day of training were used for the experiment. Acquistion levels were 
lower for HO-DI rats (30%) than for either HF.-DI (78%) or controls 
(64%) , confirming Bailey's (1975) observations of poor learning. 
Those rats which achieved criterion were tested in extinction and the 
llO-DI rats made significantly more responses Hhen tested 72,168,336 
and 504 but not 48 hrs after training compared to Jffi-01 rats and 
controls. This result is the opposite to that reported by Bohus et al 
(1975) and tliller et nl (1976). Comparing across shuttle box 
experiments suggests that shock level in training is an important 
variable in determining extinction response levels in 110-DI rats. 
Response levels ~1erc lo~1er that control when training shock was lm1 
(0.16 ma Bohus et al 1975), equal to control at intermediate shock 
levels (0.6 ma Bailey 1975) and greater than control at hi~h shock 
levels (1 ma Celestian et al 1975). In addition Bailey (1q75) found 
no differences between HO-DI and HE-DI rats during passive avoidance 
retention Hhen trained Hith 0.5 na. 
The evirlence for extinction response deficits in HO and 
HE-OI rats is clearly conflicting, furthermore , 1.1here deficits have 
emer3ed these are confounded by differences during learning. Bohus et 
. 
al (1975) reported that during pole junp avoidance training wistars 
reached criterion by day 3 COL1pared to day 6 for HO and l!E:-DI rats, 
during shuttle box training Histars and liE-D! rats reached 30% 
correct responses by day 3 compared to day 12 for HO-D! rats. Bailey 
·(1975) reported that after 10 days of training only 2 out of 3 IID-DI 
rats achei ved criterion conpared to 5 out of 7 I!E-DI' s. FurtherrJore , 
active avoidance responding hecones unstable in HO-D! rats after 3 
days (Celestian et al 1975) or after 10 days (llailey 1975; :-!iller et 
al 1976). 
Analysis of covariance using terminal acquisition levels 
as covariates sho~md that the extinction performance of HO-DI, HE-DI 
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and·nor~als was not significantly different wl~n learning differences 
Here taken into account , in fact the significantly higher regression 
slopes for the extinction performance of normals showed that HO-DI 
rats actually extinguished respondinu more slo~Tly than noroals 
(llillet: et al 1976). 
The conflicting results of avoidance extinction tests and 
the confounding influence of learning deficits sug3ests that where 
behavioural differences are found between normals and no-DI rats 
these cannot be unequivocally interpreted in ter~s of memory deficits 
due to the absence of ·vasopressin but are more likely to reflect a 
number of factors including differential shock sensitivity and 
emotionality, general debilitation, grO\·Ith hor;,lone deficiency 
(Arimura et al 19613), potassiun deficiency (Bailey 1975) or 
corticosteroid deficiency (see section 1.9.2). 
Recordings from the dorsal hippocampus indicate that HO-DI 
rats have a lo~1er mean frequency of rhythr.lic slo\1 \lave activity (7 .6 
+/- 0.1 hz) than HE-DI rats (8.1 +/- 0.04 hz) (Urban and de \lied 
1975). The difference was partially corrected uith DG-AVP (1,2 ug 
SC) although the peak frequency for HO-D I' s re1aained si,'>,nificantly 
lower. The si;~nificance of f::EG waves in this frequency range is 
uncertain although several authors have suggested a role in memory 
for;aat.ion (Adey et al 1967). Similarly Land field et al ( 1972) 
.reported that cortical EEG observed 30 mins after passive avoidance 
training followed by electrocon~ulsive shock was si3nificantly 
correlated \IIth subsequent response retention. Urban and de Hied 
(1975) suggested that the lo\·/er peak and mean frequencies in HO-D I 
rats may reflect disrupted consolidation. 
2.5.5. Avoidance Respondin~ after Anti-Vasopressin serun. 
An alternative 1aethod for e:camining the role of endogenous 
vasopressin in the maintenance of avoidance respondin3 is to destroy 
the centrally anrl peripherally available hormone in nor1~al rats by 
injecting a serut1 containin~ antibodies raised a~ainst the peptirte 
(van \Jimersma Greidanus et al 1975, 1976). Post training 
intracerehroventricular (icv) injections of anti vasopressin senu~ ( 1 
ul) reduced re-entry latencies follo~ling step throu~h pA.ssive 
avoidance trainin~ (0. 75 1.1a 3 secs) 11hen tested 4, 24 or 4<3 hrs after 
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injection but not when tested after 2 mins or hr. The 
antivasopressin ~;erum 1·/aS equally effective when injected 30 mins 
before training. Subsequent experiments showed that the retention 
deficit did not emerge 11ntil 3 hrs after injection. In contrast rats 
injected with either control or antioxytocin serum showed maximal 
retention at all tests (300 secs). Central injections of the 
anti vasopressin se rue did not alter urine flo~1 or osmolality 1~hereas 
peripheral injections of much higher rloses (lOO ul) increased flow 
and decreased the vasopressin content of the urine but did not alter 
passive avoidance retention (van \-limersma Greidanus et al 1975). The 
authors argued that centrally available vasopressin played an 
essential role in memory consolidation independent of pressor ancl 
antidiuretic activity , sup~orting conclusions fro11 earlier studies 
1~i th hypophysectomised rats (section 2.1) and vasopressin derivatives 
(section 2.3). 
In order to examine time dependency of the anti-vasopressin 
serun effect on passive avoidance retention the serum (0.1 ul ) was 
injected at various intervals before and after training and retention 
was testerl 24 and 48 hrs later (van 1/imersma Greidanus et al 1976). 
lfuen injected 30 60 or 120 oins prior to training re-entry 
latencies 24 and 48 hrs later were significantly louer than normal 
serum controls. Injections 3 hrs before trainin3 decreaserl re-entry 
latencies only at the 46 hr test and when injected 6 hrs prior to 
training the serun was ineffective. Similar effects were reported 
when 1ul of serum was injected at these intervals after training but 
injections 1~ere ineffective 11ith intervals equal to or exceeding 6 
hrs. However control injections of normal serun \/ere only ~iv"n "' JV 
mins before training and not at each .injection interval. This 
increases the rlifficulties of interpretation by failing to control 
for the behavioural effects of injection per se at different 
intervals before and after traininr,. The data presented in experiment 
(see section 5. I fig 1q ) shm1 that avoidance response levels in 
extinction vary as a function of the post training injection interval 
even with SAline injections. Sinilarly Riffee et al (1979) have 
reported that pre injection routines per se alter behavioural 
responses to rlrur, treatments. 
Dose response studies have shmm that loHer antivasopressin 
serum doses (0.1, 0.033 ul) significantly reducerl re-entry latencies 
24 and 43 hrs later when injected im1aeciiately after training (van 
Hinersr.1a et al 1976). The loHest dose tested (O.f)l ul) reduced 
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re-entry latencies only at the 48 hr test. The effects on passive 
avoidance retention cannot be attributed to increased motor activity 
as treatment with anti-vasopressin serum during pole jump avoidance 
training also facilitated extinction (van \limersma Greidanus et al 
1975). The absence of any effects on learnin~ perfor1~nce confirmed 
previous observations that vasopressin does not affect learning per 
se. 
When injected 60 mins prior to the first retention test 
antivasopressin serum (lul) significantly reduced re-entry latencies 
during the subsequent test but not during the second test 24 hrs 
later, lov1er doses (0,1, 0.033 ul) significantly reduced re-entry 
latencies in both tests. It was concluded that information retreival 
as \·Jell as consolidation was disrupted by destroying centrally 
available vasopressin, as evidenced by lo\ler re-entry l<•l«tiCit!t< dl 
the 24 hr test for all doses. r:.e-entry latencies were also lo~1er than 
control levels 48 hrs after injection in the case of the two lower 
doses but not the high dose. It was argued that the high dose 
prevented consolidation of information gained on the first re-entry 
test when re-entry 1~as rapid therefore these rats were behaving in 
the second test as if their behaviour was normal on the first. This 
is an elegant explanation but not entirely consistent with previous 
results Hhich showed that lo11 doses of serum also disrupted 
consolitl.ation. 
Disrupted passive avoidance retention follo11ing immediate 
post training destruction of centrally available vasopressin a~rees 
well ~~ith the findings of studies 1~hich used vasopressin injections. 
However the use of antiserum arp,uably constitutes a phar~cological 
manipulation ie vasopressin content is reduced below the normal 
physiological level • Subse'luent behavioural changes· nay not reflect 
the normal physiological functions of the peptitl.e. In addition , the 
specificity of antisera to their tarset conpounds is difficult to 
establish. Cross reaction uith unkno~m but structurally similar 
COIJpounds cannot be ruled out. Lack of pharmacologic<ll agonists and 
antagonists for vasopressin leaves the possibility of rcceptor 
mediation of behavioural effects unresolved and prevents the use of 
standard psychopharmacological techni'lues for identifying nornal 
physiological functions. 
2.6. :·lirl-nrain and Limbic Sites of Action. 
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A number of studies have attempted to determine the brain 
areas involved in mediating vasopressin's behavioural activity. That 
these effects are centrally mediated has been assm.1ed on the !:lasis 
that peripheral target organ effects appeared not to be involved 
(section 2.3) that central injections were more potent than 
peripheral (section 2.3) that antivasopressin seru~ disrupted 
responding when injected centrally but not peripherally (section 
2.5.5) and that vasopressin could be demonstrated in high quantities 
in tl1e CSF (section 1.3.3) and in extrahypothalamic fibres (section 
1.3.4 ), The results from lesion studies described below sug3est an 
important role for mid - brain structures. 
Nicro injections 
resistance to extinction of 
of LVP ( 0.1 ug) increased subsequent 
pole jump avoidance respondinr, 1~hen 
injected 
1973) 
posterior 
into the posterior thalamus (van \li~ersna Greidanus et al 
but not the venteror.~edial and anteronedial thalamus, 
hypo thalamus, substantia nizra, substantia grisea, 
reticular formation, 
studies sh011ed the 
putamen and 
parafascicular 
dorsal hippocampus. Subsequent 
nucleus of the thalamus to be 
sensitive to vasopressin microinjections (van IHmersma Greidanus et 
al 1974 b), In addition, electrolytic lesions in this region reduce 
the behavioural activity of the peptide (van Uimerst~a Greidanus et al 
1974 b). After post operative recovery rats 11ere trained to avoid 
shock (unspecified) in the pole junp apparatus on 4 consecutive days 
then tested in extinction on days 5 and 3 Lesioned rats showed 
poorer learning and extinction perfor10ance than sham operaterl 
controls. On day 9 rats were retrained for 10 trials then on the lOth 
day 10 extinction trials 11ere follo11erl by injections of saline or -LVP 
(1,8, 5.4 ug se), Both doses increased extinction responding in sham 
operated controls during 3 subsequent extinction tests. Extinction 
responding in lesioned rats was elevated over 3 days by the highest 
LVP dose and over the first 2 days by the lo1·1er dose • Ho~mver, 
despite these increases the response levels of lesioned rats did not 
match those of controls. It was concl•Jcled that although destruction 
of the parafascicul.tr nucleus reduced sensitivity to vasopressin the 
are'l 1~as not essential for the behavio•Jral effects of the peptide 
(van \limersrna Greidanus et al 1974 a,c). 
Lesions of the rostral septun coupletely disrupted the 
effects of LVP on pole jump avoidance extinction (van \limcrstla 
fill 
Greidanus et al 1974 a). Lesioned rats showed deficient learnina but 
during extinction saline treated shams and lesioned rats responded 
similarly. LVP (3 ug) retarded extinction in shams but neither J or 9 
ug's affected the perforuance of lesioned rats. In adclition small 
lesions to the anterodorsal hippocampus prevented the effects of lm1 
(1,3 ug) but not a high dose (9ua) of LVP. 
Lesions to the amygdaloid complex also prevented the 
extinction effects of vasopressin injectio~s. Post operative pole 
jm~p avoidance training revealed no si3nificant differences bet11een 
sham operated controls and rats with extensive bilateral electrolytic 
lesions in the amygdala during learnina or extinction. LVP (3 u~ se) 
enhanced subsequent extinction response levels when injected 
immediately after the first extinction session in sham operated rats. 
llowever,neither J nor 5 ug se exerted any influence in lesioned rats, 
(van llimerst1a Greidanus et al 1979a). 
Pre and post commisural fornix lesions which 
effectively disrupt septo-hippocampal pathways , did not prevent the 
effects of LVP on pole junp extinction responding (van llimersr.ta 
Greidanus et al 1979 b) tl~reby contradicting earlier conclusions 
that an intact Limbic system is required for the behavioural effects 
of the peptide (van \limersna Greidanus et al lq74), In 
sm.unary , the results f ron lesion studies indicate that although 
destruction of the parafascicular nucleus and dorsal hippocampus 
reduce sensitivity to the behavioural effects of vasopressin their 
anatomical integrity is not essential. In contrast destruction of 
both the rostra! septun and amygdaloid conplex block the behavioural 
effects of LVP. The functional relationship bet1~een these structures 
with respect to the behavioural activity of vasopressin is unclear 
lesion studies alone cannot C01:1pletely characterise the regional 
basis for vasopressin's behavioural effects. Although the effects of 
lesions may reflect cla1nage to vasopressinergic fibres found in the 
limbic syster.t (see section 1.3.4) there is no direct evidence to 
support this conclusion. 
Subsequent experiments usin3 post training nicroinjections 
of AVP into brain nuclei have indicated a role.for the dorsal I 
medial septal nuclei, hippocampal dentate gyri and dorsal raphe 
nucleus in mediating the effects of AVP on step throuzh passive 
avoidance responding (Kovacs et al 1979a). nilateral injections of 
AVP (25-25 pg) a dose insufficient to affect behaviour t~hcn 
injected into the ventricles (llohus et al 1978) , directly into the 
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dorsal septal nucleus immediately after passive avoidance training 
si3nificantly increased re-entry latencies 24 and 48 hrs later 
compared to saline (Kovacs et al 1979 a), Oxytocin , which is 
structurally related to vasopressin (see section 1.2) injected 
bilaterally into the dorsal septal nuclei (25-25 pg) also increased 
re-entry latencies 24 and 48 hrs later. Althou~h experiments using 
ICV (Bohus et al 1978) and peripheral (Shultz et al 1974 ) 
injections have reported opposite effects for oxytocin and AVP on 
passive avoidance retention and hippocampal theta rhytlm (llohus et al 
1978). In contrast microinjections of AVP into the hippocampal 
dentate gyri increased IJhilst oxytocin decreased subsequent 
re-entry latencies. AVP injections into the adjacent subiculum were 
ineffective (Kovacs et al 1979a). Both AVP and oxytocin increased 
re-entry latencies 24 but not 43 hrs after a midline injection of 50 
pg into the dorsal raphe nucleus. Neither peptide affected behaviour 
when injected bilaterally (25-25 pg) into the amygdaloid complex 
although previously van IHmersma et al ( 1979a) reported that 
amygdaloid lesions blocked the effects of systemic AVP (see above) on 
pole jump avoidance responding. This discrepancy may reflect 
methodological differences such as the injection route and 
behavioural task , alternatively the disruptive effects of amy3daloicl 
lesions r.:tay have heen due to damace inflicted on nearby structures or 
fibres of passage 
2.7. C::atecholatdner?,ic Involvement, 
Catecholaminergic (CA) pathways in· the OIS may play an 
important role in mediating tl1e behavioural effects of vasopressin, 
LVP (300 mu/kc) injected 10 mins prior to training dirl not aftect tile 
step up response to shock , but si~nificantly increased subsequent 
step rlown latencies in a passive avoidance task (Kovacs et al 1977) 
Pretreatment with the CA synthesis blocker alpr.a-met!:.yl-para-tyrosine 
(AliPT) (30 mg/ke) , 1-1hich did not itself alter responding blocked 
the effects of LVP. Analysis of the CA content of brain regions 
showed that 10 mins after LVP injections rlopar.Jine (DA) levels in the 
hypothalamus septuo and striatun were elevatecl compared to saline 
injected controls •1hereas noradrenaline (NA) levels renained 
unchanged. In order to determine effects on turnover AHPT (250 :.tg/kz) 
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~~as injected td·th LVP (300 mu) and 4 hrs later rats \Jere decapitated. 
This higher dose of A!·!PT reduced CA levels by 60-70% but d .~ l.u not 
affect passive avoidance responding (Xovacs et al 1977). LVP 
increased the rate of NA dis'":'appearance tn the septum hut not the 
hypothalamus or striatun and of DA in the septun and striatun but not 
the hypothalamus (Kovacs et al 1977). 
A more exact regional characterisation Has attempted by 
Tanaka et al ( l977a). AHPT (300 mg/kg ip ) injections were follo11ed 
after 30 mins by AVP ( 10,30,,100 ng icv) injecti-ons· and 3 hrs later 
rats were decapitated and brains dissected for subsequent analysis of 
NA. and DA content. 10 ng AVP did not alter CA disappearance , 30 ng 
increased the disappearance of NA in the medulla oblong·ata and of DA 
in the preoptic area. lOO ng of AVP increased !lA disappearance only 
in the thalamus and hypothalamus. NA levels in the septal region , 
preoptic area , amygdala and hippocampus and DA levels in the septal 
region basal ganglia and anygdala were unaffected. The absence of 
significant effects of 10 ng of AVP on CA metabolism despite the 
behavioural activity of much lower doses injected by the same route 
(I ng pg; Bohus et al 1978) may indicate either that: CA metabolism 
changes are not involved or that the assay technique is insensitive 
and the analysis of large areas of tissue is inappropriate. In view 
of CA metabolism changes seen in H0-01 rats and in norml rats 
treated with anti-vasopressin serun the latter interpretation has 
been widely accepted (see below), 
Lack of effects on CA netabolisn in areas which 
~icroinjection studies suggested to be sensitive to AVP 
·particularly the hippocampus pronpted rneasurenents in discrete 
nuclei on the basis that changes within major anatomical areas are 
likely to be relatively ·restricted. Tanal~a et al (1977b) raeasured 
changes in CA levels in 35 selected nuclei follotling injections of 
AVP (30 icv), AiiPT <~as injected IP 30 mins prior to peptide 
inj~ctions. Rats were decapitated 3.5 hrs later and CA levels 
neasured in nuclei di~ected by tissue punching. c!A levels tJere 
A 
depleted in the dorsal septal nucleus,· aedial fore brain bundle, 
anterior hypothalamic nucleus parafascicular nucleus and dors"l l'aplll" 
nucleus after AVP injections. Decreased steady state le~els after 
synthesis inhibition Has interpr'etecl as indicatil'lG accelerated CA 
ciisappearance due to elevated neural activity. AVP increased i!A 
levels in the supraoptic nucleus and nucleus ruber 
decreaoed neural activity. DA levels Here decreased in the caudate 
. 
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nucleus, median eminence, dorsal raphe and region A3 of the 
mesencephalon following AVP. Furthermore there •~ere no significant 
changes in NA levels in the nuclei of the amygdaloid cot:tplex, 
subiculura, dentate gyrus or CA2 region of the hippocaMpus follO\~ing 
AVP inject.ions. OA was undetectable in the cortical or merlial 
amygdaloid nuclei or in the hippocampus. 
Accelerated NA disappearance in the dorsal septal nucleus 
and of NA and DA in the dorsal raphe nucleus is in accord with the 
suggestion that the behavioural effects of microinjections of 
vasopressin into these areas may involve CA nerve terminals. 
Furthermore , NA depletion in the parafascicular nucleus supports the 
conclusion from lesion studies that this area is sensitive to the 
effects of AVP on pole jump avoidance responding (see section 2.6.1). 
The absence of CA changes in the amygdaloid conplex is in accord with 
the insensitivity of the area to AVP microinjections (Kovacs et al 
1979) but conflicts 1~ith the report that bilateral amy:;daloid lesions 
block the effects of AVP on pole jump extinction (van Hi:.tersma 
Greidanus et al 1979a). If the co11plex is essential for the effects 
of LVI' on avoidance then this may not involve CA neurons. If the 
behavioural effects of AVP are nediated l>y noradrenergic nerve 
tenninals in the dentate gyrus then the absence of CA Metabolism 
changes in the area after larger AVP injections conflicts with the 
report that this area is behaviourally sensitive to AVP 
microinj ections. Changes in !JA metabolisr.t in the supraoptic nucleus 
following AVP injections may reflect altered 
result of inhibited AVP secretion fro1'1 
although previous studies using AVP and its 
neural activity as ,J 
the posterior pituitary 
antiseruM injected ICV 
did not report alterations in peripheral AVP levels (van liimersl'la 
Greidanus et al 1975;1976). In addition the existence of an 
inhibitory feerlback loop for regulating vasopressin secretion is not 
well supported (see section 1.5).The functional si~nificance , if any, 
of decreased NA in the nucleus ruber and of altered DA Metabolism 
in the median eminence and region AS is not clear. 
Behavioural deficits in IIQ-DI rats which lack the 
capacity to synthesise vasopressin (see section 1.9.2 ) have been 
used in support of the arp,ur.tent that effects on avoidance extinction 
reflect a physiological role for the endogenous peptide. The 
evidence for this has been discussed (section 2.5.2,3,4) and found to 
be equivocal , however acceptance of this conclusion coupled with the 
evidence that AVP altererl CA 1~1etaholisrt in discrete brain rer,ions 
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(Kovacs et al 1977; Tanaka et al 1977 a,b) prompted an examination 
of CA levels in HO-D! rats compared to non rn 1i tterl!lc"ltes (Versteeg 
et al 1973). Rats were decapitated 3. 5 hrs after an injection of A:·IPT 
and nuclei dissected out using a tissue punch technique.· Steady state 
levels of NA 1-mre higher in the dorsal septal nucleus and supraoptic 
nucleus of HO-D! rats turnover was aarkedly increased in these 
regions. HO-D! rats showed lover HA rate constants in the arcuatn .~ne! 
parafascicular nuclei , the rostra! nucleus tractus solitari and 
slightly increased turnover in the periventriclar nucleus , medial 
fore brain and anterior hypo thalamic bundles. DA levels 1~ere 
unaffected but in 110-Dl rats the rate constants were reduced in the 
caudate nucleus , median eminence , the A2 region and CA2 of the 
hippocampus. Adrenaline levels and rate constants were lower in the 
paraventricular nucleus. 
Similarly , antivasopresin serun injected !CV 30 mins after 
NWT injections has been reported to decrease liA disappearance in the 
dorsal septal and parafascicular nuclei and in the nucleus of the 
solitary tract 3 hrs later. DA disappearance was decreased in the 
caudate nucleus and re3ion A2 of the medulla oblongata (Versteeg et 
al 1979). 
To evaluate the hypothesis that the opposite effects of 
exogenous vasopressin and endogenous deficiencies of the peptide on 
behaviour are mediated by opposite effects on CA activity requires 
cor.tparison across the experiments of Tanaka et al (1977) and Verstee3 
et al (1978 ,1979). The significance of such comparisons for 
unrlerstanrling the biochenical basis for the hehavioure1l actions of 
vasopressin is limited by tl1e fact that at 30 ne the dose 11sed by 
Tanaka et al (1977) <IllS considerably lar~er than that nor=lly used 
to elicit buhavioural effects \~hen injected rev and the behavioural 
effects of this ltigh dose have not been reported.Opposite effects on 
IIA metabolisr.t ucrc reported for the dorsal septal and parafascicular 
nuclei when the effects of AVP injections (Tanaka et al 1977) are 
conpared uith endogenous AVl' deficits in HO-D! rats (Verstee~; et al 
1973) and artificial deficits after antivasopressin serum injections 
(Versteeg et al 1979). Opposite effe'cts on !lA netabolism c1ere also 
reported in the supraoptic nucleus 'lnd medial forebrain and 
anterior hypothalaMic bundles 1~hen levels after AVP injection are 
compared to the effects of endo~enous deficits in 110-DI rats. CA 
metabolism in these areas remained unaffected by anti-vasopressin 
serum. This nay be due to reduced nccessability to these areas for 
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the serun , alternatively , the effects of AVP injections ~ay reflect 
phar~cological effects at 
physiological involvement. 
these nuclei 
Opposite changes 
rather than normal 
in OA neta holism 1~ere 
reported for the caudate nucleus follo11ing AVP injections compared to 
both !10-Dl and anti serun treated rats. DA was also opositely 
affected in the IJedian eminence when AVP injected rats are conpared 
to 110-DI rats. o\nti seruL1 did not affect OA netabolisr!! in this 
region. AVP also altered CA metabolism in the nucleus ruber , dorsal 
raphe nucleus and regions Al , A6 and AB of the mesencephalon whereas 
no changes were observed in these regions in 110-DI rats or following 
anti serun. The discrepancy in reeion A6 (locus coeruleus) raises the 
question of the extent to ~1hich IIA changes in the cell bodies of 
fibres formin3 the ascending noradrener3ic systen participate in 
mediating the behavioural effects of exogenous AVP. Kovacs et al 
( 1979 , 191!0 ) have argued that these cell bodies do not participate 
on the hasis of microinjection studies (see belo~1) , thouzh clearly 
the neurochemical .-!at a des cri bed indicate possible involvement. 
Areas which appear sensitive to the behavioural effects of 
vasopressin receive noradrenergic input fron fibres of the rlorsal 
noradrenergic bundle originating in the locus coeruleus. Destruction 
of this system using bilateral injections of the specific neurotoxin 
6-llydroxydopamine (6-0l!DA) injected into the dorsal noradrener_\lic 
bundle blocked the effects of AVP (5 ug se) injected i~~ediately 
after passive avoidance trainine on re-entry latencies 24 and 48 hrs 
later. IIA depletion 1.1as confirmed in the dentate gyrus and A6 
regions, DA levels in these structures were unaffected. Durin~ the 
first test lesioned rats injected with saline showed no retention 
effects althour,h 24 hrs later they had sicni ficantly lo11er re-entry 
latencies than sham saline controls , indicntin~ only a very minor 
effect of the lesion itself on passivt! avoidance responding. The 
results indicated that an intact dorsal noradrenergic bundle 1ms 
required as a substrate for the effects of vasopressin. However 
r.licroinjections of the peptide (25 pg !Jilaterally) into the locus 
coeruleus itself did not affect subsequent re-entry lntencies in 
otherwise intact rats. As the noradrene!}ic cell horlies appeared to be 
insensitive it was concluded that the effect ~ms I:lediaterl at the 
fibre ter::~inals (l~ovacs et al 1979). Post traininr, microinjections of 
AVP into the dorsal raphe nucleus, 11hich receives inputs fOia the 
locus coeruleus, ~lso facilitated subsequent retention except in rats 
Hi th lesions to the nucleus inrluced by either (>-O!IilA or 5,6 
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Dihyroxytryptamine (5,6,DIIT) t.ffiich elevated SHT uptake in the 
mesencephalon and dorsal hippocampus. Hm~ever, 5 ,6-DHT lesions did 
not block the effects of systenic AVP (5 ug se). This nay sug3est 
that an intact dorsal raphe serotonergic system is not required for 
mediating systemic effects but as comparable tests on rats •~ith 
6-0HDA lesions to this structure were not carried out the role of 
noradrenergic fibres in the dorsal raphe nucleus is uncertain. 
Schulz et al (1979) have ar~ued that the effects of AVP on 
striatal DA are mediated presynaptically. Unilateral rlestruction of 
the substantia nigra using 6-0!IDA results in ipsilateral fibre 
degeneration , reduced striatal DA levels and supersensitivity at 
post synaptic striatal OA receptors. Activation of presynaptic 
receptors induces ipsilateral rotation in rats due to the preclo"Jinant 
influence of presynaptic terminals on the intact side. Conversely 
postsynaptic activation results in contralateral .rotation due to 
supersensitivity of postsynaptic receptors on the sine of the lesion. 
LVP (50 ng ICV) induced significant increases in ipsilateral rotation 
indicating a presynaptic effect. Similar results •~ere reported for 
oxytocin and PLG. Direct microinjections of LVP into the substantia 
nigra of intact rats did not induce assynetrical rotation and Schulz 
et al ( 1979) concluded that as the effects of LVP appeared not to be 
mediated either at the level of the cell body or postsynapticRlly the 
influence of the pe!ftide was probably at DA terminala in the 
striatun. 
To sunmarise the data show that in tile absence of CA 
synthesis AVP alters CA metabolisM in discrete brain nuclei ~~hen 
injected into the brain ventricles in doses which are in excess of 
those required to demonstrate behavioural effects in intact rats. ~Jo 
changes in CA netabolism 1·1ere 'reported following 10 ng , therefore 
the .effects of AllP are either not mediated by CA neurons in llhich 
case CA metabolisn changes are pharmacolof~ical artifacts or 
alternatively the behavioural effects of AVP involve CA neurons but the 
procedures are insensitive to r~etabolism changes after lou AV!! doses. 
Evidence from studies of HO-DI rats and follm~ing the rlestruction of-
endo~enous AVP by antiserum support the second conclusion. !fo~Jever in 
the absence of phar;nacological ar;onists and antagonists questions as 
to the nechanism unrlerlying the interaction between CA neurons anrl 
vasopressin refilained unansuererl. Some of the evirlence supports the 
aq;ul.!ent that the peptide acts presynaptically on :lA Rnd nA neurons 
although the existence of presynaptic receptors rcnains speculative. 
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1-lith regard to the brain nuclei involved the evidence from lesion , 
microinjection and CA metabolism studies is contra<lictory ,with the 
exception of NA in the dorsal septal nucleus and nA in the caudate 
nucleus the effects of manipulating AVP levels are not consistent 
across studies , ho•tever these differences 11ay reflect nethodological 
factors. Delanoy et al (1973) reported that follo11ing ICV injections 
of AVP; LVP and AVT ( 0.1 1 ug) mice sho11ed hyperac ti vit y and 
excessive foraging and grooming. This response was not altered by a 
wide range of drugs known to affect CA and cholinergic transmission. 
There are no reports of similar reactions in rats, the underlying 
mechanisms are not tvell understood but may indicate changes in 
menbrane characteristics rather than at receptors , evidence from 
invertebrate cells indicatinr, that vasopressin alters Ilenbrane 
responses to stimulation in vivo have been discussed previously 
(section 1.10). 
2.8 Vasopressin's effects on ilorphine and Alcohol Tolerance. 
Vasopressin and related analogues have been reportecl to 
alter the development of morphine tolerance and self adr.linistration • 
Studies by Krivoy et al (1974) shm1ed that vasopressin enhances the 
developnent of oorphine analgesia in nice. Chronic adr.linistration 
three times daily of increasing doses of morphine sul;>hate (5-20 mg 
/k'J, bw) increased response latencies on a hot plate conpared to 
saline controls. Tolerance developed over 5 days on this re3i1ne ,as 
indicated by decreasing latencies. 1-lhen morphine injections were 
followed by DG-LVP (SO ug) reaction times were further reduced , 
indicating facilitation of tolerance development. The sane close of 
DG-LVP was ineffective in saline controls • In aclclition Cools et al 
(1977) reportecl that DG-LVP accelerated the clevelopnent of tolerance 
~then injected directly into the nucleus linearis intermedius raphe in 
freely moving cats. Conversely tlle developnent of tolerance in l!Q-DI 
rats occurs ~~ore slm1ly than in their HE-DI litter1~ates (De \lied and 
Gispen 1976). Furthermore as Terenius et al (1975) reported that 
DG-LVP shot·ted no affinity for dihydronorphine binding sites normal 
bindinr, of norphine to its receptors appears not to be disrupted by 
t~e peptirle. 
Sinilarities bet~teen the effects of drugs on learniCJr, 
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tasks and the development of morphine tolerance lerl. to the sur,3estion 
that similar mechanisns may underlie these processes ~t a cellular 
level. The action of puromycin , which blocks protein synthesis ( see 
section 2.4.1 >,on avoidance retention is blocker!. by DG-LVP (Lanrle et 
al 1971),Furthermore puror:~ycin , actinomycin and cycloheximide all 
block the developtlent of tolerance to norphine (Cohen et al 1965; Cox 
et al 1970) suggesting a cor:unon nechanisl'l involving protein synthesis 
in learning and tolerance development. Sei3el (1975) argued that 
tolerance to small morphine doses is a learned response involving 
compensatory physiological responses initially elicited by nor phi ne , 
which cone to be elicited by environraental stimuli associated tlith 
norphine administration. However the failure to observe extinction of 
tolerance to large morphine doses (Sklar and Amit 1973) and failure 
to replicate Seigel' s original findings (Shearman et al 1979) su3gests 
that learning nay not be involved • In addition the importance of 
puronycin's effect on protein synthesis per se for understanding its 
effects on behaviour are equivocal (see section 2.4.1). 
That narcotic analgesics have distinct stimulus properties 
has been shown by Colpaert (1979). Van Ree and de !Hed (1977) 
reported that pretreatment t·lith nG-AVP suppressed heroin self 
administration conpared to saline injections , an effect t~hich the 
authors argued 11as due to reduced reinforcing stimulus properties of 
the narcotic after the peptide mediated by interfering with 
dopaminer3ic transmission. In contrast Hello anrl ilendelson (1979) 
failed to find an effect of DG-AVP ( 25 ; 125 ug/kr,) on morphine self 
administration in dependent rhesus monkeys or on food self 
adr.tinistration. Although the discrepancies may reflect "'ethodological 
differences between the studies , particularly species and schedules 
of reinforcement' the findings of Hello et al ( 1979) aq~ue against a 
role for vasopressin or related analogues in ,,,odulat ins the stimulus 
properties or narcotic analgesics. ~lore recent theories of opiate 
dependence and 11ithdra1~al stre.'ls the importance of events at the 
cellular level such as reduction of opiate receptor populations 
follo11ing prolonged r.1orphine exposure ( Shulz et al 19130) 
and hypertrophy of second messenger systens (Collier et al 1980). 
Tolerance also occurs to the effects of alcohol following 
prolon~ed consunption and uithdrawal symptoms are seen uhen 
consumption is prevented. The il'lportance of learnin~ as a factor in 
the alcohol dependency syndro!le (Crab be and Rigter 1980) coupled 11ith 
the possibility that tolerance rlevelopmem: and learning may involve 
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analagous processes at the cellular level have pro~pted experi~ents 
on the effects of vasopressin derivatives on the developnent of 
a1'cohol tolerance and tdthdrm~al (Crabbe and Ri~ter 19fl0). A nu071her 
of factors ha~per the developnent of satisfactory animal modela for 
the alcohol dependency syndro11e Strong aversion to alcohol and 
hi:;her alcohol netabolis~l rates in rodents .force. experimenters to use 
special strains of rats intragastric feeding or inhalation of 
alcohol. funes , high doses and prolonged intoxicatication in order to 
demonstrate to1erance and t~ithdratml phenonena. Hoffr.~an et al (1979) 
have reported that repeated AVP injections (10 nf~) slowed dmm the 
rate at t~hich ethanol tolerance disappeared in rti.ce r.~easured hy 
changes in body temperature and sleep time. They postulated a central 
mechanism on the basis that ethanol metabolisn per se was unaffected 
by AVP, Crahbe and IU3ter (1980) have confirmed these findings using 
constant infusions of DG-AVP via r~ini;mnps , pepti:le treatment also 
exacerbated withdrawal syr1ptons e. g convulsions. In the absence of 
discrete stimulus response events these results do not easily lend 
themselves to interpretation in terms of learning. !~re convincing 
data has been reported by Hucha and !(alant ( 197'J) who found that 
DC-LVP injections enhanced the increase of alcohol intake seen Yith a 
forced consur.~ption design although it was ineffective when alcohol 
intake uas stable at the r.~aximur:~ level accepterl by each rat. Although 
this resembles facilitated response acquisition· the relevance of the 
comparison is uncertain 
high doses (42 u3), 
as LVP was conpletely ineffective even 1lith 
2.9. Sur~mary anrl Conclusions. 
Early studies showed (section 2.1) that reuoval of the 
posterior anrl anterior lobes of the pituitary gland induced a deficit 
in active avoidance respondin3 which could be corrected by 
replacelilent witl1 posterior lobe extract A.CT11 ,! IS;{ and LVP 
independently of pressor and antidiuretic functions. Suhseqtlently it 
v1as shown that synthetic vasopressins increRsed active and passive 
avoidance in extinction 11hen injecterl peri:lherally in i~tact rats 
Although soqe of the early studies 11ere 1acthodolosically narred tly 
tile use of snall <;roups , restrictive behavioural criteria , onission 
of statisticnl test;; (sec section 2.1) and failure to establish 
conditioned passive avoidance in control ~roups (Ader et al 1972 ; 
Bohus et al 1972; !~ang 1972) the evitlence fir:nly supports the 
conclusion that vasopressin injections 
avoidance extinction. As si~ilar effects 
ex~eriments using avoidance· of 
increase responding 
have been reported 
trained 
(Leshner and Roche 1977; Roche and Leshner 1979 ) 
in 
in 
t.lice 
and 
sexually re1mrded behaviour (Balms 1977) the effects of vasopressin 
injections are not restricted to shock motivated respondin~ • 
Evidence that the behavioural potency of peripherally 
injected vasopressins decreased, as the interval bet1-recn training , 
first extinction session or first retention test and vasopressin 
injection increased,sug3csted time dependent changes in the substrate 
with which the peptides interact. Of particular importance are those 
results indicating that potency diminishes as a function of t~e 
interval 11hen the peptides were injected after training, thereby 
eliminating the possibility of disrupting normal learning. Time 
dependent reductions in potency fit well with the hypothesis that 
time dependent physiolo~ical changes underlyin~:~ menory consolidation 
are affected by vasopressins. Increased respondin~ in subsequent 
extinction tests ,according to this hypothesis , reflect facilitated 
consolidation. The effects of vasopressins appear to be hi3hly 
specific to the extinction phase of behaviour , with the exception of 
de \lied (1973) uho reported facilitated learnine 11ith ornithine 
vasopressin and a transient facilitation with lysine vasopressin 
there are no reports of effects on learning per se although a nunber 
of studies ltave injected the peptides during and prior to training. 
The consolidation hypothesis alone is insufficient to 
account for all the data. A. nm:tber of studies have reported increased 
passive avoidance responding IJhen vasopressins 1-rere injectetl 1 !tour 
prior to extinction tests (23 hrs after training).Retrogratle activity 
spanning s\.lch a lon3 period has been considered unlikely and several 
authors have postulated an ad,litional effect on response retreival, 
ho1-1ever interpretation of results fron pre test injections l'lay be 
confounded by subtle influences on motor or sensory capacities. 
Pretreatment with vasopressin analocs partially reverses 
t"te response <leficits caused by anoxia, ECS, )'lentylenetetrazol and 
pnronycin, deficits normally interpreted in ter:ns of retro~rade 
amnesia. Hm1ever in the ahsence of a coherent theory of t'l.e 
physiological mechanisMs involved in these effects it is difficult to 
clr.:m an:1 conclusions as to the 1~echanisns involved in necHatin~ the 
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effects of vasopressin in these experiments. 
Direct measurement of catecholaminergic netabolism changes 
has revealed altered raetabolism in a number of discrete brain nuclei 
following vasopressin injections into the lateral ventricles of the 
brain, supporting a role for CA neurons in mediating vasopressin's 
behavioural effects. Hollever these changes l~ere seen after a dose 
which ~1as sooe lOx hir,hcr than that normally required for behavioural 
effects via this route The discrepancy proh:lbly reflects 
methodological difficul tics associated with •~ensuring small 
quantities in restricted tissue sal'lples although the extent to 11hich 
CA metabolise changes nay represent pharmacological artifacts is 
difficult to evaluate. 
Considerable experimental effort has been directed towards 
establishing whether or not vasopressin's behavioural effects and its 
effects on CA metabolism reflect a normal physiological role for the 
endogenous peptide. Evidence fron 110-DI rats which lack the capacity 
to synthesise vasopressin is conflicting, discrepancies nay reflect 
methodological differences or the confoundin~ effec~s of the severely 
abnormal endocrinolo:;y of these rats. Studies using specific 
antivasopressin serum show that the destruction of centrally but not 
peripherally available vasopressin reduces subsequent passive 
avoitiance retention , this contrasts \lith the effects of vasopressin 
injections. Attempts to demonstrate time dependency in this effect 
are r.tethodologically marred and t~hen injected prior to passive 
avoidance extinction the dose response relationshi~s were 
inconsistent with previous findings. Fu rthcr~:~ore antisera nay destroy 
unidentified conpounds with structural simil:lrities to the 
vasopressin nolecule. Studies fron intact , HO-DI rats and antiserun 
treated rats agree on the sensitivity of HA r~etabolis::~ in the Dorsal 
septal nucleus , parafascicular nucleus anrl of DA uetabolis:1 in t~\C 
caudate nucleus to altered vasopressin levels. Vasopressins also 
alter the developnent of morphine tolerance an•l alcohol consunption 
and withdra1ml syt:1ptoms, the relationship between these effects and 
altered conditioned responding is unclear but may involve CA neurons 
also Attempts to dra1v parallels between learnin[l and tolerance 
effects have met with only partial success. 
The mechanisrt underlying putative interactions between Ct\ 
neurons and vasopress ins re1nain to he cleterminecl, ltece ptor 
populations for the peptide in the C~IS have not been identified. 
Electrophysiological data fron invertebrate preparations (sec section 
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1.10} indicate effects of the peptides quite distinct from putative 
transnitter effects. These studies may provicle clues to the action of 
vasopressins in the mamnalian CNS , the activity of neuropetides is 
nm~ discussed by many authors in terms of modulating transmitter 
functions (Dismukes l9SO). 
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C!lAPTER 
TilE EFFECTS or RESl'Ot!SE PREVENTIOti Otl AVOIDAc!CE CX1'HJCTION, 
3. o n:nnnucTHW. 
In contrast to the effects of post tr'linin~ vasopressin 
injections response prevention trials , i.e. thwarting the avo.ldance 
response in the presence of the CS , decreases subsequent extinction 
responding (see belou), Behaviourally tl1is has been interpreted in 
terms of the additional 'information' conveyed durinG confine•~ent 
leading either to facilitated fear e~tinction ,learnin~ of an 
alternative response or disruption of the expectation that fail•tre to 
respond is followed by shock (see below), If the increased avoidance 
extinction response levels seen after vasopressin injections reflect 
enhanced information then vasopressin injections in 
conjunction witl1 prevention ·trials should result . in further 
reductions in extinction response levels, 'louever , King and de !lied 
(1974) found that when LVP (1 u~ SC) preceded prevention trials by 
one hour the effect 11as to increase extinction response levels 48 hrs 
later. The authors argued tl1at vasopressin did not invariably enhance 
consolici>~tion, 
This observation coupled 1~ith the effects of 
pre-retention vasopressin injections (section 2.2) are the only 
indications in t:1e literature that the consolidation hypothesis alone 
is insufficient to explain the effects of vasopressins on avoidance 
extinction. As this result may alter our understandin" of the 
behavioural actions of vasopressin, a number of experiments were 
performed to replicate and extend tl::e finding that vasopressin 
enhanced avoidance extinction when given in conjunction with preven-
tion trials (King and de Hied 1974). The purpose of t~e present 
chapter is to briefly review the response prevention literature and 
to report an experireent which replicates the effect with shuttle box 
avoidance behaviour. 
3.1 Response l'revention. 
:le thocl s for hastenin:~ avoidance extinction have attracted 
attention since i-liller (1 ~48) sug~ested that anxiety reduction 
l'lOtivate<l phobic and neurotic behaviour 
• 
avoidance respondinr, has 
since been used as an aninal model for exploring the elimination of 
persistent responding and response prevention or 'flooding' developed 
as a techni'lue for facilitating extinction. In the literature the 
ter::t5 i."esponse prevention and flooding are uRed interchangeably and 
may refer to one of three closely related procedures ; 
a) continuous presentation of the conditioned stimulus (CS) 
(Shear::Jan 1970 ;Bankart and Eliot 1971 ) also referred to as flooding 
type 1 (Baum 1973), 
b) discrete or continuous CS presentations with the response 
thwarted by a harrier (Solomon , ~nmin and l~ynne 1953 ; Pace and Hall 
1953 Carlson and Rlack 1959 ; Polin 1959 ; ) also referred to as 
flooding type 2 (Baun 1973). 
c) continuous CS exposure with part of the apparatus reraoved to 
prevent responding (Baum 1973 ; Bankart and Eliot 1973) referred to 
as flooding type 3 (Baun 1973). 
Tests of the relative efficiency of each procedure have 
producer\ conf lictin3 results. 1·/hilst sotte authors found CS exposure 
and CS exposure with responding prevented to be equally effective 
(Shearman 1970 Bauu 1973 ) and superior to CS presentations with 
responding prevented by removing part of the apparatus Oler ancl 
!laut~ 1960 ; 13anm 1973 ; La11son 1976 ) others have found CS expOflUre 
alone r.tore effective than CS exposure with respondin3 prevented 
(Polin 1959 ) and vice versa (Bennan and V.atzev 1972 ; Sankart anrl 
Eliot 1974 ) • Conflicting results probably reflect the Hide ran~e of 
methodological differences between studies. 
!terlucerl responding in extinction following response 
prevention trials has been de:;10nstrated using a nur.tber of different 
hehavioura 1 baselines inc: tntUn~ rassi vc avoidance ( Page 19 53 ; Page 
anrl Hall 1955) , one way active avoidance (B11un 1<J6(J ; 1973; 3nnl:art 
an<l Eliot 1974 :!arrazo and Riccio 1974) , shuttle box avoirlance 
(Solonon Kamin, Black 1953 ; Carlson and Ulack 1959 ; Polin 1959 
Benline and Sinnel 1967 ; Heinherger 1965 ; Shear'Jian 1970 ; Be~~an 
;md V.atzev 1972 ) , and escape respondinr, (Franchina f!t al 1975 
Franchina , 11auser and Agee 1975 ; Franchi:ta .1.nd :lyers 1976) 
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3.1.1. Additional Variables. 
Variables 1~hich have been shown· to affect the outcome of 
response prevention trials include shock level in training len~th 
of confi:1ement social facilitation , movement facilitation an~ 
positively reinforcing intracranial sti~1lation. 
In the ledee jump apparatus Baum ( 1969a) shoued that the 
effect of a fixed period (5 r.tins) of confinement on the ~rid floor of 
the shock chamber decreased as a function of increased shock levels 
in training. Tortura and Denny (1973) usinc mixed passive and active 
avoidance reported similar findings. Furthermore , a sin~le shock 
during extended overtraining trials reduced the effectiveness of 5 
mins of confiner.~ent (Baum 1961l). 
Extended confinenent in the presence of the CS rlurine 
shuttle box extinction testine; reduced e::tinction responding as a 
function of the length of confinement (Denny and \leisman 1964 
"leinherger 1965 ) • 'lowever in these studies CS exposure was 
confounded with test duration and the treatment and test fJhases were 
not independent, Su!>sequently Benline and Sinnel (1967) reported that 
Hhen variable numbers of prevention trials followed 50 shuttle box 
avoidance training trials extinction response levels >~ere inversely 
proportional to the length of confineoent, althou3h after 3 test days 
the si~nificant effect of prevention trials were eli~inated. Similar 
findings have been reported usinr, the ledge junp avoidance task ( Uau~1 
19593) • one way avoidance ( Rersh and l:eltz 19 71 j Schiff et al 1'>72 ) 
and ~1ixed active anrl pAssive avoidance (Tortura and Denny 1973)J 
although paradoxical effects have been reported ~~hen hi;3h training 
shock levels ( 1,8 oa) are combined with short confinement reriods 
(Tortura and Denny 1969a). 
These findings shou that total CS exposure or the nunber of 
response prevention trials is a key variable determining subsequent 
extinction response levels. 
variables are confounded with 
l!o~1ever J in several 
total treatment time 
studies 
(llenline 
these 
and 
Simmel P:l67; Baun 1969 ; ~ersh anrl Keltz 1971 ; Tortura ami Denny 
1973 ; Schiff et al 1972 ), Using one way shuttle hox respondin~ !~rJ 
( 1976) deconfounde:l these variables by varyinr, the nuober of response 
prevention trials then equatin~ treat~ent times across ~roups !1y 
retainin3 the rats in the apparatus l·lith the harrier re!'loved for the 
balance of their treatment period. Ten extinction trials followed 
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innedintely and shoucd a stron~ trend (p< 0,06) for an overall 
response prevention effect , therefore confounding treatment time 
~lith Cfl exposure appears to be relatively unimport11nt. 
Evidence concerning the relative importance of suppressing 
the response and.degrading response continr,ent CS termination in 
deten1lining the efficacy of response prevention trials is 
conflictinr;. Shear:nan (1970) argued that degrading the learned 
relationship betueen responding and CS terr.1ination 11as a key variable, 
Bankart and Eliot (1974) tested this hypothesis in the ledge jur.~p 
apparatus but could only confirm that response prevention procedures 
were always r.tore effective than procedures in ~1hich response 
contin3ent CS ten.tination alone was dearaded. Cassady et al (1971) 
have argued that CS termination nay only be an .i'lformative cue in 
cor.1plex tasks such as two '.lay shuttle box avoidance, the failure of 
Bankart and Eliot (1974) to replicate the findings of Shearman (1970) 
nay therefore reflect methodological differences. 
The presence of rats ~reviously hahituated to the 
apparatus , during prevention trials facilitates the effects of 
response prevention in one ~my shuttle box (Hall 1955) and ledge junp 
avoidance tasks (Baur.1 1969 b), Increased "1ovement per se rather than 
other aspects of social interaction may be the important variable as 
Lerlerhandler .:;~nd RaUla (1970) reported that mechaniclll facilitation of 
r.~ovement during confinement also increased the efficacy of a fixed 
period of confinement. Similar results have been reporterl 11ith 
movement inducer\ by electriclll stimulation of the capsule crus 
cerebri (Hunsicker et al 1973). Conversely restricted movc,:tent 
reduced the effects of confinement (llaum and i!yran 1971 ) • 
Positively reinforcing intracranial stimulation (+ICS) of 
the 1'1edial forebrain bundle (Paxton et al 1974) or lateral posterior 
hypothalal'\us (Raum et al 1973) is a potent counterconrlitioner (Reirl 
1971) and arljunct to response prevention trials. Gorrlon and naun 
(1971) reported that althour,h neither 5 nins of confinenent nor +ICS 
reduced pole jump avoidance extinction 11hen given alone a combination 
of both l·ias effective. This has heen confirmed using the le<.l3e junp 
task by Voss et al (1974) , using overtrained rats by Paxton et al 
1974) 1'ho sho\Jed that +ICS 1ms nost effective Hhen conbined 11ith 
confinenent on the grid floor, and usinc sisnalled lever press 
avoirlance by llonico (1971) ami Stone (1971). F•1rthermore the 
effects 11ere found with an interval of 72 hrs bet11cen trentnent and 
testing (Recker et nl 1977). Aversive stiMulation fron electrodes in 
!lS 
the reticularis pontis caudalis was ineffective (Baum et al 1973), 
sug:~esting that counterconditioning takes place with +!CS in 
support of this argument Prado-Alcala et al (1973) have found that 
+!CS is most effective when given tJhilst rats Here •~oving :may fron 
the safety ledge during confinenent on the 3rid floor. ~loHever 
counterconditioning is not necessarily the n1echanism unrlerlying 
response prevention itself. 
3.1.2. Theories of ltesponse Prevention, 
Four theories attempt to account for the effect of response 
prevention trials· on subsequent extinction responding. Relaxation 
theory that durin3 prevention trials ani1nals learn 
"relaxational responses". The frequency of 'emotional' responses such 
as abortive avoidance attempts and freezing decreases during 
confinement follouing avoidance training Hith do3s (Solomon Kar1in anrl. 
1-Jynne 19 SJ) and rats (naurJ and lJindra 1963). Conversely general 
mobility and 3rooming increase (Baum and Binrlra 1963; Baun 1969a; 
Spring et al 1974 ). Further::~ore variables IJhich 11.lter the efficacy 
of prevention trials also alter the occurrence of 'emotional' and 
'relaxational' responses e.g. shock levels in training (Baun 1969 b) 
, social facilitation (1\aun 1969 b), rlelayed prevention trials (llaun 
1972) and loud noise during prevention (1\aun and Cordon 1970). 
Houever , :[orokoff and Timber lake (1971) could not confirm 
these behavioural chan3es durin:~ prevention trials, despite 
significant e~cts on extinction. The term "relaxational" has been 
applied to many of the responses typically made by rats in relatively 
novel environments uith the exception of avoirlance atte•apts anti 
freezing. The rationale for this classification is not clear neither 
is it clear tJhy the occurrence of such behaviour shoulrl cause reduced 
extinction responding. 
According to two factor theory fear initially beco•Jes 
classically conditioned to the CS,Operant avoidance responding is 
then maintained by fear reduction (?1o~1rer 1947 ; Rescorla and Solooon 
1967}, Extinction of the pavlovian contingency predicts reduce<! 
avoidance respondine there fore it has been argue•1 that reduced 
avoidance responding after resnonse prevention trials re fleets 
extinction of fear of the CS. A nunber of experiments have attenptecl 
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to establish that fear of the CS is reduced after prevention trials. 
Abortive avoidance and freezing •lecreases in frequency 
during prevention trials (Baum 1969 b; naur.t and Gordon 1970; llaur.t 
1972). Following prevention trials in a one way avoidance task rats 
enter the shock compartment more rapidly than controls (Shi;"Jley et al 
1971; Bersh and Paynter 1972) and food deprived rats ate r.1ore free 
food following prevention trials ( Bersh and Paynter 1972) althoug~ 
these authors did not test extinction responding. 'Bankart and Eliot 
( 1974 ) confir~ed these findings but food consur:~ption 11as neasured 
after extinction trials thereby confounding total CS exposure across 
groups, !~hen testerl after prevention trials and before extinction 
trials foorl intake was unchanged as a result of prevention trials. 
Brief shocks during prevention increased extinction· 
responding conparecl to prevention trials alone except in the case of 
lona shock exposure (llersh and !!iller 1975; see also :tarrazo et al 
1974), Conversely , when prevention trials were paired 1~ith safety 
signals , established in training, extinction responding was further 
reduced (Hat~k and Riccio 1977). In addition !lincka ( 1976) reported 
that when rats were trained in the shuttle box ann ledge jump 
apparatus using the same CS then response prevention in either 
apparatus reduced subsequent shuttle box e}:tinctton Althou3h 
preventton trials in the shuttle box dirt not reduce ledge jut:Jp 
responding suggesting that factors other than fear extinction 
contribute to the effects of prevention trials. Suppression of 
appetitively motivated lever pressing (VI 60 secs) by the CS 11as 
reduced uhen prevention trials folloued shuttle box training Clonti 
and Snith 1976), !lm1ever this 1·1as only apparent durin[l the first 3 CS 
presentations and in Stlbsequent trials the reverse was found. Finally 
multivariate analysis of behaviour in the ledge junp apparatus 
shoHecl that response prevented rats approached the grid floor sooner 
and more frequently, spent r10re time on the grid floor and safety 
tested less and sooner than non prevented controls (approach hut not 
aliJht onto grid floor) (Corriveau and Smith 1978). 
Principal cor.tponent analysis indicated that one factor 
wltic"t the authors concluded uas fear, accounted for 52% of the total 
variance. 
Counterconditioning theory argues that :lnrinz prevention 
trials an alternative response is adventitiously patred <Jith the c~; 
and shock 011issi.on. This response, uhich is inconoatible 11ith the 
ori::;inal response then becoones the operant for fen r recluc tion. 
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In support of this hypothesis a number of studies have 
reported increased passive avoidance of the shock char~her in a one 
way avoidance tiisk follouing prevention trials. Food deprived 
response prevented rats l·Tere slmrer than controls in approachin~ free 
food in the shock compartment (Page and Hall 1953 Page 1955 
Coulter et al 1969). In these experi1~ents passive avoidance was 
tested after extinction trials thereby confoundine total CS exposure 
across groups, howeve~Linton et al (1970) reported similar findings 
when this confounding t-~as removed. !larrazo and Riccio (1974) and 
nersh and I \iller (197 5) found that prolonr,ed shocks rlurins prevention 
enhanced rather than reduced the effects of prevention trials_,a 
result \lhic:h they ar::;uer:l 1~as incotipatihle t.1ith the fear extinction 
hypothesis but supported the counterconditioning hypothesis. Further 
support for the counterconditioning theory is found in those 
experiments which sho>~ that +ICS acts as a potent adjunct to 
prevention trials (see above). 
The evidence in favour of counterconditioning is based 
alnost entirely on passive avoidance studies usi~g identical training 
procedures follo1·1ed by 5 mins of response prevention ami as such nay 
. 
reflect a specific effect of short confinenents. In support of this 
ar3ur.1ent Rorbaugh and Riccio (1970) reported that fear conditioned 
water deprived rats shmred increasinr,ly lon3 latencies to approach 
free water in the shock conpartment with confinement tines up to 5 
mins. In contrast approach latencies decreased 1dth confinement times 
from 5 to SO nins. In addition Eyesenck (1967) has reported that 
unreinforced CS exposures do not ahmys lead to enhanced extinction 
and nay have the contrary effect of enhancing fear (llapalkov 1963 
Eyesenck l96fl). 
An alternative theory of avoidance respondin~ arguer; that 
responding is naintained not by fear reduction (:!iller 19411: llo1~rer 
194 7) but by preferences and expectancies ~1hich determine the rat's 
behaviour clurin8 learning and extinction (Seligrnan and Johnston 
1973). r.:xposure to the CS-UCS contingency may activate respondin~ and 
condition fear but in terms of the 'cor,nitive' theory this simply 
reflects an animal's preference for not being shocked "'n•l allows the 
subsequent developnent of 'expectancies'.tl1at (a) responding lends to 
the preferred omission of shock and (b) not responding lends to the 
non-preferred shock. !lavin~ been established r:lurin(; traininG the 
nori'!al shock avoidance extinction procedure in uhich shock is 
sinr,ly s1ritched off, barely disrupts these established e::pect'lncies 
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as the animal will not normally detect any change in the contingencies 
until it fails to respond, at which point the expectancy that no res-
ponse leads to shock is disconfirmed, thus explaining why avoidance 
responding may be resistant to extinction (Solomon et al 1953; Seligman 
and Campbell 1965; Shearman 1970; Wilson 1973). In contrast, response 
prevention immediately leads to disconfirmation of expectancies by 
forcibly detaining the rat in the presence of the CS and omitting shock 
and therefore leads to more rapid extinction. This account does not 
depend on fear reduction for the maintenance of responding therefore 
experiments which apparently show that measures of fear and response 
rates may vary independently (see above) do not contradict the theory. 
3.2 Experiment One: The Effect of Response Prevention on Shuttle Box 
Avoidance Extinction 
Introduction 
Although extensively used in the literature, three factors render 
ledge jump responding unsuitable as a baseline for the present studies. 
The emergence of the escape ledge from the wall of the apparatus serves 
as the conditioned stimulus (CS), and does not permit presentations of 
the CS off the baseline (see Experiment 4). Furthermore, response pre-
vention in this apparatus usually involves removing the escape ledge, 
even though this is probably the least efficient method of prevention 
(see above). Finally, the ledge jump apparatus has not been used to 
study vasopressins effects on behaviour. 
These considerations prompted the choice of two way shuttle box 
avoidance as offering several advantages; the compound CS may be presented 
off the baseline (see Experiment 4); response prevention may be accom-
plished without removing part of the apparatus. Finally, it has been 
extensively used in studying the behavioural effects of vasopressins (see 
Section 2.1). 
Whilst the shuttle box offers advantages over the ledge jump 
apparatus, it also makes different behavioural demands. Bolles (1971) 
suggests that the contingencies in an avoidance schedule vary in their 
relative contributions towards establishment and maintenance of respon-
ding depending upon the apparatus used. Bi-directional avoidance res-
ponding in the shuttle box introduces an element of passive avoidance 
for the side in which shock was last experienced. 
The first objective of this experiment is to establish that shuttle 
box avoidance responding is sensitive to the effects of response preven-
tion, defined as forced exposure to the CS with prevention of the 
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avoidance response in the absence of shock. Solomon et al (1953) failed 
to find an effect of prevention using dogs and high shock. In contrast, 
Carlson and Black ( 1959) reported a marked effect using dogs with lower 
shock and massed prevention trials. Similarly, Polin (1959) found pre-
vention trials effective with rats in the shuttle box. However, Polin 
(1959) used extinction trials in which CS termination was not contingent 
upon responding. Benline and Simmel (1967) reported that prevention 
trials exerted a temporary response reduction in extinction; however, in 
this study total treatment time and the duration of response prevention 
were confounded. ·The present experiment tested the effects of prevention 
trials on rats trained with low shock levels and using response contin-
gent CS termination during extinction testing. In order to equate total 
treatment time across groups, a control group spent a period equivalent 
to that required for response prevention in the home cage. Thirty pre-
vention trials were used as extensive evidence in the literature (see 
above) suggested prolonged prevention to be more effective than short 
periods in reducing extinction responding. 
The second objective of the experiment is to establish for how 
many extinction test trials after treatment the effec.ts of prevention are 
evident. Polin (1959) and Benline and Simmel (1967) using the shuttle 
box and Crawford (1977) using the ledge jump apparatus have reported 
that the effects of prevention trials do not persist throughout extended 
extinction trials. 
The third objective l:S to determine whether or not the effects of 
prevention are found when extinction testing is delayed for 24 hours 
after prevention trials. Rats were tested either immediately (IHM) or 
24 hours after prevention. The consoHdation hypothesis proposed to 
explain the behavioural effects of LVP (see Chapter Two) should be tested 
using a post training injection (Dawson and McGaugh 19.73) in order to 
separate memory effects from confounding influences on other aspects of 
behaviour. Sufficient time must elapse between peptide treatment and 
extinction testing to allow the dissipation of short term effects. 
Therefore, it is necessary to demonstrate that the effects of prevention 
are seen 24 hours later. 
The final objective of the experiment is to establish the effects 
of 30 extinction trials on subsequent extinction responding in order to 
confirm that response prevention reduces extinction responding compared 
to an equivalent period of extinction treatment (Bankart and Elliot 
1974). However, extinction is not a well-controlled procedure; with a 
fixed number of extinction trials the experimenter cannot control the 
total CS exposure to each animal - this may prove to be an important 
90 
Fiqure4 Two way shuttle box . 
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source of variability. 
Methods 
Subjects 
Forty-eight adult male CFHB Wistars (300-500 g) from a closed 
colony at Plymouth Polytechnic (derived from stock supplied by Anglia 
Laboratory Animals Company Limited) were housed three or four to a cage 
with ad lib food and water. 
Apparatus 
Two standard commercial shuttle boxes supplied by Ugo Basille 
Company Limited and measuring 48 cm long by 21 cm high and wide (internal 
dimensions) were used. Each box was divided into two equal compartments 
by a black metal partition (21 cm x 21 cm) with a hole of 9.5 cm radius 
in the base of the partition to allow access between the two halves. In 
addition two transparent perspex partitions (3.2 .mm thick) were placed 
vertically between the floor and the roof of each compartment. These 
were positioned to form a 'v' shaped compartment with the base of the 'v' 
opening to the access hole (see Figur_e 4 ) • Pilot studies showed that 
this facilitated learning. The floor of the chamber was formed by 40 
stainless steel rods (1.25 cm (centres)) through which shock was 
delivered. The floor was pivoted at the centre and a response was 
detected when the rat moved across the centreline tilting the floor and 
activated a reed microswitch. A speaker was housed adjacent to the side 
of the chamber at the midline. Two bulbs were mounted on the roof of 
the chamber straddling the midline dividing partition. Both shuttle 
boxes were housed in sound and light attenuating chambers. 
Schedule 
There was a fixed interval of 60 secs between the start of succes-
sive CS presentations. The inter trial interval (ITI) had a minimum 
duration of 40 secs and a maximum of 60 secs. Each ITI was followed by 
10 secs of the CS alone, then 10 secs of CS plus shock. 
A compound CS was used, consisting of a mixed frequency tone (5 dbs 
above background noise of 62 dbs measured using International Scale C) 
accompanied by the illumination of two 10 watt clear bulbs mounted one 
each side of the central partition. Footshock (UCS) produced by the 
Basille control box (1.5 setting) was sufficient to induce mild flinching, 
occasionally but not usually accompanied by vocalisation. A static 
pattern of voltage differences was produced within each group of four 
consecutive bars and repeating throughout the grid floor (mean voltages: 
0.925 vac, 1.3 vac, 1.87 vac, 1.15 vac). Shock was delivered in 
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bursts of O.S seconds with I .S seconds of no shock. Pilot studies indi-
cated faster learning when shocks were spaced in this way. 
A response was detected when the animal crossed the midline whilst 
the CS was on. An avoidance response during acquisition was defined as 
a response during the CS only period which cancelled shock and returned 
the schedule to the ITI. Responses made during the CS plus UCS period 
constituted an escape response, terminated shock and returned the sche-
dule to the ITI. If the subject did not respond during either the CS 
along or the CS plus UCS period this was· a failure to respond, thereby 
preventing excessive shock exposure. Data from each shuttle box was 
recorded on a pen tracer which registered the occurrence of an avoidance, 
an escape or a failure plus the number of shocks received in each trial. 
Procedure 
Subjects were housed in an animal house separate from the labora-
tory at a constant temperature, in darkness from 6 pm to 6 am and were 
transported to the laboratory before each session. All experiments were 
run between 9 am and 6 pm. 
At the start of training subjects were allowed to adapt to the 
shuttle box for ten minutes. During training each rat received a maxi-
mum of SO trials on each of three consecutive days. Training was to a 
criterion of ten consecutive correct avoidance responses which has been 
widely used in response prevention experiments reported in the literature 
(see Section 3. 1). Thirteen rats failed to achieve criterion and were 
dropped from the study. Those animals which attained criterion were 
randomly assigned to one of six treatment groups in a 3 x 2 design. 
Three treatment conditions, retention in the home cage for 30 minutes, 
30 extinction trials and 30 response prevention trials, were first 
tested either immediately or 24 hours after treatment. These conditions 
are described below. 
(I) Home cage retention plus immediate extinction test (HC IMM). Rats 
were removed from the shuttle box and retained in the home cage for 30 
minutes then returned to the shuttle box for the SO extinction trials of 
Extinction Test I (TI). Twenty-four hours later there were SO more 
extinction tests (T2). 
(2) Home cage retention plus extinction testing 24 hours later (HC 24). 
Rats were trained to criterion then removed to the home cage. Twenty-
four hours afterwards rats were given the first extinction test (TI) 
followed 24 hours later by Extinction Test 2 (T2). 
(3) Extinction treatment plus an immediate extinction test (EXT IMM). 
Having reached criterion shock was disconnected and rats given. 30 trials 
of normal extinction with response contingent CS termination. Immediately 
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afterwards each rat was tested on SO extinction trials (TI) followed 24 
hours later by the second extinction test (T2). 
(4) Extinction treatment plus the first extinction test 24 hours later 
(EXT 24). Having reached criterion shock was disconnected and rats were 
given 30 extinction trials. Rats were returned to the home cage and 24 
hours later returned to the shuttle box for SO extinction trials (TI) 
followed 24 hours later by the second extinctio·n test (T2). 
(S) Response prevention followed immediately by the first extinction 
test (RP llfM). Having reached the criterion rats received 30 trials of 
response prevention, during which shock was disconnected and an opaque 
black barrier placed across the access hole between the two compartments, 
preventing the rat from shuttling. Twenty seconds of CS were presented 
every 60 seconds for 30 minutes. After this the barrier was removed and 
rats began the first batch of SO extinction test trials (TI) followed 24 
hours later by the second extinction test (T2). 
(6) Response prevention followed 24 hours later by the first extinction 
test (RP 24), After response prevention trials rats were returned to 
the home cage and 24 hours later returned to the shuttle box for the 
first extinction test (TI), followed 24 hours later by the second extinc-
tion test (T2). 
Training days 
Training of SO 
trials per day for 
a maximum of three 
Summary of the experimental procedure 
One 
Testing days 
Two 
HC IMM, RP IMM, HC IMM, RP IMM, 
EXT IMM groups EXT IMM groups 
given Extinction given Extinction 
Test 2 (T2). 
HC 24, RP 24, 
EXI 24 groups 
Three 
HC 24, RP 24, 
EXT 24 groups 
days. Ss trained to Test I (TI) • 
criterion of ten HC 24, RP 24, 
consecutive correct EXT 24 groups 
avoidance responses. return to home given Extinction given Extinction 
cage. Test I (TI). Test 2 (T2). 
Results 
Acquisition 
Acquisition performance was measured using five indices; trials to 
criterion, escapes to criterion, total failures to respond and total 
shock pulses. The data for each subject is contained in Table AI (the 
prefix A denotes that a table is to be found in Appendix A). Acquisition 
data were analysed with analysis of variance Winer (1962) which are 
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summarised in Table A2. No significant differences were found between 
groups on any of these measures. 
Extinction 
During extinction testing the CS could remain on, in the absence 
of shock, for a maximum period of 20 seconds, the same value used during 
training. An avoidance response was defined as one which occurred during 
these 20 seconds. Subsequently a distinction was made between short 
avoidances, ie those occurring within ten seconds of CS onset and long 
avoidances, ie those occurring between the tenth and twentieth seconds 
after CS onset. 
The performance of each subject during extinction is summarised in 
Table A3 and in Figures 5 , 6 and 7 • Analysis of covariance (Winer 
1962) showed that there was no significant covariance between short 
avoidances in extinction and either trials to acquisition criterion 
(F = 1.36, df 5,41) or the number of avoidances to acquisition criterion 
(F = 1.34, df 5,41) (see Table A4). It was concluded that differences 
in extinction response levels were not due to different acquisition per-
formance levels. 
Extinction data was recorded as the total number of each type of 
response made in each of the ten blocks of five trials contained in bo.th 
Test I and Test 2 (see Table AS) and was analysed using Friedman's two 
way non-parametric analysis of variace (Siegel 1956). The outcome of 
these analyses is summarised in Table A6. There were significant dif-
ferences in the total number of avoidance responses made by those groups 
tested immediately after treatment during Test I (p < 0.001) and Test 2 
(p = 0.012). Similarly, there were significant differences between 
groups tested 24 hours after treatment during Test I (p < 0.001) and 
Test 2 (p = 0.05). Pairwise comparisons were made between groups (Table 
A7) using the method outlined by Hollander and Wolfe (1973). 
In the immediate test groups, response prevention reduced the 
total number of avoidances made during Test I (p < 0.01) compared to home 
cage controls. Extinction treated rats had reduced responding relative 
to home cage controls during both Test I (p < 0.05) and Test 2 (p < 0.01). 
, When the first extinction test was postponed for 24 hours, response 
prevention reduced responding during Test I (p < 0.01) and Test 2 
(p < 0.05) relative to home cage controls. Extinction treatment reduced 
responding relative to home cage controls only during Test I (p < 0.037). 
There were no significant differences between response prevented and 
extinction treated rats on either Test I or Test 2. 
Analysis of short avoidance responses (Table A6) revealed signifi-
cant differences between groups in both Test I (p < 0.01) and Test 2 
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(p < 0.02) when the first extinction test followed immediately, ·and when 
the first test was postponed for 24 hours after treatment there were 
significant differences during Test I only (p < 0.001) (see Table A6). 
Pairwise comparisons (Hollander and Wolfe 1973) (Table A7) indicated 
that with immediate testing response prevention reduced the number of 
short avoidances relative to home cage controls during both Test I 
(p < 0.01) and Test 2 (p = 0.05). Similarly, extinction treatment 
reduced the number of short avoidances relative to home cage controls 
during both Test I (pc 0.05) and Test 2 (p < 0.019). 
When testing was postponed for 24 hours after treatment, response 
prevention (p < 0.01) and extinction treatment (p < 0.01) reduced the 
number of short avoidances made during Test I but not Test 2. There 
were no significant differences between response prevented and extinc-
tion treated rats in the number of short avoidance responses. 
The analysis of long avoidance responses (Table A6) revealed sig-
nificant group differences in Test 2 (p < 0.05) when tested immediately 
and when the first test was postponed for 24 hours differences approached, 
but did not reach, significance during Test 2 (p < 0.1). Pairwise com-
parisons (Hollander and Wolfe 1973) (Table A7) revealed that in the case 
of the immediate test groups, the Test 2 difference was between extinc-
tion treated and response prevented rats (p < 0.037). For those groups 
in which the first test was postponed for 24 hours there was a trend for 
extinction and response prevented rats to make more long responses than 
response prevented rats (p < 0.1). There was also a trend (p < 0.1) for 
response prevented rats to make more long avoidance responses than home 
cage controls when the first test was postponed until 24 hours after 
treatment. 
These analyses established differences between groups in responding 
after treatment. Additional comparisons were made to determine the· 
treatment effects upon rates of change of responding within each of the 
50 trial extinction tests. Group data (Table AS) were used to compute 
regression lines. The slope co-efficients are shown in Table AB. In 
order to fulfil the minimum requirements of the Kruskal . Wallis analysis 
of variance (Siegel 1956) data for immediate and 24 hour test groups 
were combined and showed significant differences in the slopes of regres-
sion lines for short avoidances over trial blocks during Test I 
(pc 0.067) (Table A9). Pairwise comparisons (Hollander and Wolfe 1973) 
showed that extinction treated rats had greater negative slopes than 
response prevented rats (p = 0.067) (see Figure 8 ). 
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Discussion 
There were significant differences between groups in the total 
number of avoidances during extinction. However, when a distinction was 
made between short (< IQ seconds) and long (> 10 seconds) responses it 
became clear that the short avoidances alone provided a more sensitive 
measure, as a result of removing the confounding influences of the long 
avoidance responses which in general were insensitive to treatment 
effects. 
Response prevention significantly reduced the number of short 
avoidance responses made in extinction compared to retention in the home 
cage for 30 minutes. Reduction in responding was greatest when the first 
extinction test was made immediately after treatment and was also evident 
when these rats were retested 24 hours later. This result confirms the 
effect of response prevention which has been widely reported in the 
literature (see Section 3.1). The effect was restricted to short 
avoidance& and there were no differences between response prevented and 
home cage control rats in the long avoidance data. 
Similar results were found when the first extinction test was 
delayed for 24 hours after response prevention. Under these conditions 
response prevented rats made fewer short avoidances than home cage 
controls during the first but not the second extinction test 24 hours 
later. Again, there were no differences between these groups in the 
long avoidance data. The response prevention procedure used therefore 
affected responding after an interval of 24 hours between treatment and 
test and is suitable as a baseline in experiments using post trial 
injections allowing dissipation of short term effects of vasopressin. 
The data also suggest that the effects of prevention are temporary; 
there were no effects during the second extinction test in animals for 
whom the first extinction test had been delayed for 24 hours after treat-
ment. This finding supports those of Polin (1959), Benline and Simmel 
(1967) and Crawford (1977) (see Sections 3.1 and 3.2). 
Response prevention did not produce significant differences in the 
number of short avoidances made during extinction compared to 30 trials 
of extinction treatment. However, long latency responses were signifi-
cantly greater in extinction treated rats compared to response prevented 
rats during Test 2 of the immediately tested groups. Similarly, there 
was a trend for long avoidance responses made by extinction treated rats 
to exceed those made by response prevented rats during Test I for the 24 
hour test groups. Long latency responses may become reinstated more 
rapidly after extinction treatment than after response prevention, 
suggesting differences in the behavioural effects of each treatment. 
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The lack of any difference between response prevention and extinc-
tion treatment in the short avoidance data may be explained by the 
observation that for Test I avoidance data the extinction treated rats 
had significantly higher negative slopes than response prevented rats, 
ie within these tests extinction treated animals extinguished at a signi-
ficantly faster rate than response prevented rats (see Figure 8 ). At 
the beginning of the extinction test, extinction treated rats responded 
like home cage rats but towards the end of the test their response rate 
resembled that of response prevented rats. This crossover in the 
avoidance rates for these groups may explai~ why no differences were 
found in the absolute number of short avoidances. 
The effects of prevention were evident as reduced responding 
throughout the session whereas extinction treatment produced a higher 
within session rate of extinction and more rapid reinstatement of long 
latency avoidance responses. This distinction may reflect procedural 
differences such as longer CS exposure, non-contingent CS termination, 
thwarting of the response or a combination of these factors. The 
greater within session response rate stability seen after response pre-
vention coupled with the fact that prevention places the schedule con-
tingencies under the experimenter's control render response prevention a 
more reliable procedure than extinction for achieving reduced responding 
1n extinction. 
In theoretical terms the reduced extinction responding seen after 
response prevention may be interpreted in terms of enhanced extinction 
of conditioned fear, greater disconfirmation of expectancies, counter-
conditioning of an alternative and incompatible response or the develop-
ment of relaxation responses. All four theories (see Section 3.2) may 
account for the result. 
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CHAPTER FOUR 
THE EFFECTS OF LVP AND RESPONSE PREVENTION ON AVOIDANCE EXTINCTION 
AND CONDITIONED SUPPRESSION 
4.0 Introduction 
Three experiments are reported; the first shows that immediate 
post training LVP (I 11g) injections increase subsequent extinction res-
ponding. The second experiment shows that when injected after either 30 
minutes in the home cage or 30 extinction trials LVP (I 11g) reduced 
extinction responding but increased extinction responding after 30 res-
ponse prevention trials. The third experiment shows that LVP (I 11g) 
increases suppression of operant level press responding by concurrent 
presentations of the aversive CS. Response prevention trials, although 
altering operant baselines, did not alter suppression but delayed the 
suppressant eff'ects of LVP injections. 
These results show that under different experimental conditions, 
possibly due to timing of injections, LVP may either increase or decrease 
extinction responding. Furthermore, under conditions conducive to 
decreased responding the effect can be reversed by preceding LVP injec-
tions with response prevention trials. Subsequent experiments (Chapter 
Five) explore the variables controlling the direction of vasopressin~s 
effects on avoidance extinction. Exploration of the interaction between 
prevention trials and LVP injections both on avoidance extinction and 
using CS presentations concurrent with operant responding showed that 
neither the effects of LVP or prevention trials could be explained in 
terms of simple psychological constructs such as "fear" or "memory" 
4.1 Experiment Two: The Effects of Post Training LVP on Shuttle Box 
Avoidance Extinction 
Introduction 
Chapter Two reviewed the behavioural effects of vasopressins and 
their analogues. Avoidance extinction responding increased when peptides 
were injected after training or before extinction testing. The object 
of this experiment was to establish whether or not shuttle box avoidance 
extinction in an automated apparatus was sensitive to the effects of LVP 
injected immediately after training. 
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Methods 
Subjects 
Twenty-two adult male cfhb Wistars rats (400-450 g) from the closed 
colony maintained at Plymouth Polytechnic were housed four to a cage 
with ad lib food and water. 
Apparatus 
The apparatus and data recording has been described in Section 3.2. 
Procedure 
Prior to training, rats were placed in the apparatus for ten 
minutes adaptation. Training continued to the criterion of ten correct 
consecutive avoidance responses and was restricted to a maximum of 50 
trials per day on two consecutive days. Two rats failed to achieve 
criterion within the limit and were discarded. A further three were 
discarded as a result of experimenter error. Responses made during the 
CS were not counted as avoidances unless the animal had received at least 
one footshock. 
Treatment 
Immediately after attaining criterion rats were randomly allocated 
to one of two treatment groups, saline or LVP. All injections were made 
subcutaneously into the rats' rear flank, The control group was injected 
with 0.5 ml of physiological saline and experimental rats with 0.5 ml of 
physiological saline containing LVP (2 ~g/ml), provided by Sigma Chemicals 
Company Limited as a crystalline solid with a pressor assay potency of 
75 IU/mg. Solutions were stored at I-5°C and injected at room temperature. 
Testing 
Twenty-four hours after treatment, rats were returned to the 
apparatus for 50 trials of extinction and this procedure was repeated on 
the following day. The extinction schedule was identical to that used 
in acquisition but shock was omitted (see also Experiment 1). 
Summary of the experimental design 
Training Treatment Testing 
S trained to a criterion of Saline or LVP S was given 50 
ten correct consecutive injected immediately extinction trials 
avoidance responses within a after S had attained per day. Tests were 
maximum of two training days the learning run at approximately 
with 50 trials per day. criterion. the same time on 
each day. 
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_figure 9 The mean number of short avoidances as a function of trial 
blocks in extinction. 
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Results 
Acquisition 
AcquisitioJ:). performances were recorded using five indices, trials 
to each criterion, the number of avoidances, escapes and failures to 
respond and shocks received whilst attaining criterion (Table AIO). 
Groups were compared using the two tailed independent 't' tests (Winer 
1962). Results are shown in Table All. There were no significant dif-
ferences between groups. 
Extinction 
Data for each subject in extinction are presented in Table Al2. 
Analyses of covariance (Winer 1962) showed no significant covariance 
between the number of short avoidance responses in extinction and either 
the number of trials to criterion (F = 0.35; df I ,14) or the number of 
avoidances to criterion (F c 0.46; df 1,14) (Table Al3). 
The mean number of avoidances responses (short plus long) per 
block of five td.als in extinction for each group were compared .using 
Wilcoxon's signed ranks test (Seigel 1956) (see Table Al4). LVP treated 
rats made significantly more responses in Extinction Test I (p < 0.0098) 
and Test 2 (p < 0.005) than saline contr~ls. When a distinction was 
made between short Avoidance responses {< 10 seconds) and long avoidance 
responses {> 10 seconds) (Table A14) Wilcoxon's signed ranks test 
(Seigel 1956) revealed that LVP treated rats made significantly more 
short avoidance responses during Test I (p < 0.009) and Test 2 (p < 0.0137) 
than saline controls and there were no significant differences between 
groups in the number of long avoidance responses. These analyses are 
suUDDarised in Table A15. 
Regression lines were calculated using the method of least squares 
for the short avoidance data as a function of trials in extinction 
(Table Al4). During Test I the saline group yielded a slope coefficient 
of 0.01·8 whereas LVP treated rats during Test I yielded a slope 
coefficient of -0.812. These slopes were compared using the Hollander 
test for parallelism (Hollander and Wolfe 1973). The slopes were not 
significantly different {T+ = I 0, n = 5, 'P = 0. 31), indicating that 
within Test extinction occurred at similar rates in both groups·. 
During Test 2, saline treated rats yielded a slope coefficient of -1.163, 
lower than that of the LVP group (-2.448). These Test 2 trend lines 
tended not to be parallel (T+ "' 14, n = 5, p = 0.062) indicating that 
extinction occurred at a slightly higher rate in LVP treated rats than 
in the saline controls in Extinction Test 2. Saline performance in 
Test I was compared with performance in Test 2 and Hollander's test for 
parallelism indicated that these lines were not parallel (T+ = IS, n = 5, 
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p a 0.062) indicating that extinction occurred at a slightly higher rate 
in LVP treated rats than in the saline controls in Extinction Test 2. 
Saline performance in Test I was compared with performance in Test 2 and 
Hollander's test for parallelism indicated-that these lines were not 
parallel (T+ =IS, n = S, p = 0.031). Similar differences were seen 
when the data for LVP treated rats in Test I was compared with perfor-
mance in Test 2 (T+ = IS, n = S, p = 0.031). Therefore the rate of 
extinction was higher for both groups in Test 2 than in Test I. 
Discussion 
LVP significantly increased the total number of avoidance responses 
during Extinction Tests I and 2 compared to saline treated controls. 
Furthermore, these differences were due primarily to changes in the 
number of short avoidance responses with no significant differences in 
the number of long avoidance responses made by each group. These 
results support those reported in the literature (Chapter Two). In 
addition, the absence of any effects on the number of long avoidances 
together with the peptide effect 48 hours after treatment, despite evi-
dence for a short metabolic half life (see Section I. ), argue against 
an explanation of vasopressin's effect by short term motor effects. 
Increased avoidance responding seen after vasopressin treatment is 
greatest during the early portion of each extinction test and this leads 
to the higher rate of extinction seen in LVP treated rats, especially 
during Test 2. The effect of vasopressin therefore fades within each 
extinction test but is reinstated in the 24 hour interval between tests, 
an effect not previously reported. The data are compatible with the 
consolidation of memory hypothesis (Chapter Two),proposed to account 
for the effects of LVP, if it is assumed that enhanced consolidation of 
information into long term memory should lead to an increase in the 
avoidance response level during extinction. 
4.2 Experiment Three: The Effects of LVP and Response Prevention on 
Shuttle Box Avoidance Responding 
Introduction 
In the preceding experiments, two procedures were described which 
have opposite effects upon the extinction of avoidance responding. In 
Experiment One, 30 response prevention trials reduced responding during 
subsequent extinction whilst in Experiment Two a post training injection 
of LVP (I ~g) increased responding during subsequent extinction testing. 
The interaction between these two procedures has been studied by King 
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and De Wied ( 1974) using the pole jump avoidance who showed that LVP 
injected before response prevention increased subsequent extinction res-
ponding. If decreased extinction responding after prevention trials can 
be explained by associative changes then this result cannot be explained 
by the consolidation of memory hypothesis proposed to explain the effects 
of LVP (Chapter Two). Indeed, if LVP facilitated consolidation of 
recently acquired behavioural information it would be expected that when 
given in conjunction with prevention trials extinction responding should 
be reduced even further. In the King and De Wied (1974) study LVP was 
injected before response prevention and pretreatment may have confounded 
an effect on consolidation with motor or motivational changes; Dawson 
and McGaugh (1973) have suggested that compounds which affect time 
dependent consolidation processes should be effective when injected after 
behavioural procedures. The first object of this experiment is there-
fore to E~TEND the findings of King and De Wied (1974) using post 
training injections to maximise the chances of detecting and minimise 
the chances of confounding a consolidation effect. 
The second object of the experiment is to examine the effect of 
the peptide given after extinction treatment. In view of the similar 
effects which 30 extinction trials and 30 trials of prevention had on 
the responding during extinction testing in Experiment One, it was of 
interest to determine whether or not these procedures were identically 
affected by LVP (I ~g), 
The third object of the experiment is to determine whether or not 
the effects of LVP could be detected during extended extinction testing. 
Results in the literature (Section 2. ) indicate that a post training 
injection of the peptide may exert an increase in extinction responding 
which extends long after treatment. 
Methods 
Subjects 
Forty-eight adult male cfhb rats (350-450 gms) from the closed 
colony maintained at Plymouth Polytechnic were housed three or four to a 
cage, with ad lib access to food and water. 
Procedure 
The apparatus and the training schedule have been described in 
detail in Experiment One. Briefly, the animals were placed in the shuttle 
box for five minutes in order to adapt and then received 50 training 
trials per day on each of a maximum of two days. Training stopped when 
the subject had reached the learning criterion of ten correct consecutive 
avoidance responses. Fourteen animals which failed to attain this 
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criterion within two days were discarded from the experiment. During 
the early stages of training a small number of rats responded to the CS 
without having received footshock; in order that these responses should 
not bias the acquisition data a response was only included as an avoidance 
if the animal had received a shock on a previous trial. When each rat 
had attained the criterion it was randomly allocated to one of the 
following six treatment groups. 
Treatment 
(I) Home cage retention plus saline injection (HCS). Having attained 
learning criterion the rat was returned to the home cage for 30 minutes 
and was then given an injection of saline. 
(2) Home cage retention plus LVP injection (HCL). Having attained the 
criterion each rat was returned to the home cage for 30 minutes and then 
given an injection of LVP (I ~g SC). 
(3) Extinction treatment plus saline injection (EXT S). Having 
attained criterion, each rat remained in the shuttle box for 30 extinc-
tion trials. During extinction the schedule remained the same as for 
acquisition but the shock source was disconnected. 
(4) Extinction treatment plus LVP injection (EXT L) •. Having attained 
the criterion each rat remained in the shuttle box for 30 extinction 
trials followed by LVP (I ~g SC) injection. 
(5) Response prevention plus saline injection (RP S). Having attained 
criterion each rat remained in the shuttle box for 30 trials of response 
prevention during which a black barrier blocked the access between com-
partments preventing the shuttle response and retaining the animal in 
the presence of the CS. On each trial the CS remained on for 20 seconds 
and at the end of these trials each rat received a saline injection. 
(6) Response prevented plus LVP injection (RP L). These rats were 
treated in the same manner as those in group RP S but were injected with 
LVP after the prevention trials. 
Peptide treatment 
All rats were injected SC with a constant volume.of solution, at 
room temperature. Lysine vasopressin was supplied as a crystalline 
powder by Sigma Chemicals Limited (lot number 6Sc-0156) with a pressor 
potency of approximately 75 IU mg and was injected dissolved in 0.5 ml 
of physiological saline (0.09%) in a dose of 2 ~g/ml. Saline controls 
received 0.5 ml of physiological saline. Solutions were stored at I-5°C. 
Testing 
After training and treatment each subject was tested during three 
sessions, Tl, T2 and T3. Each consisted of 50 extinction trials on each 
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of three consecutive days. Testing began approximately 24 hours after 
injection and was repeated at approximately the same time on each day. 
During extinction the schedule remained the same as in acquisition but 
the shock source was disconnected. Training and testing spanned either 
four or five days depending on whether the subject had reached criterion 
on the first or second day of acquisition. In addition to Tl, T2 and 
T3, subjects were given two short extinction tests, T4 and T5, each of 
ten extinction trials. For subjects which attained criterion on the 
first day of training T4 and T5 were run 168 and 192 hours respectively 
after T3. However, if criterion was reached on the second day of 
training then T4 and T5 followed T3 at 144 and 168 hours respectively. 
This complication was unavoidable in view of the number of animals 
involved in the study and the limited time available. 
Results 
Acquisition 
Performance during acquisition is summarised in Table Al6, Five 
indices were recorded; avoidances to criterion, trials to criterion, 
escapes to criterion, shocks to criterion and failures to respond whilst 
attaining criterion. Data from acquisition was compared using one way 
analysis of variance (Winer 1962) and outcomes from these analyses are 
contained in Table Al7. There were no significant differences between 
groups on any of these indices. 
Extinction 
During extinction testing a distinction was made between short 
avoidances responses, made within ten seconds of the CS onset, and long 
avoidances, made between ten and 20 seconds after CS onset. When added 
together, these two categories yield the total number of responses made 
during extinction. These data are presented in Table Al8 and in 
Figures 10, I I and 12. In order to test the hypothesis that differences 
in extinction responding could be the result of differences in acquisi-
tion performance, two analyses of covariance were run (Winer 1962). No 
significant covariance was found between the number of trials to 
criterion and the number of short avoidances in Extinction Test I 
(F,df 5,41 = 0.83) or between the number of avoidances to criterion and 
the number of short avoidances in Extinction Test I (F,df 5,42 = 0,85). 
These analyses are summarised in Table Al9, 
Data from extinction tests were reduced by dividing each animal's 
test performance into blocks of five trials and counting the total number 
of responses, the number of ~hort avoidance responses and the number of 
long avoidance responses in each block of five trials. In Table A20 
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extinction data are presented as the mean number of each response type 
per animal per block of five trials. These data were analysed using 
FriEdman's non-parametric two way analysis of variance (Seigel 1956) and 
outcomes are presented in Table A21. During Test I there were signifi-
cant differences between groups in the total number of avoidances 
(p < 0.001), short avoidances (p < 0.001) and long avoidances (p < 0.02). 
During Test 2 also there were significant differences between groups in 
total avoidances (p < 0.001), short avoidances (p < 0.001) and long 
avoidances (p < 0.05). During Test 3 there were significant differences 
between groups in the total number of responses (p < 0.001) and short 
avoidance& (p < 0.02). There were no significant differences between 
groups during Tests 4 and 5. Breakdown analyses were made in order to 
locate significant differences between groups within each extinction 
test (Hollander and Wolfe 1973); selected outcomes are presented in 
Table A23. 
Response prevention followed by saline tended to reduce the number 
of short avoidance responses in Test I (p < 0.1) compared to animals 
which were retained in the home cage and given saline. During Test 2 
this difference was significant (p < 0.009) and there was a strong trend 
to reduce the total number of responses (p < 0.1). During Test 3 the 
total number of responses was reduced by response prevention (p < 0.023) 
and short avoidances showed a strong trend towards being reduced 
(p < 0.1). There were no significant effects of response prevention on 
the number of long avoidance responses during any of the extinction 
tests. 
Extinction trials followed by a saline injection significantly 
increased the total number of responses made in Extinction Test I 
(p < 0.047) compared to home cage saline rats. During this test there 
were no significant differences between these two groups in the number 
of short or long avoidance responses. During Test 2 there was a trend 
(p < 0.1) for extinction saline rats to make fewer long avoidance res-
ponses than home cage saline rats. During Test 3 there were no signifi-
cant differences between these groups. 
Extinction trials followed by saline significantly increased the 
total number of avoidance responses made during Extinction Test I com-
pared to response prevented saline treated rats (p < 0.009). Further-
more, this difference was due to the greater number of short avoidance 
responses made by the extinction saline rats (p < 0.009) as there was no 
significant difference in the number of long avoidance responses made by 
these two groups. Similarly, extinction treatment plus saline signifi-
• 
cantly increased the total number of responses made during Test 2 
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compared to response prevented rats treated with saline (.p < 0.009). 
This increase was also due to increased short avoidance responses 
(p < 0.008) with no change in the number of long avoidances. During 
Test 3 there were no significant differences between these two groups. 
LVP given after 30 minutes of retention in the home cage tended to 
reduce the total number -of responses made during Extinction Test I, com-
pared to a saline injection given after retention in the home cage 
(p< 0;08). During this test LVP significantly reduced the number of 
short avoidances (p 0.05) and did not affect the number of long 
avoidance responses. During Extinction Test 2 LVP significantly reduced 
total number of avoidance responses (.p < 0.009) and the number of short 
avoidance responses (p < 0.009) compared to saline when given to rats 
which had been retained in the home cage for 30 minutes before injection. 
There were no effects of the peptide on long avoidances during Test 2. 
During Test 3 the total number of responses (p < 0.023) and the number 
of short avoidance responses (p < 0.023) were significantly reduced in 
the LVP treated rats. Again, there was no effect upon the number of 
long avoidance responses. 
LVP given to extinction treated rats significantly reduced the 
total number of responses (p < 0.047) and the number of short avoidances 
made during Test I (p < 0.009) compared to extinction treated rats given 
saline. There was no effect upon long avoidance responses. During 
Test 2 there was no effect of the peptide on responding by extinction 
treated rats bu·t there was a strong trend for LVP to decrease the number 
of short avoidances (p < 0.1) and increase the number of long avoidances 
(p < 0.1). During Test 3 there were no significant effects of the peptide 
on either short or long avoidance responses although ther.e was a strong 
trend for LVP to reduce the total number of responses compared to saline 
(p < 0. I ) • 
During Test I LVP tended to increase the total number of responses 
compared to saline (p < 0. I) when given to response prevented rats and 
significantly increased the number of short avoidance responses compared 
to saline in response prevented rats (p < 0.009) but did not affect the 
number of long avoidances. During Test 2, LVP significantly increased 
the total number of avoidance responses made compared to saline in res-
ponse prevented rats (p = 0.05). There were no significant effects on 
either the short or long avoidances. During Test 3 there were no signi-
ficant differences between the LVP and saline response prevented groups; 
When animals which had been retained in the home cage then given 
LVP were compared with animals which had been response prevented then 
given LVP, it was found that in Test response prevention significantly 
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increased the total number of responses (p < 0.009), the number of short 
avoidances (p < 0.009) and the ni.nnber of long avoidance responses 
(p < 0.023). During Test 2 response prevention significantly increased 
the total number of avoidance responses (p < 0.023) but did not signi-
ficantly affect either short or long avoidance responses when considered 
alone. There were no significant differences between these groups during 
Test 3. 
Trend lines were calculated for the performance of each group 
during each extinction test using the method of least squares with the 
short avoidance data (Table A22}. Slopes were compared across groups 
using the Kruskall Wallis non-parametric analysis of variance (Seigel 
1956) but there were no significant differences between groups (H "' 6.39, 
df "'K- I~ 5, p < 0.3). 
Discussion 
Control animalS retained in the home cage for 30 minutes then 
injected with saline showed stable response levels throughout the three 
major extinction tests (TI, T2 and T3). Response prevented rats injected 
with saline made consistently fewer responses than home cage saline 
controls. During Test I, response prevention tended to reduce the number 
of short avoidance responses, during Test 2 there was a trend to reduce 
the total number of responses and a significant reduction in the number 
of short avoidance responses. In Test 3 response prevention significantly 
reduced the total number of responses and there was a strong trend to 
reduce the number of short avoidance responses. Failure to observe 
changes in regression lines fitted to the within test data indicated 
that no ·treatment affected the within test pattern of response change. 
These results confirm the effects of prevention which have been 
widely reported in the literature (Section 3.1) and the results of 
Experiment One. In addition, failure to observe an effect of response 
prevention during Tests 4 and 5 support the findings of Experiment One 
and those of the literature (Polin 1959, Benline and Simmel 1969, 
Crawford 1977) which suggest that the effects of prevention diminish 
with repeated trials , although the duration of the effect varies between 
studies. 
Thirty trials of extinction followed by saline injection signi-
ficantly increased the total number of responses made during Test I com-
pared to home cage saline controls without affecting within test regres-
sion slopes, but this effect did not persist through the later extinction 
tests. This result contrasts to the effects seen 1n Experiment One where 
it was found that extinction trials reduced response levels and increased 
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the rate of within test response change. Furthermore, extinction treated 
rats given a saline injection made significantly more responses than 
response prevented saline treated rats during Tests and 2 without 
altering regression slopes. These increases in the total number of res-
ponses were due to increases in the number of short avoidances made by 
the extinction treated rats relative to response prevented rats as 
there were no changes in the long avoidances. These results contrast to 
the effects of extinction trials compared to response prevention in 
Experiment One where it was found that these two treatments both reduced 
the absolute response level relative to home cage controls although 
extinction treatment resulted in a higher within test extinction rate. 
Differences between Experiment One and the present experiment 
suggest that extinction trials are not a reliable way of reducing res-
ponding during extinction tests. In the present experiment., animals 
were given a saline injection after 30 trials of extinction and this may 
account for the differences between the results of these two experiments. 
Indeed, Riffee et al (1979) have observed changes in behaviour as a 
result of saline injections. An additional factor may be that the 
experimenter has little control over experimental contingencies during 
extinction trials, CS exposure and te~tion are related to individual A 
response rates and are uncontrolled variables. The effect of the treat-
ment is therefore likely to vary between batches of animals depending on 
response levels during treatment. 
Response prevention did not reduce responding in extinction, 
relative to home cage saline controls, when followed by LVP instead of 
saline. In Test I response prevented rats given LVP tended to make a 
greater total number of responses and made significantly more short 
avoidances than response prevented rats given saline. Similarly, in 
Test 2 response prevented rats given LVP made significantly greater 
number of total responses than their saline treated counterparts. There 
were no significant differences between these groups during Extinction 
Test 3. 
This effect of the peptide was only evident, therefore, during the 
first two extinction tests; indeed during the third extinction test the 
usual response reducing effect of prevention trials was evident as these 
animals were responding at the same level as response prevented saline 
treated rats and both these groups made significantly fewer responses 
than home cage saline controls during Extinction Test 3. This result 
confirms the effect reported by King and De Wied (1974) and differs only 
in that these authors found the effect of the peptide to be strongest on 
the second day of extinction testing whereas in the present experiment 
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the effect was most pronounced during early extinction tests. Therefore 
it may be argued, as King and De Wied (1974) did, that the peptide does 
not invariably enhance consolidation of recently acquired behavioural 
information. If such were the case, then responding should have been 
further reduced after response prevention. This interpretation assumes, 
as do all the peptide experiments reviewed in Chapter Two, that in an 
experiment which uses post learning peptide treatment an increased res-
ponse rate in extinction represents enhanced memory storage and decreased 
responding reflects disrupted consolidation. In addition, it is assumed 
that new behavioural information is conveyed during response prevention 
which accounts for decreased responding after prevention (see Section 
3.1). 
Two further aspects of the present data point away from the con-
solidation hypothesis. When 30 trials of extinction were followed by 
LVP rats made a significantly fewer total avoidance responses and short 
avoidances during Test than their saline treated counterparts. 
Furthermore, there was a strong trend for LVP to reduce the number of 
short avoidances during Test 2 and the total number of responses during 
Test 3. In addition, when LVP was given to rats 4etained in the home 
cage for 30 minutes, it significantly reduced the total number of res-
ponses and the number of short avoidance responses made during Tests I, 
2 and 3. Therefore, the effects of LVP injected after either extinction 
trials or home cage retention is to reduce extinction responding, a novel 
finding which stands in sharp contrast to data discussed in Chapter Two. 
If the results from response prevented and extinction treated rats, 
under saline and under vasopressin, are considered together, then an 
interesting set of effects is apparent. After saline extinction treated 
rats make more responses than response prevented rats during Tests I and 
2. However, both groups react to LVP in opposite ways. Avoidance res-
ponding goes down in extinction treated rats and up in response prevented 
rats. The normal effects of each treatment are reversed to the extent 
that there are no significant differences between them after the peptide. 
It is possible to argue that these opposite effects of the peptide 
reflect the presence of some contingency in one behavioural procedure and 
not in the other. This could be greater CS exposure, non-contingent CS 
termination or the thwarting of the avoidance response, all factors 
present in response prevention but not in the extinction procedure. In 
theoretical terms, the difference in reaction to LVP could reflect the 
fact that response prevention induces a counterconditioned response not 
present in the extinction treated group (cf Section 3.1.2), or discon-
firms the rat's expectancy that shock follows no response and no shock 
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follows a response (Seligman and Johnston 1973). It seems unlikely, 
from the present result that LVP increases fear of the CS, at least in 
the terms of two factor avoidance theory; if such was the case then LVP 
should have increased responding in both extinction treated rats and 
response prevented rats. 
Rats retained in the home cage and those given extinction trials 
are similar in as much as neither experience any radical change in the 
contingencies of the avoidance schedule. Extinction treated rats main-
tained a high response rate during the actual extinction treatment; these 
data are summarised in Table A25 (saline mean+ sem = 27.875 
± 1.63 LVP mean+ sem = 26.25 ± 1.971). It is possible to argue, there-
fore, that the opposite effects of LVP with response prevented rats com-
pared to both extinction treatment and home cage retention may be 
accounted for in terms of the schedule changes (changes in behavioural 
information) which occur during response prevention but not during either 
extinction treatment or retention in the home cage. These contingency 
changes may alter the animal's cognitive expectancies or induce a 
counterconditioned response (see Section 3.1.2). In view of the limited 
conditions under which this latter effect has been demonstrated, it 
appears that the data most strongly support an explanation in terms of 
cognitive expectancies. However, there is a very strong proviso which 
must be considered before accepting an explanation of this nature. The 
explanation is based upon comparisons involving effects of vasopressin 
which have not previously been reported, ie responding was reduced 
following both home cage retention and extin.ction treatment. Therefore 
for both empirical and theoretical reasons it is necessary to investigate 
the reasons for this reversal of the normal and widely reported effects 
of vasopressin which were confirmed in Experiment Two. One difference 
between the design of the present experiment and that of Experiment Two 
is that LVP was injected after a 30 minute interval of retention in the 
home cage; in Experiment Two LVP was injected immediately after training. 
According to the results from De Wied (1973) and King and De Wied (1974) 
(see Section 2.2) this time lag should not affect the outcome of vaso-
pressin treatment which has an estimated behavioural half life of one 
hour at the dose used in the present experiment. The effect of varying 
the time of the injection was therefore examined in later experiments 
(see Chapter Five). 
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4.3 Experiment Four: TheEffect of LVP on Suppression of Lever Pressing 
by the CS Following Response Prevention or Confinement in the Home 
Cage 
Introduction 
Behavioural effects of LVP and its analogues have been extensively 
studied using aversive conditioning procedures, in particular two way 
shuttle box avoidance (De Wied 1971), the pole jump task (King and 
De Wied 1974) and step through passive avoidance task (Ader and De Wied 
1972) (see Chapter Two), In these procedures animals were trained, 
treated with the peptide at the appropriate time, then returned to the 
apparatus in order to measure the change in response probability as a 
result of peptide treatment. The results reported in the .literature 
indicate that LVP and its analogues increase the probability of respon-
ding during active avoidance extinction and increase the latency to re-
enter the shock compartment in the passive avoidance task. The results 
of Experiment Two confirm these findings in the shuttle box but it is 
clear from the results of Experiment Three that this effect of LVP cannot 
be found under all experimental conditions. The results of Experiment 
Three, combined with the consideration that previous studies had concen-
trated on test situations which required the animal to perform the 
trained response in extinction, prompted the design of the present 
experiment. This study was designed to measure disruption of lever 
press responding caused by concurrent presentation of the compound CS 
previously used in training the avoidance task and examined whether LVP 
and response prevention affected this variable in the same way as they 
affected avoidance extinction. 
Garrud (1974) failed to see an effect of LVP (2 ~g) on operant 
responding during concurrent CS paired with footshock; this may have been 
due to the use of pre-test injections combined with a procedure which 
elicited strong stimulus control, rendering the procedure rather 
insensitive. The present experiment was based on a design used by Kamin, 
Brimer and Black (1963) in which the CS was presented in the absence of 
shock. The training and treatment schedules of Experiment 3 were 
repeated using rats which had also been trained to lever press for food 
on a variable interval schedule in which a pellet was delivered on 
average every 60 seconds (VI 60 secs). Twenty-four hours after the post 
training injection of LVP or saline subjects were placed in the lever 
press box and the conditioned stimulus used in the avoidance schedule 
was presented during lever pressing. Changes in the operant response 
rate were evaluated as a function of treatment. 
Ill 
Experiments using concurrent classical and operant schedules form 
the background against which the present experiment should be viewed. 
Since its experimental inception by Estes and Skinner (1941) the approach 
has fostered a huge literature and diverse theoretical accounts. In a 
recent review, Henton (1978) points to two broad classes of theories 
proposed to account for changes in the operant baseline during classical 
trials. 
Inductive and experimental approaches have stressed the importance 
of interactions which occur between the responses controlled by each 
schedule. Thus Brady and Hunt (1955) proposed a research strategy, 
based on results from Estes and Skinner (1941), which led to the com-
peting response hypothesis (Brady 1971). Changes in the operant baseline 
during CS presentations were ascribed to the elicitation of responses 
conditioned to the CS but not necessarily compatible with the execution 
of the lever pressing response. Similarly, Lyon (1968) proposed that 
changes in the operant baseline could either be the result of "inter-
ference from competing responses or to punishment of the operant by 
adventitious pairing of the lever press response with shock. Henton and 
Iversen (1978) extended the competing response hypothesis proposed by 
Brady and Hunt (1955), arguing that experiments which use aversive 
classical trials superimposed on an appetitive baseline should be viewed 
as part of a wider class of procedures in which simultaneous schedules 
interact, producing local changes in the response pattern elicited by 
either schedule in a manner dependent on the controlling variables of 
both schedules. 
In contrast to inductive approaches stand a number of deductive or 
i.nferential models. Kamin ( 1965) has suggested that alterations in the 
operant rate may serve as an indirect quantification of classical con-
ditioning processes. In support of this hypothesis Annau and Kamin 
(1961) reported systematic changes in the index of suppression as a 
function of UCS intensity. Similarly, Kamin, Brimer and Black (1963) 
/' observed systematic changes in a suppression index during training and 
extinction of an avoidance response. These changes were attributed to 
alterations in the level of conditioned fear. Rescorla and Solomon 
(1967) have also proposed that changes in the operant rate during the CS 
could be an indirect measure of conditioned emotions. Azrin and Hake 
(1969) explained operant rate changes as a function of a general 
emotional state, which stemmed from pairing a stimulus with a strong 
positive or negative reinforcer, accompanied by both overt and covert, 
autonomic and cardiac, responses. Although the present experiment is 
not intended to unravel the complexities of opposing theories, the 
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results will be discussed in terms of compatibility with these major 
theoretical positions. 
Methods 
Subjects 
Thirty-two adult male cfhb Wistar rats (200-250 g) from the closed 
colony maintained at Plymouth Polytechnic were housed three or four to a 
cage with ad lib access to tlater. 
80% of their free feeding weight. 
Rats were reduced to approximately 
Body weight was routin·ely checked at 
the start of each lever pressing session. 
Apparatus 
Avoidance responding was established using the apparatus described 
in detail in Experiment One. A compound CS was provided by the illumina-
tion of two 10 watt clear bulbs, mounted on the roof of the cage, coupled 
with a mixed frequency tone (90 dbs) measured on international Scale A, 
mounted on the rear wall panel of the apparatus. 
Lever pressing was trained in a standard two lever skinner box 
(Grason Stadler model number I 11 I) housed in a ventilated, sound and 
light attenuating cabinet (Grason Stadler model number 1101). Events 
were programmed and recorded using Grason Stadler Series 1201 programming 
equipment. In order to present the CS from the avoidance schedule whilst 
rats were lever pressing the rear wall and lid of a Basille shuttle box, 
with the speaker housing used to generate the tone CS and the light 
housing was strapped to the rear wall and roof of the Skinner box. 
Background noise, originating mainly from the ventilating fan in the 
Skinner box, was rated at 74 dbs measured on international Scale A. 
Tone volume in the shuttle box and the avoidance apparatus were equated. 
Procedure 
Lever press training pilot studies confirmed the conclusion of 
Blackman (1968) that the absolute response rate contributed to the 
magnitude of the suppressive effect of a concurrent CS. The VI 60 
second schedule was selected in order to produce stable response rates 
which were comparable across subjects. In addition the limited hold was 
included to stabilise the number of reinforcements available throughout 
the 30 minute test sessions independently of the response rate. The 
intervals were chosen from Clark (1958) and yielded an inter-reinforcement 
interval with an arithmetic mean of 60 seconds. 
At the start of the experiment rats were reduced to 80% of their 
free feeding body weight and during this period were fed at midday on 
each day with approximately IS g of standard laboratory food with ad lib 
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water. Having been reduced to their target body weight, they were 
stabilised on the feeding regime for. seven days and then response shaping 
began. During the period of response shaping the bulk of each rat's 
daily food requirement was met with 4S mg pellets (Campden Instruments 
Company Limited) dispensed as reinforcement for approaching and then 
pressing the lever. Additional standard lab pellets were provided for 
individuals as required to maintain their target weights. Having been 
shaped to press the lever rats were then established on a continuous 
reinforcement schedule (CRF) and those which failed to acquire the res-
ponse were dropped from the experiment. 
Schedule control was programmed in such a way that the interval 
between the availability of reinforcements could be reduced to less than 
one second, ie shorter than the time required to retrieve and consume 
the previously delivered pellet. At such a low inter reinforcer 
availability interval the programme therefore mimicked a CRF schedule. 
By gradually extending this interval it was possible to transfer each 
subject to the final goal of a VI 60 second schedule, at a rate suited 
to each individual subject. Responding on this schedule was stabilised 
for IS experimental days (three calendar weeks) with one 30 minute 
session per day. At the end of each session subjects were fed 
with sufficient food to maintain their body weight. 
Avoidance training 
After IS days on the VI 60 schedule, rats were trained to avoid 
footshock in the shuttle box up to a criterion of ten correct consecutive 
avoidance responses. This training procedure has been described in 
detail in Experiment One. Lever pressing sessions were maintained 
throughout avoidance trainins. 
Treatment 
Having attained the learning criterion rats were randomly allocated 
to one of four groups in a 2 x 2 design. Two groups were returned to 
the home cage for 30 minutes and two groups received 30 trials of res-
ponse prevention, as described in Experiment One. Following these 
behavioural treatments subjects were given an injection of either saline 
or LVP (I ~g/O.S ml) SC. Batch details and the method of preparing the 
solution have been described in Experiment Two. Following injection, 
each rat was returned to the home cage. 
Testing 
Approximately 24 hours after injection, rats were returned to the 
Skinner box for 30 minutes of lever pressing. The first ten minutes 
were used as a warm-up period; during the subsequent 20 minutes the 
114 
compound CS, used in avoidance training, was presented ten times ·(trials) 
for 20 seconds on each occasion. These trials were distributed through-
out the 20 minutes of the test session according to a VI two minute 
schedule. Intervals were selected from Clark (1958) to yield the arith-
metic mean interval of 120 seconds. Twenty-four hours after this first 
test (Test I) the procedure was repeated (Test 2). The control apparatus 
was programmed to count the number of lever presses made during the 20 
seconds immediately preceding a presentation of the CS (Period A) and 
during the 20 seconds of CS presentation (Period B) on a digital print-
out unit. It was then possible to compute an index of disruption of base-
line responding (suppression ratio: SR) as a result of CS presentation, 
according to the formula from Kamin, Brimer and Black (1963): 
responses during Period B 
sr = -----------.~~~~~~~~~~~~~~~~--~--~~~ rP.sponses during Period A + responses during Period B 
This formula yields values ranging from 0 (maximum suppression) to 
(maximum facilitation). A value of 0.5 indicates that the CS did not 
affect lever press responding relative to pre-CS levels. Clearly the 
ratio may fluctuate as a function of changes during either Period A or 
B; however, given a constant response rate during Period A on a series 
of trials then a steady recovery of responding in Period B will yield a 
decelerating curvi-linear function with an asymptotic value of 0.5 
(Henton 1978). This formula was chosen to provide maximal comparability 
with the study of Kamin, Brimer and Black (1963) in describing the rapid 
extinction of suppression which was anticipated. 
Extinction of the avoidance resfonse 
Approximately 24 hours after the second suppression test, subjects .. 
were returned to the shuttle box for 50 trials of extinction testing; 
this was repeated 24 hours later. The details of extinction testing 
have been described in Experiment One. 
Summary of the experimental design 
(I) Establish and maintain VI 60 sec schedule (five to six weeks); 
(2) train the avoidance response to a criterion of ten consecutive 
correct responses; having attained the criterion, subjects were 
immediately given 
(3) behavioural treatments; rats were either retained in the home cage 
for 30 minutes or received 30 trials of response prevention; this 
was followed immediately by 
(4) vasopressin or a saline injection; 
(5) 24 hours after the injection each rat was returned to the Skinner 
box for the first suppression test; 
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(6) 24 hours after the first suppression test each rat was returned to 
the Skinner box for the second suppression test; 
(7) 24 hours later each rat was tested for extinction of the avoidance 
response in the shuttle box; 
(8) the extinction test was repeated 24 hours later. 
Results 
Acquisition of the avoidance response 
The performance of animals during acquisition was recorded using 
five measures. These were: the number of trials taken to reach 
criterion, the number of avoidance responses, escape responses and 
failures to respond whilst reaching criterion and the number of foot-
shocks received. The data from each subject are presented in Table A25. 
Data were analysed using a parametric one way analysis of variance 
(Winer 1962) and the outcomes are presented in Table A26. There were no 
significant differences between groups during acquisition. 
Lever pressing performance 
Table A27 and Figures 13, 14 and IS show the number of lever 
presses made by each rat during periods A and B on each suppression 
trial. The data for each group were summed across subjects to give the 
sum, mean, standard deviation and standard error of responses during 
each period on every trial. 
To examine comparability of response rates across groups at the 
beginning of the first suppression test the number of responses made 
during Period A of the first suppression trial were compared. Home cage 
saline rats (X= 5.25) did not differ significantly from home cage LVP 
rats (X= 5.125) (t = 0,0602, df = 14). Response prevented saline rats 
(X = 10.86) made significantly fewer responses than home cage saline 
controls (t = 2.3016, df = 13, p < 0.05) and response prevented LVP rats 
(12.33) did not differ significantly from response prevented saline rats 
(t = 0.6599, df = 14). 
For the main statistical comparisons the suppression tests were 
divided into blocks of five trials (see Table A28). The mean number of 
responses per subject during Period A wete analysed as a function of 
trials and groups using analysis of variance (see Table A29). Signifi-
cant overall F ratio was followed by multiple comparisons using Neuman 
Keuls test (Table A32) (Winer 1962). 
In Test 1, trials one to five, there was a significant effect of 
treatments (p < 0.010) and trials (p < 0.05). During trials 6-10 of 
Test I, there was a significant effect of treatments (p < 0.01) but not 
of trials. In Test 2, trials 1-5, there was no effect of either 
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treatments or trials, but during trials 6-10 of Test 2 there was a sig-
nificant effect of treatment (p < 0.01). 
Responding during the B periods of each suppression trial (Table 
A28) was analysed in an identical way (Table A30). During Test I, 
trials 1-5, there was a significant effect of treatment (p < 0.01) and 
trials (p < 0.01). In Test I, trials 6-10, there was a significant 
effect of treatment (p < 0.05) but no effect of trials. In Test 2, 
trials 1-5, there was. a significant effect of treatment (p < 0.0 I) and 
trials (p < 0.01). In Test 2, trials 6-10, there was an effect of 
treatment (p < 0.01) but not trials. 
A suppression ratio (sr) was calculated for each animal on each 
trial using the formula described previously (sr = A!B) (see Table A28). 
The mean ratio for each trial was then analysed as a function of trials 
and treatments (see Table A31) as described for period A and B data. 
There was a significant effect of treatments (p < 0.01) in Test I, 
trials 1-5, and in Test 2, trials 1-5 (p = 0.05). 
Selected comparisons are given below in Table I (see also Table A32). 
Trials effects can be seen in Figures 13, 14 and 15. During Test I, 
trials 1-5, Newman Keuls comparisons showed more period A responses 
during trial I than on trials 2, 3, 4 or 5 (all p's < 0.05). There were 
also fewer period B responses during trials I and 2 than during trial 4 
(p's < 0.05). Similarly there were fewer period B responses during 
trials I, 2, 3 and 4 than in trial 5 (p's < 0.05). In Test 2, trials 
1-5, there were fewer period B responses made during trial I than in 
either trial 4 or 5 (p's < 0.05). There were also fewer responses made 
during trial 3 than trial 5 (p < 0.05). 
Extinction of avoidance responding 
The data from extinction tests were analysed in the manner des-
cribed in Experiment One. Data from each subject are presented in 
Table A33 and in Figures 16, 17 and 18. The data were summed across 
subjects to obtain the mean number of responses made· on each extinction 
trial per group (see Table A34) and were analysed using Freidman's two 
way analysis of variance (Seigel 1956). In Extinction Test I there were 
significant effects on the total responses (p < 0.01) and short avoidances 
(p < 0.01). During Test 2 there were significant effects on total res-
ponses (p < 0,001), short avoidances (p < 0.05) and long avoidances 
(p < 0.05). Multiple comparisons (Hollander and Wolfe 1973) (see Table 
A35) indicated that all significant effects were due to differences 
between home cage animals and response prevented animals with no signi-
ficant effects of peptide treatment. Response prevented LVP treated 
rats made significantly fewer total avoidance responses than home cage 
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Table I: Selected outcomes from Newman Keuls comparisons on lever pressing data. Table shows the 
relative response rate between selected groups where differences are significant (p < 0.05) 
Responses Trials 1-5 Trials 6-10 Trials 1-5 Trials 6-10 
Home cage saline A ns Hcs > Rps ns ns 
versus B Hcs < Rps ns ns Hcs > Rps 
Response prevented saline SR ns ns ns ns 
Home cage saline A ns Hcs > Hcl ns ns 
00 versus B Hcs > Hcl Hcs > Hcl ns ns 
Home cage LVP SR Hcs > Hcl ns ns ns 
Response prevented saline A ns Rps < Rpl ns ns 
versus B ns ns Rps > Rpl Rps > Rpl 
Response prevented LVP SR ns ns Rps > Rpl ns 
Home cage LVP A Hcl < Rpl Hcl < Rpl ns Hcl > Rpl 
versus B Hcl < Rpl Hcl < Rpl Hcl > Rpl Hcl > Rpl 
Response prevented saline SR Hcl < Rpl ns ns ns 
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LVP treated rats in Test I (p < 0.029) and Test 2 (p < 0.01). Further-
more, they made fewer short avoidances in Test I (p < 0.01) and Test 2 
(p < 0.029) and fewer long avoidances in Test 2 (p < 0.029). Response 
prevented saline rats made fewer total responses than home cage LVP rats 
in Test I (p < 0.029). In Test 2 response prevented LVP rats made fewer 
total avoidance responses than home cage saline rats (p < 0.01). 
Discussion 
Figure 14 shows that during the initial CS presentation (period B) 
the response rate was low and gradually increased as a function of 
repeated CS presentations; this conclusion is supported by the signifi-
cant trials effects in the period B data. In Test I, trials 1-5, the 
response rate during trial 4 was significantly higher than on trials I 
and 2 (p's < 0.05). Similar effects were found in the first five trials 
of Test 2, period B responding was greater on trial 4 than on trial 
(p < 0.05) and greater on trial 5 than on either trials I or 3 (p < 0.05). 
Reduced responding was not restricted to periods in which the CS 
was superimposed. The data in Figure 13 clearly show that period A 
responding in all treatment groups dropped markedly after the first CS 
trial. During Test I responding on trial I was significantly greater 
than on trials 2, 3, 4 and 5. This contrasts with response rats in the 
B periods during these trials which did increase with repeated CS presen-
tations. Figure 13 shows a slight though non-significant increase in 
period A responding. Therefore changes in responding were not restricted 
to the periods of CS presentation but generalized to the inter CS 
periods. The response reduction during CS presentations tended to 
extinguish more rapidly than the changes during the inter CS periods (A). 
Comparison of lever press response rates in the 20 seconds which 
immediately preceded the. first CS presentation showed that the initial 
rate for response prevented saline treated rats was significantly 
greater than for home cage saline controls (p < 0.05). This difference 
cannot be attributed to differences in reaction to the CS. However, 
there were components of the shuttle box attached to the transparent 
walls of the Skinner box for presenting the CS concurrently. Higher 
pre-CS response rates in response prevented groups suggest a change in 
the status of these components of the training environment. 
Response prevention did not change suppression ratios relative to 
home cage saline controls during either Test I or 2. This contrasts 
with the result reported by Monti and Smith (1976) who found that res-
ponse prevention significantly reduced suppression compared to non-
prevented rats. In addition, Monti and Smi"th (1976) did not find that 
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response prevention increased the pre-CS response rate, Conflicting 
results from the present study and that of Monti and Smith (1976) may 
reflect procedural differences. In particular, Monti and Smith (1976) 
used only IS prevention trials, tested suppression immediately afterwards 
and used a much longer inter-CS interval (four minutes), 
~ 
The conflicting results from these experiments could be inter-
preted as differences in the interactions between the avoidance CS and 
operant responding resulting from schedule and treatment differences 
rather than as conflicting accounts of whether or not fear of the CS or 
apparatus cues are extinguished during prevention trials. 
Extinction tests confirmed the results of previous experiments 
(see Experiments One and Three) that response prevention reduced avoidance 
responding in extinction. Failure to find differences in suppression 
ratios did not therefore reflect an ineffective response prevention pro-
cedure. Monti and Smith (1976) did not report the effects of their pro-
cedure on avoidance responding in extinction. 
LVP injected after home cage retention did not alter pre-CS operant 
response rates. This suggests that although LVP and response prevention 
had similar effects on extinction responding when given separately 
(Experiment Three) they could be distinguished by their action on the 
operant baseline. This interpretation was supported by the finding that 
relative to saline LVP significantly increased period B responding and 
suppression ratios (p's < 0.05) in Test I, trials 1-5, but did not 
affect period A responding during these trials. Failure to observe 
changes in the period A response rate between these groups suggests that 
the significant difference in suppression ratios must be attributed to 
the significant decrease in the period B response rate under LVP and not 
to differences in the baseline sensitivity of each group to the suppres-
sive effects of the CS (Blackman 1968, 1974), As Test I proceeded into 
trials 6-10 home cage LVP treated rats retained their significantly 
lower period B response rates, although LVP also reduced period A res-
ponding during these trials (both p's < 0.05), thereby abolishing the 
effect of the peptide on suppression ratios observed in trials 1-5 of 
Test I. Home cage LVP rats did not differ from home cage saline rats 
during Test 2; peptide effects on the operant rate therefore extinguished 
relatively rapidly. This rapid extinction coupled with additional CS 
exposure during the second test may account for the absence of any 
efifect of the peptide during subsequent extinction testing. 
Vasopressin induced changes in the operant rate and suppression 
ratios are novel and considered in isolation may be interpreted in the 
theoretical terms used by Kamin et al (1963) and Monti and Smith (1976) 
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to explain changes in the operant rate, ie that LVP increased conditioned 
fear of the CS. Indeed this would fit the many observations (see 
Chapter 2) that post learning injections of LVP significantly increased 
subsequent extinction responding. However, using identical training and 
treatment procedures it was found in Experiment Three that LVP reduced 
avoidance responding in extinction. This result is not compatible with 
an interpretation of LVP's effect on extinction responding in terms of 
increased conditioned fear, at least within the terms of t~1o factor 
avoidance theory (Mowrer 1947; t~iller 1948; Rescorla and Solo~on 1967). 
Post training LVP i~jections clearly altered t~e status of the CS 
measured by operant response changes; however, the relationship between 
this and the peptide's effects on avoidance extinction rew.ain to be 
clarified. 
Relative to response prevented saline controls, the LVP treated 
rats did not differ in any aspect of their operant response rate during 
trials 1-5 of Test I. During trials 6-10, LVP significantly increased 
period A responding, although this did not persist throughout later 
trials. LVP after prevention did, however, exert persistent effects 
during Test 2 by reducing period B response rates during trials 1-5 and 
6-10 (p's < 0.05). During trials 1-5 this reduction was sufficient to 
significantly reduce (p < 0.05) suppression ratios. Insofar as LVP 
reduced both period B responding and suppression ratios after response 
prevention its effects are the same as those seen after retention in the 
home cage. However, these effects were not evident until Test 2 in res-
ponse prevented rats whereas in home cage rats they were found only in 
Test I. Thus, although response prevention reversed the effects of LVP 
on extinction of the avoidance response compared to home cage retention 
(Experiment Three) it delayed but did not reverse the peptide effect on 
the operant rate and suppression ratios. Once again this configuration 
of changes argues against any change in an inferred central state and in 
favour of schedule induced changes in the local interactions between the 
operant and avoidance schedules. 
The complexity of interactions between response prevention and LVP 
are further illustrated by comparing data· from home cage LVP rats and 
response prevented LVP rats. In Test I, trials 1-5, response prevented 
LVP rats had higher period A and period B response rates and showed 
greater suppression than home cage LVP controls (all p's < 0.05). 
Similarly, during trials 6-10 response prevented LVP rats had greater 
period A and period B response rates (p's < 0.05) than home cage LVP 
treated rats. However, during Test 2, this relationship was reversed; 
response prevented LVP rats showed lower period B rates during trials 1-5 
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and lower period A and period B rates during trials 6-10 (all p's < 0.05). 
Reversal of this relationship from Test I to Test 2 suggests that when 
prevention and LVP are combined the outcome is not simply to reverse the 
effects of LVP upon some inferred psychological state, as may be suggested 
from considering the avoidance extinction data in isolation. Rather the 
data indicate that a complex interaction between the avoidance and the 
operant schedule is further complicated by altering the status of the CS 
using LVP. The reversal of the relationship between home cage LVP rats 
and response prevented LVP rats on operant rate between Tests I and 2· 
reflects a large increase in the period A response rate of home cage LVP 
rats between tests combined with a slightly decreasing rate for response 
prevented LVP rats. A similar pattern is evident for the period B data. 
Thus preceding LVP injections with a period of response prevention not 
only reverses the effect of LVP on avoidance extinction (Experiment Three) 
but also delayed recovery of period A and B response rates. In 
Experiment Three there is also evidence that the combination of response 
prevention and LVP is not the reversal of one simple effect. Whereas 
both LVP and response prevention, in isolation, reduced extinction res-
ponding throughout the three extinction tests, the combination of these 
treatments increased extinction responding but the increase was sustained 
only over two extinction tests and not over three. 
The results may be summarised as follows. Response prevention 
increased the pre-CS response rate and also showed inconsistent effects 
on period A and period B response rates but did not affect suppression 
ratios as was reported by Monti and Smith (1976) and was predicted from 
deductive theories which suggest that changes in the suppression ratio 
indicate correspondent changes in conditioned fear (Kamin, Brimer and 
Black 1963; Rescorla and Solomon 1967; Monti and Smith 1976). If these 
deductive arguments are correct, it must be assumed that failure to con-
firm their predictions and the observations of Monti and Smith (1976) 
in the present experiment is due to a number of procedural factors which 
have been outlined. As an alternative, it has been argued that neither 
operant baseline changes or suppression changes reflect changes in 
inferred psychological states. Instead the results of the present 
experiment and those reported by Monti and Smith (1976) may be reconciled 
by theories which interpret operant rate changes and suppression changes 
in terms of interactions between the concurrent operant and avoidance 
schedules. The form of such interactions being dictated by schedule 
characteristics, the changes which have been observed may be attributed 
to changes in these schedule characteristics. This interpretation has 
been extended to classical-operant interactions by Henton and Iversen 
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(1978) and is closely allied to the competing response hypothesis of 
Brady and Hunt (1955). 
When given to home cage retained rats LVP reduced period B res-
ponding and suppression ratios relative to saline treatment; there was 
no effect of the peptide during Test 2 or during subsequent extinction 
testing. From these data, and taking into account the observations of 
Experiment Three, it was argued that LVP altered the status of the CS. 
This effect could be detected with extinction testing (Experiment Three) 
or with the concurrent presentation of the CS during the operant schedule. 
Whereas the former test, in which performance of the response is 
possible, yielded long term effects of the peptide, the latter test, in 
which responding was not possible, rapidly extinguished the peptide 
effect. Again the data are not compatible with the theoretical position 
of deductive accounts but could be interpreted in terms of alterations 
in the local schedule interactions. 
The interaction between response prevention and LVP were relatively 
straightforward during the extinction tests of Experiment Three (see 
also King and De Wied 1974). In the case of the operant rate tests, LVP 
had a similar effect after response prevention and after home cage 
retention. Period B responses and suppression rates were reduced, but 
in the case of response prevented rats this did not appear until the 
second test whereas in the home cage rats these effects were apparent in 
Test I. The complexity of the interaction between these two treatments 
was apparent when home cage LVP and response prevented LVP rats were 
compared. Differential rates of change in period A and B response rates 
in these two groups contributed to a reversal in the magnitude of their 
respective response rates. The complexity and the direction of the 
operant rate and suppression ratio changes combined with the direction 
of the changes seen in the avoidance extinction data of the present 
experiment and Experi~ent Three do not fit an explanation in terms of 
changes in a single psychological construct such as conditioned fear or 
memory consolidation. 
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CHAPTER FIVE 
THE EFFECTS OF VARYING POST TRAINING INJECTION INTERVALS, 
DOSES AND PEPTIDE STRUCTURE 
5.0 Introduction 
Five experiments are reported, the first showing that post training 
sensitivity to the response reducing effects of LVP (I ~g) is maximal one 
hour after training (Experiment Five). Tests with higher doses 
(Experiment Six) suggested that in the range 2-4 ~g the dose response 
curve is negative when injected 30 minutes after training. A wider dose 
range was therefore examined and Experiment Seven, using a modified 
training and test procedure, showed that the dose response curve for 
0.036-2.97 ~g is an inverted U shape at this interval. 
Opposite effects .of 0.11 ~g and 2.97 ~g were still seen after 
training at a higher shock level (0.45 ma) (Experiment Nine). Further-
more, although 0.11 ~g increased extinction responding when injected 
immediately 30 or 60 minutes after training, 2.97 ~g was ineffective 
immediately after training, decreased responding when injected after 30 
minutes and increased responding when injected after 60 minutes 
(Experiment Eight). The response reducing effects of various LVP doses 
do not appear to be mediated by classical endocrine effects of the pep-
tide because none of the doses of DG-LVP which were tested increased 
subsequent extinction although several reduced it (Experiment Ten). 
5.1 Experiment Five: The Effects of Varying the Interval between LVP 
Injections and Training or Response Prevention on Avoidance 
Extinction 
Introduction 
In Experiment Two it was shown that LVP (I ~g) increased avoidance 
responding in extinction when injected immediately after training in 
agreement with results reported in the literature (see Chapter Two). In 
Experiment Three rats were trained on the same schedule and injected 
after 30 minutes spent in the home cage. In this case LVP reduced extinc-
tion responding, a result which does not support the hypothesis that 
LVP enhances the consolidation of memory (see Chapter Two). 
The conflicting results from Experiments Two and Three suggest 
that varying the interval between training and injection may alter the 
effect of LVP on extinction other than by a simple time dependent decre-
ment as studies in Section 2.2 suggest. Therefore, in order to 
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re-examine this question LVP (I ~g) was injected at several intervals 
after training. 
Response prevention reduced extinction responding when given alone 
(Experiment One) or when followed by a saline injection (Experiment 
Three). These results are in agreement with the effects of prevention 
trials which have been widely reported in the literature (see Chapter 
Three). ·Response prevention followed immediately by an LVP injection 
increased extinction responding relative to response prevention followed 
by saline (Experiment Three). This is in agreement with the results 
reported by King and De Wied (1974) who gave peptide before response 
prevention. Thus, comparing the results from King and De Wied (1974) 
with those of Experiment Three suggests that, relative to saline, LVP 
increases responding whether it precedes or follows a period of response 
prevention. In this respect, the LVP effect on response prevented rats 
resembles that for non prevented rats described in the literature (see 
Chapter Two). According to data from extinction testing (Experiment 
Three; King and De Wied 1974) LVP appears to counter the effect of res-
ponse prevention, despite the evidence (Experiment Three) that given 
separately the effects of these treatments may be identical. However, 
the data from Experiment Four clearly distinguish LVP and response pre-
vention by their differential effects on the operant response rate. 
Furthermore these data suggest that the interaction between LVP and res-
ponse prevention cannot be interpreted as the summation of two effects 
on an inferred psychological state. 
As LVP and response prevention may affect different aspects of 
behaviour and as the effect of LVP on extinction may be reversed when 
peptide treatment is preceded by prevention trials it was of interest to 
determine if this reversal varied as a function of the interval between 
prevention and injection and if the direction and magnitude of any 
changes were comparable to those seen in non prevented rats. 
The basic design of Experiment Three was repeated in the present 
experiment. Rats were trained to a criterion of ten correct consecutive 
avoidances, half were randomly selected for response prevention (RP) and 
half for no behavioural treatment (home cage). Rats retained in the home 
cage were injected with either saline or LVP immediately (0 mins), 30 
mins, 60 mins, 6 hours or 24 hours after the end of training. Response 
prevented rats were given 30 trials of response prevention followed by 
saline or LVP at one of the intervals mentioned previously. The interval 
was timed from the end of the behavioural procedure, whether or not this 
included response prevention. 
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Methods 
Subjects 
Adult male cfhb Wistar rats (250-350 g) were housed three or four 
to a cage and maintained on ad lib food and water. One hundred and sixty 
rats were used, 40 supplied by Anglia Laboratories Limited and the 
remainder taken from the Plymouth Polytechnic closed colony; 25 rats 
failed to reach the learning criterion and were dropped from the 
experiment. 
Apparatus 
The two way shuttle box and the schedule used have been described 
in detail in Experiment One. 
Training 
Each day rats were brought from the animal house to the laboratory 
at approximately 9.15-9.30 am. The experiment was run in a series of 
replications, each starting on a Monday. Animals were first weighed and 
then placed in the shuttle box for five minutes of adaptation to the. 
environment. Training was according to the schedule described in 
Experiment One and continued for a maximum of 50 trials on each of two 
consecutive training days or until the ani~~l had made ten consecutive 
correct responses. Subjects which did not attain the criterion within 
the hundred trials were dropped from the experiment. 
Treatment 
Having attained the criterion, half of the animals were randomly 
selected to receive 30 trials of response prevention, according to the 
method described in Experiment One. After response prevention animals 
were removed from the shuttle box and returned to the home cage. These 
animals were injected with either saline (0.5 ml physiological saline SC) 
or LVP (I ~g/0.5 ml physiological saline SC). The batch details, pre-
paration details and method of administration have been described in 
Experiment Two. Rats were randomly allocated to receive injections 
immediately (0 mina), 30 mins, 60 mins, six hours or 24 hours after the 
end of response prevention. The remaining rats were returned to the 
home cage immediately after training injected with either saline or LVP 
after one of the intervals described. 
Testing 
Twenty-four hours after injection rats were returned to the shuttle 
box for 50 extinction trials (Test I) and 24 hours later this was 
repeated (Test 2). The extinction test procedure has been described ~n 
detail in Experiment One. 
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Results 
Acquisition performance 
Groups were compared on five aspects of their performance during 
training, the number of trials taken to reach criterion, the number of 
avoidances, escapes and failures to respond whilst attaining the criterion 
and the number of shocks received. These data are presented in Table 
A36. Groups were compared on each of these measures using analysis of 
variance (Winer 1962) and these analyses are summarised in Table A37. 
There were no significant differences between groups on any of the 
measures used. 
Extinction 
The technique for analysing extinction data has been described in 
Experiment One. Briefly, responses for each subject were summed across 
five successive extinction trials. Group totals per trial block were 
computed by summing across subjects to obtain the total number of res-
ponses per group in each block of five trials. These data are presented 
in Table AJB. The total number of responses in each trial block is the 
sum of the short avoidances (latency ~ 10 secs) and the long avoidances 
(latency~ 10 secs). Groups were then compared statistically for dif-
ferences in each class of response during extinction Tests I and 2 using 
Fr-iedman's analysis of variance (Siegel 1956) followed by multiple com-
parisons between groups using the method outlined by Hollander and Wolfe 
(1973). 
There were significant treatment effects in the total number of 
avoidances made during Test I (p < 0.001) and Test 2 (p < 0.001). 
Similarly, there were significant treatment effects in the number of 
short avoidances in Test I (p < 0.001) and in Test 2 (p < 0.001). There 
were no significant treatment effects on the number of long avoidance 
responses made in either test. The results of these tests are summarised 
in Table A 
Multiple comparisons were made between groups using the method of 
Hollander and Wolfe (1973) based on the differences between rank sums of 
groups (see Table A40) exceeding a critical difference (see Table A40) 
with a set experimentwise at 0.05. This method allows all possible com-
parisons to be made; however, as only selected comparisons are of 
interest, these are presented Ln Table A41. 
Changes in the mean number of total responses and short avoidances 
during Test I as a function of the injection interval are shown in 
Figures 19 and 20 respectively. 
The differences between home cage saline groups were evaluated in 
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order to establish the effects of varying the time of saline injection 
after training. In Test I animals injected immediately after training 
(He sal 0) made significantly fewer total avoidances than animals 
injected after 30 minutes (p < 0.05) or 60 minutes (p < 0.05); there 
were no differences in the number of short avoidances. When animals 
were injected 24 hours after training they made significantly fewer 
total avoidances than those injected either 30 minutes (p < 0,01) or 60 
minutes (p < 0.05) after training, Similarly rats injected 24 hours 
after training made significantly fewer short avoidances than those 
injected either 30 (p < 0.025) or 60 minutes (p < 0.01) after training. 
During Test 2 these differences had disappeared. Therefore during Test 
animals injected immediately after training responded in extinction at a 
rate comparable to rats injected after 24 hours. In contrast, when 
injection was delayed for either 30 minutes or 60 minutes after injection 
responding was significantly increased. These effects can clearly be 
seen in Figures 19 and 20. 
The differences between responsepreventedsaline groups were 
evaluated in order to establish the effect of saline injections when a 
period of response prevention intervened between the end of training and 
the injection (see Table A41, Section 2). Figures 19 and 20 show that 
the rate of Test extinction responding tended to decrease to a minimum 
at the 30 minute interval and thereafter to increase. There were no 
significant differences between response prevented saline groups in the 
total number of avoidances made during Extinction Test I but rats 
injected 30 minutes after response prevention made significantly fewer 
short avoidances (p < 0.05) than animals injected after six hours. This 
difference was greater during Test 2 as response prevented rats injected 
30 minutes after prevention made significantly fewer total responses 
(p < 0.025) and short avoidances (p < 0.01) than animals injected after 
six hours. The data from response prevented saline injected rats 
therefore suggest that when a period of response prevention intervenes 
between training and injection this counters time dependent effects of 
the saline injection which were evident in home cage saline rats. 
Extinction responding tends to decrease and then significantly increase 
as a function of the increasing interval. 
Comparing home cage saline groups with response prevented saline 
rats confirmed the response reducing effect of prevention trials (see 
Table A41, Section 5). During Test 1, response prevented rats injected 
after 30 minutes made significantly fewer total avoidances (both 
p's < 0.05) and short avoidances (both p's < 0.01) than home cage animals 
injected after 30 or 60 minutes. During Test 2 response prevented rats 
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injected with saline after 30 minutes maintained their low rate of res-
ponding and made significantly fewer short avoidances than home cage 
rats injected 60 minutes (p < 0.01), six hours (p < 0.025) or 24 hours 
(p < 0.01). Additional Freidman tests shows that response prevented 
rats injected with saline immediately after prevention made significantly 
fewer short avoidances (p < 0.029) than home cage saline rats injected 
30 minutes after training, confirming the results of Experiment Three. 
However, when these data formed a subset of the overall experimental 
analysis (see Table A41, Section 5) the difference did not achieve sig-
nificance, reflecting non-monotonicity in the FrLedman test (Hollander 
and Wolfe 1973, p 118). 
The significant differences in Test I extinction performance 
between home cage rats given saline injections at various intervals 
after training (see earlier discussion) were abolished by LVP (I ~g) 
(see Table A41, Section 3). During Test 2, however, animals injected 
with LVP immediately after training made significantly fewer total 
avoidances than rats injected 30 minutes (p < 0.025), 60 minutes (p < 0.01), 
six hours (p < 0.01) or 24 hours (p < 0.01) after training. Similarly, 
immediately injected rats made significantly fewer short avoidances than 
those injected 60 minutes (p < 0.01), six hours (p < 0.01) or 24 hours 
(p < 0.05) after training. 
When response prevented rats were injected with saline the sub-
sequent between group differences were mainly seen in the short avoidance 
data (see Table A41, Section 2). Furthermore, responding in both Tests 
I (see Figures 19 and 20) and 2 (see Table A38) first tended to decrease 
with the intermediate intervals (30 and 60 minutes) then increase with 
the six hour injection. When response prevention was followed by I ~g 
of LVP this pattern was accentuated (see Figure 21). Statistical ana-
lysis (Table A41, Section 4) shows that in Test rats injected 60 
minutes after prevention made significantly fewer short avoidances than 
those injected immediately (p < 0.025) or six hours (p < 0.01) after 
injection. Rats injected immediately responded at a similar rate to 
those injecte~ after six hours and both groups made significantly more 
short avoidances than those injected after 24 hours (p's < 0.025 and 
< 0.01 respectively). In Test 2 response prevented rats injected with 
LVP after 30 minutes made significantly fewer total avoidances (p < 0.05) 
and short avoidances (p < 0.05) than those injected after six hours. 
Therefore in Test I when response prevention was followed by LVP (I ~g) 
the rate of short avoidance responding varied in a U shaped function as 
the interval between prevention and injection increased. This time 
dependent function in the short avoidance data is opposite to that seen 
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in the total avoidance data from the home cage saline controls (see 
Figures 19 and 20). 
The effects of LVP were compared to the effects of saline in home 
cage animals (see Table A41, Section 7) and in no case did LVP increase 
the extinction response rate relative to saline. On the contrary, when 
significant differences did occur LVP reduced the response rate. In 
Test I rats injected with LVP immediately after training made signifi-
cantly fewer total avoidances than rats injected with saline 60 minutes 
(p c 0.05) after training. Similarly, those rats injected with LVP 
after 60 minutes made significantly fewer total avoidances than those 
injected with saline either 30 minutes (p < _0.01) or 60 minutes (p < 0.01) 
after training. During Test 2, rats injected with LVP immediately after 
training made significantly fewer total avoidances than those injected 
with saline either 60 minutes (p < 0.01) or 24 hours (p < 0.01). 
Similarly, rats injected with LVP immediately after training made sig-
nificantly fewer short avoidances than those injected with saline after 
60 minutes (p < 0.01), six hours (p < 0.01) or 24 hours (p < 0.01). 
During Test I there were no significant differences in the total 
avoidance responding made by response prevented saline and LVP treated 
rats. Differences in short avoidance responding between these two 
groups are summarised in Table A41 (Section 8). 
Discussion 
When the interval between the end of training and saline injection 
was increased, in rats which had been detained in the home cage, res-
ponding during Extinction Test I was lowest in groups which had been 
injected immediately or 24 hours after training. For groups with an 
intermediate interval the response rate was higher (see Figures 19 and 
20). The statistical analysis of the data from Extinction Test I shows 
that response rates varied as an inverted U shaped function of the 
interval between the end of training and saline injection. This pattern 
was less clear in Test 2 although immediately injected rats still tended 
to make fewer responses than those injected after 60 minutes. The basis 
for this effect is unknown but may be related to the stress of handling 
and injection. Reports of endocrinological changes following handling 
stress in rats have recently been confirmed by van Dijk using a radio-
immunoassay to measure plasma ACTH (van Dijk 1979, personal communication). 
In addition, Riffee et al (1979) have found that saline injections reduce 
locomotor activity and that both handling and pre injections with saline 
could alter behavioural arousal (composite locomotor activity) induced 
by apomorphine and dextroamphetamine. Therefore pituitary adrenal 
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activation or stress induced arousal changes may play a part in mediating 
the differences seen in extinction between saline injected animals, 
possibly by interacting with post training changes in the behavioural 
substrate. Kamin (1957) found that when rats were partially trained on 
an avoidance schedule and were returned for retraining at various 
intervals after the first session, then the level of avoidance responding 
during retraining varied as a function of the intervening interval. The 
intervals used by Kamin (1957) were the same as those in the present 
experiment; furthermore, responding in the Kamin (1957) study was minimal 
at the 60 minute interval, the interval showing maximum avoidance res-
ponse rates in the present experiment and maximal sensitivity to the 
response inhibiting action of LVP (see Figure 21). 
When LVP was injected there were no significant differences bet-
ween home cage LVP groups during Test I, although when injected imme-
diately after training LVP significantly reduced total avoidance res-
ponses in Extinction Test 2 relative to all other LVP home cage groups. 
A similar pattern was seen in the short avoidance data. These data 
indicate that LVP disrupts the time dependent effects of saline injec-
tions. In Test 2 immediately injected rats made significantly fewer 
responses than rats injected with LVP after any other interval. 
Comparing home cage saline groups with home cage LVP groups at 
different intervals confirmed that LVP significantly reduces responding 
in Extinction Test I, as seen in Experiment Three. However, in the 
present experiment the response reducing effect of LVP was evident only 
when injections were given 60 minutes after training. 
The increase in responding seen in Experiment Two when LVP was 
given immediately after training was not replicated, In the present 
experiment home cage LVP and home cage saline rats responded similarly 
in Test I at all injection ineervals except 60 minutes. The sensitivity 
of the 60 minute injection interval to the response reducing effect of 
LVP can be seen from Figure 21 in which the Test I total avoidance data 
for each group is plotted as a percentage of the home cage saline control 
performance over all injection intervals. 
Response prevention tended to reverse the inverted U shaped func-
tion in the extinction performance of home cage saline rats in Test I , 
suggesting an interaction between response prevention and the saline 
injection procedure. Comparing response prevented saline rats with the 
home cage saline controls confirms the response reducing effect of pre-
vention treatment (Experiments One, Three and Four). Lowest response 
rates were found when saline followed response prevention by 30 minutes; 
this was confirmed in Test 2. 
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Combining response prevention with LVP injections reversed the 
relationship between the injection interval and Test I avoiding seen in 
the home cage saline rats. In the response prevented LVP treated rats 
Test I responding declined to a minimum at the 60 minute interval, 
yielding a U shaped relationship between response rate and interval (see 
Figure 21). These data also suggest that at 60 minutes after training 
the animals are maximally sensitive to the response reducing effect of 
LVP. Response prevention is capable of reversing, only for a limited 
time, the response reducing effect of LVP (see Experiment Three). 
Several aspects of the data point to sensitivity changes after 
training or response prevention. The 'placebo' effect of saline on 
Test I avoidance rates was greatest when the injection was given after 
60 minutes; the response reducing effect of LVP was maximal 60 minutes 
after the end of either training or prevention and, although response 
prevention reversed the response reducing effect of LVP when injected 
immediately or after 30 minutes, after 60 minutes the response reducing 
effect of LVP was once more prominent. Kamin (1957) pointed out the 
response deficits evident in partially trained rats 60 minutes after 
original training and Anisman (1975) has suggested that this may be 
related to neurochemical changes after training. Performance changes in 
the present experiment may reflect interactions between time dependent 
neurochemical changes and the treatment variables of saline, response 
prevention and LVP. Subsequent experiments examined the interactions 
between various peptide doses and treatment intervals. 
5.2 Experiment Six: The Effect of LVP (2,3,4 ~g) on Extinction 
Responding when Injected 30 Minutes after 1raining or Immediately 
after 30 Response Prevention Trials 
Introduction 
Evidence discussed in Chapter Two suggested that increasing the 
dose of vasopressin injected after passive avoidance training increased 
subsequent passive retention latencies in a dose dependent manner. 
Experiments Three and Six found that a ~g of LVP injected either 30 
minutes (Experiment Three) or 60 minutes (Experiment Six) after shuttle 
box training led to significant decreases in extinction responding. It 
was decided to examine whether higher doses injected 30 minutes after 
training would increase or decrease extinction responding. In the 
present experiment rats were injected with either 2, 3 or 4 ~g of LVP 
after training or response prevention trials. 
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Methods 
Subjects 
Seventy adult male CFHB wistar rats (2S0-3SO g) from the colony 
maintained at Plymouth Polytechnic were housed three or four to a cage 
with ad lib access to food and water. Twenty-two rats failed to attain 
the learning criterion and were therefore discarded from this experiment, 
but used in a subsequent experiment. 
Apparatus and schedule 
These have been described in Experiment One. Rats were trained to 
make ten consecutive avoidances during a maximum of two training 
sessions consisting of SO trials each and run on two consecutive days. 
Rats which achieved this criterion were randomly allocated to one of 
two conditions, 30 minutes retention in the home cage or 30 response 
prevention trials as described in Experiment One. 
Treatment 
After 30 response prevention trials or 30 minutes in the home cage 
rats were randomly allocated to receive either a saline injection or one 
of three doses of LVP. Control animals were injected with O.S ml of 
physiological saiine (0.9%), Experimental animals received either 2, 
3 or 4 microgrammes of LVP in O.S ml of physiological saline and pre-
pared from the batch described in Experiment Two. All injections were 
se. 
Testing 
Approximately 24 hours after injection, animals were returned to 
the shuttle box for SO extinction trials (Test I) and this was repeated 
on the following day (Test 2). 
Results 
Acquisition 
Performance during training was compared on five measures; 
avoidance responses, escape responses, failures to respond, trials to 
criterion and shocks received in training (see Table A42) and analysed 
using analyses of variance (see Table A43), There were no significant 
differences between groups during the acquisition phase of the experi-
ment. 
Extinction 
Table A44 shows the number of short avoidance responses (< IQ 
seconds), long avoidances (> 10 seconds) and the total number of 
avoidances (short plus long) responses made during extinction Tests 
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and 2. Responses were summed across·every block of five trials for each 
rat. Totals SUIIIIIIed across subjects in each group are shown in Table A45 
and formed the basis of comparisons using Freidman's analysis of 
variance (Seigel 1956). The outcome of these analyses is shown in 
Table A46. There were significant treatment effects in the total 
avoidance data of Test I (p < 0.001) and Test 2 (p < 0.001). Similarly 
there were significant treatment effects in the short avoidance data 
from Test I (p < 0.001) and Test 2 (p < 0.01). There were no significant 
treatment effects in the long avoidance data. 
Multiple comparisons between groups were made, using the method 
described by Hollander and Wolfe ( 1973), in order to locate significant 
effects (Table A46). Within the home cage groups animals given 4 ~g of 
LVP tended to make fewer total responses than those given 2 ~g (p < 0. 1), 
suggesting a negative dose response relationship between the dose of 
peptide and subsequent extinction response levels. Although response 
prevention (plus saline) did not reduce response levels compared to 
those of home cage saline controls, data from response prevented rats 
supported the suggestion that the dose response relationship is negative 
as differences in extinction as a function of dose were more apparent in 
the response prevented rats. During Test I, response prevented rats 
given 4 ~g LVP made significantly fewer total avoidances (p < 0,01) and 
short avoidances (p < 0.01) than those given 2 ~g. These differences 
were maintained in Test 2; rats given 4 ~g made fewer total (p < 0.01) 
and short (p < 0.01) avoidance responses than rats given 2 ~g. In Test 
2, response prevented rats given 4 ~g tended to make fewer total res-
ponses than response prevented saline controls (p < 0.06). In Test I, 
response prevented·. rats (3 ~g) made significantly fewer short avoidances 
than rats given 2 ~g LVP (p < 0.01). Similarly, in Test 2, rats treated 
with 3 ~g made significantly fewer short avoidances than those given 
2 ~g (p < 0.031). 
There were no significant differences between behavioural treat-
ments (RC v RP) when comparisons were made within a single dose level, 
although there were a number of differences between home cage and res-
ponse prevented rats across different dose levels, conforming to the 
negative dose ·response function with higher doses invariably producing 
lower response rates than low doses regardless of the behavioural treat-
ment (see Table A46). Regression lines calculated for Test I short 
avoidance data using the method of least squares did not indicate any 
systematic effects in line slopes as a function of dose or behavioural 
treatment (see Table A47). 
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Discussion 
Rats retained in the home cage for 30 minutes after training then 
injected with 4 ~g of LVP tended to make fewer total avoidance responses 
in Test I than rats injected with 2 ~g ·of LVP, suggesting a negative 
dose response relationship between the post training peptide dose and the 
subsequent extinction response rats, ie higher doses leading to lower 
response rates. 
Response prevention per se did not affect extinction rates. 
Furthermore, this lack of effect does not appear to be due to rapid 
within test extinction rate differences, a factor which confounded the 
effects of extinction trials in Experiment Three. This lack of effect 
contrasts with the findings of Experiments One, Three, Four and Five. 
However, prevention trials rendered the rats more sensitive to the res-
ponse reducing effects of high doses of LVP. Data from these rats 
suggest a negative dose response relationship as response prevented rats 
injected with 3 ~g made significantly fewer short avoidance responses in 
Test I than those injected with either 2 ~g or saline. Similarly, in 
Test 2, 3 ~g produced fewer short avoidance responses than 2 ~g. The 
effect of 4 ~g was more pervasive. In Test I, 4 ~g reduced responding 
relative to 2 ~g in both the total avoidance and short avoidance data. 
In Test 2, response prevented rats treated with 4 ~g made fewer total 
responses than those treated with saline. In addition 4 ~g produced 
fewer total and short avoidance responses than 2 ~g. The absence of 
response prevention effects per se permits the comparison of doses across 
behavioural treatments. In all cases these differences conform to the 
principle that 3 or 4 ~g yield lower response rates than either saline 
or 2 ~g. 
It may be concluded that, within the dose range tested, the 
relationship between the dose of a post training LVP injection and 
extinction responding is negative, higher doses leading to lower extinc-
tion responding. The results confirm the previous findings (Experiments 
Three and Five) that post training LVP may reduce subsequent extinction 
response levels. 
5.3 Experiment Seven: The Effects of Five Doses of LVP Injected 30 
~unutes after Shuttle Box Training 
Introduction 
Although Experiments Three, Five and Six showed that post training 
LVP injections reduced avoidance responding in extinction, they failed 
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to replicate the findings of Experiment Two and those in the literature 
(see Chapter Two) which show that vasopressin's increase extinction 
responding. As Experiment Six showed that higher doses than 2 ~g tended 
to further reduce responding, the present experiment examined the 
effects of lower doses on a modified shuttle box task. 
Methods 
Subjects 
Adult male Wistar rats of an inbred strain (cpb TNO, Zeist, 
Netherlands) were housed five to a cage with ad lib access to food and 
water under conditions of constant temperature (22°C) and regulated 
illumination; the animal house was in darkness between 1900 and 0500 
hours. Animals weighed 200-220 g and were brought to the laboratory at 
least one hour before the experimental sessions which were run between 
1300 and 1700 hours. 
Apparatus 
A manually controlled two-way shuttle box (internal dimensions 
48 x 25 x 17 cm) with a centrally placed hurdle (height 4 cm) was housed 
in a sound attenuating chamber under reduced illumination. The shuttle 
box was lit by a single overhead houselight and a constant level of 
background noise was maintained by the foots hock scrambler. A loud 
buzzer was placed immediately behind the shuttle box to act as the 
conditioned stimulus (CS). Ten seconds of the CS alone were followed by 
ten seconds of the CS accompanied by scrambled foo~pock as the uncon-
ditioned stimulus (UCS) set at 0.15 ma. 
If the rat crossed the central hurdle after the onset of the CS 
but before the UCS, then impending shock was cancelled (avoidance); if 
the crossing occurred during the UCS, the shock was terminated (escape). 
In both cases the CS was also switched off. Training trials were not 
allowed to exceed 20 seconds in order to eliminate excessive exposure to 
shock. Each trial began with the onset of the CS every 60 seconds; 
therefore the inter trial interval varied as a function of response 
rapidity between the minimum of 40 seconds and a maximum approaching 60 
seconds. A hurdle crossing in the absence of the CS was designated as 
an intertrial response (ITR). 
Procedure 
Five minutes of adaptation to the shuttle box preceded training. 
Learning then began and continued until each animal had made ten correct 
consecutive avoidance responses. Having reached the criterion, animals 
were removed from the shuttle box and returned to the home cage for 
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treatment with the various doses described below. Approximately 24 
hours later they were returned to the shuttle box and after two minutes 
of adaptation were tested with ten extinction trials. Shock was omitted 
during extinction but otherwise the schedule was the same as for 
training. A response within ten seconds of CS onset was an avoidance 
and responses in the absence of the CS were intertrial responses. 
This experiment examined the effects of five doses of LVP injected 
30 minutes after training. Animals were returned to the home cage 
immediately after training and were randomly allocated to receive either 
saline or LVP. The experiment was run in two consecutive, independent 
phases; in the first phase three doses were compared with saline, 0. 11, 
0.33 and 0.99 ug/rat. The second phase extended the dose range to 
0.036 and 2.97 ug/rat. 
Peptides 
LVP was stored at 1-5°C as a dry powder and was freshly prepared 
before each session. A single drop of HCL (0.01 N) plus sufficient 
physiological saline were added to yield the required dose in a constant 
injection volume of 0.5 ml. Lysine vasopressin (LVP; pressor activity > 
200 IU/mg) were supplied by Organon, Oss, Netherlands, All injections 
were subcutaneous (SC). 
Data analysis 
Acquisition performance was recorded using four measures, the 
number of trials to reach criterion and the number of avoidances, 
escapes and intertrial responses made in training. Independent t-tests 
and one way analysis of variance (Winer 1962) were used to determine 
significant differences between groups in acquisition on 'these measures. 
For the analysis of extinction data the number of avoidance& or inter-
trial responses were summed across subjects within each group to obtain 
the total number of each response made by the group on every trial, The 
trial totals from each group, within each experiment, were then analysed 
using a two way analysis of variance (treatment x trials) with repeated 
measures on the trials factor (Winer 1962). Neuman-Keuls test (Winer 
1962) was then used to determine significant differences between pep-
tides and saline, between peptide doses and between trials. For all 
tests p < 0.05 (two tailed) was considered significant. 
Results 
The results are summarised in Table 2. Analysis of the acquisi-
tion data showed that there were no significant differences during 
training between treatment and control groups in either phase. Analysis 
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Table 2: Acquisition and extinction of shuttle box avoidance responding using 0.15 ma footshock 
in training and a 30 minute interval between the end of training and injecting various 
d9ses of. lysine vasopressin 
ACQUISITION 1 EXTINCTION2 
Trials Avoidances Escapes Avoidances ITRs 
Saline (8) 18.63 ± 1.58 12.62 ± 0.42 5.87 ± I. 24 4.0 ± 0.36 2.9 ± 0.56 
LVP 0. I I ll& (8) 20.87 ± 2. I I 13.87 ± I. 53 6.37 ± 0.9 6.3 ± 0.26c 8.9 ± 0.84c 
w LVP 
CD 
0.33 )Jg (7) 21.28 ± I. 99 14.43 ± 1.04 6.0 ± I. 23 4.8 ± 0.44c 2.7 ± 0.49 
LVP 0.99 )Jg (8) 23.25 ± 2.87 13.25 ± 0.97 8.87 ± 2.31 4.9 ± 0.3lc 2.4 ± 0.6 
Saline (8) 23.75 ± 2.51 15.0 ± 1.08 8.62 ± I. 74 5.5 ± 0.31 5.2 ± 0.64 
LVP 0.036 ll& (8) 22.62 ± 2.25 13.75 ± 0.99 8.25 ± I. 37 5. I ± 0.37a 2.9 ± 0.91 
LVP 2.97 )Jg (8) 23.25 ± 2.53 15.75 ± I. 38 7. 12 ± I. 39 4.5 ± 0.3lc 3.0 ± 0.69 
Mean ± SEM per subject a < 0.05 (compared to saline controls) p 
2 Mean ± SEM per trial b < 0.02 p 
( ) Number of subjects c < 0.01 p 
of the extinction data from phase one revealed significant effects of 
treatments on both avoidance (F(3/27) = 16.646, p < 0.01) and inter-
trial (F(3/27) = 11.646, p < 0.01) responding. In addition there were 
significant effects of trials in avoidance (F(9/27) = 7.12, p < 0.01) 
and intertrial responding (F(9/27) = 15.33, p < 0.01). Neuman-Keuls 
comparisons revealed that after 0. 11, 0.33 and 0.99 ~g avoidance res-
ponding was significantly greater than in saline controls (all p's < 0.01). 
Furthermore, 0.11 ~g resulted in significantly more avoidances than 
either 0.33 or 0.99 ~g (p's < 0.01). Neuman-Keuls comparisons on the 
trials effect in the avoidance data showed that responding was higher 
on trial one (p's < 0.05) and higher on trial two than on subsequent 
trials (p's < 0.05). Neuman-Keuls comparisons showed that 0.11 ~g 
increased intertrial responding relative to saline (p < 0.01). Analysis 
of the trial effect in the intertrial response data showed that res-
ponding on trials 2 and 3 was significantly lower than on trials 5 to 10 
(p's < 0.05), responding on trial I was lower than on both trials 6 and 
8 (p < 0.05), and responding was maximal by trial 8 which had a signi-
ficantly higher total than all other trials (p < 0.05). 
Analysis of extinction data from phase two showed that there were 
significant effects of dose (F(2,18) = 5.51, p < 0.05) and trials 
(F(9,18) = 5.23, p < 0.05) on avoidance responding but no significant 
effects on intertrial responses. Neuman-Keuls tests showed that res-
ponding was significantly reduced by both 0.036 ~g (p < 0.05) and 
2.97 ~g (p < 0.01) compared to saline controls. Furthermore the res-
ponse level after 2.97 ~g was significantly lower than after 0.036 ~g 
(p < 0.01). Neuman-Keuls comparisons of trial effects in the avoidance 
data showed that the response level on trial I was significantly higher 
than on any subsequent trial (p's < 0.05); also levels on trials 2 and 
10 were significantly greater than on trial 4 (p < 0.05). 
Discussion 
All five doses of vasopressin altered avoidance responding in 
extinction. However, the direction of change depended on the dose. 
This is clear from Figure 22 in which data from each dose, calculated as 
a percentage of saline controls, facilitate comparison between the two 
phases. Avoidance responding was reduced by the lowest (0.036 ~g) and 
the highest dose (2.97 ~g); in contrast the intermediate doses (0.11, 
0.33 and 0.99 ~g) increased avoidance responding. The most potent dose 
in this respect was 0.1 I ~g which yielded higher response levels than 
either 0.33 or 0.99 ~g and was the only dose to significantly increase 
intertrial responding above the level of saline controls. The effects 
139 
lll 
-0 
'-
........ 
c 
0 
u 
Q) 
c: 
·-
-0 
lll 
"' 
0 
FIGURE 23 Post training effects of LVP. on ex ti net ion 1so · · ~do 
160 
14-0 
120 
100 
0...... 
80 
0 
........... 
+· 
+ 
........... ../ 
+ 
+ 
30 
avoidances 
250 
200 
150 \. 
/ 
" 100 
I 
' 
....... 0 ·11 ug/rat 
o-o 2·97 ug/ rot 50 
60 0 
Trci'ining- Injection Interval (mins) 
+ 
+ 
ITR'S 
,P 
/ 
/ 
v .. + 0 01 :: +p ,, 
30 60 
of 0.11, 0.33 and 0.99 ~g confirm previous reports that post training 
vasopressin injections increase resistance to extinction in intact rats 
(de Wied and Bohus 1966; de Wied 1971; Bohus et al 1972; King and de Wied 
1974; Bohus et al 1978a,b; Krejci, Kupkova, Metys, Barth and Jost 1979; 
see also Experiment Two) whereas the effects with 0.036 and 2.97 ~g con-
firm previous findings with high doses (Experiments Three, Five and Six). 
Taken together, the data suggest that the direction and magnitude of 
vasopressin's effect on extinction responding varies as an inverted U 
shaped function of the dose. 
Analysis of the trials effects in the avoidance data from phases 
one and two showed that response levels were initially high and then 
declined rapidly. Phase two showed that the lowest response rate had 
been attained by trial 4 and thereafter gradually increased till the 
last trial although the final level was still significantly lower than 
on trial I. In contrast, the pattern in intertrial data from phase one 
was for responding to increase from trials I , 2 and 3 through to trial 
8, suggesting that the trial dependent reduction in responding was due 
to a loss of stimulus control rather than a reduction in general 
activity. 
5.4 Experiment Eight: The Effects of Oppositely Acting LVP Doses 
Injected Immediately or 60 Minutes after Training on Avoidance 
Extinction 
Time dependent changes in the effectiveness of post training vaso-
pressin injections have been a central aspect in the evidence relating 
the action of the peptides to processes concerned with memory consolida-
tion (de Wied 1971; Bohus et al 1972; King and de Wied 1974; Bohus et al 
1978a,b; van Wimersma Greidanus et al 1975). However, Experiments 
Three, Five, Six and Seven showed that LVP may also reduce extinction 
responding and that sensitivity to this effect increases rather than 
decreases 60 minutes after training (Experiment Five). It was therefore 
of interest to determine the pattern of time dependent changes for 
oppositely acting doses of LVP in this behavioural model. Experiment 
Seven established the relationship at the 30 minute interval. Therefore 
in the present experiment either 0.1 I or 2.97 ~g were injected 
immediately or 60 minutes after the end of training in the shuttle box. 
Methods 
All aspects of the methods and procedures were identical to those 
described for Experiment Seven. Rats were injected with saline, 0.11 
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or 2.97 ~g LVP immediately or 60 minutes after the end of training; for 
the 60 minute groups the intervening period was spent in the home cage. 
Results 
During training there were no significant differences between 
groups according to the number of trials, avoidances, escapes or inter-
trial responses. Data from both the acquisition and extinction phases 
of the experiment are summarised in Table 3. Analysis of the extinction 
data revealed significant effects of dose (F(2,18) = 9.948, p < 0.01) 
and trials (F(9,18) = 2.947, p < 0.05) on avoidance responding but no 
significant effects on intertrial responding when animals were injected 
immediately after training. Neuman-Keuls tests showed that 0.11 ~g 
resulted in significantly more avoidance responses than either saline or 
2.97 ~g (p's < 0.01), whereas 2.97 ~g did not affect avoidance responding 
relative to saline. Neuman-Keuls comparisons of trial totals showed 
that responding on trial I was higher than on 5 (p < 0.05). When the 
injections were withheld for 60 minutes there were significant effects 
of dose on the avoidance data (F(2,18) = 4.77, p < 0.025) but no effects 
of trials. Neuman-Keuls tests shmied that both 0.11 and 2.97 ~g resulted 
in significantly more avoidances than saline (p's < 0,01). There were 
no significant effects in the intertrial response data. 
Discussion 
To facilitate comparison with data from Experiment Seven, the 
results from each group were calculated as a percentage of their saline 
controls and these data are shown in Figure 23. 0.11 ~g LVP increased 
avoidance responding in extinction when injected either immediately or 
60 minutes after training. Comparing the data from Experiment Seven 
shows that 0.1 I ~g enhanced responding when injected within one hour of 
training, thus confirming earlier indications on the most effective 
intervals for treatment (de Wied 1971; Bohus et al 1972; King and de Wied 
1974). The low dose appeared to be equipotent at the 0 and 60 minute 
intervals but more active when injected 30 minutes after training. In 
contrast, the effect of the high dose (2.97 ~g) varied in direction as a 
function of the intervening interval. lJhen injected immediately after 
training, there was no effect; when injected after 30 minutes avoidance 
responding was reduced; and if the injection was delayed for 60 minutes 
avoidance responding was significantly increased. 
The data suggest that there are time dependent changes in the dose 
response curve with particular sensitivity to both the low and high dose 
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Table 3 Acquisition and extinction of a shuttle box avoidance response using 0.15 ma footshock 
in training followed by 0. 11 IJg or 2. 97 ll8 LVP .injected either immediately or 60 
minutes after training 
ACQUISITION I EXTINCTION2 
Training 
injection Trials Avoidances Escapes ITRs Avoidances ITRs 
interval 
.,. Saline ~ (8) 0 minutes 19.5 ± 2.28 13.5 ± 1.24 5.75 ± I. 22 2.0 ± 0.65 5.5 ± 0.5 3.3 ± 0.68 
LVP 0. I I 118 (8) 0 minutes 25.(1 ± 2.85 15.62 ± I. 74 6.75 ± I. 13 4.75 ± 1.2 6.7 ± 0.15c 5.7 ± 0. 77 
LVP 2.97 118 (8) 0 minutes 21. 12 ± I. 74 13.87 ± I. 27 7. 12 ± 1.26 5.75 ± 2.15 5.2 ± 0.2 4.7 ± 0.57 
Saline (8) 60 minutes 26.87 ± 3.82 16.37 ± 2.2! 8.75 ± I. 21 5.0 ± 1.37 4.3 ± 0.26 2.8 ± 0.48 
LVP 0. I I ll8 (8) 60 minutes 24.5 ± 3.54 15.62 ± 2.32 8.0 ± 1.72 6.87 ± 2. 11 5.4 ± 0.3c 4.9 ± 0. 72 
LVP 2. 97 118 (8) 60 minutes 24. 12 ± 2.96 16.87 ± 1.87 6.5 ± I. 21 2.75 ± 0.92 5.3 ± 0.42c .3.9 ± 0.56 
See Table 2 for key 
effects 30 minutes after training. 
5.5 Experiment Nine: The Effects of OpPOSitely Acting LVP Doses 
Injected 30 Minutes after Training with a Higher Shock Level 
(0.45 ma) on Avoidance Extinction 
The results from Experiment Seven indicated that extinction 
avoidance responding varied as an inverted U shaped function of the 
vasopressin dose when injected 30 minutes after the training session. A 
similar dose response relationship has been reported for Adrenocorti-
cotrophic hormone (Acth) when injected immediately after passive 
avoidance training (Gold and van Buskirk 1976a,b). These authors also 
found a strong interaction between dose and training shock level, thus a 
high dose facilitated retention after training with low shock but dis-
rupted retention after an intermediate or high shock. Moreover a low 
dose facilitated retention after both low and intermediate training 
shock levels but disrupted retention after high shock (Gold and 
van Buskirk 1976b). This interaction was interpreted as support for the 
hypothesis that Acth modulated the normal hormonal response to training 
thereby mimicking the effects of higher footshock in training (Gold and 
van Buskirk 1976a,b; Gold and McGaugh 1977). 
Previous research had shown that small increases in footshock 
intensity, or the use of overtraining procedures, in a passive avoidance 
task reduced the amnestic effects of protein synthesis inhibitors 
(Flood, Bennett, Rosenweig and Orme 1973; Flood et al 1974). Similarly 
the duration of amnestic treatment needed to be prolonged in order to be 
effective in mice which were overtrained in an active avoidance task 
(Flood, Bennett, Orme and Rosenweig 1975). Pharmacological manipulations 
of post training arousal using stimulant drugs also counteracted the 
amnestic effects of protein synthesis inhibitors (Flood, Jarvik, Bennett, 
Orme and Rosenweig 1977). 
These data suggested that if either the hormonal consequences of 
training or post training arousal were affected in a dose dependent 
manner by LVP then the characteristics of the inverted U shaped dose 
response curve observed in Experiment Seven should be changed by 
increasing the footshock level in training. Two oppositely acting doses 
(0.11, 2.97 ~g) were therefore selected and were injected 30 minutes 
after training in the shuttle box at a higher shock level. 
Methods 
All aspect~ of the procedure and methods were identical to those 
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described for Experiment Seven with the exception that the shock level 
in training was increased to 0.45 ma. 
Results 
The data from Experiment Nine are summarised in Table 4. During 
training there were no significant differences between groups in the 
avoidances, escapes, trials to criterion or intertrial responses. 
Analysis of the extinction data showed that there were significant 
effects of dose (F(2,18) = 16.08, p < 0.01) and trials (F(9,18) = 14.575, 
p < 0.01) on avoidance responding. Neuman-Keuls tests revealed that 
0.1 I ~g resulted in significantly more avoidance& than either saline 
(p < 0.01) or 2.97 ~g (p < 0.01). Furthermore, 2.97 ~g produced fewer 
avoidances than saline (p < 0.01). Neuman-Keuls comparisons between 
trial totals showed ·that avoidance responding on trial I was significantly 
higher than on all subsequent trials (p's < 0.05). Intertrial responding 
was almost totally suppressed during extinction and there were no signi-
ficant effects of either trials or doses. 
Discussion 
The results from this experiment confirm those from Experiment 
Seven; 0.11 ~g increased whereas· 2.97 ~g decreased subsequent avoidance 
responding in extinction. Unlike the effects of post training ACTH 
(Gold and van Buskirk 1976a), the effectiveness of the low and high dose 
of LVP remained essentially the same after training at the higher level 
of footshock; this tends to rule out an explanation in terms of LVP 
modulating the hormonal consequences of training. Furthermore it 
appears unlikely that LVP mediates its effects by altering post training 
arousal as has been found for other drugs which affect memory storage 
(Flood et al 1973, 1974, 1975, 1977). 
Increased shock did not appear to affect the rate of response 
acquisition compared to Experiment Seven or later experiments. Inter-
trial responding appeared lower during training in the present experi-
ment and in extinction was almost totally suppressed. During extinction 
the level of baseline avoidance responding was approximately 50% of that 
seen in the control groups of Experiments Seven and Eight yet despite 
the different baselines extinction also preceded very rapidly within the 
test. These baseline changes do not agree with previous suggestions of 
an inverse relationship between shock levels and acquisition rate in the 
shuttle box (Moyer and Korn 1964; Levine 1966; Theios, Lynch and Lowe 
1966; McAllister and McAllister 1971) and in the passive avoidance task 
(Pearce 1978), but suggest that with relatively small increases in shock 
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Table 4: Acquisition and extinction of a shuttle box avoidance response using 0.45 ma of footshock 
in training followed by 0.11 or 2.97 ~g of LVP injected 30 minutes after training 
ACQUISITION 1 EXTINCTION2 
Trials Avoidances Escapes ITRs Avoidances 
Saline (8) 14.87 ± I. 23 8.5 ± 2.44 2.7 ± 0.42 0.3 
~ LVP 0. 11 ~g (8) 
V1 
23.87 ± 3.32 
22.12 ± 2.28 
22.5 ± 1.28 
14. 12 ± I. 12 8.25 ± I .56 
2.0 ± 0.84 
0.62 ± 0.37 
I. 87 ± I. 06 
3.2 ± 0. 32c 0.2 
LVP 2.97 ~g {8) 12.87 ± 0.76 9.5 ± 1.44 2.0 ± 0.29c 0.3 
See Table 2 for key 
ITRs 
± 0.21 
± 0. 13 
± 0.21 
decreased responding may be evident in extinction before the effects are 
seen in acquisition. 
5.6 Experiment Ten: Dose Response Studies with DG-LVP 
Structure activity studies using the pole jump active avoidance 
response have shown that the increased resistance to extinction seen 
after post training injections of LVP or AVP does not appear to be 
mediated by the peptides' effects on endocrine function (see Section 2.2). 
When the C terminal glycinamide was removed the resulting des-glycinamide 
analogs (DG-AVP, DG-LVP) retained approximately 50% of their behavioural 
activity but were almost devoid of classical endocrine pressor and anti-
diuretic effects (Lande et al 1971; de Wied et al 1972) (see Section 2.2). 
In the present experiment a range of doses of DG-LVP were injected 30 
minutes after the end of shuttle box training in order to determine if 
the entire vasopressin molecule was required for the inhibitory effects 
of low and high doses and whether or not this effect could be ascriced 
to the classical endocrine functions of the peptide. 
Methods 
The methods and procedures were identical to those described for 
Experiment Seven with the exception that des-glycinamide lysine vaso-
pressin (DG-LVP (Organon, Oss, Netherlands) was used. The experiment 
was run in five independent phases in each of which saline was compared 
with a number of peptide doses ranging from 0.012 ~g to 8.91 ~g. 
Results 
The acquisition and extinction data from Experiment Ten are 
summarised in Table 5. Analysis of the acquisition data from phase one 
showed that there were no significant differences between groups during 
training. Analysis of the extinction data showed that 8.91 ~g DG-LVP 
significantly reduced avoidance responding {F(I,9) = 176.09, p < 0.01). 
There was no significant effect of·trials and no significant effects on 
intertrial responding. 
During phase two there were no significant differences between 
groups in training. Analysis of avoidances in extinction revealed a 
significant effect of doses (F(2,18) ~ 5.72, p < 0.05) but not trials. 
There were no significant effects on the intertrial response data. 
Neuman-Keuls comparisons showed that saline treated controls made signi-
ficantly more avoidances than rats treated with either 0.11 or 0,33 ~g 
(p's < 0.01). Furthermore the number of avoidances was higher after 
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Table 5: Acquisition and extinction of shuttle box avoidance responding using 0.15 ma footshock 
in training and a 30 minute interval between training and injection of various doses 
of DG-LVP 
(I) 
(2) 
(3) 
Phase 
Saline 
DG-LVP 
Saline 
DG-LVP 
DG-LVP 
8.91 )Jg 
0.11 )Jg 
0.33 )Jg 
(9) 
(9) 
(8) 
(8) 
(8) 
Saline (10) 
DG-LVP 2.97 )Jg (10) 
Saline (8) 
(4) DG-LVP 0.012 )Jg (8) 
·nG-LVP 0.036 JJ& (8) 
Saline (8) 
. (5) DG-LVP 0.024 )Jg (8) 
DG-LVP 0.073 JJ& (8) 
Trials 
18.44 ± 1.29 
18.66 ± 2.19 
17.5 ±2.18 
17.75± 1.21 
19.75 ± 2.69 
19.3 ± 1.82 
20.5 ± 2.27 
17.2 ± 1.0 
25.5 ± 3. 14a 
19.87 ± 2. I 7 
22.25 ± 1.58 
22.12 ± 2.98 
24.37 ± 3.49 
ACQUISITION I 
Avoidances 
13.0 ± 0.64 
12.66 ± I. 4 
12.87 ± I . 14 
12.37 ± 0.82 
I 3. 62 ± I • 3 7 
13. 3 ± I . 07 
13.1 ± 1.2 
Escapes 
5.5 ± 1.01 
6.0 ± 1.1 
4. 25 ± I. 21 
4.62 ± 0.92 
5.37 ± 1.36 
5.3 ± 1.03 
6.3 ± 1.83 
12.62 ± 0.56 3.75 ± 0.62 
16.37 ± 2.09 
13.12 ± 1.09 
13.25 ± 0.84 
15.12±1.53 
15.62 ± 1.63 
8. 12 ± I. 83 
5. 25 ± I. 22 
7.87±1.66 
6.5 ± 1.77 
7.62 ± 1.97 
See Table 2 for key 
ITRs 
3.11 ± 0.75 
3.66 ± 0.91 
8.12 ± 2.63 
7.5 ± 1.96 
3.0 ± 0.86 
4.4 ± I. 13 
2.7 ± 0.93 
6.75 ± 2.64 
4.75 ± 2.47 
5.37 ± 1.32 
3.75 ± 1.53 
3.37 ± 1.32 
2.12 ± 0.61 
EXTINCTION2 
Avoidances. 
6.7 ± 0.36 
5.0 ± 0.36a 
7.1 ± 0.17 
6.3 ± 0.268 
5.5 ± 0.528 
6.5 ± 0.65 
5.6 ± 0.45 
5.7 ± 0.36 
5.2 ± 0.38 
6.0 ± 0.45. 
6.0 ± 0.45 
4.1±0.38a 
6.5 ± 0.27 
ITRs 
5.2 ± 0.73 
5.7±1.15 
6.3 ± 0.45 
5.4 ± 0.37 
5.7 ± 0.75 
6.4 ± 1.18 
4.4 ± 0.62 
3.0 ± 0.21 
3.5 ± 0.68 
4.5 ± 0.83 
5.3 ± 0.56 
2.8 ± 0.2c 
7. 0 ± I. 17c 
\ 
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0.11 ~g than after 0.33 ~g (p < 0.01). 
Analysis of the acquisition data from phase three revealed no 
significant differences between groups. During extinction 2.97 ~g of 
DG-LVP tended to reduce avoidance responding compared to saline 
(F(I,9) = 4.314, p < 0.1) and there was a significant effect of trials 
on the avoidance response (F(9,9) = 5.734, p < 0.01). Neuman-Keuls tests 
showed that responding was significantly higher on trial I than on all 
subsequent trials (p's < 0.05) with the exception of trial 2 and that 
responding on trial 2 was significantly greater than on trial 4 (p < 0.05). 
The lowest level of responding had been reached by trial 4. 
During phase four the analysis of acquisition data showed a signi-
ficant difference between groups in the number of trials to criterion 
(F(2,21) = 3.5, p < 0.05). Neuman-Keuls comparisons revealed that 
animals which were subsequently injected with 0.012 ~g took more trials 
to attain the criterion than either saline·controls or the 0.036 ~g 
group (p's < 0.05). There were no other significant differences in 
acquisition. Analysis of the extinction data showed that there were no 
effects of dose on either avoidance or intertrial responding but there 
were significant trials effects in both (F(9,18) = 2.504, p < 0.05; 
F(9,18) = 3.23, p < 0.05 respectively). Neuman-Keuls comparisons of 
trial totals in the avoidance data showed that responding was signifi-
cantly higher on trial I than on all subsequent trials with the excep-
tion of trial 10 (p's < 0.05). Neuman-Keuls comparisons of trial totals 
in the intertrial response data showed that responding on trial 8 was 
significantly greater than on trials I, 2, 3, 4, 5 and 10 (p's < 0.05). 
Finally, during phase five there were no significant differences 
between groups in acquisition. Analysis of the extinction data showed a 
significant effect of dose in both the avoidance (F(2,18) = 15.518, 
p < 0.01) and the intertrial response data (F(2,18) = 8.66, p < 0.01). 
There were no significant trial effects in either set. Neuman-Keuls 
comparisons showed that animals treated with 0.024 ~g made fewer 
avoidance responses than either saline controls (p < 0.05) or animals 
treated with 0.073 ~g (p < 0.01). lntertrial responding was significantly 
lower in the 0.024 ~g group than in either the saline or 0.073 ~g group 
(p's < 0.01). In addition 0.073 ~g resulted in significantly more inter-
trial responses than saline (p < 0.01). 
Discussion 
The data from each treatment group in this experiment were cal-
culated as a percentage of their saline controls and this form of the 
data is presented in Figure 24. None of the doses tested increased 
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avoidance responding in extinction although 0.073 ~g significantly 
increased intertrial responding. On the contrary, significant reductions 
in avoidance responding and intertrial responding were seen with 0.024 ~g 
and significant reductions in avoidance alone were seen with 0.1 I, 0.33 
and 8.91 ~g. 
These data indicate that the C terminal glycinamide is not 
necessary in order to show response reductions when the peptide is 
injected 30 minutes after training. Therefore the effects observed in 
Experiments Three, Five, Six, Seven, Eight and Nine with various doses 
were probably not mediated by effects on classical endocrine targets 
(see Sections 1.8 and 1,9) (Lande et al 1971; de Wied et al 1972). 
Rather they suggest that the increased extinction responding seen with 
0.1 I, 0.33 and 0.99 ~g LVP in Experiments Two and Seven and in the 
literature (see Chapter Two) required the full molecular structure. 
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CHAPTER SIX 
6.0 Introduction 
Extensive evidence suggests that vasopressin injections alter 
'catecholaminergic metabolism in discrete brain nuclei (Section 2.7) and 
that this may be the neurochemical mechanism which underlies their 
behavioural effects. Substantial evidence also implicates cholinergic 
neurons in memory mechanisms and therefore the first experiment of this 
chapter des·cribes the effects of the cholinergic drugs scopolamine and 
physostigmine on the outcome of LVP injections and response prevention 
trials. 
Tests with rats which failed to achieve learning criterion showed 
that the effects of LVP (I ~g) were opposite to those seen in rats which 
achieved criterion (Experiments Twelve and Thirteen). In addition, 
rats which failed to reach criterion showed a different interaction 
between cholinergic drugs and LVP injections (Experiment Fourteen). 
6.1 Experiment Eleven: The Effects of LVP and Prevention Trials on 
Extinction Responding after Injections of Scopolamine or 
Physostigmine 
Introduction 
Cholinergic neurons have been implicated in processes related to 
storage and recall of learned responses. Deutsch et al (1966) found 
that the anticholinesterase diisopropyl fluorophosphate (0.01 mg) 
injected directly into rat hippocampi 30 minutes after training a Y maze 
. 
escape response resulted in amnesia for the response for up to three 
days after the injection. Following intra-hippocampal injections of 
scopolamine hydrobromide (0.19 mg/6 ~1), a cholinergic antagonist, 
Wiener et al {1973) sh~d good retention for three days after injection 
but performance was disrupted five, seven and ten days later. Localisa-
tion of the amnestic effect in the hippocampus could not be confirmed by 
Todd et al (1979) with subseizure doses of physostigmine (10 ~g/~1) 
immediately after avoidance training. Earlier positive findings for 
this region (Deutsch et al 1966; Wiener et al 1973) could have been due 
to a spreading of effects as a result of relatively high doses and 
injection volumes. However, Todd et al (1979) did find an amnesic 
effect of physostigmine following post training injections into the 
ISO 
amygdala. 
Retrieval processes are affected by physostigmine (0.4 mg/kg ip) 
injected seven days after passive avoidance training and 30 minutes 
prior to retention testing (Hanbury et al 1976). Signorelli (1976) 
confirmed that the retention effect could only be found when the drug 
was still pharmacologically active suggesting that apparent effects on 
retrieval may not be due to altering the substrate of memory. 
Post training systemic injections of physostigmine may result in 
facilitation of subsequent retention. Alpern and Marriot (1973) trained 
rats on a reversal learning task in a T maze and found that a post 
training injection of scopolamine (2 mg/kg ip) disrupted responding 25 
minutes later. In contrast, physostigmine (0.2 mg/kg ip) facilitated 
subsequent performance. The authors argued that the data indicated 
effects upon short term memory processes. However, this interpretation 
may be confounded by two factors: firstly, despite prolonged training, 
control animals reverted to responding at chance levels 25 minutes 
later; secondly, the injections were given immediately after training 
and 25 minutes before the retention test, allowing no clear temporal 
distinction between consolidation and retrieval stages. Stronger evi-
dence for an amnesic effect of physostigmine was reported by Barrati et 
al (1979). These authors trained mice on a one trial step through 
passive avoidance task, injected physostigmine or oxotremorine, a 
cholinergic receptor agonist, immediately after training and during 
retention testing 24 hours later found that both drugs, in equimolar 
doses, produced dose dependent and time dependent increases in passive 
avoidance. A dose of 0.25 ~ mol/kg of physostigmine enhanced passive 
avoidance 24 hours later when injected within ten minutes of the 
learning trial. These data suggest a role for cholinergic neurons in 
consolidation processes. 
Extensive evidence that vasopressin plays a role in consolidation 
has been reviewed in Chapter Two (see also Wimersma Greidanus & Versteeg 1980). 
These findings have been confirmed in Experiments Two, Seven, Eight and 
Nine. However, it has also been shown that both high and low doses of 
LVP may reduce subsequent extinction responding (Experiments Three, Five, 
Six, Seven, Eight and Nine). Furthermore, the response reducing effects 
of both I ~g (Experiment Five) and 2.97 ~g (Experiments Seven and Eight) 
appear to first increase and then decrease during the post training 
period. The present experiment is designed to test the hypothesis that 
cholinergic neurons are involved in mediating the response reducing 
effect of LVP. 
In an extensive study, Taub et al (1977) found that the only 
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effective pharmacological adjunct to response prevention was atropine in 
a dose of 3 or 6 mg/kg ip. One hundred and fifty ledge jump training 
trials were followed by an injection of the drug followed 30 minutes 
later by ten trials of response prevention. Extinction testing was 
carried out 72 hours after injection. The design did not allow a dis-
tinction to be made between possible consolidation type effects of the 
drugs, resulting from immediate post learning injections, and inter-
actions with the prevention trials which followed the injection after 30 
minutes. Non response prevented drug treated rats were not tested. 
However, in view of the possible interaction between the anticholinergic 
drug atropine and response prevention and considering that response 
prevention may, under certain conditions, reverse the effects of post 
training LVP (see Experiments Three and Six) it was of interest to 
determine the effect of scopolamine and physostigmine on extinction 
responding after _prevention trials 
Methods 
Subjects 
Seventy-two adult male wistar rats (350-450 gm) from the Plymouth 
Polytechnic colony were housed three or four to a cage with free access 
to food and water. 
Procedure 
The apparatus and schedule have been described in Experiment One. 
Rats were trained in the shuttle box to a criterion of ten correct con-
secutive avoidance responses within a maximum of two 50 trial training 
sessions, run on consecutive days. Rats which attained criterion were 
randomly assigned to be detained in the home cage for 30 minutes or to 
receive 30 trials of response prevention (see Experiment One). Following 
this each rat was then randomly assigned to receive one of six combina-
tions of peptide and drug treatments. In the first of two injections 
each rat was given either saline or LVP (SC). The second injection 
followed immediately and was either saline, scopolamine or physostigmine 
(SC). The details of LVP preparation have been described in Experiment 
Two; the peptide was administered in a dose of I ug per rat in 0.5 ml of 
saline vehicle. Scopolamine hydrobromide crystals (Sigma Chemicals 
Limited, Lot Number 16c-0359) were dissolved in 0.9% saline (2 mg/ml), 
and injected in a dose of 0.5 mg/kg body weight calculated as the weight 
of the salt. Solutions were stored at I-5°C and injected at room 
temperature. Approximately 24 hours after injection rats were returned 
to the shuttle box for 50 extinction trials (Test I) and repeated 24 
hours later (Test 2). 
152 
28 
26 
u) 24 
Q) 
u 
c 
0 
:022 
0 
> 
0 
18 
Figure 25 Total avoidances for treatment groups in extinction 
test one (mean and s.e.m:) 
h response prevented. ome cage. 
I 
T - I T 
-
-.- T 
--
--
--
1 
sal. sal. sal. l vp. sal. l v p. sal. sal. sal. lv p. sal. lvp. 
sal. lvp. scop.scop. phy. pny. sal.lvp. scop.scop. phy. phy. 
treatment groups. 
24 
Figure 26 Short avoidances for treatment groUQS in extinction 
test one (mean and s e.m.) 
home cage. response prevented. 
u) 20 --
<1> -
--
u --
c - --
0 
-o 
·o 18 
--
--
> 0 -
14 
I 
sal. sal. sal. lvp. sal. lvp. sal. sal. sal.lvp. sal.lvp. 
sal. lvp. scop.scop. phy. phy. sal. lvp. scop.scop. phy. phy. 
treatment groups. 
Results 
Acquisition 
Performance during training was recorded using five measures; the 
number of avoidance responses, escape responses, failures to respond, 
shocks received in training and trials to criterion (see Table A48) and 
analysed using analysis of variance (Winer 1962) (see Table A49). There 
were no significant differences between groups on any of these measures. 
Extinction 
The mean number of avoidance responses, short avoidance responses 
(< 10 seconds) and long avoidance responses (> 10 seconds) made in 
extinction is presented in Table A50. The number of responses made by 
each subject in each block of. five extinction trials was summed across 
subjects to obtain the total number of each class of response per trial 
block (see Table A51). The performance of each group was compared using 
Freidman's two way non parametric analysis of variance (Seigel 1956); the 
outcomes of these tests are presented in Table A52. There were signi-
ficant treatment effects in the total avoidance data in Test I (p < 0.001) 
and Test 2 (p < 0.02), in the short avoidance data in Test I (p < 0.001) 
and in the long avoidance data of Test I (p < 0.02) and Test 2 (p < 0.02). 
The method described by Hollander and Wolfe ( 1973) ~ms used to locate 
significant differences between groups (see Table A52). The mean number 
of total avoidances and the mean number of short avoidances made by each 
group in Test I are shown in Figures 25 and ::6. 
The highest response rate was seen in rats injected with saline 
and scopolamine; these animal~ made more total responses than LVP saline 
rats (p = 0.06) and LVP scopolamine rats (p < 0.03). Saline scopolamine 
treated rats also made significantly more total responses (p < 0.01) and 
short avoidances (p < 0.01) than rats treated with saline and physo-
stigmine. In addition saline scopolamine rats made more total avoidances 
(p < 0.047) and tended to make more short avoidances (p < 0.1) than rats 
treated with LVP and physostigmine. 
The lowest number of total responses in Test I was found in res-
ponse prevented rats injected with LVP and saline. These rats made 
fewer total avoidances than those treated with saline only (p < 0.03) or 
saline and physostigmine (p < 0.01) and tended to make fewer than rats 
injected with saline and scopolamine (p = 0.06), LVP and scopolamine 
(p = 0.085). Saline plus physostigmine treated rats made significantly 
more total avoidances (p < 0.01) and short avoidances (p = 0.05) than 
rats treated with LVP plus physostigmine. 
Comparing results of drug and peptide treatments across the 
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behavioural conditions of home cage retention versus response prevention 
showed that home cage rats given saline and physostigmine made signifi-
cantly fewer total responses than response prevented rats given saline 
and physostigmine (p = 0.05). Similarly home cage rats given saline and 
scopolamine made significantly more short avoidance responses than res-
ponse prevented rats given saline and scopolamine (p < 0.047) (see also 
Table A52). 
Discussion 
LVP (I ~g) tended to reduce avoidance responses in Test I after 
home cage retention (see Figure 25 ) • Failure to find a significant dif-
ference may be d·ue to differential rates of change in the within session 
response levels (see also Experiment Three). Test total avoidance 
data for saline control rats (see Table A53) yielded a slope coefficient 
of -0.31 compared to -1.32 for LVP treated rats indicating a higher 
within session rate of change in response levels. 
Scopolamine injected 30 minutes after training tended to increase 
whilst physostigmine tended to decrease the level of Test I extinction 
responding relative to saline controls. Although the differences between 
drug treated rats and saline controls did not reach significance, 
scopolamine significantly increased Test I total avoidances and short 
avoidances relative to physostigmine. These dr~g induced changes in 
extinction support the hypothesis that cholinergic neurons are· involved 
in mediating post training neurochemical processes and supports previous 
observations, using central injections, suggesting that physostigmine 
acts as an amnesic agent (Deutsch et al 1966; Todd et al 1979). The 
findings contrast with those from experiments which used systemic 
injections and found that physostigmine enhanced recall when injected 
immediately after learning (Barrati et al 1979; Hanbury et al 1976). 
These differences may reflect procedural differences, eg training task, 
injection route or dose. 
LVP significantly reduced the total number of avoidance responses 
in Test I compared to saline when both of these treatments immediately 
preceded a scopolamine injection. LVP did not alter avoidance response 
levels compared to saline in physostigmine treated, home cage rats. 
Those rats which had been treated with either LVP or saline and physo-
stigmine responded at similar levels in Tests and 2 and both of these 
groups made significantly fewer total avoidance responses and short 
avoidance responses than rats treated with saline and scopolamine. 
Assuming that the effects of the cholinergic drugs and LVP take 
comparable times to develop, the data suggest that the response reducing 
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effect of LVP seen in rats which have been detained in the home cage for 
30 minutes is not dependent upon the level of activity in cholinergic 
neurons. 
Response prevented rats injected with saline did not show signi-
ficantly reduced extinction responding relative to home cage saline 
controls. However, as in the case of the LVP treated home cage rats, 
these animals had a greater within test regression slope (-1.11) than 
home cage saline controls (-0.31) indicating a greater rate of change in 
the probability of responding for the response prevented rats. When 
response prevention was followed by an injection of LVP there was a sig-
nificantly lower number of total avoidance responses in Test I than res-
ponse prevented rats injected with saline, contrasting with results from 
Experiment Three and King and de Wied (1974). When response prevented 
rats were injected with scopolamine they made significantly fewer short 
avoidance responses than home cage rats injected with scopolamine, 
supporting the findings of Taub et al (1977). Conversely, response 
prevented rats injected with physostigmine made significantly more total 
avoidances than home cage rats given physostigmine. Therefore the 
effects of scopolamine and physostigmine in home cage control rats were 
reversed when drug treatments were preceded by 30 response prevention 
trials. These results suggest that the response reducing effect of 
prevention trials widely reported in the literature (see Chapter Three) 
and confirmed in Experiments One and Three may be explained in terms of 
altered activity of cholinergic neurons. As the effects of prevention 
may also be found after 24 hours (Experiments One, Three Four and Six) 
this may indicate that prevention trials may activate a cholinergically 
controlled mechanism for the elimination or inhibition of irrelevant 
responding and not by fear extinction (see Section 3.1.2). This hypo-
thesis is strongly supported by the consistent failure to find an 
'anti anxiety' drug which acts as an effective adjunct to prevention 
trials (Kamano 1968, 1972; Baum 1973; Cooper et al 1974; Christy et al 
1975, Taub et al 1977). 
Response prevention trials reversed the effects of subsequent 
scopolamine and physostigmine injections found with home cage rats. 
Following prevention trials physostigmine increased the response rate 
relative to scopolamine. Despite this reversal of effect, the response 
reducing action of LVP prevailed and LVP significantly reduced responding 
relative to saline when given to physostigmine treated rats. Therefore 
the response reducing effect of LVP can be found regardless of the 
changes in response levels found after manipulating cholinergic activity. 
This supports the conclusion from the data with home cage rats in 
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suggesting that cholinergic neurons are not involved in mediating the 
response reducing effects of LVP. 
6.2 Experiment Twelve: The Effect of LVP Conditioned Suppression and 
Avoidance Extinction in Rats which Failed to Reach Learning 
Criterion 
Introduction 
Experiment Four showed that LVP (I ~g) injected 30 minutes after 
training altered operant lever pressing rate changes during concurrent 
CS presentations 24 hours after injection. A number of rats, which were 
trained to lever press on the VI 60 second schedule, failed to attain 
the avoidance learning criterion of ten consecutive responses. Each of 
these rats received 100 training trials which should be sufficient to 
condition fear to the CS. If LVP increases conditioned fear, then 
suppression ratios should be significantly reduced relative to saline 
controls. 
Methods 
Methods and procedures were identical to those described in 
Experiment Four. The small number of animals available prohibited 
examining the effect of response prevention. Rats were injected with 
saline or LVP (I ~g) 30 minutes after the end of avoidance training 
trials. 
Results 
Acquisition 
Performance during avoidance training is summarised in Table AS4. 
Independent 't' tests (Winer 1962) showed that there were no significant 
differences between groups in the number of avoidances, escapes or 
failures to respond or in the number of shocks received in training (see 
Table AS4). 
Lever pressing data 
The number of responses made by each animal in each period A (pre 
CS and inter CS) is presented in Table ASS. Analysis has been described 
in Experiment Four. There were no significant differences between groups 
in the period A data from any of the trial blocks (see Table ASS). 
The number of responses made in each period B (during the CS) is 
also presented in Table ASs. Analysis of variance revealed that during 
Test I, trials 1-S, LVP treated rats (~ ~ 4.2S) tended (p < 0.1) to make 
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more responses than saline controls (i = 2.15). There were no signifi-
cant aifferences between groups on trials 6-10. In Test 2, trials 1-5, 
LVP treated rats (x = 8.35) made significantly (p < 0.05) more responses 
than saline controls (x = 6.55). In trials 6-10 of Test 2 there was a 
trend for LVP rats (x = 10.6) to make fewer responses (p < 0.1) than 
saline controls (x = 11.35). 
Suppression ratios were calculated and analysed in the manner 
described for Experiment Four (see Table A55). In Test I, trials 1-5, 
LVP treated rats (x = 0.2914) tended to show less suppression (p < 0.1) 
than saline controls (x = 0.1338). There were no significant differences 
between groups in any other trial block (see Table A56). 
Extinction data 
The number of responses made by each animal during extinction 
testing is presented in Table A57. Data from each group were compared 
using the Wilcoxon test (Seigel 1956) on responses summed across subjects 
on each block of five extinction trials. In Test I LVP treated rats 
made significantly more total responses (p < 0.02) than saline controls. 
This was due to a significantly greater number of short avoidances 
(p < 0.01) as there were no significant effe~ts on long avoidance res-
ponses. During Test 2 LVP treated rats also made more total responses 
than saline controls (p < 0.05). However, in this test the difference 
was due to a greater number of long avoidance responses (p < 0.01) as 
there was no significant difference between groups on the number of 
short avoidances. 
Discussion 
LVP showed a strong trend (p < 0.1) to decrease suppression ratios 
compared to saline controls during the first five trials of Test I. 
There were no differences between groups during any other trial blocks. 
LVP did not affect responding during period A but tended to increase 
period B responding during trials 1-5 of Test I and significantly 
increased period B responding in trials 1-5 of Test 2. This outcome 
contrasts with the results from Experiment Four in which LVP was found 
to decrease period B responding and consequently increase suppression 
ratios, and supports the conclusion of Experiment Four in which it was 
argued that increased fear of the CS cannot explain the effects of LVP 
on suppression ratios. 
The pattern of operant response rate changes seen in the present 
experiment are the opposite of those seen in Experiment Four. Subjects 
in these two experiments differ primarily in their learning performance; 
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those in the present experiment failed to reach the learning criterion 
despite extended training trials. This suggests that the direction and 
magnitude of the LVP's effects on the operant response rate may be 
related to the level of_response acquisition during avoidance learning. 
It is apparent from the present results that LVP may alter operant res-
ponse rate changes induced by the CS even in rats which showed a very 
low probability of responding during training. Furthermore, LVP 
increased extinction responding in these animals; indeed, the response 
rate in extinction was only slightly lower than that seen in previous 
experiments in which rats had attained the learning criterion. This 
suggests that although attaining the criterion of ten correct consecutive 
avoidances is not essential to show considerable responding in extinc-
tion, the direction of the LVP effect seen in extinction may to some 
extent depend upon the level of responding during acquisition. Similarly 
the direction of operant response rate changes may depend upon this 
factor. Thus Experiments Three and Four showed that in rats which had 
acquired the response criterion LVP increased period B responding and 
suppression ratios and decreased extinction responding. In the present 
experiment, animals which failed to attain the criterion showed opposite 
effects on period B responding, suppression ratios and extinction res-
ponding. 
6.3 Experiment Thirteen: The Effects of LVP (2, 3 or 4 ~g) on Shuttle 
Box Extinction Responding in Rats which Failed to Reach Learning 
Criterion 
Introduction 
Experiment Twelve showed that I ~g of LVP increased extinction 
responding when injected 30 minutes after training to rats which failed 
to reach the learning criterion of ten correct consecutive avoidances. 
This contrasts with the results from Experiments Three and Six in which 
this same dose given 30 or 60 minutes after training reduced subsequent 
extinction responding in rats which had attained the criterion. These 
findings may suggest that the outcome of"LVP treatment may depend upon 
the level of response acquisition. Interpretation of the result from 
Experiment Thirteen is complicated by the interpolation of operant sup-
pression tests. Therefore rats which failed to achieve criterion in 
Experiment Six were tested with various doses of LVP. 
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Methods 
Subjects 
Twenty-two adult male cfhb wistars from Experiment Six which failed 
to achieve the learning criterion were housed three or four to a cage 
with ad lib food and water. 
Procedure 
The apparatus and avoidance schedule have been described in 
Experiment One. Each of these rats received 50 training trials on each 
of two consecutive days. After the second acquisition session rats were 
returned to the home cage for 30 minutes and then injected with either 
2, 3 or 4 ~g of LVP or saline. Preparation and administration of the 
peptide has been described in Experiment Two. Approximately 24 hours 
after the end of training rats were returned to the shuttle box for 50 
extinction trials (Test I) and repeated 24 hours later (Test 2), 
Results 
Acquisition 
The number of avoidance responses, escape responses, failures to 
respond and shocks received in training are summarised in Table ASS. 
Performance was compared using the one way analysis of variance (Winer 
1962) and the outcomes from these analyses are shown 1n Table A58. 
There were no significant differences between groups on any of these 
measures. 
Extinction 
Extinction performance is summarised in Table A59. Total number 
of each type of response, short avoidance (latency < 10 seconds), long 
avoidances (latency > 10 seconds) and total responses (short plus long 
avoidances) in each block of five trials was divided by n to obtain the 
mean number of responses per block of five trials for each group (see 
Table A59). Freidman's analysis of variance (Seigel 1956) was used to 
compare group performances in extinction (see Table A59). There were no 
significant effects of treatment in the total avoidance data of Test 
or Test 2. There were significant treatment effects in the short 
avoidance data of Test I (p < 0.02) but not Test 2. There were no sig-
nificant treatment effects in the long avoidance data from Test I or 2. 
In order to locate the significant treatment effects in the Test I short 
avoidance data multiple comparisons were made between groups using the 
procedure described by Hollander and Wolfe (1973), 3 ~g of LVP tended 
to increase the number of short avoidances relative to saline (p < 0,1) 
and 2 ~g significantly increased short avoidances relative to saline 
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(p < 0.046). Furthermore, a 4 ~g significantly increased short 
avoidances in Test I relative to 2 ~g (p < 0.05). 
Discussion 
The results confirm the earlier indications (Experiment Twelve) 
which showed that LVP increased extinction responding when given to rats 
which failed to achieve the learning criterion. In the present study 
both 3 and 4 ~g increased responding relative to saline and 2 ~g. This 
contrasts with the results from Experiment Six in which the reverse 
relationship was found for increasing doses. Taken together with the 
results from Experiment Six, therefore, these results suggest that in 
this dose range the dose response relationship between LVP and extinc-
tion responding is positive in animals with very low levels of avoidance 
learning in training and negative in animals which had reached criterion. 
6.4 Experiment Fourteen: The Effects of LVP, Scopolamine and Physo-
stigmine on Extinction in Rats which Failed to Reach the Learning 
Criterion 
Introduction 
The results from Experiment Eleven showed that the response 
reducing effects of LVP given after 30 minutes of retention in the home 
cage did not involve cholinergic neurons. In Experiments Twelve and 
Thirteen LVP has been shown to have a different profile of effects when 
given to rats which failed to achieve the learning criterion. LVP (I ~g) 
given to criterion achievers 30 minutes after training decreased sub-
sequent avoidance responding in extinction (Experiment Three) but 
increased responding in rats which failed to achieve the criterion 
(Experiment Twelve). This same dose increased suppression ratios in a 
conditioned suppression test when given to criterion achievers (Experi-
ment Four) but tended to decrease suppression ratios when given to rats 
which failed to achieve the criterion (Experiment Twelve). Higher doses 
of the peptide yielded a negative dose response relationship in rats 
which had achieved the criterion (Experiment Six) but a positive dose 
response curve in those which had failed to achieve criterion (Experiment 
Thirteen). It was therefore of interest to examine the effect of LVP in 
rats which had failed to achieve the criterion and were also treated with 
either scopolamine or physostigmine. 
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Methods 
Subjects 
Thirty-four adult male rats which failed to attain the learning 
criterion in Experiment Eleven were used. 
Procedure 
The apparatus and training schedule have been described in 
Experiment One. During 50 training trials on each of two consecutive 
training days these rats failed to make ten correct consecutive avoidances. 
At the end of the second training session each animal was removed from 
the training cage and returned to the home cage for 30 minutes before 
injections. 
Each animal was randomly allocated to receive one of six treatments: 
saline + saline, LVP + saline, saline + scopolamine, LVP + scopolamine, 
saline + physostigmine, LVP + physostigmine. The preparation, batch 
details and administration of these drugs has been described in 
Experiment Eleven. 
Approximately 24 hours after treatment each rat was returned to 
the shuttle box for 50 trials of extinction testing (Test 1), repeated 
24 hours later (Test 2). 
Results 
Acquisition 
The performance of each animal during training was recorded using 
four measures: the number of avoidances, escapes, failures to respond 
and shocks received during training (see Table A60). The performance of 
each group was compared using analysis of variance (Winer 1962); outcomes 
are presented in Table A60. There were no significant differences 
between groups on any of the measures. 
Extinction 
The total number of avoidance responses, short avoidance responses 
(latency < 10 seconds) and long avoidance responses (latency > 10 seconds) 
made in extinction Tests I and 2 are summarised in Table A61. Data were 
summed to obtain the number of each type of response made by each animal 
in every block of five trials and then across rats to obtain the total 
number of each response type made by each group in every block of five 
trials. As there are unequal numbers in each group the total for each 
trial block was divided by n for each group (see Table A62). The total 
number of avoidances, the number of short avoidances and the number of 
long avoidances made by each group in each test was then compared using 
Freidman's two way analysis of variance (Seigel 1956) (see Table A62). 
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There were significant treatment effects in the total avoidances from 
Test (p < 0,001) and Test 2 (p < 0.001), the short avoidance data from 
Test (p < 0.001) and Test 2 (p < 0.001) and the long avoidance data 
from Test (p < 0,05). 
The significant differences between treatment groups in each test 
were located using the multiple comparison technique described by 
Hollander and Wolfe (1973), The outcome of these comparisons is shown 
in Table A63. LVP plus saline tended to increase Test total avoidances 
and short avoidances relative to saline saline rats (p < 0.1); in Test 2 
this difference achieved significance and LVP saline rats made signi-
ficantly more total avoidances (p < 0.009) than saline saline controls. 
Rats injected with saline and scopolamine responded at similar.rates to 
saline saline controls although in Test I there was a trend for scopo-
lamine to increase the number of long avoidance responses (p = 0.09). 
Rats treated with saline and physostigmine made significantly more total 
avoidance responses (p < 0.047) and short avoidances (p < 0.009) than 
saline saline controls in Test I. Similarly physostigmine increased 
both total avoidances (p < 0.009) and short avoidances (p < 0.009) in 
Test 2. Those rats which were injected with saline and physostigmine 
made significantly more total avoidance responses in Test 2 than those 
injected with saline and scopolamine (p < 0.047). 
When LVP was injected in scopolamine treated rats the number of 
total avoidances was significantly increased (p < 0.023) and the number 
of long avoidances tended to increase (p < 0.09) relative to saline 
scopolamine treated rats in Test I. These differences were not signifi-
cant in Test 2. In addition, LVP scopolamine treated rats made signi-
ficantly more total avoidances (p < 0.023) and short avoidances (p < 0.009) 
than LVP saline treated rats in Test I but not in Test 2. Although 
neither LVP nor scopolamine affected responding relative to saline saline 
controls in Test I when they were each given in combination with a saline 
injection when they were given together there were significant effects 
on extinction responding. Thus LVP scopolamine treated rats made sig-
nificantly more total avoidances (p < 0.009) and short avoidances 
(p < 0.009) than saline saline controls in Test I. 
There were no significant differences between saline physostigmine 
treated rats and those treated with LVP and physostigmine. The signifi-
cant increases seen when saline physostigmine rats were compared with 
saline saline controls were also found with LVP physostigmine rats. 
Thus, LVP physostigmine treated rats made significantly more total 
avoidance responses (p < 0.023) and short avoidances (p < 0.009) than 
saline saline controls in Test I. Similarly, in Test 2 rats treated 
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with LVP and physostigmine made significantly more total avoidance res-
ponses (p < 0.009) and short avoidance responses (p < 0.009) than saline 
saline controls. 
Discussion 
When LVP was injected 30 minutes after the last training trial in 
rats which had failed to achieve the learning criterion the peptide 
increased avoidance respondi~g in extinction Test 2 but not in Test I. 
This increase is in agreement with the results of previous experiments 
(Experiments Twelve and Thirteen) and confirms that the effect of LVP at 
this dose in these rats is opposite to that seen in trained rats 
(Experiments Three and Six). 
When scopolamine was injected with saline there were no signifi-
cant differences in extinction with respect to saline saline controls. 
In contrast, when physostigmine was injected with saline, avoidance 
response rates in both Tests I and 2 were increased significantly with 
respect to saline saline controls. This contrasts with the effects of 
these drugs seen in Experiment Eleven when injected into rats which had 
attained the criterion. In that experiment neither treatment signifi-
cantly altered response rates in extinction with respect to the saline 
saline controls although scopolamine treated rats made significantly 
more extinction responses than physostigmine treated animals. The dif-
ferences between drug treatments were not significant in the present 
experiment although_ the trend in the relationship was the reverse of 
that seen in Experiment Eleven with scopolamine treated rats making 
fewer responses than physostigmine treated rats. The effect of these 
two drugs given in the same doses at the same time after training is 
different in rats which failed to learn the response than in those which 
learned the response. 
There was evidence in Test I that scopolamine acted to facilitate 
the effects of LVP. The peptide alone did not significantly increase 
response levels in Test I and scopolamine did not affect response levels 
in either Test I or Test 2. However, when scopolamine and LVP were 
given together this combination increased Test I response levels relative 
to saline saline controls, LVP saline treated rats and saline scopolamine 
treated rats. LVP did not affect the response levels found in physo-
stigmine treated rats. These data suggest the blockade of post training 
cholinergic activity with scopolamine facilitates the response 
increasing effect of LVP in rats which failed to achieve criterion. 
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CHAPTER SEVEN 
EFFECTS OF LVP ON APPETITIVELY MOTIVATED RESPONDING 
7.0 Introduction 
The experimental literature on the behavioural effects of the 
vasopressins is largely dominated by experiments which have used aver-
sively motivated responding. Pole jump avoidance, passive avoidance and 
shuttle box avoidance responding are very sensitive to these peptides. 
Appetitively motivated responding has received less attention. This may 
in part be attributed to negative results in earlier experiments; 
Garrud et al (1974) could find no effect of DG-LVP on an open field test 
or in the extinction of a straight runway task involving approach to 
food. However, more recent data from Hostetter et al (1977) have demon-
strated that pitressin can affect responding in a T maze discrimination 
task. Food deprived rats were rewarded for making the correct choice 
between the black and the white arm of a maze. When pitressin (0.4 IU) 
was injected SC before each training session there was no effect on the 
number of trials required to reach the extinction criterion. However, 
when the same dose was injected before extinction testing the number of 
trials to reach the extinction criterion was increased although only in 
rats trained to enter the black arm of the maze but not in those trained 
to enter the white arm. Time required to execute the maze did not dif-
ferentiate the groups confirming earlier negative results (Garrud et al 
1974). Bohus (1977) was able to demonstrate an effect of vasopressin 
when male rats were rewarded with copulation following a correct choice 
in a T maze. These two studies demonstrate that the peptides are active 
under conditions of positive reinforcement when the measures used are 
sufficiently sensitive. 
Garrud (1975) observed that 2 ~g of LVP reduced responding on a 
variable interval appetitive baseline. 
These studies suggest that appetitively motivated responses are 
sensitive to the action of_ the vasopressins. Experiments described in 
this chapter examine the effects of LVP on appetitively motivated res-
ponding maintained on Variable Interval (VI) and differential reinforce-
ment of low rates (DRL) schedules. 
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7.1 Experiment Fifteen: The Effects of Five Doses of LVP on Lever 
Pressing Maintained on a Variable Interval 60 Second (VI 60) 
Schedule 
Methods 
Subjects 
Six adult male rats (cfhb wistar) from the closed colony maintained 
at Plymouth Polytechnic were housed four to a cage with ad lib access to 
water. Rats weighed between 200 and 250 g at the start of the experiment. 
Apparatus 
The lever press apparatus has been described in detail in 
Experiment Four. Briefly, one lever was removed from a two lever rat 
operant chamber housed in a sound and light attenuating cabinet. 
Illumination was provided by a single house light located in the top of 
the operant chamber. Reinforcement was provided by 45 mg food pellets 
(Campden Instruments Company Limited) delivered automatically from a 
solenoid operated magazine. 
Schedule 
The variable interval schedule was programmed using the Grason 
Stadler 1201 solid state seriesof control modules. Intervals ranging 
from 2 to 120 seconds (Clarke 1958) were randomly arranged to yield a 
variable interval schedule with an arithmetic mean of 60 seconds. A 
limited hold of two seconds was incorporated in the programme. A 
further refinement was introduced in order to avoid confounding due to 
predictability in the interval sequence. The interval sequence was 
divided into two and these were randomly juxtaposed periodically. A 
response within two seconds of reinforcement becoming available auto-
matically terminated the limited hold and the response availability to 
prevent multiple reinforcements. Inter response times were recorded, to 
the nearest tenth of a second, using automatic timers and a re-set 
printer. 
Peptide treatment 
The batch details, solution preparation and storage details have 
been described in Experiment Two. Five doses of LVP were used plus a 
saline control; 0.5 ~g. I ~g, 2 ~g, 3 ~g or 4 ~g were injected SC in a 
constant volume of 0.5 ml 60 minutes before each experimental session. 
Procedure 
Rats were reduced to 80% of their free feeding body weight by 
reducing the weight of food available per day and restricting the time 
. 
for which it remained available. In this way the subjects were adapted 
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to feeding at the same time each day; having reached their target weight 
the feeding schedule was stabilised for one week before starting to 
magazine train. Body weights were checked before each experimental 
session. 
During magazine training the rats were placed in the operant 
chamber and a free food pellet delivered every 60 seconds for 40 minutes. 
This continued until each rat readily approached and ate from the hopper. 
Rats were then shaped to lever press; a food pellet was awarded for pro-
gressively closer· approaches to the lever, then for touching and finally 
for depressing the lever. Once each animal had acquired the bar press 
response, it was introduced to and stabilised for two days on an auto-
matically controlled schedule of continuous reinforcement (CRF). The 
variable interval schedule was programmed in such a way that the time 
base for the intervals could be reduced to milliseconds, effectively 
mimicking a CRF. The VI schedule was introduced by increasing the inter-
val time base and reducing the limited hold until the required VI 60 
seconds with two seconds limited hold had been reached. Rats were 
stabilised on the VI 60 second schedule for two weeks in 40 minute 
sessions at the same time of day. After each session additional 
standard lab diet was-made available in the home cage in order to main-
tain each subject at 80% of its free feeding weight. 
Experimental phase 
Each rat was given one of the six treatments on one of six experi-
mental days. The order of treatments in this 6 x 6 x 6 design was 
specified by a latin square (Kirk 1968). The six treatment days were 
spaced over three calendar weeks. Two test days (Tuesday and Friday) 
were spaced by at least two rest days and each test day by at least one 
day when subjects responded on the schedule in the absence of any treat-
ment (Monday and Thursday). Injections were made 60 minutes before the 
start of each test session, which lasted for 30 minutes and was preceded 
by ten minutes of warm up responding. 
Results 
Inter response ti~es were checked and punched onto computer cards. 
Data from each of the 36 cells of the experiment were processed by a 
computer program which sorted the inter response times into 49 bins of 
0.1 seconds. Bins 1-49 contained all the inter response times spanning 
from 0.1 second to 4.9 seconds. The 50th bin contained all inter res-
ponse times in excess of 4.9 seconds. 
After visual inspection, two aspects of the data were selected for 
statistical analysis:· the total number of inter response intervals and 
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the 50% interquartile range. Table A64 shows the total number of res-
ponse intervals in each cell. These values were divided by a constant 
(460) and analysed by analysis of variance for latin squares according 
to the method of Kirk (1968). The analysis determined whether or not 
the total number of responses intervals was affected significantly by 
one of the three factors -of dose, treatment day or subjects. The out-
come of this analysis is shown in Table A65. There was a significant 
difference in the number of inter response times as a function of the 
treatment dose (F 5,20 = 3.331, p < 0.05). No other factors were signi-
ficant. Newman-Keuls test (Kirk 1968) was used with the error rate set 
experimentwise at a = 0.05 to locate the significant differences between 
doses. These are summarised in Table A65. 3 ~g of LVP significantly 
reduced inter response intervals compared to saline, 0.5 ~g. I ~g. 2 ~g 
and 4 ~g of LVP (p's < 0.05). The change in the number of inter response 
intervals as a function of the dose is shown in Figure 27. 
In order to locate changes which occurred in the response distri-
bution independent of changes in the total number of inter response 
intervals the 50% interquartile range for each cell was calculated; this 
is the point in the range of bin values by which 50% of the total number 
of intervals had occurred. The 50% IQR did not coincide exactly with 
bin boundaries; therefore the value was estimated using a method of 
proportional allocation, eg suppose that an animal had 1786 inter res-
ponse intervals, 50% of this value is 893. The cumulative total at bin 
3 is 840 and at bin 4 is 947. Therefore 47.03% of the inter response 
intervals were less than 0.3 seconds and 53.02% of the inter response 
times were less 0.4 seconds. The 50% value lies in bin 4 and was 
estimated as the ratio of two differences: 
(A) the difference between the 50% value (893) and the cumulative 
total at the first bin with value lower than this (bin 3 with a 
cumulative total of 840 inter response intervals); 
(B) the difference between the cumulative total at the first bin with 
a value lower than the 50% value (bin 3, 840) and the cumulative 
total at the first "bin with a value higher than the 50% value 
(bin 4, 947). 
Thus, for the example described, 
893 - 840 
947 - 840 = 0 •4953 • 
This value is added tothe number of the lower bin (bin 3) to yield 
3.4953 as the estimated 50% IQR. According to this estimate 50% of the 
inter response times made by the rat in this cell were shorter than 
0.34953 seconds and 50% were longer. 
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The 50% IQR was calculated for each of the 36 cells of the experi-
ment and are shown in Table A66. Analysis of variance for this latin 
square design (Kirk 1968) was used to analyse the effects of LVP dose, 
treatment day and variation between subjects. There were significant 
effects of LVP dose (F = 3.457, df 5,20, p < 0.05) and treatment days 
(F = 3.984, df 5,20, p < 0.05) (see Table A67). Newman-Keuls tests 
(Kirk 1968), summarised in this table, revealed that 4 ~g of LVP yielded 
a significantly greater 50% IQR value than saline, 0.5 ~g, I ~g and 2 ~g 
(all p's < 0.05). The IQR decreased as a function of the treatment day. 
The mean on day one was significantly greater than on day four (p < 0,01) 
and on days five and six (p's < 0.05). The changes in IQR as a function 
of the LVP dose and the treatment day are shown in Figure 28. 
Discussion 
3 ~g of LVP significantly. reduced the total number of inter res-
ponse intervals compared to saline and to all other LVP doses. This may 
have been due to very low responding from one rat at this dose. The IQR 
statistic allows an evaluation of changes in the response distribution 
independent of gross changes in the number of intervals. It is clear 
from Figure 28 that the IQR statistic increased as a function of dose of 
LVP. The highest dose used (4 ~g) showed the highest mean IQR; this was 
significantly greater than the value found for saline, 0.05, I or 2 ~g. 
Therefore 4 ~g induced a significant shift in the distribution of the 
inter response intervals. 
The IQR statistic decreased as a function of the treatment day and 
this shift occurred in the absence of any increase in the total number 
of inter response intervals as a function of treatment days. These two 
indices did not vary in a similar fashion as a function of treatment 
days. Progressive increases in motivation to respond could decrease the 
IQR but if this were the case then both the IQR and the total number of 
inter response intervals should vary in parallel or at least in a 
similar pattern, which they do not. Alternatively, the progressive 
decrease in the IQR as a function of the treatment day may reflect 
changes due to cumulative treatment effects, either as a result of 
repeated stressful injections per se or as a result of cumulative effects 
of LVP. 
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7.2 Experiment Sixteen: The Effects of Five Doses of LVP on Rats 
Responding on a Differential Reinforcement of Low Rates (DRL) 
11.8 Second Schedule 
Introduction 
In Experiment Fifteen it was shown that LVP affected the total 
number of inter response intervals and the 50% interquartile range 
statistic of response interval distribution when rats were responding on 
a VI 60 second schedule. This schedule was characterised by rapid sus-
tained responding which maximises reinforcement rate. In contrast, 
schedules using differential reinforcement of low response rates (DRL) 
require rats to withhold responses. Inter response intervals shorter 
than the pre determined interval do not produce reinforcement whilst 
those which are equal to or longer than the stipulated interval do 
produce a reinforcement. The distinction between responses which achieved 
reinforcement (hits) and those which did not (false alarm) permit an 
animal's response profile to be examined as a function of these two 
rates. A range of doses of LVP were tested on this schedule, to deter-
mine if there were effects on the total number of inter response 
intervals or if effects were restricted to the rate of false alarm or 
hit responding. 
Methods 
Subjects 
Six adult male cfhb wistar rats were housed four to a cage, with 
other experimental animals, and ad lib access to water. They weighed 
200-250 g at the time of the experiment. 
Apparatus 
The two lever Skinner box used in this experiment has been des-
cribed previously (Experiments Four and Eleven). One lever was removed 
from the standard chamber; a single house light provided illumination 
and the cage was housed in a sound and light attenuating cabinet. 
Automatic schedule control and data recording were provided by the 
Grason Stadler 1201 series of solid state modules. 
Schedule 
The schedule was programmed so that a· response could only be 
reinforced with a food pellet (45 mg Campden Instruments Limited) if 
11.8 seconds or longer had elapsed from the previous response, whether 
or not the previous response had been reinforced. If the animal res-
ponded before 11.8 seconds had elapsed then the timers re-set the 
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interval and the 11.8 second period re-started. If the interval between 
responses was equal to or greater than 11.8 seconds the rat was rein-
forced with a single pellet and the interval re-set. There was no upper 
limit on the inter response times. Responding was monitored on a cumu-
lative recorder and inter response times were recorded using a print out 
counter. 
Procedure 
Rats were reduced to 80% of their free feeding weight and 
stabilised at this weight for one week before being magazine trained. 
During magazine training rats were adapted to being fed at the same time 
each day; the procedure used to shape the bar press response has been 
described in Experiment Eleven. Having learned the response, each rat 
was shifted to the CRF schedule as described in Experiment Eleven. The 
interval for which rats were required to withhold responding was gradually 
increased to the full 11.8 seconds and responding with this interval was 
stabilised for three weeks before starting the experimental phase of the 
experiment. 
The experiment design was a latin square design outlined by Kirk 
(1968) and identical to that used in Experiment Eleven. Six doses of 
LVP (0.5 ~g. I ~g. 2 ~g. 3 ~g. 4 ~g) or saline were injected (SC) on one 
of six experimental days. The experimental phase extended over three 
weeks; two experimental sessions were run in each week and each experi-
mental session was separated by at least two days with no treatment on 
at least one of which subjects were run on the DRL schedule. 
Prior to each experimental session rats were taken from the home 
cage, weighed, injected and returned to the home cage for one hour. 
Then rats were placed in the Skinner box for the 40 minutes of bar 
pressing. At the end of each session the rats were removed from the 
cage and given free food sufficient to maintain their body weight at 80% 
of their free feeding levels. The 23 hour food deprivation state was 
maintained by running the animals in the same order and at the same time 
each day. 
Data 
Inter response times, to the nearest tenth of a second, were 
recorded for each session and these values were punched onto paper tape 
and processed by a PDP8 computer programmed to classify latencies into 
30 bins of one second width. Bins 1-29 contained all inter response 
times up to 29 seconds. Thus bin I counted all response times up to 
one second long, bin 2 counted the number of inter response intervals 
which were between one and two seconds long, etc. Bin 30 counted inter 
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response times in excess of 29 seconds. 
From histograms, obtained from each of the 36 cells of the experiment, 
the following indices were calculated: 
(I) the total number of inter response intervals per cell; 
(2) the total number of rapid responses (latency less than or equal to 
one second); 
(3) the total number of long responses (latency greater than 29 seconds). 
These indices refer to the total data in each cell; the fo.llowing 
were calculated from an 11 second bandwidth, ie all inter response 
intervals occurring within 11 seconds of the target time of 11.8 seconds 
(bins 2-23): 
(4) the number of false alarms (sum of intervals in bins 2-1 I inclu-
sive); 
(5) the number of hits (sum of intervals in bins 12-23 inclusive). 
From these values the conditional probability of a false alarm was 
calculated using the formula: 
(6) X P(fa) "'--Z -P where X "' sum of false alarms within the sample 
bandwidth 
Z = sum of all inter response intervals 
P "' sum of all false alarms outside the 
sample bandwidth (rapid responses). 
Similarly the conditional probability for a hit: 
(7) P (hit) = Z _;_X' where Z, X and P are defined above 
Y = sum of hits within sample bandwidth. 
A breakdown in the recording equipment resulted in loss of data 
from three of the 36 experimental cells. 
Results 
The data obtained under each peptide dose is presented in 
Table A68. Loss of data from three cells precluded a latin square 
analysis of variance on each of the indices. One tailed paired 't' tests 
were used to compare performance under each dose with performance under 
saline. The outcome of these tests is presented in Table A69. Total 
number of responses tended to increase with 0.5 ~g (p < 0.1). There 
were no significant effects on either the number of rapid responses or 
the number of long latency responses. False alarms and the probability 
of a false alarm tended to increase after the highest dose, 4 ~g 
(p's < 0.1). The total number of hit responses was significantly 
decreased after both 3 ~g (p < 0.05) and 4 ~g (p < 0.01), but the 
probability of a hit response was not significantly changed at any dose. 
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The false alarm and hit data are shown in Figure 29. The variability 
between doses and within doses was higher in the false alarm than in the 
hit data; therefore significant effects were only seen in the hit data. 
Total number of responses did not vary as a function of the dose and 
therefore the mean number of false alarms was inversely proportional to 
the mean number of hit responses. The mean number of hit responses 
under each dose was negatively correlated with the mean number of false 
alarms (r = 0.816, p < 0.05 two tailed; slope= -Q,4). 
Discussion 
LVP did not affect the total number of responses, the number of 
responses with latencies less than one second or greater than 29 seconds 
after any of the doses tested. The data show that rats remained under a 
constant state of motivation, and were not suffering from motor incapa-
cities, therefore keeping the extremes of the response latency distribu-
tion constant. 
Figure 29 shows that the number of false alarm responses tended to 
increase withthe dose of LVP as compared to saline control levels. 
These changes did not achieve significance due to the increased varia-
bility seen after each peptide treatment. However, the number of hit 
responses was significantly decreased by both 3 ~g and 4 ~g (see Figure 
29). The data suggest that the significant decrease in the level of hit 
responding was parallelled by a non significant increase in false 
alarms. In the absence of shifts in the total number of responses this 
suggests that the higher doses affected a shift in the response latency 
distribution. The inverse relationship between false alarms and hits is 
also supported by the significant negative correlation seen between 
these measures. 
In Experiment Eleven it was found that 4 ~g LVP injected 60 minutes 
before responding on a VI 60 second schedule induced a significant shift 
in the response distribution, measured by the. 50% IQR statistic, in the 
absence of significant changes in the total number of responses. This 
conclusion is supported by the results from the present experiment. Thus 
high doses of the peptide shifted the response latency distribution under 
two schedules which make very different demands in terms of response 
characteristics. A number of hypotheses may be excluded; motor 
inefficiency or incapacity is unlikely in view of the absence of changes 
in the total number of responses or in the number of very short and very 
long latency responses in the present experiment. Similarly, marked 
changes in motivation appear unlikely in view of the constancy in total 
responses in both experiments. Both experiments suggest that vasopressin 
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CHAPTER EIGHT 
CONCLUSIONS 
It is well established that vasopressin, synthesised in the supra-
optic and paraventricular nuclei of the anterior hypothalamus (Section 
1.2.1) and secreted into.circulating blood via the posterior lobe of the 
pituitary gland regulates water reabsorption at the kidney (Section 
1.8.1) and pressor responses (Section 1.8.2). The neurochemical 
mechanism controlling this route of secretion involves complex inter-
actions between catecholaminergic, cholinergic and histaminergic neurons 
(Section 1.4). Peripheral vasopressin levels are sensitive to changes 
in levels of hydration (Section 1.6.1), blood volume (Section 1.6.3), 
angiotensin and renin (Section 1.6.2), sexual stimulation (Section 1.6.5) 
and some stressors (Section 1.6.4). The identification of vasopressin 
as the CRF remains controversial (Section 1.9.3) although some evidence 
suggests that ACTH secretion is stimulated by vasopressin injections, 
particularly in high doses (Section 1.9.1). These findings implicate 
vasopressins in regulation of physiological functions and the maintenance 
of homeostasis through changing environmental and behavioural conditions. 
In addition to its established endocrinological activity and its 
putative role as a CRF (Section 1.9.3) extensive evidence shows that 
vasopressins exert marked behavioural effects (see Chapter Two). Rats 
with depleted endogenous vasopressin levels as a result of surgical 
removal of the posterior lobe of the pituitary gland (Section 2. 1), 
central injections of antivasopressin serum (Section 2.5.5) and in some 
instances as a result of genetic deficiencies in vasopressin synthesis 
(Sections 2.5.2, 2.5.3 and 2.5 .4) show reduced active and passive avoidance 
extinction, which can be corrected with injections of pitressin, a 
posterior pituitary extract, vasopressin (Section 2.1) or its des-
glycinamide analogues (Section 2.3). Conversely these substances have 
been universally reported to increase subsequent extinction responding 
after central or peripheral injections (see Chapter Two). These 
observations, coupled with the fact that the behavioural potency of 
vasopressin and centrally injected antivasopressin serum have been 
reported to decline as a function of the interval between injection and 
either the end of training or the first extinction test and exert long 
term influences on behaviour which far exceed the metabolic half life of 
the peptides (Section 2.2) have led to the widely accepted hypothesis 
that endogenous vasopressin plays an important physiological role in 
regulating the consolidation of associative or cognitive information 
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about the behavioural schedule or schedule changes from short to long 
term memory stores. Additional supportive evidence comes from studies 
showing that vasopressins antagonise the amnestic effects of puromycin 
(Section 2.4.1), anoxia (Section 2.4.2), electroconvulsive shock and 
pentylenetetrazol injections (Section 2.4.2). 
The consolidation hypothesis appeared to account for much of the 
data described in Chapter Two although it was also necessary to propose 
additional involvement in "retrieval" mechanisms in order to explain 
effects of the peptide when injected 24 hours after training and one 
hour before extinction or passive avoidance retention testing (Sections 
2.2 and 2.3). Further difficulties stemmed from the fact that much of 
the corroborative evidence from rats with a genetic incapacity to syn-
thesise vasopressin is conflicting (Sections 2.5.2, 2.5.3 and 2.5.4) and 
that the physiological mechanisms which underlie the effects of experi-
mental amnestic treatments and their relevance to normal memory pro-
cesses are poorly understood, Furthermore, increasing evidence from 
human neuropsychological studies suggest that the consolidation hypo-
thesis does not offer a satisfactory account of memory disturbances 
characteristic of clinical amnesia (Section 2.0). 
A number of additional arguments, based on the experimental evi-
dence described in Chapters Three to Six, may be advanced against the 
consolidation hypothesis and in favour of the contention that consolida-
tion of short term memories are not invariably enhanced by vasopressin 
injections (King and de Wied 1974). 
Vasopressin injections one hour before (King and de Wied 1974) and 
immediately after response prevention trials (Experiment Three) increased 
subsequent extinction responding despite extensive evidence th'at 
prevention trials alone (Sections 3.0 and 3.1) and when followed 
immediately by saline injections (Experiment Three) reduce subsequent 
extinction responding. The response reducing effects of prevention 
trials have been interpreted in terms of the additional "information" 
conveyed during· confinement concerning the contingencies of the avoidance 
schedule whether this be conceived in terms of enhanced fear extinction, 
learning alternative responses or altered expectancies (Sections 3. I and 
3.2). The fact that response deficits are seen when tests are delayed 
for 24 hours after prevention trials (Experiments One and Three) argues 
against an explanation in terms of reduced mobility or perseveration of 
alternative responses. If the action of vasopressin was to enhance con-
solidation of "information" contained in short term stores then the 
peptides should have further reduced extinction responding when given 1n 
conjunction with extinction trials and this was not found. This shows 
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that the effects of vasopressin injections may be dissociated from the 
informational content of the behavioural procedure with which the injec-
tions were associated. 
Vasopressin and prevention trials do not appear to affect the same 
mechanism. Cholinergic drugs did not substantially alter LVP's response 
reducing effects but did alter the outcome of response prevention trials 
(Experiment Eleven). It was shown in Experiment Four that the effects 
of LVP injections and prevention trials were clearly distinguishable on 
concurrent operant suppression during CS presentations. Prevention 
trials altered baseline response rates but neither response levels during 
CS presentations or suppression ratios whereas post training LVP injec-
tions increasedsuppressionof the operant baseline during CS presenta-
tions but left baseline response rates undisturbed. Taken together with • 
the results from Experiment Three, in which it was found that the 
effects of LVP injected after 30 minutes of home cage retention or 30 
extinction trials were opposite to its effects after prevention trials, 
the data suggest that the effects of prevention trials and LVP injections 
cannot be explained in terms of consolidating the storage of information. 
Similarly, increased fear of the CS after post training LVP injections, 
which might be suggested by Experiment Four despite difficulties of 
interpreting operant suppression as a measure of conditioned fear (see· 
Experiment Four) does not explain the data. According to two factor 
theory of avoidance greater suppression should be associated with more 
avoidance responding in extinction and the opposite was found, and 
according to the more recent cognitive explanation of avoidance respon-
ding variations in conditioned fear have no direct consequences for res-
ponse rates (Seligman and Johnston 1973). As the peptide was invariably 
injected after training and approximately 24 hours before extinction 
testing this tends to rule out effects on arousal, attention or motor 
activity during training. 
Furthermore, rats which were either retained in the home cage for 
30 minutes or given 30 extinction trials before LVP (I ~g) injections 
showed reduced responding during subsequent extinction tests. These 
results stand in sharp contrast tothose discussed in Chapter Two in 
which vasopressin injections have been universally found to increase 
subsequent extinction responding. That this unusual result was not due 
to peculiarities in the avoidance training schedule, impurities in the 
vas.opressin batch or faulty preparation, storage or injection procedures 
was shown by Experiment Two in which identical injections immediately 
after training increased subsequent extinction responding and by sub-
sequent replications with manual shuttle box training (Experiments Seven, 
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Eight, Nine and Ten). Assuming that retention in the home cage per se 
has no bearing on the subsequent execution of a previously trained res-
ponse and conveys no additional information the results show that LVP 
injections may reduce extinction responding in the absence of changes in 
the informational content of the training schedule and confirm conclu-
sions from response prevented rats that vasopressin's effects on subse-
quent extinction responding are independent of the informational content 
of the behavioural procedures with which its injection· is associated. 
This was further substantiated in Experiments Twelve and Thirteen which 
showed that in rats which failed to reach learning criterion LVP (I ~g) 
increased subsequent extinction responding. 
Comparisons between Experiments Two and Three, which showed 
opposite effects with the same dose of LVP, suggested that the interval 
between the end of training and injection is an important variable in 
determining the direction of LVP's effects on subsequent extinction. 
Previous studies (Section 2.2) had shown interval to be an important 
determinant of potency but not direction. Studies using prolonged 
extinction tests (Experiment Five) confirmed the response reducing 
effects of LVP (I ~g) and showed maximal reductions when injections were 
delayed for 60 minutes after training but failed to confirm the response 
increasing effects of this dose injected immediately after training 
which were reported in Experiment Two. In addition at the 60 minute 
interval prevention trials acted as an effective adjunct to the response 
reducing effect of vasopressin injections, in contrast to the effects 
when injected immediately after prevention trials(Experiments Three and 
Five). Additional studies (Experiment Six) suggested that when injected 
30 minutes after training in the range 2-4 ~g LVP tended to decrease 
subsequent extinction responding in a dose dependent manner; this was 
more pronounced in response prevented rats. In rats which failed to 
reach learning criterion the dose response curve was positive 
(Experiment Thirteen) in this dose range. 
Subsequent experiments examined more closely the interaction 
between dose and injection interval using a manually operated shuttle 
box and fewer extinction trials. With this procedure the response was 
learned rapidly and during extinction trials the probability of an 
avoidance response tended to diminish whereas that of an intertrial 
response tended to increase. Experiment Seven showed that in the range 
0.036 to 2.97 ~g the effects on avoidance responding in extinction 
varied as an inverted U shaped function of the dose. The lowest and 
highest doses reduced whilst intermediate doses increased subsequent 
responding. Maximal facilitation of the extinction response rate, 
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including elevated intertrial responding, was found after 0.1 I ~g. 
Although 0.99 ~g also increased avoidance responding in extinction, the 
effect was smaller than for either 0.1 I or 0.33 ~g. Vasopressin injec-
tions affected within test rates of response change. Responding on 
initial test trials tended to be high regardless of dose, group dif-
ferences depended on subsequent reductions or increases in response rate 
compared to saline controls. The dose response curve from 0.11 to 2.97 
~g was negative, confirming indications from Experiment Six for a 
similar range and the weak effect seen after 0.99 ~g may explain why the 
effects of I ~g LVP reported in Experiment Two were not replicated in 
Experiment Five. 
These results suggest a complex interaction between dose and 
injection interval. Experiment Eight showed that whereas 0.11 ~g also 
increased responding when injected immediately or 60 minutes after 
training, the direction in which 2.97 ~g influenced subsequent extinc-
tion responding was found to vary as a function of the interval between 
training and injection. In contrast to its response reducing effects 
when injected 30 minutes after training 2.97 ~g was ineffective when 
injected immediately and increased responding when injected 60 minutes 
after training. 
The mechanism by which LVP exerts its behavioural influence in 
these experiments is unknown. The opposite effects of 0.1 I and 2.97 ~g 
injected 30 minutes after training were confirmed using a higher shock 
level in training (Experiment Nine) and it was argued that, unlike a 
similar dose response curve reported for ACTH (Gold and van Buskirk 1976), 
the inverted U shaped dose response curve for vasopressin could not be 
attributed either to dose dependent changes in post training arousal or 
to modulation of the hormonal consequences of shock. 
Data from Experiment Ten argue against a role for target organ 
related endocrine effects in mediating the response reducing effects of 
LVP. Endogenous vasopressin is known to affect endocrine target organs 
(Section 1.8) in addition to its behavioural effects. However, DG-LVP 
is thought to retain only behavioural activity, at least using acute 
treatments (Section 2.3). Therefore finding that DG-LVP injected in a 
wide range of doses 30 minutes after training reduced but never increased 
subsequent responding suggests that endocrine effects may in fact be 
required for the response increasing effects of intermediate doses of 
the full vasopressin molecule. Although these effects of vasopressin 
may reflect direct actions on the CNS accessed following peripheral 
injections via the CSF (Section 1.3.3) and possibly involving extra-
hypothalamic vasopressinergic pathways (Section 1.3.4), the involvement 
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of corticosteroids and ACTH, particularly after high vasopressin doses 
(Section 1.9), cannot be ruled out. 
It is interesting to note that others have reported similar 
anomalies using post training injection procedures. Gold, van Buskirk 
and Haycock (1977) reported an inverted U shaped dose response relation-
ship between post training epinephrine injections and subsequent passive 
avoidance retention. Furthermore, a low dose of epinephrine (50 ~g/kg) 
increased subsequent retention when injected immediately but not 10 or 
30 minutes after training. In contrast, a ten times higher dose was 
ineffective when injected immediately or 30 minutes after training but 
improved retention when injected after 30 minutes. Recently Messing et 
al (1979) reported that intermediate doses of naloxone (I mg/kg) 
increased subsequent retention when injected immediately or 30 minutes 
after passive avoidance training whereas a low dose (0.1 mg/kg) and a 
high dose (10 mg/kg) were ineffective. Furthermore, 0.5 mg/kg of 
naloxone was inactive when injected immediately after passive avoidance 
training but significantly reduced retention when injection was delayed 
for 30 minutes. 
The observations of inverted U shaped dose response relationships 
and anomalous time related effects with such a wide range of drugs may 
suggest a complex interaction with post training neurochemical changes 
and a common modeof action. Recent work using experimentally induced 
"amnesias" suggests that these may have a common mechanism (Gold and 
Sternberg 1979). Pretreatment with the a-adrenergic blocker phenoxy-
benzamine blocked the development of several different types of amnesia. 
The extensive evidence outlined in Section 2.7 suggesting that vaso-
pressin alters catecholamine metabolism in discrete brain nuclei may 
provide an explanation for the results of the experiments reported in 
terms of fluctuations in post training activity at catecholaminergic 
nerve terminals in the CNS. This is speculative but could be tested by 
examining the effects of altered post training CA activity on oppositely 
acting vasopressin doses. The complexity of dose response relationships 
and the effects of varying training - injection intervals coupled with 
the difficulties of explaining the data in terms of behavioural con-
structs such as consolidation, fear, anxiety or arousal suggests that, 
whilst experiments on the neurochemical and physiological bases for 
vasopressin's actions may prove fruitful, these must be accompanied by 
stringent analysis of behavioural variables in order to characterize 
more fully the behavioural importance of vasopressin's pharmacological 
effects. The use of global but imprecise psychological constructs such 
as memory is of doubtful significance in furthering our understanding of 
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these phenomena, more restricted but precise concepts are required. The 
data from Experiment Eleven argue against any significant involvement of 
cholinergic neurons in mediating the response reducing effects of LVP in 
well trained rats although this did not appear to be the case for poor 
responders (Experiment Fourteen). Poor shuttle box avoidance learners 
may also be distinguished from good performers by their lower disappearance 
rate for labelled catecholamines in the hippocampus, hypothalamus, brain 
stem and cortex (Hraschek, Paulik and Endroczi 1977). Investigations of 
the peptide's physiological basis of action may be facilitated by the 
use of appetitive response schedules. Experiments Fifteen and Sixteen 
show that although a variable interval schedule was sensitive to the 
effects of vasopressin a DRL schedule was not. This was thought to 
reflect different demands in the speed of responding for these schedules 
rather than different psychological processes involved. 
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Table AI: Experiment One. Acquisition performance 
Home cage Home cage Extinction Extinction Response Response prevention prevention immediate 24 hours immediate 24 hours immediate 24 hours 
Trials to criterion 
Sum 293 455 310 468 296 418 
-X 36.625 56.875 38.75 58.5 37 52.25 
SD 40.01 33. 138 22.44 47.277 18.647 46.876 
SE 14. 146 I I. 716 7.93 16.715 6.593 16.573 
Avoidances to criterion 
Sum 165 201 189 246 161 211 
X 20.625 25. 125 23.625 30.75 20. 125 26.375 
SD 16.071 11.407 10.809 20.886 5.592 15.061 
SE 5.682 4.033 3.822 7.384 1.977 5.325 
Escapes to criterion 
Sum 99 102 87 119 45 102 
-X 12.375 12.75 10.875 14.875 5.625 12.75 
SD 18.913 9.823 11.051 10.973 6.301 16.49 
SE 6.687 3.473 3.907 3.88 2.228 5.83 
Failures to criterion 
Sum 26 149 38 107 87 96 
X 3.25 18.625 4.75 13.375 10.875 12 
SD 5.064 23.120 4.527 30.720 18.427 18. 189 
SE I. 79 8. 174 1.60 10.861 6.515 6.431 
Shocks to criterion 
Sum 340 943 314 718 547 701 
X 42.5 117.875 39.25 89.75 68.375 87.625 
SD 69.463 121.961 2 7. 773 165.503 99.863 133.252 
SE 24.559 43. 12 9.819 58.514 35.307 4 7. 112 
Table A2: Experiment One. Analysis of acquisition data 
Source ss df MS F p 
Between groups 4258.917 5 851.78 0.64 NS 
Trials to Within groups 
criterion 
55879.75 42 1330.47 
Total 60138.667 47 
Between ~roups 622.94 5 124.59 0.62 NS 
Avoidances 
to criterion 
Within groups 8396.88 42 199.93 
Total 9019.88 47 
Between groups 410.42 5 80.28 0.48 NS 
Escapes to Within groups 
criterion 
7058.5 42 168.06 
Total 7459.92 47 
Between groups 1298.35 5 259.67 0. 71 NS 
Failures to Within groups 15363.63 42 365.8 
criterion 
Total 16661.98 47 
Between groups 36718.85 5 7343.77 0.58 NS 
Shocks to Within groups 529135.63 42 12598.47 
criterion 
Total 565854.48 47 
• 
SI 
52 
53 
54 
ss 
56 
57 
ss 
X 
SD 
SE 
/). 
• 
0 
+ 
2S 
20 
8 
s 
Table A3: 
Home cage 
Immediate 24 hours 
Tl T2 Tl T2 
29 27 so so 
49 so 49 49 
4S 44 32 23 
3S 43 47 40 
24. 49 4S 42 
so 4S 48 44 
20 34 38 41 
so so 43 46 
3S.S 43.12S 44.37S 41.87S 
12.S81 8.42S 
4.448 2.979 
trials lost 
trials lost 
trials lost 
trials lost 
6.346 8.442 
2.244 2.98S 
Experiment One. Extinction performance 
Extinction 
Immediate 24 hours 
Tl T2 Tl T2 
Total responses in extinction 
12 46 4S 42 
31 3S so 46 
20 4S 44 3S 
46 1St. 31 37 
37 22 4S 36 
2 17 12 28 
40 so 34 41+ 
42 4S 42 37 
28.7S 3S.I2S 37.87S 37.7S 
IS. 791 14.126 
S.S83 4.994 
12.1S9 S.392 
4. 299 I . 906 
Response prevented 
Immediate 
Tl T2 
17 23 
46 so 
32 3S 
41 so 
21 4S 
2 27 
8 
3S so 
24.37S 36.7S 
I 7 . 02 I 5. 881 
6.018 5.615 
Continued ... 
24 hours 
Tl T2 
so so 
43 4S 
47 47 
6 4 
48 so 
so 46 
18 2S 
8 41° 
33.7S 38.87S 
19.S43 16.30S 
6.909 5.765 
Table A3 (continued) 
Home cage Extinction Response prevented 
Immediate 24 hours Immediate 24 hours Immediate 24 hours 
Tl T2 Tl T2 Tl T2 Tl T2 Tl T2 Tl T2 
Responses 0 - 10 seconds 
SI 21 12 50 43 10 43 36 31 14 14 49 46 
S2 44 48 47 46 23 16 47 43 44 44 38 38 
S3 46 32 11 I 7 19 36 34 25 26 34 37 37 
S4 34 38 43 38 39 13t. 26 30 27 50 4 2 
ss 16. 48 42 30 34 17 41 33 18 41 47 50 
S6 50 45 47 42 0 11 7 22 2 21 47 43 
S7 15 29 27 35 35 48 28 31+ 5 11 20 
ss 49 45 40 41 40 37 25 30 35 50 6 60° 
Sum 275 297 307 292 200 221 244 245 167 259 239 252 
-
X 34.375 37. 125 38.375 36.5 25 27.625 30.5 30.625 20.875 32.375 29.87 5 31.5 
so 15.01 12.449 13.092 9.335 14.599 14.87 12. 154 6. 163 15. 142 17.113 19.511 16.903 
SE 5.308 4.401 4.629 3.3 5. 162 5.257 4.297 2.179 5.353 6.050 6.898 5.976 
t. 25 trials lost 
• 20 trials lost continued . .. 
0 8 trials lost 
+ 5 trials lost 
Table A3 (continued) 
Home cage Extinction Response prevented 
liiiiile d i ate 24 hours liiiiile d i ate 24 hours liiiiilediate 24 hours 
Tl T2 Tl T2 Tl T2 Tl T2 Tl T2 Tl T2 
Responses I 0 - 20 seconds 
SI 8 15 0 7 2 3 9 I I 3 9 4 
52 5 2 2 3 8 19 3 3 2 6 5 10 
53 2 12 21 6 12 10 10 6 4 10 I I 
54 4 5 4 2 7 5[1 5 7 14 0 2 2 
55 B• 6 12 3 5 4 3 3 7 0 
56 0 3 2 2 6 5 6 0 6 3 3 
57 5 5 I I 6 5 2 6 10+ 0 3 7 5 
58 5 3 5 2 8 17 7 0 0 2 25° 
Sum 33 48 48 43 30 60 59 57 28 35 31 60 
X 4. 125 6 6 5.375 3.75 7.5 7.375 7. 125 3.5 4.375 3.875 7.5 
SD 2. 997 4.928 6.969 3.292 2.605 5.581 4.565 3.091 4. 721 3.249 3.227 8.018 
SE 1.06 I. 742 2.464 I. 164 0.921 I. 973 I. 614 1.093 1.669 I • 149 I. 141 2.835 
[I 25 trials lost 
• 20 trials lost 
0 8 trials lost 
+ 5 trials lost 
Table A4: Experiment One. Analysis of covariance on acquisition and extinction performance 
Source df ss SP ss df ss. MS· F 
X y y y 
(I) X = number of trials to acquisition criterion; y = number of short avoidances in Extinction Test 
Between groups 5 4258.92 1396.58 1581.17 5 1581 • 17 317.8 1.36 (F = 0.64;5;42 NS) 
X 
Within groups 42 55879.75 -847.25 9573.5 41 9573.5 233.19 NS (F = 1.39;5;42 NS) y 
Total 47 60138.67 549.33 11154.67 46 11154.6 7 
(2) X number of avoidances to acquisition criterion; y number of short avoidances in Extinction Test I 
Between groups 5 622.94 283.25 1581. 17 5 1560.2 312.04 1.34 (F 0.62;5;42 NS) 
X 
Within groups 42 8396.88 19 7. 25 95 73.5 41 9568.87 233.39 NS (F = 1.39;5;42 NS) y 
Total 47 9019.81 480.5 11154.6 7 46 11129.07 
Table A5: E~eriment One. Total number of resl!onses in eveEI block of 
five trials for each groul! 
Home cage Extinction Response prevention 
Trial Immediate 24 hours Immediate 24 hours Immediate 24 hours blocks 
Tl T2 Tl T2 Tl T2 Tl T2 Tl T2 Tl T2 
Total responses 
I 31 29 37 40 29 35 31 38 20 39 28 36 
2 32 35 37 39 34 34 34 36 24 31 30 33 
3 35 39 38 37 32 29 32 27 20 33 32 35 
4 35 33 39 38 28 29 34 31 21 32 29 36 
5 37 34 37 36 18 31 34 36 19 35 27 34 
6 37 35 37 36 21 28+ 33 33 14 28 27 30 
7 29+ 33 35 31 27 23+ 28 23 22 24 26 28 
8 29+ 38 34 31 20 29+ 26 29 23 22 26 30 
9 23+ 37 29" 25 12 26+ 26 26 15 26 22 29 
10 20+ 32 32 22 9 17+ 25 23 17 24 23 21+ 
Short avoidances 
I 27 21 33 37 29 33 29 31 14 34 22 26 
2 29 29 34 36 31 25 29 32 23 28 24 25 
3 32 32 34 34 27 26 26 22 18 32 29 27 
4 29 27 34 33 24 21 27 24 17 26 29 28 
5 32 33 34 33 14 24 28 28 17 28 23 31 
6 34 31 30 31 19 21+ 27 27 13 23 25 25 
7 27+ 33 26 24 24 21+ 24 15 19 23 25 24 
8 27+ 31 28 26 17 22+ 20 27 20 22 23 27 
9 19+ 33 27 19 9 16+ 19 20 11 23 20 22 
10 19+ 27 27 19 6 12+ 15 19+ IS 20 19 17+ 
Sum 275 297 307 292 200 221 244 245 167 259 239 252 
Long avoidances 
I 4 8 4 3 0 2 2 7 6 5 6 10 
2 3 6 3 3 3 9 5 4 I 3 6 8 
3 3 7 4 3 5 3 6 5 2 I 3 8 
4 6 6 5 5 4 8 7 7 4 6 0 8 
5 5 I 3 3 4 7 6 8 2 7 4 3 
6 3 4 7 5 2 7+ 6 6 I 5 2 5 
7 2+ 0 9 7 3 2+ 4 8 3 I I 4 
8 2+ 7 6 5 3 7+ 6 2 3 0 3 3 
9 4+ 4 2 6 3 10+ 7 6 4 3 2 7 
10 I+ 5 5 3 3 5+ 10 4+ 2 4 4 4+ 
Sum 33 48 48 43 30 60 59 57 28 35 31 60 
+ 5 trials missing 
Table A6: Experiment One. The outcomes of Friedman's non-Earametric 
ANOVA apE lied to extinction data 
Immediate test 24 hour test 
T1 T2 T1 T2 
Total responses 
I:R.2 1326 1286 1382 1264.5 
J 
xr2 12.6 8.6 18.2 6.45 
p < 0.001 0.012 < 0.001 0.05 
Short avoidances 
I:R·2 J 1304 1287.5 1352 1219.5 
xr2 10.4 8.75 15.2 I. 95 
p < 0.01 < 0.02 < 0.001 ns 
Long avoidances 
I:R· 2 J 1209.5 1269.5 1240.5 1246.5 
xr2 0.95 6.95 4.05 4.65 
p ns < 0.05 ns < 0. I 
Table A7: E~eriment One. Pairwise comparisons of grOUJ2 performance 
in extinction (Hollander and Wolfe 1973) 
Immediate test 
Home Cage Home Cage v Extinction v 
v Extinction Response Prevented Response Prevented 
Ol Tl r 12 15 3 
QJ 
.... m 
< 0.05 < 0.01 NS as l'l p 
... 0 
0 r;l. 
E-4 Ol T2 r 13 8 5 QJ 
"' p < 0.01 NS NS 
Ol Tl r 10 14 4 
QJ 
... CJ p 0.05 < 0.01 NS 
"' d o as 
..c"" C/.1 .... T2 r 12.5 10 2.5 0 
> as p < 0.019 0.05 NS 
Ol Tl r 0.5 4 3.5 
QJ 
CJ NS NS NS COd p l'l ., 
0"0 
..:I .... T2 r 8 3,5 11.5 0 
> as NS NS < 0.037 p 
24 hour test 
Tl r 11 19 8 
Ill 
QJ 0.037 < 0.01 NS .... Ill p 
., d 
... 0 
0 r;l. T2 9 10.5 1.5 E-4 Ill r 
QJ 
"' NS 0.05 NS p 
Tl r 16 14 2 
Ol 
QJ 
< 0.01 < 0.01 NS 
... CJ p 
"' d o as ..c~ T2 r 6 4,5 1.5 C/.1 0 
> NS NS NS as p 
Tl r 4.5 4.5 9 
Ol 
QJ NS NS 0.1 CJ p COQ Q ., 
0"0 T2 7.5 9 1.5 ..:I .... r 
0 
> NS 0. I NS ., p 
Critical differences for r (a,k,n) k = 3; n = 10 (from Hollander and 
Wolfe 1973); r = 11, p = 0.037; r = 12, p = 0,019; r = 13, p = 0.01, 
-----
Table AS: Experiment One. Trend line slope coefficients for extinction data 
Home cage Extinction Response prevented 
Immediate 24 hours Immediate 24 hours Immediate 24 hours 
Test I 
Total responses -1.272 -0.806 -2.387 -0.963 -0.466 -o. 848 
Short avoidances -I. 036 -0.975 -2.46 -1.43 -0.381 -0.575 
Long avoidances -0.236 0. 169 0.072 0.466 -0.084 -o. 212 
Test 2 
Total responses 0.224 -1.884 -1.448 -I. 345 -I • 551 -I. 309 
Short avoidances 0.563 -2.12 -1.66 -I. 18 -I. 363 -0.727 
Long avoidances -0.339 0.236 0.218 -o. 163 -0. 187 -0.581 
Table A9: E~eriment One. Outcomes of Kruskall Wallis ANOVA on 
linear regression coefficients (Seigel 1956) 
Total responses Short avoidances Long avoidances 
H 2.571 4.57 2.512 
Test I p NS 0.067 NS 
H 0 0.2325 I. 942 
Test 2 p NS NS NS 
Table AIO: Experiment Two: Performance in acquisition 
Measures to criterion l:x X SD SE 
Avoidances Sal 168 21 .o I O. 24 3.62 
LVP 149 16.55 2.24 0.74 
Trials Sal 316 39.5 23.53 8.31 
LVP 270 30.0 12. 13 4.04 
Escapes Sal 73 9. 12 12.26 4.33 
LVP 86 9.55 12.27 4.09 
Failures Sal 52 6.5 7.92 2.8 
LVP 21 2.33 4.87 I. 62 
Shocks Sal 384 48.0 46.51 16.44 
LVP 227 25.22 28.54 9.51 
Table All: Experiment Two: Analysis of acquisition data 
(two tailed 't' test, Winer 1962) 
Heasure t df p 
Avoidances I .273 IS NS 
Trials I. 065 IS NS 
Escapes 0.07 IS NS 
Failures I. 32 IS NS 
Shocks 1.23 IS NS 
Table Al2: Experiment Two. Responses during extinction 
Total avoidances Short avoidances Long avoidances 
Subject 
Sal LVP Sal LVP Sal LVP 
5 49 4 40 9 
2 44 so 27 44 17 7 
3 30 46 13 38 17 8 
4 so 48 46 41 4 7 
5 so 48 so 39 0 9 
6 so so 49 so 0 
7 44 30 38 23 6 7 
8 21 49 14 47 7 2 
9 8 6 2 
Ex 294 378 241 328 53 SI 
-X ' 36.75 42.0 30. 125 36.44 6.625 5.66 
SD 16.61 14.203 18. 16 13.7 6.86 3.39 
SE 5.87 4.734 6.42 4.56 2.42 I. 13 
Table Al3: Experiment Two. Analysis of covariance on acquisition and extinction performance 
(I) X= number of trials to acquisition criterion; y number of short avoidance a in Extinction Test I 
Source df SSx SP SSy df SSy MSy F 
Between 83.66 -118,95 169. 14 94.6 94.6 0.35 f = X I, 62 (I, 15) NS 
Within 15 774.22 -234.22 3813. I 14 3742.24 267.3 NS f = y 0.67 (1, 15) NS 
Total 16 857.88 -353.18 3982.24 15 3836.84 
(2) X = number of avoidances to criterion; y = number of short avoidances ~n Extinction Test I 
Between 382.24 -254.26 169. 14 125.67 125,67 0,46 f = X 1.13 (1,15) NS 
Within 15 5054.0 -356.5 3813.1 14 3787,95 270,57 NS f = y 0.67 (1,15) NS 
Total 16 5436.24 -610,76 3982.24 15 3913,62 
Table Al4: E~eriment Two. Res~onses made in extinction as 
a function 
of extinction trial block (saline n = 8; LVP n = 9) 
Total Short Long 
Trial avoidance a avoidances avoidances 
block 
Sal LVP Sal LVP Sal LVP 
Test I 
I 23 37 22 32 5 
2 30 35 25 34 5 
3 30 37 25 34 5 3 
4 32 40 27 36 5 4 
5 32 40 28 36 4 4 
6 31 38 23 32 8 6 
7 29 3~ 23 37 6 2 
8 29 38 23 32 6 6 
5 35 3E 28 28 7 10 
10 31 33 23 23 8 10 
Test 2 
I 34 40 24 38 10 2 
2 29 38 20 32 9 6 
3 37 41 30 39 7 2 
4 29 42 21 40 8 2 
5 29 39 23 35 6 4 
6 30 35 21 28 9 7 
7 28 39 20 I 7 8 12 
8 23 38 17 18 6 10 
9 21 29 18 22 3 7 
10 20 28 12 21 8 7 
Table A15: Experiment Two. Summary of Wilcoxon rank signed rank tests 
on extinction data (Seigel 1956) (one tailed tests) 
Test 
T n p 
Total responses 5 10 0.0098 
Short avoidances 4.5 10 < 0.009 
Long avoidances 13 10 NS 
Test 2 
Total responses 10 < 0.005 
Short avoidances 6 10 0.0137 
Long avoidances 13 10 NS 
Table Al6: Experiment Three. Acquisition performance 
Home cage Extinction Response prevented 
Saline LVP Saline LVP Saline LVP 
HCS HCL Ext S Ext L RPS RPL 
Avoidances 
l:x 110 169 141 138 153 169 
-X 13.75 21. 125 17.625 17.25 19. 125 21. 125 
SD 2.964 13.485 B. 193 11.285 I 0. 5 75 8.61 
SE I. 048 4.768 2.897 3.99 3. 739 3.044 
Trials 
l:x 307 486 355 331 377 434 
X 38.375 60.75 44.375 41.375 47.125 54.25 
SD 28. 137 42.04 27.428 20.021 22.242 26.092 
SE 9.948 14.86 9.697 7.078 7.864 9.225 
Escapes 
l:x 39 68 39 73 95 121 
-X 4.875 8.5 4.875 9. 125 11.875 15. 125 
SD 6.221 11.326 7.24 9.862 15. 142 17.78 
SE 2. 199 4.004 2.56 3.487 5.353 6. 286 
Failures 
l:x 88 63 78 76 27 Ill 
X 11.0 7.875 9.75 9.5 3.375 13.875 
SD 13.277 7.24 16.859 14.784 6. 14 19.0 
SE 4.694 2.56 5.96 5.227 2. 171 6.717 
Shocks 
l:x 528 440 429 500 286 736 
-
X 66.0 55.0 53.525 62.5 35.75 92.0 
SD 78.831 49.616 90.432 76.878 34.074 91.558 
SE 27.871 17.542 31.973 27. 181 12.047 32.371 
Table Al7: E~eriment Three. Acquisition Eerformance: outcomes 
from analyses of variance 
Source ss df MS F p 
Between groups 311. 17 5 62.23 0.65 NS 
Avoidances Within groups 3997.5 42 95. 18 
Total 4308.67 47 
Between groups 2812.42 5 562.48 0.69 NS 
Trials Within groups 34213.5 42 814.61 
Total 37025.92 47 
Between groups 640.44 5 128.09 0. 89 NS 
Escapes Within groups 6034.38 42 143.68 
Total 6674.81 47 
Between groups 489. 35 5 97.87 0.52 NS 
Failures Within groups 7911. 13 42 188.36 
Total 8400.48 47 
Between groups 13727.94 5 2745.59 0.51 NS 
Shocks Within groups 226157.38 42 5384.7 
Total 239885.31 47 
Table Al8: Experiment Three. Extinction performance 
Total avoidance responses 
I:x X SD SE 
HC s 289 36. 125 17.96 6.35 
HC L 213 26.625 20.61 7. 29 
Ext s 345 43.125 5.27 1.86 
Test I 
Ext L 285 35.625 14.04 4.96 
RP s 252 31.5 IS. 89 5.61 
RP L 321 40. 125 12. 12 4.28 
HC s 304 38.0 10.37 3.66 
HC L 216 27.0 18.97 6.7 
Ext s 284 35.5 14. 16 5.0 
Test 2 Ext L 248 31.0 17.82 6.3 
RP s 224 28.0 14.88 5.26 
RP L 261 32.62 13.49 4.76 
HC s 301 37.62 13.81 4.88 
HC L 179 29.83 18.01 7.35 
Ext s 257 32. 125 14.8 5.23 
Test 3 
Ext L 217 2 7. 125 20.71 7.32 
RP S 151 30.2 13.0 5.81 
RPL 214 30.57 25.06 5.69 
HC S 71 8.87 2.8 0.99 
HC L 46 5.75 4. 16 I. 47 
Ext s 67 8.37 3.27 I • 16 
Test 4 
Ext L 56 7.0 3.74 I. 32 
RP s 36 6.43 4.42 I. 67 
RP L 71 8.87 I. 35 0.47 
HC s 68 8.5 3. 11 I • I 
HC L 66 8.25 2.96 I. 04 
Ext s 60 7.5 3.34 I. 18 
Test 5 
Ext L 64 8.0 3. 16 I. 11 
RP s 53 7.571 3.78 I. 43 
RP L 70 8. 75 1.91 0.6 7 
Table Al8 (continued) 
Short avoidance responses 
-l:x X SD SE 
HC S 260 32.5 19. 17 6.78 
HC L 199 24.87 20.87 7.38 
Ext s 263 38.87 7.93 2.8 
Test I 
Ext L 234 29.25 17.36 6. 13 
RPS 213 26,62 15.87 5.61 
RPL 280 35.0 12.24 4.33 
HC S 261 32.62 12. 18 4.3 
HC L 180 22.5 18.55 6.56 
Ext S 261 32.62 14.75 5.21 
Test 2 Ext L 213 26.62 17.75 6.27 
RPS 182 22.75 14.63 5. 17 
RPL 212 26.5 12.28 4.34 
HC S 262 32.75 13.54 4.78 
HC L 145 24. 16 17.01 6.94 
Ext s 208 26.0 15.32 5.41 
Test 3 Ext L 179 22.37 19.69 6.96 
RP s 133 26.6 14.79 6.61 
RP L 193 27.57 14.21 5.37 
HC s 68 8.5 zpz 0.96 
HC L 38 4.75 4.23 1.49 
Ext s 57 7. 12 3.35 I. 18 
Test 4 Ext L 52 6.5 4.0 1.41 
RP s 37 5.28 3.98 I. 5 
RPL 64 8.0 I. 77 0.62 
HC s 60 7.5 3. I I 1.1 
HC L 53 6.62 3.92 I. 38 
Ext s 54 6.75 4.06 1.43 
Test 5 Ext L 55 6.87 3.6 I. 27 
RP s 44 6.28 3. 98 1.5 
RP L 58 7.25 2.25 0. 79 
Table Al8 (continued) 
Long avoidance responses 
I:x X SD SE 
HC S 29 3.62 3.88 I. 37 
HC L 14 I. 7S I. 98 0.7 
Ext S 34 4.2S 3.61 I. 27 
Test I 
-Ext L SI 6.37 S.73 2.02 
RPS 39 4.87 3.31 I. 17 
RPL 41 s. 12 3.3S I. 18 
HC S 43 S.37 3.06 I. 08 
HC L 36 4.S 2.82 1.0 
Ext S 23 2.87 2.69 0.9S 
Test 2 
Ext L 3S 4.37 4.9S I. 7S 
RP S 42 S.2S 4.83 I • 7 
RPL 49 6. 12 4.22 I. 49 
HC S 39 4.87 3. 31 I • 17 
HC L 34 S.66 3.32 I. 3S 
Ext S 49 6. 12 s.os I. 78 
Test 3 
Ext L 38 4.7S 4.9S I. 7S 
RPS 18 3.6 2. SI I • 12 
RPL 21 3.0 2.76 1.04 
HC S 3 0.37 O.SI 0. 18 
HC L 8 1.0 I. 19 0.42 
Ext s 10 I. 2S I. 28 0.4S 
Test 4 
Ext L 4 o.s 0.92 0. 32 
RPS 8 I • 14 I. 21 0.4S 
RPL 7 0.87 I. 3S 0.48 
HC S 8 1.0 1.3 0.46 
HC L 13 1.62 I. 76 0.62 
Ext S s 0.7S I. 16 0.41 
Test S 
Ext L 9 I. 12 1.64 O.S8 
RPS 9 I. 28 1.6 0.61 
RPL 12 I. S I. 19 0.42 
-------- ------------------------------------------------------------------------, 
Table Al9: Experiment Three. Analysis of covariance on acquisition and extinction performance 
Source df ss SP ss df SSA MSA F 
X y y y 
(I) X = number of trials to criterion; y = number of short avoidances in Extinction Test 
Between groups 5 311. 17 -159.63 1118. 19 5 1037.85 207.57 0.83 (F x' df 5,42 0.65) 
Within groups 42. 399 7. 5 -1758.38 10989.13 41 10215.67 249. 16 NS (F ' df 5,42 0.85) y 
Total 47 4308.67 -1918.0 12107.31 11253.52 
(2) X = number of avoidances to criterion; y = number of short avoidances in Extinction Test 
Between groups 5 2812.42 -642.63 I 118. 19 5 1117.87 223.57 0.83 (F x' df 5,42 0.69) 
Within groups 42 34213.5 306.25 10989. 13 41 I 0986.38 26 7. 96 NS (Fy, df 5,42 = 0.85) 
Total 47 37025.92 -336.38 12107.31 46 12104.26 
Table A20: Experiment Three 
Mean number of short avoidances in every block of five trials 
llC S HC L Ext S Ext L RP S RPL 
Test I 
3. 125 3.0 4.25 3.0 3.75 3.875 
3.25 3.0 3.875 3.0 2.625 4. 125 
3. 125 3.25 4.25 3.375 3.875 4.0 
3.875 3.25 4.75 3. 125 3.0 4.25 
3.8 3. 125 3.625 2.875 2. 125 3.5 
3. 125 2. 125 4. 125 2.875 2.75 4. 125 
3.125 I. 625 4.375 2.875 2.25 3.625 
3. 125 I .875 3.625 2.875 2.42 2. 857 
2. 875 2.0 3.0 2.875 2.85 3.0 
3.25 I. 625 3.0 2. 375 I. 625 2. 714 
Test 2 
3.25 2.375 4. 125 3.375 3.875 3.625 
3. 125 2.375 4.25 3.375 3. 125 3.25 
3.375 2.625 4.0 3.5 2.75 3. 14 
3.75 2.85 3.75 3. 125 2.625 2.71 
3.75 2.375 3.714 3.0 2. 75 3.0 
3.375 2.625 3.28 2.71 2.25 2.85 
3.0 2.375 2.75 2. 142 I. 625 2.57 
3.25 I. 625 3.28 2.42 I. 75 2. 714 
3.375 2.28 2.75 2. 142 I. 14 2.375 
2.375 I. 857 2.875 2.28 I. 14 2.0 
Test 3 
3.375 3.5 2.5 3.6 4.57 
3.75 3.83 3. 125 2.75 3.6 4.0 
4. 125 2.66 3.0 2.25 3.8 2.85 
4.25 2.66 3.25 2.875 4.2 3.43 
3.375 3.0 3.5 2.375 2.6 2.28 
3.5 I. 833 3.0 2.375 2.8 2.0 
2.625 2.3 2. 142 1.625 1.6 2.28 
3.0 I. 66 2.375 1.5 1.6 2.42 
2.625 0.833 2.25 2.0 1.6 2.28 
2. 125 I. 833 2.0 2. 125 1.2 I. 428 
Test 4 
4.0 2.5 3.875 3.75 0. 71 0.5 
4.375 2.25 3.25 2.75 0.43 I. 0 
Test 5 
4. 125 3.25 3.5 3.75 0.57 0.5 
3.375 3.375 3. 125 3. 125 0.86 0.625 
Tab·le A20 (continued) 
Mean number of long avoidances in every block of five trials 
HC S HC L Ext s Ext L RP S RPL 
Test I 
0.125 o. 125 o. 125 0.75 0.75 0.5 
0.375 0.25 0.375 0.375 0.875 0.75 
0.5 0.25 0.25 0.125 0.375 0.375 
0 o. 125 0.25 0.5 0.375 0.25 
0.5 0. 125 0 0.5 0.5 0.875 
0.375 0 0.142 0.625 0.25 0.375 
0.375 0.5 0.625 I. 375 0.625 0.625 
0.5 0.25 0.875 I. 125 0.428 0.571 
0.375 0 o. 75 0.5 0.285 0. 142 
0.5 o. 125 0. 875 0.5 I. 0 0.857 
Test 2 
0.25 0.25 0.125 0.25 0.25 0.625 
0.5 1.0 0.25 0.5 0.25 0. 75 
0.5 o. 75. 0.25 0.25 0.75 0.714 
0.25 0.428 0.5 1.0 0.625 I. 0 
0.625 0.5 0.285 0.5 0.625 0.571 
0.875 0.375 0.428 0.428 0.625 0.285 
o. 75 0. 125 0.5 0.857 o. 75 0.428 
0.625 0.5 0. 142 0.714 0.25 0.571 
0.375 0.25 0.375 I. 0 0.571 1.0 
0.625 0.375 0.25 0.571 0.428 0.625 
Test 3 
0.75 0.333 1.0 0.625 0 0. 142 
o. 75 0.333 0.625 0.5 1.0 0.285 
0.375 0.666 I. 25 1.0 0 0.428 
0.375 I. 333 0.25 0.375 0.6 0.428 
0.625 0.33 I. 142 0.5 0.6 0.428 
0.375 0.66 0.428 0.625 0.8 0. 142 
0.5 0.5 0.625 0.25 0 0. 142 
0.25 0.66 0.375 0.625 0 0.428 
0.375 0.5 0.25 0.25 0 0.285 
0.5 0.33 o. 375 0 0.2 0. 285 
Test 4 
0.375 0.625 0.5 0.25 0.714 0.25 
0 0.375 0. 75 0.25 0.428 0.625 
Test 5 
0.25 I. 125 0.375 0.5 0.57 0. 125 
0.75 0.5 0.375 0.625 o. 85 7 I. 37 
Table A20 (continued) 
Mean number of total avoidances in every block of five trials 
HC S HC L Ext S Ext L HC S HC L 
Test I 
3.25 3. 125 4.375 3.75 4.5 4.375 
3.625 3.25 4.25 3.375 3.5 4.875 
3.625 3.5 4.5 3.5 4.25 4.375 
3.875 3.375 5.0 3.625 3.375 4.5 
4.3 3.5 3.625 3.375 2.625 4.375 
3.5 2. 125 4.267 3.5 3.0 4.5 
3.5 2. 125 5.0 4.25 2.875 . 4. 25 
3.625 2. 125 4.5 4.0 2.848 3.428 
3.25 2.0 3.75 3.375 3. 135 3. 142 
3.75 I. 75 3.875 2.875 2.625 3.571 
Test 2 
3.5 2.625 4.5 3.625 4. 125 4.25 
3.625 3.375 4.5 3.875 3.375 4.0 
3.875 3.375 4.25 3.75 3.5 3.854 
4.0 3.278 4.25 4. 125 3.25 3. 71 
4.375 2.875 3.999 3.5 3.375 3.571 
4.25 3.0 3.708 3. 138 2.875 3. 135 
3.75 2.5 3.25 2.999 2.375 2. 998 
3.875 2. 125 3.422 3.134 2.0 3.285 
3.75 2.53 3.125 3. 142 I. 711 3.375 
3.0 2.232 3. 125 2.851 I. 568 2.625 
Test 3 
4.125 3.833 4. 125 3. 125 3.6 4.712 
4.5 4. 163 3.625 3.25 4.6 4.285 
4.5 3.326 4.5 3.25 3.8 3.278 
4.625 3. 993 3.75 3.25 4.8 3.858 
4.0 3.33 4. 142 2.875 3.2 2.708 
3.875 2. 493 2.57 3.0 3.6 2. 142 
3.125 2.8 3.0 1.875 1.6 2.422 
3.25 2.32 2.625 2. 125 1.6 2.848 
3.0 I. 333 2.25 2.25 1.6 2.565 
2.625 2. 163 2.375 2. 125 1.4 I. 713 
Test 4 
4.375 3. 125 4.375 4.0 I. 424 0.3 
4.375 2.625 4.0 3.0 0.858 I. 625 
Test 5 
4.375 4.375 3.875 4.25 I. 14 0.625 
4. 125 3.875 3.5 3.75 I. 717 I. 995 
Table A21: Experiment Three. The outcomes of Friedman's ANOVAs on 
extinction data 
2 Sum R. x2 p 
J r 
Test 
Short avoidances 8584.0 35.24 < 0.001 (for tl, T2 and T3 
Long avoidances 7895.5 15.585 < 0.02 n = 10, k = 6) 
Total 8652.0 37.187 < 0.001 
Test 2 
Short avoidances 850 I. 0 32.85 < 0.001 
Long avoidances 7784.0 12.388 < 0.05 
Total 8502.0 32.902 < 0.001 
Test 3 
Short avoidances 7892.5 15.488 < 0.02 
Long avoidances 7598.5 7.089 ns 
Total 8086.0 21.017 < 0.001 
Test 4 
Short avoidances 342.0 6.8376 ns (for T4 and T5 
Long avoidances 334.5 5.766 n = 2, k = 6) ns 
Total 362.5 9.765 < 0. I 
Test 5 
Short avoidances 323.5 4. 1958 ns 
Long avoidances 310.0 2.268 ns 
Total 360.5 9. 4 79 . < 0. I 
Table A22: Experiment Three. Trend lines for short avoidances 
in extinction 
Home cage Extinction Response prevented 
Saline LVP Saline LVP Saline LVP 
Tl -0.026 -0.194 -0. 128 -0.059 -0. 16 -0.153 
T2 -0.056 -0.069 -o. 174 -0.164 -0.284 -0. 142 
T3 -0. 178 -0.261 -0.154 -0.097 -0.328 -0.279 
Table A23: Experiment Three. The outcomes of Nemenyi' s multiple comparisons 1n extinction data 
Short avoidances Long avoidances Total avoidances 
r p r p r p 
Tl 23.0 0.05 15.5 ns 22.0 0.08 
HCSvHCL T2 30.0 < 0.009 I I. 5 ns 34.0 < 0.009 
T3 25.0 < 0.023 2.5 ns 27.0 < 0.023 
Tl 15.5 ns 2.5 ns 24.5 < 0.047 
HC S v Ext S T2 7.5 ns 12.0 0. I 1.5 ns 
T3 16.5 ns 3.5 ns 14.0 ns 
Tl 13.5 ns 14.0 ns 0 ns 
HC S v Ext L T2 13.5 ns 1.5 ns 17.5 ns 
T3 30.5 < 0.009 6.0 ns 34.0 < 0.009 
Tl 20.0 0. I 6.0 ns 7.0 ns 
HCSvRPS T2 29.5 < 0.009 1.5 ns 20.0 0. I 
T3 21.5 0. I 11.0 ns 26.0 < 0.023 
Tl 8.0 ns 11 . 0 ns 13.5 ns 
HCSvRPL T2 12.0 ns 2.5 ns 7.0 ns 
T3 17.5 ns 13.0 ns 25.0 < 0.047 
Tl 35.5 < 0.009 3.5 ns 32.5 < 0.009 
Ext S v RP S T2 37.0 < 0.008 19.5 ns 31.5 < 0.009 
T3 5.0 ns 14.5 ns 12.0 ns 
Table A23 (continued) 
Short avoidance a Long avoidances Total avoidances 
r p r p r p 
Tl 21.5 < 0. I 3.0 ns 13.5 ns 
Ext L v RP L T2 1.0 ns 1.0 ns 10.5 ns 
T3 13.0 ns 7.0 ns 9.0 ns 
Tl 9.5 ns 29.5 < 0.009 22.0 < O. I 
HC L v Ext L T2 16.5 ns 13.0 ns 16.5 ns 
T3 5.5 ns 8.5 ns 7.0 ns 
Tl 3.0 ns 21.5 < 0. I 15.0 ns 
HC L v RP S T2 0.5 ns 10.5 ns 4.0 ns 
T3 3.5 ns 13.5 ns 1.0 ns 
Tl 31.0 < 0.009 26.5 < 0.023 35.5 < 0.009 
HCLvRPL T2 17.5 ns 14.0 ns 27.0 < 0.023 
T3 7.5 ns 15.5 ns 2.0 ns 
Tl 29.0 < 0.009 11.5 ns 24.5 < 0.047 
Ext S v Ext L T2 21.5 < 0. I 22.5 < 0. I 19.0 ns 
T3 14.0 ns 10.5 ns 20.0 0. I 
Tl 28.0 < 0.009 5.0 ns 20.5 0. I 
RP S v RP L T2 17.0 ns 4.0 ns 23.0 0.05 
T3 4.0 ns 2.0 ns 1.0 ns 
Table A24: Experiment Three. Responses made during 30 trials of extinction treatment 
Extinction plus saline Extinction plus LVP 
Subject Total Short Long Total Short Long 
responses avoidances avoidances responses avoidances avoidances 
30 30 0 22 I 7 5 
2 30 30 0 28 24 4 
3 30 30 0 30 29 
4 30 28 2 29 28 
5 30 30 0 28 27 
6 17 I 2 5 30 30 0 
7 30 30 0 14 14 0 
8 26 26 0 29 27 2 
Ex 223 216 7 210 196 14 
X 27.875 27 0.875 26.25 24.5 I. 75 
SD 4. 6 I I 6.23 I. 807 5.574 5.879 I. 832 
SE 1.63 2.202 0.638 I. 97 I 2.079 0. 64 7 
Table A25: Experiment Four. Acquisition performance 
Home cage Response prevented 
Saline LVP Saline LVP 
Trials 
l:x 340 330 282 398 
-X 42.5 41.25 40.285 44.222 
SD 24.28 31.75 25.62 33.31 
SE 8.58 11.22 9.68 11. 10 
Avoidances 
l:x 165 171 127 187 
X 20.625 21.375 18. 142 20.777 
SD 7.05 B. 77 6.44 9.4 
SE 2.49 3. I 0 2.43 3. 13 
Escapes 
l:x 83 91 100 154 
X 10.375 11.375 14.285 I 7. I I I 
SD 8.72 13.08 22.32 18.46 
SE 3.08 4.62 8.43 6. 15 
Failures 
l:x 69 70 37 52 
X 8.625 8. 75 5.285 5. 777 
SD 10.84 14.44 3. 77 9.27 
SE 3.83 5.10 I. 42 3.09 
Shocks 
l:x 479 472 304 515 
-
X 59.875 59.0 43.428 57.222 
SD 63.84 86.52 16.89 72. 16 
SE 22.57 30.59 6.38 24.05 
Table A26: Experiment Four. Analyses of variance on acquisition data 
Source ss df MS F p 
Between groups 70.39 3 23.46 0.03 NS 
Avoidances Within groups 23996.8 28 857.02 
Total 24066.88 31 
Between groups 44.71 3 14.9 0.23 NS 
Trials Within groups 1842.16 28 65.79 
Total 1886.88 31 
Between groups 235.43 3 78.48 0.3 NS 
Escapes Within groups 7446.07 28 265.93 
Total 7681.5 31 
Between groups 79. 14 3 26.38 0.24 NS 
Failures Within groups 3054.36 28 109.08 
Total 3133.5 31 
Between groups 124302. 14 3 432.24 0. I NS 
Shocks Within groups 1296.73 28 4439.36 
Total 125598.88 31 
Ex 
-
X 
SD 
SE 
Ex 
X 
SD 
SE 
Ex 
-
X 
SD 
SE 
Table A27: Experiment Four. Responses made by subjects in Periods A and B in Suppression Tests I and 2 
Period A Period B 
2 3 4 5 6 7 8 9 10 2 3 4 5 6 7 8 9 10 
Home cage saline: Test I 
42 39 35 35 42 46 72 
5.25 4.87 4.37 4.37 5.25 5.75 9.0 
84 
10.5 
68 
8.5 
62 
7.75 
4.26 3.56 5.09 5.7 6.86 5.28 7.59 5.68 6.56 5.97 
1.51 1.25 1.8 2.01 2.42 1.86 2.68 2.01 2.32 2.11 
Home cage saline: 
56 63 67 62 87 72 76 62 75 81 
7.0 7.87 8.37 7.75 10.8 9.0 9.5 7.75 9.37 10.12 
6.0 6.1 4.83 6.27 6.97 6.59 6.39 4.02 4.89 5.51 
2.12 2.15 I. 71 2.22 2.46 2.33 2.26 1.42 I. 73 1.94 
41 16 15 19 24 
5.125 2.0 1.875 2.375 3.0 
4.02 2.67 3.56 3.85 5.01 
21 17 28 
2.625 2.125 3.5 
5.04 4.02 5.42 
Home cage LVP: 
27 26 
3.375 3.25 
4.69 4.53 
1.42 0.94 1.26 1.36 1.77 1.78 1.42 1.92 1.66 1.60 
15 14 15 24 28 38 46 59 54 60 
1.875 1.75 
1.72 1.98 
0.61 0. 7 
I. 87 3.0 3.5 
1.72 5.01 2.51 
0.61 I. 77 0.88 
4.75 5.75 7.37 6.75 7.5 
4.77 4.43 5.55 4.94 4.66 
I. 68 I. 56 I. 96 I. 7 5 I. 64 
Test 2 
56 68 65 67 63 84 68 
7.0 8.5 8.12 .837 7.87 10.5 8.5 
5.34 7.38 6.97 6.45 4.76 5.95 4.5 
1.89 2.61 2.46 2.28 1.68 2.1 1.59 
Test 
12 6 8 14 16 22 16 
1.5 0. 75 1.0 I. 75 2.0 2. 75 2.0 
1.77 1.39 2.14 2.49 3.42 4.50 3.21 
79 91 78 
9.87 11.37 9.75 
5 • 59 6 . 16 4. 7 I 
I. 9 7 2. 17 I . 66 
26 32 42 
3.25 4.0 5.25 
3.69 5.90 5.70 
0.63 0.17 0.75 0.88 1.20 1.59 1.13 1.30 2.09 2.02 
Home cage LVP: Test 2 
Ex 87 64 64 59 84 77 80 76 88 72 46 50 55 70 93 87 80 83 76 72 
X 10.875 8.0 8.0 7.375 10.5 9.62510.0 9.5 11.0 9.0 5. 75 6.25 6.875 8. 75 11.62510.87510.0 10.375 9.5 9.0 
SD 5.67 6.52 6.74 4.98 2.67 6.32 6.65 9.55 6.80 5.50 3.37 4.53 4.55 4.98 7.39 6.38 5.40 7.17 7.56 7.78 
SE 2.0 2.31 2.38 1.76 0.94 2.23 2.35 3.38 2.40 1.94 1.19 1.60 1.61 I. 76 2.61 2.26 1.91 2.53 2.67 2. 75 
Table A27 (continued) 
Period A Period B 
2 3 4 5 6 7 8 9 10 2 3 4 5 6 7 8 9 10 
Response prevented saline: Test 
Ex 76 15 50 44 40 35 41 49 33 58 I 7 16 33 34 44 30 39 38 49 60 
-X 10.857 2.143 7.143 6.286 5.714 5.0 5.85 7.0 4.71 8.28 2.43 2.28 4.71 4.85 6.28 4.28 5.57 5.43 7.0 8.57 
2.51 2.42 4.07 3.76 4.27 4.68 4.86 4.24 6.11 4.46 
0.95 0.91 1.54 1.42 1.61 1.77 1.84 1.60 2.31 1.68 
SD 5.18 3.24 7.49 5.56 3.98 4.93 5.84 7.09 6.29 6.44 
SE 1.958 1.224 2.83 2.1 1.5 1.86 2.21 2.68 2.38 2.44 
Response prevented saline: Test 2 
Ex 50 43 57 53 71 44 69 57 53 52 35 48 48 63 56 64 58 47 57 67 
X 7.14 6.14 8.14 7.57 10.14 6.28 9.85 8.14 7.57 7.43 5.0 6.85 6.85 9.0 8.0 9.14 8.28 6. 71 8.14 9.57 
SD 
SE 
Ex 
X 
SD 
SE 
Ex 
X 
SD 
SE 
5.39 4.87 6.03 6.18 8.07 4. 71 7.9 6.52. 6.85 7.11 
2.04 1.84 2.28 2.33 3.05 1.78 2.98 2.46 2.59 2.68 
3.46 4.09 5.64 6.27 6.29 5.95 6.1 5.64 7.33 7.65 
1.31 1.55 2.13 2.37 2.38 2.25 2.31 2.13 2. 77 2.89 
Response prevented LVP: Test I 
I I I 81 59 58 68 7 7 
12.33 9.0 6.55 6.44 7.55 8.55 
71 78 79 
7.88 8.66 8. 77 
65 
7.22 
3.77 8.93 7.36 6.65 8.7 9.0 7.34 6.91 7.03 6.42 
1.26 2.97 2.45 2.22 2.9 3.0 2.44 2.3 2.34 2.14 
27 32 35 39 59 63 67 53 42 31 
3.0 3.55 3.88 4.33 6.55 7.0 7.44 5.88 4.66 3.44 
3.97 4.64 4.78 4.09 8.18 6.38 5.72 5.68 4.38 3.84 
1.32 1.54 1.59 1.36 2.73 2.13 1.91 1.89 1.46 1.28 
Response prevented LVP: Test 2 
35 65 60 68 53 52 78 65 55 52 62 
7.22 6.66 7.55 5.88 5.77 8.66 7.22 6.11 5.77 6.88 
5.74 6.55 8.23 6.31 6.87 8.27 8.13 5.68 6.16 7.22 
1.91 2.18 0.91 2.1 2.28 2.76 2.71 1.89 2.05 2.4 
34 44 54 57 59 57 76 51 33 
3.66 3.88 3.77 4.88 6.0 6.33 6.55 6.33 8.44 5.66 
5.47 5.39 4.23 6.33 6.57 6.06 6.08 5.14 6.26 4.79 
I. 82 I. 79 I • 4 I 2. 11 2. 19 2. 02 2. 03 I . 71 2. 08 I. 59 
Table A28: Experiment Four. Suppression ratios 1n Suppression Test (Blocks One and Two) and Test 2 (Blocks Three and Four) 
Block One Block Two Block Three Block Four 
2 3 4 5 6 7 8 9 10 2 3 4 5 6 7 8 9 10 
Home cage saline: Test 
Ex 2. 715 I. 397 3.716 2.508 4.254 3.027 3.41 2. 719 3.658 4.04 3.081 3.373 3.045 3.221 3. 103 4.148 4.063 3.947 3. 807 3.48 
X o. 339 o. 174 0.464 0.313 0.531 0.378 0.426 0.339 0.457 0.505 0.385 0.421 0.381 0.402 0.387 0.518 0.508 0.493 0.476 0.435 
SD 0.319 0.226 0.373 G.351 0.357 0.204 0.265 0. 182 0.255 0.279 0.278 0.204 0.22 0.257 0.241 0.279 o. 101 0.208 0.218 0.181 
SE 0. 112 0.08 0.132 0.124 0.126 0.072 0.093 0.064 0.09 0.098 0.098 0.072 0.077 0.091 0.085 0.098 0.036 0.074 0.077 0.063 
Home cage saline: Test 2 
Ex 1.~95 0.563 0.65 1.402 I. 145 2.833 2.905 3.028 3.652 4.625 3.376 2.794 3.225 5.159 3.954 4.155 .4. 105 4.385 4.081 3.345 
X 0.224 0.070 0.081 0.175 0.143 0.354 0.363 0.378 0.456 0.578 0.422 0.349 0.403 0.644 0.494 0.519 0.513 0.548 0.510 0.418 
SD 0.209 0.137 0.156 0.260 0.199 0.440 0.439 0.42 0.438 0.417 0.139 0.212 0.208 0.239 0.146 0.153 0.114 0.203 0.232 0.193 
SE 0.073 0.048 0.055 0.091 0.07 0.155 0.155 0.148 0.155 0.147 0.049 0.074 0.073 0.084 0.052 0.054 0.04 0.072 0.082 0.068 
Response prevented saline: Test I 
Ex 1.068 2.267 2.857 3.038 3.228 2.44 3.682 2.603 3.462 3.252 2.578 3.39 3.19 3.658 4.142 3.481 3.05 3.157 2.976 4.149 
X 0.153 0.324 0.408 0.434 0.461 0.349 0.526 0.372 0.495 0.465 0,368 0,484 0.456 0.523 0.592 0.497 0.436 0.451 0.425 0.593 
SD 0.121 0.344 0.347 0.333 0.264 0.378 0.368 0.350 0.381 0.232 0.183 0.262 0.311 0.298 0.284 0.260 0.250 0.306 0.350 0.341 
SE 0.046 0.126 0.131 0.126 0.099 0.143 0.139 0.132 0.144 0.088 0.069 0.099 0.118 0.113 0.107 0.098 0.094 0.116 0.132 0.129 
Response prevented saline: Test 2 
Ex 2.0 1.778 1.795 3.465 2.841 4.071 4.561 3.146 2.886 2.788 2.766 3.405 3.744 3.399 2.81 3.085 3.216 5.117 5.339 4.983 
X 0.222 0.198 0.199 0.385 0.316 0.452 0.507 0.349 0.321 0.310 0.307 0.378 0.416 0.378 0.312 0.343 0.357 0.569 0,593 0,554 
SD 0.241 0.209 0.197 0.294 0.346 0.360 0.295 0.312 0.309 0.308 0.345 0.315 0.376 0.346 0.348 0.222 0.303 0.317 0.280 0.360 
SE Q.080 0.070 0.066 0.098 0.115 0.120 0.098 0.104 0.103 0.103 0.115 0.105 0.125 0.115 0.116 0.074 0.101 0.106 0.093 0.120 
Table A29: Exeeriment Four. Analysis of variance of the mean number of 
lever press responses during Period A (non CS presentation) 
Source ss df MS F p 
Suppression Test I . 
' 
trials 1-S 
Treatment 82. 11 3 27.37 10.64 < 0.01 
Trials 39.82 4 9.9S 3.67 < o.os 
Error 30.88 12 2.S7 
Total IS2.8 
Suppression Test I. 
• 
trials 6-10 
Treatment 93·.46 3 31. IS 23. IS < 0.01 
Trials 7.8S 4 1.96 1.46 NS 
Error 16. IS 12 I. 34 
Total 117.4S 
Suppression Test 2. 
• 
trials 1-S 
Treatment 14.78 3 4.92 3.34 ( < 0. I) 
Trials 12.43 4 3. 11 2. 11 NS 
Error I 7. 7 12 1.47 
Total 44.92 
Suppression Test 2. 
• 
trials 6-10 
Treatment 2S.2S 3 8.42 7.24 < 0.01 
Trials 3.29 4 0.82 0.71 NS 
Error 13.94 12 I. 16 
Total 42.48 
Table A30: Exeeriment Four. Analysis of variance of the mean number of 
lever eress responses during Period B (under CS presentation) 
Source ss df MS F p 
Suppression Test I. 
' 
trials 1-5 
Treatment 28.69 3 9.563 19. IS < 0.01 
Trials 16.9 4 4.225 8.46 < 0.01 
Error 5.99 12 0.499 
Total SI. 59 
Suppression Test I • 
' 
trials 6-10 
Treatment 27.6 3 9.2 3.86 < o.os 
Trials 4.83 4 I. 2075 0.51 NS 
Error 28.63 12 2.358 
Total 61.06 
Suppression Test 2. 
' 
trials 1-5 
Treatment 40.8 3 13.6 11.55 < 0.01 
Trials 23.22 4 5.805 4. 93 < 0.01 
Error 14. 13 12 I. 177 
Total 78. 14 
Suppression Test 2· 
' 
trials 6-10 
Treatment 37.52 3 12.506 12. 71 < 0.01 
Trials 4.04 4 1.01 1.03 NS 
Error 11.8 12 0.983 
Total 53.36 
Table A31: ExEeriment Four. Analx:sis of variance of mean 
suEpression ratios 
Source ss df MS F p 
Suppression Test I • 
' 
trials 1-5 
Treatment 0. 17 3 0.056 6. 15 < O.OI 
Trials 0.08 4 0.02 2. I 2 NS 
Error 0. I I I2 0.009I6 
Total 0.35 
Suppression Test I • 
' 
trials 6-10 
Treatment O.OI 3 0.003 0.42 NS 
Trials 0.03 4 0.0075 I. 38 NS 
Error 0.07 I2 0.0058 
Total 0. 11 
Suppression Test 2. 
' 
trials I-5 
Treatment 0.05 3 O.OI6 3.5 0.05 
Trials 0.03 4 0.0075 I. 56 NS 
Error 0.06 I2 0.005 
Total 0.14 
Suppression Test 2. 
' 
trials 6-IO 
Treatment O.OOI3 3 0.0004 0.07 NS 
Trials 0.01 4 0.0025 0.38 NS 
Error 0.08 I2 0.0066 
Total 0.09 
Table A32: Outcome of Newman Keuls tests on differences 
between means (Winer 1962) 
Period A responses: Test I; trials 1-5 
Treatment effects 
Treatment totals HC s 24. 11 
HC L 14.37 HC S <RP L p < 0.05 
RP s 32. 14 HC L <RP s p < o.os 
RP L 41.87 HC L <RP L p < 0.05 
Trial effects 
Trial totals I. 33.56 trial > trial 2 p < 0.05 
2. 18.0 I trial > trial 3 p < 0.05 
3. 19.93 trial > trial 4 p < 0.05 
4. 19.47 trial > trial 5 p < 0.05 
5. 21 .SI 
Period A responses: Test I• 
• 
trials 6-10 
Treatment effects 
Treatment totals HC s 41.5 HC s > HC L p < 0.05 
HC L 14.88 HC s > RP S p < o.os 
RP s 30.84 RP s > HC L p < 0.05 
RP L 41.0 RP L > HC L p < 0.05 
RP L > RP S p < 0.05 
Period A responses: Test 2; trials 6-10 
Treatment effects 
Treatment totals HC S 45.74 HC s > RP L p < 0.05 
HC L 49. 13 HC L > RP L p < 0.05 
RP S 39.27 HC L > RP s p < 0.05 
RPL 34.64 
Period B responses: Test I. 
• 
trials 1-5 
Treatment effects 
Treatment totals HC S 12.0 HC s > HC L p < 0.05 
HC L 7.0 RP s > HC S p < 0.05 
RP s 20.55 RP s > HC L p < 0.05 
RP L 21.31 RP L > HC L p < 0.05 
RP L > HC s 
Table A32 (continued) 
Period B responses: Test I . 
' 
trials 1-5 
Trial effects 
Trial totals I. 8.81 trial 4 > trial 2 p < 0.05 
2. 8.33 trial 4 > trial p < 0.05 
3. 11.46 trial 5 > trial p < 0.05 
4. 13.93 trial 5 > trial 2 p < 0.05 
5. 18.33 trial 5 > trial 3 p < 0.05 
trial 5 > trial 4 p < 0.05 
Period B responses: Test I . 
' 
trials 6-10 
Treatment effects 
Treatment totals HC s 32. 12 HC s > HC L p < 0.05 
HC L 17.25 RP s > HC L p < 0.05 
RP s 30.85 RPL > HC L p < 0.05 
RPL 28.42 
Period B responses: Test 2· 
' 
trials 1-5 
Treatment effects 
Treatment totals HC S 39.86 HC S > RP L p < 0.05 
HC L 39.25 HC L > RP L p < 0.05 
RP s 35.7 RP S > RPL p < 0.05 
RP L 22. 19 
Trial effects 
Trial totals I . 21.41 trial 4 > trial p < 0.05 
2. 25.48 trial 5 > trial p < 0.05 
3. 25.62 trial 5 > trial 3 p < 0.05 
4. 31.0 
5. 33.5 
Period B responses: Test 2· 
' 
trials 6-10 
Treatment effects 
Treatment totals HC S 49.99 HC s > RP S p < 0.05 
HC L 49.75 HC S > RP L p < 0.05 
RP s 41.84 HC L > RP s p < 0.05 
RP L 33.31 HC L > RP L p < 0.05 
RP S >RP L p < 0.05 
Table A32 (continued) 
Mean suppression ratios: Test I; trials 1-5 
Treatment effects 
Treatment totals HC S 
HC L 
RPS 
RPL 
1.82 
0.69 
I. 78 
I. 32 
HC S > HC L 
RPS>HCL 
RP L > HC L 
Mean suppression ratios: Test 2; trials 1-5 
Treatment effects 
Treatment totals HC S 1.98 RPS>RPL 
HC L 2.31 
RP S 2.42 
RP L I. 79 
p < 0.05 
p < 0.05 
p < 0.05 
p < 0.05 
Table A33: Experiment Four. Extinction data 
Home cage Response prevented 
Saline LVP Saline LVP 
Test I : Total avoidance& 
I:x 232 249 163 219 
X 29.0 31. 125 23.28 24.33 
SD 12.27 15.78 12. 16 17.58 
SE 4.338 5.58 4. 597 5.86 
Test I : Short avoidance& 
I:x 173 192 116 157 
X 21.625 24.0 16.571 17.44 
SD 11. 134 15.39 11 .83 14.52 
SE 3.937 5.441 4.47 4.84 
Test I : Long avoidance a 
I:x 59 57 47 62 
X 7.375 7. 125 6.714 6.888 
SD 4. 103 4.015 1.603 5.883 
SE I. 451 I. 419 0.606 I. 961 
Test 2: Total avoidance& 
I:x 229 233 161 175 
-
X 28.625 29. 125 23.0 19.444 
SD 10.446 9.417 6.831 18.31 
SE 3. 693 3.33 2.582 6, I 0 
Test 2: Short avoidance& 
I:x 143 165 102 129 
- 17.875 20.625 14.57 14.33 X 
SD 6.379 7.799 3.95 17.421 
SE 2.255 2.758 I. 493 5.807 
Test 2: Long avoidance& 
I:x 86 68 59 46 
X 10.75 8.5 8.428 5. Ill 
SD 5.8 2. 725 4.894 5.464 
SE 2.051 0.963 I. 85 1.821 
Table A34: Ex~eriment Four. Extinction ~erformance as a function 
of extinction trials 
Trial HC S HC L RPS RPL 
Test I: Mean number of total responses per trial 
I 4. 125 3.75 2. 142 3.443 
2 3.25 2.875 3.142 2.443 
3 3.0 3.5 2.428 2.888 
4 3. 125 3.25 2.0 2.666 
5 2.625 2.875 2.5657 I. 888 
6 2.75 3.5 I. 999 I. 777 
7 I. 875 3. 125 2.285 2. 777 
8 2.5 3.0 I. 999 I. 777 
9 2.875 3.0 2. 142 2.555 
10 2.875 2.25 2.571 2. 11 
Test I : Mean number of short avoidances per trial 
I 3.375 3.375 I. 714 2. 777 
2 2.375 2.5 2.0 I. 666 
3 I. 875 2.625 1.571 2.0 
4 I. 875 2.25 1.0 I. 666 
5 2.625 2.25 2.28 I. 222 
6 2.0 2.625 I. 571 I. 222 
7 I. 375 2.25 I. 285 2. I 11 
8 2.0 2.375 I .428 1.555 
9 2.25 2.25 I. 857 2.0 
IQ I. 875 I. 5 I. 857 I. 222 
Test I : Mean number of long avoidances per trial 
I 0.75 0.375 0.428 0.666 
2 0.875 0.375 I. 142 0. 777 
3 I. 125 0.875 0.857 0.888 
4 1.25 I. 0 1.0 1.0 
5 0 0.625 0.2857 0.666 
6 0.75 0.875 0.428 0.555 
7 0.5 0.875 1.0 0.666 
8 0.5 0.625 0.5714 0.222 
9 0.625 o. 75 0.285 0.555 
10 1.0 0.75 0.714 0.888 
Table A34 (continued) 
Trial RC s HC L RP s RPL 
Test 2: Mean number of total responses per trial 
I 3.75 3.625 3.571 2.333 
2 2.625 3. 125 2.999 1.888 
3 2.25 2.875 2. 142 I. 999 
4 2. 875 2.625 I. 5 71 I. 777 
5 3.0 3.25 I. 999 1.885 
6 2.5 2.75 2. 142 I. 666 
7 2.625 3.625 2.4284 I. 777 
8 3.5 3.5 2. 142 I. 777 
9 2.25 2.0 I. 713 2.221 
10 3.25 I. 75 2. 285 2. 11 
Test 2: Mean number of short avoidances per trial 
I 3.125 2.625 2.714 2.0 
2 I. 75 2. 125 I. 857 I. 555 
3 1.375 I. 75 I. 142 I. Ill 
4 2.0 I. 625 1.0 I. 555 
5 I. 375 2.25 I. 142 I. 33 
6 1.5 2.375 I. 142 I . I I I 
7 1.0 2.25 1.5714 I. 333 
8 I. 75 2.75 I. 285 I. 333 
9 1.25 I. 75 I. 142 I. 444 
10 2.75 I. 125 I .571 I. 555 
Test 2: Mean number of long avoidances per trial 
I 0.625 I. 0 0.857 0.333 
2 0.875 1.0 I. 142 o. 333 
3 0.875 I. 125 I. 0 0.888 
4 0.875 1.0 0.571 0.222 
5 I. 625 1.0 o. 857 0.555 
6 1.0 0.375 1.0 0.555 
7 1.625 1.375 0.857 0.444 
8 I. 75 0.75 0. 857 0.444 
9 I. 0 0.25 0.571 0. 777 
10 0.5 0.625 0.714 0.555 
Table A35: Experiment Four. Outcomes of Freidman's anal~sis of 
variance on extinction data (Seigel 1956) 
Total responses Short avoidances Long avoidances 
Test I 
l:R~ 
J 2 74 7. 5 2695.5 2534.0 
x2 14.85 11.73 2.04 
r 
p < 0.01* < 0.01 NS 
Test 2 
l:R? J 2776.25 2658.0 2633.25 
x2 
r 16.57 9.48 7. 995 
p < 0.001 < 0.05 < 0.05 
Multiple comparisons (Hollander and Wolfe 1973) 
Test I 
HC 1 v RP L 19.5 17.5 
p < 0.029 < 0.01 
Test 2 
HC L v RP L 20.0 17.0 17.0 
p < 0.01 < 0.029 < 0.029 
Test 
HC L V RP s 16.5 
p < 0.029 
Test 2 
HC S v RP L 19.5 
p < 0.01 
* n = 10, k = 4 
Table A36: Experiment Five. Acquisition performance 
Home cage saline Home cage LVP Response prevented saline Response prevented LVP 
I mm 30 60 6 24 I mm 30 60 6 24 I mm 30 60 6 24 I mm 30 60 6 24 
Avoidances to criterion 
I:x 136 180 141 154 182 135 144 202 127 145 177 135 186 120 167 192 157 114 165 138 
X 17.0 22.5 17.63 19.25 22.75 16.88 18.0 25.25 15.88 18. 13 22.125 16.88 23.25 15.0 20.88 24.0 19.63 14.25 20.63 17.25 
SD 2. 39 6.48 2. 72 7.09 12.74 3. 76 2.2 18.54 3.83 8. 84 8.67 8.63 14.9 3.02 9. 19 4.38 4.78 3.92 6.7 4.86 
Trials to criterion 
Ex 266 359 292 265 298 259 260 362 306 232 304 238 349 235 256 374 279 206 389 257 
-X 32.25 44.88 36.55 33. 13 37.25 32.38 32.5 45.25 38.25 29.0 38.0 29.75 43.63 29.38 32.0 46.75 34.88 25.75 48.63 32. 13 
SD 10.9 25.65 24.45 13.66 21.65 25.71 10.85 25.81 25.69 16.04 16.0 15.26 25.91 14.83 13.55 19.72 16.22 18.21 28. 11 13.68 
Escapes to criterion 
Ex 45 53 71 48 54 42 67 65 54 44 Ill 33 56 30 37 65 28 67 49 91 
-
X 5.63 6.63 8.87 6.0 6.75 5.25 8.37 8.125 6. 75 5.5 13.87 4. 12 7.0 3.75 4.63 8. 125 3.5 8.37 6.12511.37 
SD 6.71 4.89 11.65 6.84 6.52 5. 75 7.46 7.04 10.87 4.63 18.87 4.52 8.67 3.88 3.25 4.64 3.66 16. 17 4.97 13.67 
Failures to respond 
Ex 56 108 32 23 37 32 48 47 67 39 26 34 35 IS 36 99 42 24 153 29 
X 7.0 13.5 4.0 2.87 4.62 4.0 6.0 5.87 8.375 4.87 3.25 4.25 4. 375 1.87 4.5 12.37 5.25 3.0 19. 13 3.625 
SD 9.57 22.4 6.25 5.76 7.33 8.52 9.68 5.97 12. 14 4.99 3.5 5.59 6.3 2. I 6.54 18.68 5. 12 7.31 22.28 5.09 
Shocks in training 
I:x 349 628 255 211 267 227 331 347 443 257 277 149 271 I 18 242 638 273 196 842 257 
X 43.63 78.5 31.87 26.4 33.4 28.37 41.37 43.4 53.4 32. 13 34.63 18.63 33.8 14.75 30.25 79.75 34. 12 24.5 105.25 32. 12 
SD 49.41·113.7 39.9 28.5 44. I 46.05 48. 16 32.85 75.9 2 7. I I 37.5 25.3 42.72 14.54 38.5 106.0 31.02 37.3 liS. 78 22.4 
Table A37: Analysis of acquisition performance 
Source ss df MS F p 
Between groups 1522.818 19 80. 14 1.2199 NS 
Avoidances Within groups 9197.87 140 65.6991 
Total 10720.0 159 
Between groups 6901.275 19 363.225 0.9235 NS 
Trials Within groups 55066.5 140 393. 33 
Total 61967.0 159 
Between groups 976.875 19 51.4145 0.6601 NS 
Escapes Within groups 10904.5 140 77.8893 
Total 11881.375 159 
Between groups 2752.725 19 144.8803 I. 3319 NS 
Failures Within groups 15228.25 140 108.7732 
Total 17980.97 159 
Between groups 77146.7 19 4060.35 1.2527 NS 
Shocks Within groups 453767.25 140 3241.19 
Total 530913.9 159 
Table A38: Experiment Five. Extinction data: Number of responses per block of five trials 
Home cage saline Home cage LVP Response prevented saline Response prevented LVP 
I mm 30 60 6 24 I mm 30 60 6 24 I mm 30 60 6 24 I mm 30 60 6 24 
Total responses: Test I 
I 31 36 36 35 26 21 32 25 27 29 29 31 34 31 30 35 38 36 35 27 
2 32 40 37 36 34 22 28 27 31 28 25 29 32 32 33 32 35 35 29 24 
3 26 36 37 34 33 29 32 27 33 34 30 32 30 31 37 35 30 27 28 30 
4 31 37 32 34 28 28 33 24 28 31 33 31 34 31 35 34 28 27 34 28 
5 29 33 32 30 27 29 37 32 32 28 31 33 34 34 34 32 35 24 33 25 
6 23 34 35 37 29 28 30 34 34 33 29 28 33 33 24 31 30 27 41 32 
7 21 30 38 29 21 32 39 26 31 32 34 23 27 31 27 35 29 20 31 24 
8 23 30 33 28 21 29 32 23 33 28 33 24 27 29 27 32 24 19 35 22 
9 24 27. 31 23 12 25 31 26 28 25 25 19 21 31 24 28 24 16 36 19 
10 24 28 29 21 16 26 25 17 20 25 23 17 14 23 22 25 25 18 24 23 
Ex 264 331 340 307 247 269 319 261 297 293 292 267 286 306 293 319 298 249 326 254 
X 26.4 33. I 34.0 30.7 24.7 26.9 31.9 26. I 29.7 29.3 29.2 26.7 28.6 30.6 29.3 31.9 29.8 24.9 32.6 25.4 
SD 4.005 4.25 3.02 5.49 7. 12 3.41 4.01 4.67 4. 16 3. 13 3.79 5.64 6.63 2.98 5.25 3. 28 4.89 6.87 4.78 3.89 
SE 1.26 I. 34 0.95 I. 74 2.25 1.07 I. 27 1.48 I. 32 0.98 I • 198 I • 78 2. 09 0.94 1.66 1.04 1.55 I. 89 I. 51 1.23 
Total responses: Test 2 
1 34 36 38 37 34 26 36 32 33 35 33 32 33 31 37 40 33 33 38 31 
2 28 37 38 35 35 18 35 36 32 32 37 36 33 35 32 34 31 34 34 35 
3 28 34 32 34 31 25 36 39 33 36 36 29 31 33 30 32 28 35 34 28 
4 30 31 33 31 39 23 31 31 39 33 31 31 34 33 35 39 25 38 36 25 
5 30 33 38 30 37 20 32 32 34 36 33 29 33 34 34 33 35 32 36 27 
6 27 30 32 27 35 24 30 31 32 29 32 20 29 32 28 31 27 26 37 28 
7 29 24 28 22 24 18 29 31 33 30 23 16 20 34 26 31 23 17 29 29 
8 23 21 29 2 I 28 18 27 23 27 23 19 10 20 33 24 30 24 19 24 26 
9 21 17 28 24 28 14 17 27 23 30 33 13 I 7 26 22 20 27 20 23 19 
10 19 17 20 20 23 14 13 22 24 31 19 14 17 17 16 26 19 19 32 17 
Ex 269 280 316 281 314 200 286 304 310 315 296 230 267 308 284 316 272 273 323 265 
X 26.9 28.0 31.6 28. 1 31.4 20.0 28.6 30.4 31.0 31.5 29.6 23.0 26.7 30.8 28.4 31.6 27.2 27.3 32.3 26.5 
SD 4.58 7.65 5.69 6. 19 5.48 4. 35 7.82 5.25 4. 89 3.92 6. 72 9. 39 7.26 5.45 6.53 5. 79 4. 82 7.97 5.31 5.29 
SE 1.45 2.42 1. 80 1.96 I. 73 1.37 2.47 1.66 I. 55 1.24 2. 12 2.97 2.29 I. 72 2.06 I. 83 I. 53 2.52 1. 68 I. 67 
Table A38 (continued) 
Home cage saline Home cage LVP Response prevented saline Response prevented LVP 
llliill 30 60 6 24 llliill 30 60 6 24 llliill 30 60 6 24 llliill 30 60 6 24 
Short avoidances: Test 
I 28 35 33 31 25 20 29 25 24 24 27 24 28 29 26 29 31 25 31 25 
2 26 35 35 31 29 20 27 25 26 27 20 24 24 28 28 28 29 31 26 19 
3 24 30 33 29 25 24 31 26 31 25 25 24 20 25 31 27 26 20 25 20 
4 28 32 28 28 23 23 27 23 23 27 27 25 27 26 25 28 27 21 30 22 
5 25 27 26 25 21 27 33 26 26 19 26 24 28 29 26 28 28 18 26 18 
6 17 26 30 32 19 20 27 31 31 26 23 23 24 26 21 26 23 20 32 25 
7 IS 24 28 22 19 26 29 22 25 25 30 17 24 27 23 24 23 13 26 20 
8 17 21 25 22 15 24 24 16 27 19 23 18 21 26 19 27 17 15 29 18 
9 21 22 25 20 8 21 23 17 21 20 20 12 18 27 14 25 IS 14 30 15 
10 23 20 23 18 13 19 21 13 14 19 17 12 I I 20 15 20 20 16 23 14 
Ex 224 272 286 258 197 224 271 224 248 231 238 203 225 263 228 262 239 193 278 196 
X 22.4 27.2 28.6 25.8 19.7 22.4 27. I 22.4 24.8 23. I 23.8 20.3 22.5 26.3 22.8 26.2 23.9 19.3 27.8 19.6 
SD 4. 72 5.59 4.03 5.07 6. 32 2.79 3.66 5.5 4.94 3.45 3.96 5. 14 5.25 2.58 5.53 2.66 5.28 5.49 2. 97 3.68 
SE I. 49 I. 77 I. 27 I. 60 2.0 0.88 I. 16 I. 74 1.56 1.09 1.25 1.63 1.66 0.82 I. 75 o. 84 I ~67 I. 74 0.94 I. 16 
Short avoidances: Test 2 
I 28 31 34 31 29 21 31 28 30 29 28 28 29 31 28 34 30 31 32 28 
2 22 29 32 30 29 15 30 29 29 28 30 29 27 31 25 28 26 33 29 27 
3 24 29 26 31 29 22 26 31 30 29 31 19 27 27 27 26 23 29 29 23 
4 23 29 30 24 31 17 26 23 33 27 26 18 31 30 28 34 20 31 30 23 
5 23 25 33 25 32 16 26 26 31 29 26 16 31 32 28 28 25 25 31 22 
6 26 27 27 27 33 20 24 27 26 23 24 IS 24 23 23 25 22 18 29 26 
7 24 17 23 19 17 17 24 26 27 22 18 14 16 28 21 28 18 16 25 20 
8 19 18 24 20 26 16 22 20 21 19 13 7 14 28 19 26 18 10 23 20 
9 15 11 25 21 22 8 10 25 21 24 26 I I 15 19 15 18 18 13 21 15 
10 16 12 17 18 19 8 I I 21 18 26 16 I I 16 14 15 22 13 13 27 IS 
Ex 220 228 271 246 267 160 230 256 266 256 238 168 230 263 229 269 213 219 276 219 
-
X 22.0 22.8 2 7. I 24.6 26.7 16.0 23.0 25.6 26.6 25.6 23.8 16.8 23.0 26.3 22.9 26.9 21.3 21.9 27.6 21.9 
SD 4. 16 7.58 5.26 5.01 5.56 4.81 7. 12 3. 47 5.01 3.47 6.08 7. 11 6.99 5.88 5. 19 4. 86 4.92 8.81 3.56 4.53 
SE I. 32 2.39 1.66 1.59 I. 76 I. 52 2.25 1.09 I. 59 1.09 I. 92 2.25 2.21 1.86 1.64 I. 54 I. 56 2.78 I. 13 I. 43 
Table A38 (continued) 
Home cage saline Home cage LVP Response prevented saline Response prevented LVP 
I nun 30 60 6 24 I mm 30 60 6 24 Innn 30 60 6 24 I nun 30 60 6 24 
Long avoidances: Test 
I 3 I 3 4 I I 3 0 3 5 2 7 6 2 4 6 7 I I 4 2 
2 6 5 2 5 5 2 2 5 I 5 5 8 4 5 4 6 4 3 5 
3 2 6 4 5 8 5 I I 2 9 5 8 10 6 6 8 4 7 3 10 
4 3 5 4 6 5 5 6 I 5 4 6 6 7 5 10 6 I 6 4 6 
5 4 6 6 5 6 2 4 6 6 9 5 9 6 5 8 4 7 6 7 7 
6 6 8 5 5 10 8 3 3 3 7 6 5 9 7 3 5 7 7 9 7 
7 6 6 10 7 2 6 10 4 6 7 4 6 3 4 4 11 6 7 5 4 
8 6 9 8 6 6 5 8 7 6 9 10 6 6 3 8 5 7 4 6 4 
9 3 5 6 3 4 4 8 9 7 5 5 '7 3 4 10 3 9 2 6 4 
10 I 8 6 3 3 7 4 4 6 6 6 5 3 3 7 5 5 2 9 
Ex 40 59 54 49 50 45 48 37 49 62 54 64 61 43 65 57 59 56 48 58 
X 4.0 5.9 5.4 4.9 5.0 4.5 4.8 3.7 4.9 6.2 5.4 6.4 6.1 4.3 6.5 5.7 5.9 5.6 4.8 5.8 
SD I. 88 2.23 2.36 1.28 2.71 2.27 3.08 2.91 . I. 66 2.57 2.0 I, I. 35 2.51 1.49 2.5 2.31 2. 18 2. 72 2.29 2.48 
SE 0.59 0. 71 0. 75 0.41 0.86 0. 72 0.97 0.92 0.53 0.81 0.63 0.43 0.79 0.47 o. 79 0.731 0.69 0. 86 0.73 0. 78 
Long avoidances: Test 2 
I 6 5 4 6 5 5 5 4 3 6 5 4 4 0 9 6 3 2 6 3 
2 6 8 6 5 6 3 5 7 3 4 7 7 6 4 7 6 5 I 5 8 
3 4 5 6 3 2 3 10 8 3 7 5 10 4 6 3 6 5 6 5 5 
4 7 2 3 7 8 6 5 8 6 6 5 13 3 3 7 5 5 7 6 2 
5 7 8 5 5 5 4 6 6 3 7 7 13 2 2 6 5 10 7 5 5 
6 I 3 5 0 2 4 6 4 6 6 8 5 5 9 5 6 5 8 8 2 
7 5 7 5 3 7 I 5 5 6 8 5 2 4 6 5 3 5 I 4 9 
8 4 3 5 I 2 2 5 3 6 4 6 3 6 5 5 4 6 9 I 6 
9 6 6 3 3 6 6 7 2 2 6 7 2 2 7 7 2 9 7 2 4 
10 3 5 3 2 4 6 2 I 6 5 3 3 I 3 4 6 6 5 2 
Ex 49 52 45 35 47 40 56 48 44 59 58 62 37 45 55 47 59 54 47 46 
X 4.9 5.2 4.5 3.5 4.7 4.0 5.6 4.8 4.4 5.9 5.8 6.2 3.7 4.5 5.5 4.7 5.9 5.4 4.7 4.6 
SD I. 91 2.09 I. 18 2.22 2. 16 I. 76 2.01 2.44 I. 71 I. 28 1.47 4.34 1.7 2.63 2.27 I. 42 2.08 2.95 2.0 2.5 
SE 0.6 0.66 0.37 o. 70 0. 68 0.56 0.63 0.77 0.54 0.41 0.46 I. 373 0.54 0.83 0. 72 0.45 0.66 0.93 0.63 o. 79 
Table A39: Experiment Five. Outcomes of Freidman's Analysis of 
variance on extinction data (Siegel 1956) 
I:R~ 2 p 
J xr 
Test I 248094.5 78.83 0.001 
Total avoidances 
Test 2 252439.0 91.24 0.001 
Test 252199.5 90.559 0.001 
Short avoidances 
Test 2 251365.59 87.9 73 0.001 
Test 228965.5 24.177 NS 
Long avoidance& 
Test 2 227254.25 19.28 NS 
Table A40: E~eriment Five. Extinction Analysis: Sums of Freidman 
ranks per group 
I mm 30 60 6 24 
Test 
HC sal 135.0 41.0 39.5 74.0 156.0 
HC LVP 132.5 84.5 161 .0 95.5 107.5 
Total avoidances 
RP sal 118 .o 138.5 114.5 83.0 107.5 
RP LVP 66.5 89.0 139.5 56.0 161.0 
HC sal 87.0 153.5 171.0 130.5 51.5 
HC LVP 84.5 155.0 77.5 I I I • 0 93.5 
Short avoidances 
RP sal 109.0 45.5 86.5 143.0 90.5 
RP LVP 147.5 114.0 47.0 157.5 45.5 
Test 2 
HC sal 145.5 105.5 53.5 133.0 68.0 
HC LVP 194.0 94.0 78.0 80.5 65.0 
Total avoidances 
RP sal 95.0 169.5 141.5 65.5 121.0 
RP LVP 64.5 144.5 96.5 50.5 134.5 
HC sal 75.5 94.5 157.5 129.5 145.5 
HC LVP 21.5 99.5 131.0 148.5 117.5 
Short avoidances 
RP sal 108.5 29.5 91.5 140.0 83.0 
RP LVP 144.0 62.5 89.5 158.5 72.5 
Reject H0 (R = R ) if R - R 
~ ( k ~)[n(k).(k+l)]l/2 
U V u V q a, ' 12 
Ru(v) = E ranks for groups u/v 
Critical differences for rank sums 
a (experimentwise) d (critical difference) 
0. I 87.816 
0.05 93.76 
0.025 99. 134 
0.01 105.607 
Table A41: E~eriment Five. Selected comparisons between groups in 
extinction data 
Index Groups d p 
(I) Comparison between home cage saline groups 
Test Total avoidances HC sal 30 > HC sal 0 94.0 < 0.05 
HC sal 60 > HC sal 0 95.5 < 0.05 
HC sal 30 > HC sal 24 115.0 < 0.01 
HC sal 60 > HC sal 24 116.5 < 0.01 
Test I Short avoidances HC sal 30 > HC sal 24 102.0 < 0.025 
HC sal 60 > HC sal 24 119.5 < 0.01 
Test 2 Total avoidances HC sal 60 > HC sal 0 91.5 [ < 0. I] 
Test 2 Short avoidances NS 
(2) Comparison between response prevented saline groups 
Test Total avoidances NS 
Test Short avoidances RP sal 30 <RP sal 6 97.5 < 0.05• 
Test 2 Total avoidances RP sal 30 < RP sal 6 104.0 < 0.025 
Test 2 Short avoidances RP sal 30 <RP sal 6 110.5 < 0.01 
(3) Comparison between hoo:e cage LVP groups 
Test NS 
Test 2 Total avoidances HC LVP 0 < HC LVP 30 100.0 < 0.025 
HC LVP 0 < HC LVP 60 116.0 < 0.01 
HC LVP 0 < HC LVP 6 113.6 < 0.01 
HC LVP 0 < HC LVP 24 129.0 < 0.01 
Test 2 Short avoidances HC LVP 0 < HC LVP 60 109.5 < 0.01 
HC LVP 0 < HC LVP 6 127.0 < 0.01 
HC LVP 0 < HC LVP 24 96.0 < 0.05 
(4) Comparison between response prevented LVP groups 
Test Total avoidances RP LVP 0 > RP LVP 24 94.5 < 0.05 
RP LVP 6 > RP LVP 24 105.0 < 0.01 
Test I Short avoidances RP LVP 0 >RP LVP 60 100.5 < 0.025 
RP LVP 0 >RP LVP 24 102.0 < 0.025 
RP LVP 60 <RP LVP 6 110.5 < 0.01 
RP LVP 6 >RP LVP 24 112.0 < 0,01 
Table A41 (continued) 
Index Groups d p 
Test 2 Total avoidance a RP LVP 30 <RP LVP 6 94.0 < 0.05 
Test 2 Short avoidance a RP LVP 30 < RP LVP 6 96.0 < 0.05 
(5) Comparison between response prevented saline and home cage saline 
groups 
Test Total avoidance a HC sal 30 >RP sal 30 97.5 < 0.05 
HC sal 60 >RP sal 30 99.0 «0.05 
Test Short avoidances HC sal 30 > RP sal 30 108.0 < 0.01 
HC sal 60 > RP sal 30 125.5 < 0.01 
HC sal 60 > RP sal 60 84.0 [0. I] 
HC sal 24 < RP sal 6 91.5 0.06 
Test 2 Total avoidances NS 
Test 2 Short avoidances HC sal 60 > RP sal 30 127.5 < 0.01 
HC sal 6 > RP sal 30 100.0 < 0.025 
HC sal 24 > RP sal 30 116.0 < 0.01 
(6) Comparison between response prevented LVP and home cage LVP groups 
Test Total avoidances HC LVP 60 <RP LVP 6 105.0 < 0.025 
Test I. Short avoidances ~IC LVP 30 > RP LVP 60 108.0 < 0.01 
HC LVP 30 > RP LVP 24 109.5 < 0.01 
Test 2 Total avoidances HC LVP 0 < RP LVP 0 129.5 < 0.01 
HC LVP 0 < RP LVP 6 144.0 < 0.01 
Test 2 Short avoidances HC LVP 0 < RP LVP 0 122.5 < 0.01 
HC LVP 0 < RP LVP 6 137.0 < 0.01 
(7) Comparison between home cage saline and home cage LVP groups 
Test Total avoidances HC sal 30 > HC LVP 0 91.5 0.06 
HC sal 30 > HC LVP 60 120.0 < 0.01 
HC sal 60 > HC LVP 0 93.0 0.05 
HC sal 60 > HC LVP 60 121.5 < 0.01 
HC sal 6 > HC LVP 60 87.0 [ < 0. I] 
Test I Short avoidances HC sal .60 > HC LVP 60 93.5 0.05 
HC sal 24 < HC LVP 30 103.5 < 0.025 
Table A41 (continued) 
Index Groups d p 
Test 2 Total avoidances HC sal 30 > HC LVP 0 88.5 [< 0. I] 
HC sal 60 > HC LVP 0 141.0 < 0.01 
HC sal 24 > HC LVP 0 126.0 < 0.01 
Test 2 Short avoidances HC sal 60 > HC LVP 0 136.0 < 0.01 
HC sal 6 > HC LVP 0 108.0 < 0.01 
HC sal 24 > HC LVP 0 124.0 < 0.01 
(8) Comparison between response prevented saline and response prevented 
LVP groups 
Test Total avoidances NS 
Test Short avoidances RP sal 30 < RP LVP 0 102.0 < 0.025 
RP sal 30 < RP LVP 6 112.0 < 0.01 
RP sal 6 > RP LVP 60 96.0 < 0.05 
RP sal 6 > RP LVP 24 97.5 < 0.05 
Test 2 Total avoidances RP sal 30 < RP LVP 0 105.0 0.01 
RP sal 30 <RP LVP 6 109.0 < 0.01 
RP sal 60 < RP LVP 6 91.0 0.06 
Test 2 Short avoidances RP sal 30 <RP LVP 0 114.5 < 0.01 
RP sal 30 < RP LVP 6 129.0 < 0.01 
(9) Comparison between home cage saline and response prevented LVP 
groups 
Test I. Total avoidances HC sal 30 > RP LVP 60 98.5 < 0.05 
HC sal 30 > RP LVP 24 120.0 < 0.01 
HC sal 60 > RP LVP 60 100.0 < 0.025 
HC sal 60 > RP LVP 24 121.5 < 0.01 
HC sal 24 <RP LVP 0 89.5 [<0.1] 
HC sal 24 < RP LVP 6 100.0 < 0.025 
Test I Short avoidances HC sal 30 > RP LVP 6 106.5 < 0.01 
HC sal 30 > RP LVP 24 108.0 < 0.01 
HC sal 60 > RP LVP 60 124.0 < 0.01 
HC sal 60 > RP LVP 24 125.5 < 0.01 
HC sal 24 < RP LVP 0 96.0 < 0.05 
HC sal 24 < RP LVP 6 106.0 < 0.01 
Table A41 (continued) 
Index Groups d p 
Test 2 Total avoidances HC sal 0 RP LVP 6 95.0 < 0.05 
HC sal 60 RP LVP 60 91.0 0.05 
Test 2 Short avoidances HC sal 60 RP LVP 30 95.0 < 0.05 
( 10) Comparison between response _prevented saline and home cage LVP 
groups 
Test Total avoidances NS 
Test Short avoidances HC LVP 30 >RP sal 30 109.5 < 0.01 
Test 2 Total avoidance a HC LVP 0 <RP sal 0 99.0 0.025 
HC LVP 0 <RP sal 6 128.5 < 0.01 
HC LVP 60 > RP sal 30 91.5 0.05 
RC LVP 6 > RP sal 30 89.0 0.06 
Test 2 Short avoidances HC LVP 0 <RP sal 0 87.0 [0. I] 
RC LVP 0 <RP sal 6 118.5 < 0.01 
HC LVP 60 > RP sal 30 10 I. 5 < 0.025 
RC LVP 6 >RP sal 30 119.0 < 0.01 
RC LVP 24 > RP sal 30 88.0 [< 0.1] 
Table A42: E~eriment Six. Number of avoidances, esca2es, trials 1 
failures to res2ond and shocks received during 
acquisition training 
Home cage Response prevented 
Saline 2 \lg 3 llg 4 llg Saline 2 llg 3 llg 4 llg 
Avoidances 
Ex 87 143 128 148 103 144 129 159 
-
X 14.5 23.83 21.33 24.66 17. 16 24.0 21.5 26.5 
SD 3.88 8.06 8.66 10.63 5.23 7.79 7.96 9.64 
SE I. 58 3.29 3.53 4.34 2. 136 3. 18 3.25 3.94 
Trials 
Ex 211 286 311 245 184 320 278 250 
-X 35. 16 47.66 51.83 40.83 30.66 53.33 46.33 41.66 
SD 22.81 15.32 18.01 25.4 10.46 22.6 17.95 16.74 
SE 9.316 6.25 7.35 10.37 4.27 9.23 7.33 6.84 
Escapes 
Ex 30 88 58 41 27 60 87 33 
X 5.0 14.66 9.66 6.83 4.5 10.0 14.5 5.5 
SD 2.75 12. 13 9. I I 8.08 3.98 7. 13 8.43 4. 97 
SE I • 12 4.95 3. 72 3.3 I. 63 2.91 3.44 2.03 
Failures 
Ex 80 47 98 48 40 116 45 47 
-X 13.33 7.83 16.33 8.0 6.66 19.33 7.5 7.83 
SD 18.47 8.25 16.22 5.47 7.36 24.45 7.96 6.25 
SE 7.54 3.37 6.62 2.23 3.0 9.98 3.25 2.55 
Shocks 
Ex 465 345 596 304 244 689 343 290 
-X 77.5 57.5 99.33 50.66 40.66 114.83 57. 16 48.33 
SD 98.93 37.55 82.21 34.43 30.45 117. I 36.87 34.59 
SE 40.39 15.33 33.57 14.06 12.43 47.82 15.06 14. 125 
Table A43: Experiment Six. Analysis of variance on 
acquisition data 
Source ss df MS F p 
Between groups 685.479 7 97.92 I. 527 NS 
Avoidances Within groups 2564.83 40 64. 12 
Total 3250.3125 47 
Between groups 2616.64 7 373.8 1.0143 NS 
Trials Within groups 14741. 16 40 368.52 
Total 17357.81 47 
Between groups 700.66 7 100.09 I. 7198 NS 
Escapes Within groups 2328.0 40 58.2 
Total 3028.66 47 
Between groups 979.48 7 139.9 o. 7681 NS 
Failures Within groups 7826.5 40 182. 16 
Total 8265.97 47 
Between groups 29561.0 7 4223.0 0.9297 NS 
Shocks Within groups 181694.0 40 4542.35 
Total 211255.0 47 
Table A44: Experiment Six. Extinction data 
Home cage Response prevented 
Saline 2 lJ& 3 lJ& 4 jJg Saline 2 JJg 3 JJg 4 lJ& 
Total avoidances: Test I 
l:x 232 235 221 206 241 247 210 188 
X 38.66 39. 16 36.83 34.33 40. 16 41. 16 35.0 31.33 
SD 11.893 5.56 15.75 12. 71 11.78 10.72 8.34 7.5 
SE 4.856 2.27 6.43 5. 18 4.81 4.38 3.4 3.062 
Total avoidances: Test 2 
l:x 224 223 186 189 221 244 190 187 
-X 37.33 37. 16 31.0 31.5 36.83 40.66 31.66 31. 16 
SD 7.58 4.62 15.96 12. 11 10.51 9.58 6. 71 13.54 
SE 3.09 I. 88 6.52 4.94 4.29 3. 91 2.74 5.53 
Short avoidances: Test 
l:x 185 189 188 163 190 204 145 146 
X 30.83 31.5 31.33 27. 16 31.66 34.0 24. 16 24.33 
SD 12.86 8.96 15.48 9. 174 11.91 11 .ss 11.48 7.53 
SE 5.25 3.66 6.32 3.746 4.86 4. 72 4.68 3.07 
Short avoidances: Test 2 
l:x 168 176 137 151 170 200 137 130 
X 28.0 29.33 22.83 25. 16 28.33 33.33 22.83 21.66 
SD 9.96 5.95 12.7 13.79 8.24 10.76 8.7 I 0. 91 
SE 4.06 2.43 s. 18 5.63 3.36 4.39 3.55 4.45 
Long avoidances: Test 
l:x 47 46 33 43 SI 43 67 42 
X 7.83 7.66 5.5 7. 16 8.5 7. 16 11 . 16 7.0 
SD 4. 12 4.46 3.51 6.55 2.58 3.06 4.07 3.28 
SE 1.68 1.82 I. 43 2.67 1.056 I. 25 I. 66 I. 34 
Long avoidances: Test 2 
l:x 56 47 49 38 SI 44 53 57 
X 9.33 7.83 8. 16 6.33 8.5 7.33 8.83 9.5 
SD 2.65 2. 86 5.03 4.32 3.78 4.32 3.92 4. 72 
SE 1.08 I. 16 2.05 I. 764 I. 54 I. 76 1.6 1.928 
Table A4S: Experiment Six. Extinction responding as a function of the trial block 
Test I Test 2 
Home cage Response prevented Home cage Response prevented 
Sal 2 llg 3 llg 4 llg Sal 2 llg 3 llg 4 llg Sal 2 llg 3 llg 4 llg Sal 2 llg 3 llg 4 ll& Total avoidances 
I 21 17 20 21 22 23 IS 20 21 30 22 26 22 28 22 21 2 22 24 22 22 23 28 17 21 25 2S 17 23 20 2S 19 2S 3 22 26 21 2S 23 28 20 23 22 23 IS 2S 26 23 24 22 4 23 26 21 19 22 28 23 20 23 26 17 23 23 24 22 21 5 22 28 22 20 26 28 23 21 26 28 18 2S 20 24 22 21 6 26 26 24 2S 26 25 23 20 20 27 23 19 27 2S 23 20 7 28 2S 24 26 27 23 26 19 26 22 21 14 22 2S 21 13 8 2S 24 22 20 2S 22 23 17 23 21 22 12 22 26 14 16 9 23 20 26 16 29 23 22 16 21 10 20 13 20 23 13 12 10 20 19 19 12 18 19 18 11 17 9 IS 9 19 21 10 16 
I:x 232 23S 221 206 241 247 210 188 224 221 190 189 221 244 190 187 
X 23.2 23.S 22. I 20.6 24. I 24.7 21.0 18.8 22.4 22. I 19.0 18.9 22. I 24.4 19.0 18.7 SD 2.44 3.S9 2.08 4.32 3. 14 3. 19 3.39 3.39 2.84 7.18 2.98 6.3S 2.64 1.89 4.87 4.22 SE 0. 77 I. 14 0.6S7 I. 36 0.99 1.01 1.07 I .073 0.89 2.27 0.94 2.0 0.84 0.6 I.S4 I. 33 
Table A45 (continued) 
Test I Test 2 
Ho ~re cage Response prevented Home cage Response prevented 
Sal 2 ]Jg 3 ]Jg 4 ]Jg Sal 2 ]Jg 3 ]Jg 4 ]Jg Sal 2 ]Jg 3 ]Jg 4 ]Jg Sal 2 ]Jg 3 ]Jg 4 ]Jg 
Short avoidances 
I 16 15 16 20 18 19 11 17 18 26 18 23 19 21 15 19 
2 12 21 19 15 22 22 10 13 I 7 21 12 21 14 21 12 19 
3 18 25 19 21 20 24 17 18 11 19 8 19 23 20 17 12 
4 21 20 20 16 12 20 15 16 16 19 14 22 15 17 19 15 
5 17 23 15 14 21 22 18 17 16 22 13 15 16 20 18 13 
6 23 24 19 21 19 22 14 17 15 21 13 14 24 21 18 15 
7 . 23 16 19 19 23 20 18 18 20 16 17 10 15 23 12 9 
8 21 18 19 I 7 23 19 17 13 23 16 19 9 16 20 9 8 
9 19 12 24 11 20 21 I I 10 18 8 14 9 16 20 9 7 
10 15 15 18 9 12 15 14 7 14 8 9 9 12 17 8 13 
Ex 185 189 188 163 190 204 145 146 168 176 137 151 170 200 137 130 
X 18.5 18.9 18.8 16.3 19.0 20.4 14.5 14.6 16.8 17.6 13.7 I 5. I 17.0 20.0 13.7 13.0 
SD 3.59 4.38 2.39 4. 137 4.03 2.45 3.03 3.74 3.29 5.83 3.59 5.76 3.86 1.82 4.22 4. 18 
SE I. 14 I. 38 0.76 I • 31 I. 27 o. 77 0.96 I. 18 1.04 I. 84 I. 13 1.82 I. 22 o. 57 I. 33 I. 32 
Long avoidances 
I 5 2 4 I 4 4 4 3 3 4 4 3 3 7 7 2 
2 10 3 3 7 I 6 7 8 8 4 5 2 6 4 7 6 
3 4 I 2 4 3 4 3 5 11 4 7 6 3 3 7 10 
4 2 6 I 3 10 8 8 4 7 7 3 I 8 7 3 6 
5 5 5 7 6 5 6 5 4 10 6 5 10 4 4 4 8 
6 3 2 5 4 7 3 9 3 5 6 6 5 3 4 5 5 
7 5 9 5 7 4 3 8 I 6 6 4 4 7 2 9 4 
8 4 6 3 3 2 3 6 4 0 5 3 3 6 6 5 8 
9 4 8 2 5 9 2 I I 6 3 2 6 4 4 3 4 5 
10 5 4 3 6 4 4 4 3 I 6 0 7 4 2 3 
Ex 47 46 33 43 51 43 65 42 56 45 49 38 SI 44 53 57 
X 4.7 4.6 3.3 4.3 5. I 4.3 6.5 4.2 5.6 4.5 4.9 3.8 5. I 4.4 5.3 5.7 
SD 2. I I 2.67 1.94 1.94 2.92 1.83 2.55 I. 87 3.47 1.9 I. 37 2.82 1.91 I • 71 2. 16 2.45 
SE 0.66 0.84 0.61 0.61 0.92 0.57 0.81 0.59 1.09 0.6 0.43 0.89 0.6 0.54 0.68 0. 77 
Table A46: Ex12eriment Six. Analysis of extinction data using Freidman's 
analysis of variance (Seigel 1956) 
l:R~ 2 P* 
J xr 
Test 18064.5 31. 135 < 0.001 
Total avoidances 
Test 2 17757.75 26.021 < 0,001 
Test Short avoidances 
17752.5 25.93 < 0,001 
Test 2 17559.0 22. 708 < 0.01 
Test 16586.75 6. so 112 NS 
Long avoidances 
Test 2 16509.5 5.21337 NS 
Multiple comparisons (Hollander and Wolfe 1973) 
Groups d p+ 
HC LVP 2 > HC LVP 4 32.0 [ < 0. I] 
RP LVP 2 > RP LVP 4 47.0 < 0.01 
Test I : Total avoidances 
HC Sal > RP LVP 4 37.0 < 0.031 
HC LVP 2 > RP LVP 4 49.0 < 0.01 
RP Sal > RP LVP 3 31.0 [ 0. I] 
RP LVP 2 > RP LVP 3 42.5 < 0.01 
Test I: Short avoidances 
RP LVP 2 > RP LVP 4 40.0 < 0.01 
HC LVP 2 >RP LVP 3 30.5 [ 0. I] 
RP Sal > RP LVP 4 32.5 [ 0.06] 
RP LVP 2 >RP LVP 4 42.5 < 0.01 
'J;est 2: Total avoidances 
HC LVP 3 < RP LVP 2 38.5 < 0.01 
HC LVP 4 <RP LVP 2 35.0 0.031 
RP LVP 2 > RP LVP 3 35.0 0.031 
Test 2: Short avoidances RP LVP 2 > RP LVP 4 40.5 < 0.01 
HC LVP 3 < RP LVP 2 40.5 < 0.01 
* Reject H0 when 
2 ;;:: 2 for df k - I (k 8) d p xr X a· = r ' 
34 0.04 
+ Critical differences in sums of ranks (for 
N = I 0; k = 8) 35 0.031 
38 0.01 
Table A47: Experiment Six. Extinction data 
Test I : Total avoidances 
Home cage Response prevented 
Sal 2 11& 3 11& 4 11& Sal 2 11g 3 11& 4 ]Jg 
Correlation coefficient (r) +0. 341 -0.456 +0.4138 -0.581 -0.1 -0.507 +0.236 -0.636 
Slope +0.406 -0.66 +0.327 -0. 794 -0. 13 -0.412 +0.236 -0.787 
Y' intercept 12.2 22.5 17 .o 20.66 19.73 22.66 13.2 18.93 
y = 10 predicted 16.26 15.92 20.27 12.72 18.4 18.54 15.56 11.05 
Table A48: Experiment Eleven. Acquisition data 
Home cage Response prevented 
Sal LVP Sal LVP Sal LVP Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy Sal Sal Scop Scop Phy Phy 
Trials 
Ex 211 290 276 388 289 372 210 21 I 226 280 345 270 
-X 35.16 48.33 46.0 64.66 48.16662.0 35.0 35. 16 37.66 46.66 57.5 45.0 
SD 15.66 23.38 28.29 28.91 34.22 31.85 32.57 8. 84 15.0 28.02 27.46 30.29 
SE 6. 39 9.54 11.54 11.80313.97 13.0 13.29 3.61 6.12 11.44 11,21 12.36 
Avoidances 
Ex 108 132 173 214 165 166 144 126 127 128 181 151 
-X 18.0 22.0 28.83 35.66 27.5 27.66 24.0 21.0 2 I. 16 21.33 30, 16 25. 16 
SD 8.44 9.05 18.77 14.36 17.7 12.59 23.29 5.83 7.27 8,21412.44 IS, 727 
SE 3.44 3.69 7.66 5.86 7.22 5. 14 9.51 2.38 2.97 3.35 5.08 6.42 
Es:capes 
Ex SI 32 75 92 49 130 31 52 66 109 103 46 
-X 13.5 5.33 12.5 15.33 8. 16 21.66 s. 16 8.66 11.0 18. 16 17. 16 7.66 
SD 12.09 4.41 9.42 18.99 8.61212.22 6.88 4.88 5.14 2C.4 17,05 5.5 
SE 4.93 1.8 3.84 7.75 3.516 4.99 2.81 1.99 2. 09 8.32 6.96 2.24 
Failures 
Ex 13 117 32 66 60 82 22 14 27 23 63 74 
X 2. 16 19.5 5.33 11.0 10.0 13.66 3.66 2.33 4.5 3,83 10,5 12.33 
SD 3.92 17.23 6.05 9.51 22.05 16.657 4.96 4.08 7.064 3.81616.07 23.51 
SE 1.6 7.03 2.47 3.88 9.0 6.8 2.03 I. 66 2.88 1.56 6.56 9.59 
Shocks 
Ex 180 650 275 449 378 607 151 153 250 295 452 445 
X 30.0 108.33 45.83 74.83 63.0 I 01. 16 25.16 25.5 41.66 49.16 75,33 74. 16 
SD 17.37 85.02 33.03 53.39 Ill. 31 88.35 34.67 18.66 38.85 35.66 82.26 114. 15 
SE 7.09 34.71 13.48 21.79 45.44 36.06 14. IS 7. 619 15.86 14.55 33.58 46.61 
Table A49: Experiment Eleven. Analysis of acquisition data 
Source ss df MS F p 
Between groups 6997. 11 11 636.101 0.9040 NS 
Avoidances \-li thin groups 42175.3 60 702.92 
Total 49172.44 71 
Between groups 1627.0417 11 147.9129 0. 7772 NS 
Trials Within groups 11418.8333 60 190.3139 
Total 13045.875 71 
Between groups .1850. 9444 I I 168.2677 1.2064 NS 
Escapes Within groups 8369.0 60 139.4833 
Total 10219.9444 71 
Between groups 1940. 1528 I I 176.3775 0.9983 NS 
Failures Within groups 10600.8333 QO 176.6806 
Total 12540.9861 71 
Between groups 51903.4861 11 4718.4987 1.0147 NS 
Shocks Within groups 279006.5 60 4650. 1083 
Total 330909.9861 71 
Ex 
X 
SD 
SE 
Table ASO: Experiment Eleven. Extinction data 
Home cage 
Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy 
Response prevented 
Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy 
Test 1: Short avoidances 
183 181 230 170 160 172 
30.5 30.16 38.33 28.33 26.66 18.66 
12.91 15.38 8.64 10.96 12.72 14.66 
5.27 6.28 3.53 4.47 5. 19 5.98 
179 154 165 
19.83 25.66 27.5 
12. 49 15. 08 I I. 39 
5.1 6.16 4.65 
Test 2: Short avoidances 
181 
30. 16 
9.02 
3.68 
189 134 
31.5 22.33 
7. 5 I 3. 03 
3.06 5.22 
Ex 177 180 182 166 160 164 151 145 181 152 169 168 
-X 29.5 30.0 30.33 27.66 26.66 27.33 25.16 24.16 30.16 25.33 28.16 28.0 
SD 
SE 
Ex 
X 
SD 
9.89 10.54 9.54 9.31 
4.04 4.3 3.89 3.8 
9.81 
4.0 
9.91 
4.05 
I 7 .209 12. 76 13. 2 I 7. 08 9. 78 11 • 24 
7. 02 5. 2 I 5. 39 2 . 89 3. 9 9 4. 56 
Test 1: Long avoidances 
58 32 42 
9.66 5.33 7.0 
5.92 3.2 4.81 
41 35 50 
6.83 5.83 8.33 
5.07 3.06 4.8 
53 26 51 
8.83 4.33 8.5 
3.18 2.5 4.41 
58 60 
9.66 10.0 
3.72 3.4 
49 
8. 16 
3.76 
SE 2.42 1.31 1.96 2.07 1.25 1.96 I . 3 I . 02 I . 8 I . 52 I . 39 I . 54 
Test 2: Long avoidances 
Ex 32 40 51 68 54 53 38 40 37 61 41 29 
X 5.33 6.66 8.5 11.33 9.0 8.83 6.33 6.66 6.16 10.16 6.83 4.83 
SD 4.13 3.72 3.14 4.54 4.86 2.93 3.33 2.34 1.94 3.37 4.99 2.86 
SE 1.68 1.52 1.28 1.85 1.98 1.19 I. 36 0. 9 5 0. 79 I. 3 7 2. 04 I. 16 
Test 1: Total avoidances 
X 40.16 35.5 45.33 35.16 34.16 37.0 38.66 30.0 36.0 39.83 41.5 30.5 
so 8.82 17.78 4.76 10.03 15.26 16.07 10.87 16.97 10.12 7.41 5.17 14.85 
SE 3.6 7.26 1.94 4.09 6.23 6.56 4.44 6.93 4.13 3.03 2.11 6.06 
Test 2: Total avoidances 
X 34.83 36.66 38.83 39.0 35.66 36.16 33.16 30.83 36.0 35.5 35.0 32.83 
so 9.66 10.31 8.11 7.59 5.64 9.74 13.26 13.66 11.78 10.07 12.89 12.64 
SE 3.94 4.21 3.31 3.09 2.30 3.97 5.41 5.57 4.81 4. I I 5.26 5.16 
Table ASI: Experiment Eleven. Extinction aata: Sum of responses per 
block of five trials 
Home cage 
Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy 
Response prevented 
Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy 
Test 1: Total avoidances 
2 
3 
4 
5 
6 
7 
8 
9 
10 
23 
26 
24 
24 
28 
27 
21 
25 
22 
21 
25 . 24 
25 28 
25 30 
22 30 
24 29 
22 28 
24 28 
19 27 
18 27 
9 21 
20 
20 
26 
27 
28 
24 
19 
18 
16 
13 
21 
25 
24 
24 
25 
20 
16 
18 
9 
13 
21 
24 
24 
23 
26 
23 
23 
23 
19 
16 
X 24. I 2 I • 3 2 7. 2 2 I. I 19.5 22. 2 
SD 2.42 4.99 2.78 4.98 5.48 2.86 
SE 0. 77 I. 58 0. 88 I • 57 I. 7 3 0. 9 
28 
27 
26 
26 
25 
21 
20 
21 
19 
19 
20 
24 
22 
20 
19 
20 
19 
IS 
10 
11 
24 
28 
25 
30 
27 
22 
19 
14 
IS 
12 
23 
25 
23 
22 
27 
28 
25 
27 
23 
18 
25 
28 
24 
26 
24 
25 
29 
2·3 
26 
19 
22 
23 
17 
20 
23 
22 
23 
13 
8 
12 
23.2 18.0 21.6 24.1 24.9 18.3 
3.52 4.57 6.31 2.96 2.77 5.5 
1.1 I 1.45 2.0 0.94 0.87 I. 74 
Test 2: Total avoidances 
2 
3 
4 
5 
6 
7 
8 
9 
10 
25 
24 
29 
25 
21 
19 
22 
IS 
17 
12 
30 
26 
22 
24 
28 
23 
16 
16 
17 
18 
28 
26 
29 
27 
27 
28 
27 
22 
11 
8 
26 
28 
26 
25 
24 
28 
25 
22 
18 
12 
24 
26 
27 
23 
24 
27 
20 
17 
13 
13 
24 
22 
27 
27 
24 
17 
23 
18 
17 
18 
23 
24 
19 
21 
20 
23 
20 
IS 
14 
10 
25 
27 
26 
25 
19 
21 
16 
9 
8 
6 
33 
25 
25 
25 
29 
21 
16 
17 
IS 
12 
27 
27 
23 
26 
22 
20 
24 
16 
IS 
13 
27 
24 
24 
25 
26 
25 
IS 
IS 
13 
16 
28 
25 
25 
24 
25 
20 
19 
9 
11 
11 
X 20.9 22.0 23.3 23.4 21.4 21.7 18.9 18.2 21.8 21.3 21.0 19.7 
SD 5.2 5. I 7.54 4.97 5.4 3.95 4.53 8.04 6.73 5.12 5.5 6.98 
SE 1.64 1.61 2.39 1.57 1.71 1.25 1.43 2.54 2.13 1.62 1.74 2.21 
2 
3 
4 
5 
6 
7 
8 
9 
10 
-X 
SD 
Table A51 (continued) 
Home cage 
Sal LVP Sal LVP Sal LVP 
Sal Sal Seep Seep Phy Phy 
Response prevented 
Sal LVP Sal LVP Sal LVP 
Sal Sal Seep Seep Phy Phy 
Test 1: Short avoidances 
19 
23 
20 
19 
23 
22 
11 
18 
17 
11 
22 
25 
23 
19 
21 
20 
18 
16 
9 
8 
20 
25 
28 
25 
26 
23 
23 
23 
20 
17 
20 
17 
19 
21 
23 
19 
14 
15 
12 
10 
16 
23 
17 
24 
20 
15 
13 
12 
9 
11 
19 
19 
22 
18 
19 
19 
20 
14 
11 
11 
18.3 18.1 23.0 17.0 16.0 17.2 
4.35 5.67 3.27 4.16 5.06 3.82 
21 
21 
24 
20 
19 
17 
14 
16 
13 
14 
I 7 
19 
22 
17 
16 
18 
15 
12 
10 
8 
21 
18 
18 
26 
21 
20 
11 
10 
11 
9 
21 
21 
17 
13 
20 
24 
19 
19 
17 
10 
17.9 15.4 16.5 18. I 
3.67 4.27 5.84 4.09 
19 
24 
17 
21 
21 
13 
18 
17 
22 
17 
18 
16 
15 
13 
16 
14 
17 
9 
6 
10 
18.9 13.4 
3. 18 3. 89 
SE 1.37 I. 79 1.03 1.32 1.6 I . 21 I. 16 1.35 1.85 1.29 1.0 1.23 
2 
3 
4 
5 
6 
7 
8 
9 
10 
X 
SD 
Test 2: Short avoidances 
19 
22 
24 
22 
17 
18 
19 
11 
14 
11 
20 
21 
17 
20 
22 
23 
14 
13 
13 
17 
23 
19 
17 
24 
23 
23 
25 
15 
8 
5 
20 
23 
21 
19 
18 
17 
16 
9 
13 
10 
21 
17 
21 
19 
20 
19 
11 
I I 
9 
12 
17.7 18.0 18.2 16.6 16.0 
4.52 3.74 6.99 4.65 4.71 
19 
17 
22 
21 
22 
11 
13 
12 
12 
15 
16.4 
4.38 
17 
16 
15 
17 
16 
18 
15 
14 
13 
10 
21 
21 
15 
23 
16 
17 
9 
9 
6 
5 
24 
23 
20 
21 
25 
17 
16 
14 
12 
9 
25 
18 
18 
20 
17 
12 
17 
9 
7 
9 
18 
21 
16 
23 
22 
21 
10 
13 
12 
13 
28 
23 
24 
19 
17 
17 
17 
6 
8 
9 
15.1 14.2 18.1 15.2 16.9 16.8 
2.33 6.56 5.38 5. 73 4.72 7.27 
SE I • 43 I. 18 2. 2 I I. 4 7 I • 49 I. 38 0. 7 4 2. 08 I. 7 I. 8 I I. 49 2 • 3 
Table A51 (continued) 
Home cage 
Sal LVP Sal LVF Sal LVP 
Sal Sal Scop Scop Phy Phy 
Response prevented 
Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy 
Test 1: Long avoidances 
4 3 4 0 5 2 7 3 3 2 6 4 
2 3 0 3 3 2 5 6 5 10 4 4 7 
3 4 2 2 7 7 2 2 0 7 4 7 2 
4 5 3 5 6 0 5 6 3 4 9 5 7 
5 5 3 3 5 5 7 6 3 6 7 3 7 
6 5 2 5 5 5 4 4 2 2 4 12 8 
7 10 6 5 5 3 3 6 4 8 6 I I 6 
8 7 3 4 3 6 9 5 3 4 8 6 4 
9 5 9 7 4 0 8 6 0 4 6 4 2 
10 10 4 3 2 5 5 3 3 8 2 2 
X 5.8 3.2 4.2 4.1 3.5 5.0 5.3 2.6 5.1 5.8 6.0 4.9 
SD 2.44 2.57 1.4 1.97 2.46 2.4 1.42 1.58 2.56 2.25 3.27 2.38 
SE 0.77 0.81 0.44 0.62 0.78 0.76 0.45 0.5 0.81 0.71 1.03 0.75 
Test 2: Long avoidances 
2 
3 
4 
5 
6 
7 
8 
9 
10 
6 
2 
5 
3 
4 
3 
4 
3 
10 
5 
5 
4 
6 
0 
2 
3 
4 
5 
7 
12 
3 
4 
5 
2 
7 
3 
3 
6 
5 
5 
6 
6 
11 
9 
13 
5 
2 
3 
9 
6 
4 
4 
8 
9 
6 
4 
5 
5 
5 
6 
2 
6 
10 
6 
5 
3 
X 3.2 4.0 5.1 6.8 5.4 5.3 
SD 1.62 2.83 2.96 3.26 2.67 2.11 
SE 0.51 0.89 0.94 1.03 0.85 0.67 
6 
8 
4 
4 
4 
5 
5 
0 
4 
6 
11 
2 
3 
4 
7 
0 
2 
9 
2 
5 
4 
4 
4 
0 
3 
3 
3 
2 
9 
5 
6 
5 
8 
7 
7 
8 
4 
9 ' 
3 
8 
2 
·4 
4 
5 
2 
3 
0 
2 
5 
8 
3 
2 
3 
3 
2 
3.8 4.0 3.7 6.1 4.1 2.9 
2.49 3.27 2.31 2.13 2.6 2.23 
0.79 1.03 0.73 0.67 0.82 0. 71 
Table A52: Experiment Eleven. Analysis of extinction data 
ER~ 2 P* 
J xr 
Test 58020.5 56.3111 < 0.001 
Total avoidances 
Test 2 53645.5 22.6572 < 0.02 
Test 56022.0 40.938 < 0.001 
Short avoidances 
Test 2 52847.5 16.518 NS 
Long avoidances Test 53666.5 22.818 < 0.02 
Test 2 53841.0 24.16112 < 0.02 
Multiple comparisons (Hollander and Wolfe 1973) 
Groups d p 
Test I : Total avoidances 
HC Sal Scop > HC LVP Sal 52.0 0.06 
HC Sal Scop > HC LVP Scop 56.5 < 0.03 
HC Sal Scop > HC Sal Phy 73.0 < 0.01 
HC Sal Scop > HC LVP Phy 54.0 < 0.047 
RP Sal Sal > RP LVP Sal 56.5 < 0.03 
RP Sal Scop > RP LVP Sal 52.0 0.06 
RP LVP Scop > RP LVP Sal 50.5 0.085 
RP Sal Phy > RP LVP Sal 68.0 < 0.01 
RP Sal Phy >RP LVP Phy 61.0 < 0.01 
HC Sal Sal > RP LVP Sal 57.0 < 0.03 
HC Sal Sal > RP LVP Phy 50.0 [0. I] 
HC Sal. Scop > RP LVP Sal 88.5 < 0.01 
HC Sal Scop > RP LVP Phy 81.5 < 0.01 
HC Sal Phy <RP Sal Phy 52.5 0.05 
Test I: Short avoidance a 
HC Sal Scop > HC Sal Phy 64.0 < 0.01 
HC Sal Scop > HC LVP Phy 50.0 [0. I] 
RP LVP Scop > RP LVP Phy · 50.0 [0. I] 
RP Sal Phy >RP LVP Phy 52.5 0.05 
HC Sal Sal > RP LVP Phy 51.5 0.07 
HC LVP Sal > RP LVP Phy 51.5 0.07 
HC Sal Scop > RP LVP Sal 72.0 < 0.01 
HC Sal Scop > RP Sal Scop 53.0 < 0.047 
HC Sal Scop > RP LVP Phy 87.5 < 0.01 
Table A52 (continued) 
Groups d p 
Teat I : Long avoidances 
RP LVP Sal < RP LVP Scop 49 .o 0. I 
Teat 2: Total avoidances 
RC Sal Scop >RP Sal Sal 53.0 0.047 
RC Sal Scop > RP LVP Sal 49.0 0. I 
RC LVP Scop > RP Sal Sal 49.0 0.1 
Test 2: Long avoidances 
HC LVP Scop > RC Sal Sal 45.0 0. I 
RP LVP Scop > HC Sal Sal 45.0 0. I 
* df "' 11 
Table A53: Experiment Eleven. Extinction data: Trend lines for total avoidances in Test I 
Home cage Response prevented Sal Sal Sal LVP Sal LVP Sal Sal Sal LVP Sal LVP Sal LVP Scop Scop Phy Phy Sal LVP Scop Scop Phy Phy 
Correlation coefficient (r) 
-0.39 
-0.8 
-0.37 
-0.58 
-0.81 
-0.56 
-0.96 
-0.87 
-0.85 
-0. 17 
-0.42 
-0.69 Slope (s) 
-0.31 
-I. 32 
-0.34 
-0.96 
-I. 47 
-0.53 -I. 11 
-I. 31 
-I. 77 
-0. 17 
-0.38 
-I. 25 Y' (x = I) 25.8 28.6 29.0 26.4 27.6 25. 13 29.33 25.2 31.33 25.06 27.0 25.2 Y' (x 10) 22.71 15.33 25.6 16.76 12.87 19.8 18. 18 12. 12 13.63 23.3 23.18 12.65 
Y' c predicted number of responses on trial blocks (x) I and 10 
Table A54: E~eriment TWelve. Analysis of acquisition data 
Avoidances Escapes Failures Shocks 
Ex 16 44 318 1661 
- 4.0 11.0 79.5 415.25 
X Saline 
SD 2.449 16. 186 28.5 118. 7 SE I. 224 8.093 14.25 59. 35 
Ex 37 90 258 1745 
X 9.25 22.5 64.5 436.25 LVP SD 7. 088 35. 123 36.05 59.264 SE 3.54 17.56 18.02 29.63 
df 6 6 6 6 
t* 1.4 0.595 0.653 0.316 p NS NS NS NS 
* t test for independent samples (lviner 1962) 
Table ASS: Experiment Twelve. Lever press responses made by subjects during Periods A and B of Suppression Tests I and 2 
Period A Period B 
2 3 4 5 6 7 8 9 10 2 3 4 5 6 7 8 9 10 
Test I : Saline group 
I:x 33 18 10 12 I I 9 23 30 30 35 3 10 12 7 I I 12 25 35 33 20 
X 8.25 4.5 2.5 3.0 2.75 2.25 5.75 7.5 7.5 8.75 0.75 2.5 3.0 I. 75 2.75 3.0 6.25 8.75 9.25 5.0 
SD 5.73 5.44 5.0 3.56 3.2 3.86 3.77 1.0 I. 29 0.5 1.5 5.0 6.0 3.5 3. 77 2~45 3.68 4.03 4.35 2. 16 
SE 2.86 2. 72 2.5 I. 78 1.6 I. 93 I. 88 0.5 0.64 0.25 0.75 2.5 3.0 I. 75 1.88 I. 22 1.84 2.01 2. 17 1.08 
Test 2: Saline group 
I:x 22 21 36 35 32 27 37 - 41 31 29 12 22 25 38 34 48 38 47 49 45 
X 5.5 5.25 9.0 8. 75 8.0 6.75 9.25 10.25 7.75 7.25 3.0 5.5 6.25 9.5 8.5 12.0 9.5 11. 75 12.25 11.25 
SD 3.78 4.5 4. 89 4.57 0.81 3.3 3.59 3.59 4.57 3.3 4.24 5.4 1.89 1.0 ·2.08 3. 16 4.79 3.3 I. 25 3.86 
SE I. 89 2.25 2.45 2.28 0.41 1.65 I. 79 I. 79 2.28 1.65 2. 12 2.7 0.94 0.5 I. 04 I. 58 2.39 I. 65 0.63 I. 93 
Test I : LVP group 
I:x 37 14 IS 29 33 30 29 25 25 27 5 12 IS 22 31 29 32 35 28 25 
X 9.25 3.5 3.75 7.25 8.25 7.5 7.25 6.25 6.25 6.75 1.25 3.0 3.75 5.5 7.75 7.25 8.0 8.75 7.0 6.25 
SD 5.62 5.06 4.5 5. 18 5.73 5.97 4.85 4. 19 4. 19 4.57 2.5 4.69 4.78 4.51 6.39 5. 12 5.41 6. 18 4.69 4. 19 
SE 2.81 2.53 2.25 2.59 2.86 2.98 2.43 2.09 2.09 2.28 1.25 2.34 2. 39 2.25 3. 19 2.56 2. 71 3.09 2.34 2.09 
Test 2: LVP group 
I:x 34 26 33 38 29 33 27 28 39 30 22 28 2.9 41 47 34 35 47 47 49 
X 8.5 6.5 8.25 9.5 7.25 8.25 6.75 7.0 9. 75 7.5 5.5 7.0 7.25 10.25 I I • 75 8.5 8.75 11.75 11.75 12.25 
SD 4. 12 4. 36 5.5 6.55 4.99 5.9 4.71 3.46 2.06 5.44 2.08 4.96 5.25 5.37 4.03 5.56 6. 34 2.06 2.06 4.35 
SE 2.06 2. 18 2.75 3.27 2.49 2.95 2.35 I. 73 1.03 2.72 1.04 2.48 2.62 2.68 2.01 2.78 3. 17 1.03 1.03 2. 17 
Table ASS (continued): Experiment Twelve. Su~pression ratios durin~ 
Tests I and 2 
Trials 
2 3 4 s 6 7 8 9 10 
Test I : Saline group 
Ex 0.214 0.476 O.S4S o.s 0.946 2.3S7 2.0S2 2.044 I. 948 I. 4 7 
-
X O.OS3 0.119 o. 136 o. 12S 0.236 0. S89 O.SI3 O.SII 0.487 0.367 
SD o. 107 0.238 0.272 0.2S 0.284 0.401 0. 147 0. 14S 0.177 0. 119 
SE O.OS3 o. 119 0. 136 0. 12S 0. 142 0.201 0.073 0.072 0.088 O.OS9 
Test 2: Saline group 
Ex 0.802 2.439 I. 7S7 2.221 2.04 2.S82 2.016 2. 161 2.SS8 2.473 
X 0.2 0.609 0.439 o.sss O.SI 0.64S O.S04 O.S4 0. 639 0.618 
SD 0.2S4 0.336 0.12S 0. 179 0.049 0. 149 0. 131 0.044 0.149 0. 036 
SE 0. 127 0. 168 0.063 0.089 0.024 0.074 0.06S 0.022 0.07S 0.018 
Test I : LVP group 
l:x 0.2S I. 976 0.982 I. 27 I. 3SS I. SOS I .S71 I. 736 I. S8S 3.333 
-X 0.063 0.494 0.24S 0.317 o. 338 0.376 0. 392 0. 434 0.396 0.833 
SD 0. 12S 0.41 0.303 0.22 0.246 0.28 0.262 0.292 0.26S 0.786 
SE 0.063 0.204 0. IS2 o. 11 0.123 o. 14 0. 131 0. 146 0. 132 0.393 
Test 2: LVP group 
Ex I .644 I .S42 I. 387 2.46 2.7SS 2.493 3.687 2.SSS 2. 186 2. 717 
X 0.411 0.38S 0.346 0.61S 0.688 0.623 0.921 0.638 O.S46 0.679 
SD 0.088 0.263 0.237 0.273 0.207 0.263 0.719 0.091 0.094 0.241 
SE 0.044 0. 131 0.118 o. 137 0. I 04 0. 131 0.3S9 0.04S 0.047 0. 12 
Table A56: Anal;tsis of variance for Periods A and B and sup12ression 
ratios 
Source ss df MS F p 
Period A: Test I . 
• 
trials 1-5 
Between groups 12. I 12. I 3.5 NS 
Trials 36.79 4 9. 19 2.66 NS 
Error 13.84 4 3.46 
Total 62.73 
Period A: Test I ; trials 6-10 
Between groups 0.51 I 0.51 0. 11 NS 
Trials 8.91 4 2.227 0.5 NS 
Error 17.96 4 4.49 
Total 27.38 
Period A: Test 2· 
• 
trials 1-5 
Between groups 1.23 I. 23 1.0 NS 
Trials 13.4 4 3.35 2.73 NS 
Error 4.9 4 I. 225 
Total 19.53 
Period A: Test 2· 
• 
trials 6-10 
Between groups 0.4 0.4 0.14 NS 
Trials 3. 16 4 o. 79 0.28 NS 
Error 11. 16 4 2.79 
Total 14.73 
Period B: Test I· 
• 
trials 1-5 
Between groups 11 • 03 11.03 4.88 < 0. I 
Trials 18.91 4 4. 727 2.09 NS 
Error 9.04 4 2.26 
Total 38.98 
Period B: Test I. 
• 
trials 6-10 
Between groups 3.6 3.6 I. 69 NS 
Trials 17.47 4 4.367 2.05 NS 
Error 8.5 4 2. 125 
Total 29.58 
Table A56 (continued) 
Source ss df MS F p 
Period B: Test 2· 
' 
trials 1-5 
Between groups 8. I 8.1 14.64 < 0.05 
Trials 50.41 4 12.6 22.79 < 0.01 
Error 2.21 4 0.552 
Total 60.73 
Period B: Test 2· 
' 
trials 6-10 
Between groups I. 41 I I. 41 1.0 NS 
Trials 12.4 4 3. I 2.2 NS 
Error 5.63 4 1.407 
Total 19.43 
Suppression Ratios: Test I. 
' 
trials 1-5 
Between groups 0.06 I 0.06 6.56 < 0. I 
Trials 0.08 4 0.02 2.05 NS 
Error 0.04 4 0.01 
Total 0.18 
Suppression Ratios: Test I• 
' 
trials 6-10 
Between groups 0.000129 0.000129 0.00356 NS 
Trials 0.03 4 0.075 0.22 NS 
Error 0. I 5 4 0.03 
Total 0. 18 
Suppression Ratios: Test 2· 
' 
trials 1-5 
Between groups 0.00174 0.00174 0. I NS 
Trials 0. 13 4 0.0325 1.88 NS 
Error 0.07 4 0.0175 
Total 0.2 
Suppression Ratios: Test 2; trials 6-10 
Between groups 0.02 I 0.02 I. 11 NS 
Trials 0.02 4 0.005 0.26 NS 
Error 0.08 4 0.02 
Total 0. 12 
Table A57: Experiment Twelve. Extinction performance for each subject 
Saline LVP 
Total Short Long Total Short Long 
responses avoidances avoidances responses avoidances avoidances 
Test I* 
X 20.0 12.75 7.25 27.0 20.75 6.25 
SD 16.431 7. 141 5.678 23.36 20. 139 4. 193 
SE 8.215 3.57 2. 839 11.68 10.069 2.096 
Test 2* 
X 17.5 12.75 4.75 26.0 14.5 11.5 
SD 20.24 19.05 6.601 12.987 10.63 5.446 
SE I 0. 12 9.525 3.3 6. 493 5.31 2. 723 
* n = 4 
Table A57 (continued): Experiment Twelve. Extinction performance as a 
function of extinction trials 
Total Short Long 
responses avoidances avoidances 
Sal LVP Sal LVP Sal LVP 
Test T** N P* 
6 9 5 7 2 
2 4 11 2 9 2 2 
3 6 12 4 8 2 4 Total 4.5 9 < 0.02 
responses 
4 7 11 6 9 2 
5 6 10 4 8 2 2 Short 1.0 9 < 0.01 
avoidances 
6 11 11 7 9 4 2 
7 9 11 4 8 5 3 Long 19.0 7 NS avoidances 
8 6 12 2 9 4 3 
9 12 11 9 8 3 3 
10 13 10 8 8 5 2 
Test 2 
6 14 5 8 6 
2 10 12 6 8 4 5 
3 7 9 6 4 5 Total 6.5 10 < 0.05 
responses 
4 6 IS 4 9 2 6 
5 6 9 5 5 4 Short 17.5 9 NS 
avoidances 
6 8 9 5 7 3 2 
7 7 11 6 5 6 Long 1.5 9 < 0.01 
avoidances 
8 8 10 6 8 2 2 
9 8 5 6 2 4 
10 7 9 5 3 2 6 
** Wilcoxon signed ranks test (Seigel 1956) 
* P = two tailed 
Table ASS: Experiment Thirteen. Acquisition data 
Sal 2 ).lg 3 ).lg 4 ).lg 
Avoidances 
l:x 42 82 54 46 
-X 7.0 16.4 10.8 7.66 
SD 2. 828 21.836 B. 93 7.06 
SE I. 154 7 9.765 3.99 2.88 
Escapes 
Ex 94 56 22 109 
X 15.66 11.2 4.4 18. 16 
SD 12.42 6. 79 4.39 21.36 
SE 5.07 3.04 1.96 B. 72 
Failures 
Ex 461 363 423 430 
X 76.83 72.6 84.6 71.66 
SD 12.73 21.915 13.01 31.66 
SE 5. 198 9.801 5.818 12.92 
Shocks 
Ex 2451 1889 2170 2420 
-X 408.5 377.8 434.0 403.33 
SD 47.89 106.95 56.414 106.18 
SE 19.55 47.83 25.23 43.35 
Table A58 (continued): Experiment Thirteen. Analysis of var~ance on 
acquisition data 
Source ss df MS F p 
Between groups 293.93 3 97.9798 0.7012 NS 
Avoidances Within groups 2515.33 18 139. 7407 
Total 2809.27 21 
Between groups 587.697 3 195.899 1.064 NS 
Escapes Within groups 3314.1667 18 184.1204 
Total 390 I. 8636 21 
Between groups 543.297 3 181.099 0.3871 NS 
Failures Within groups 8420.5667 18 467.8093 
Total 8963.86 21 
Between groups 7976.1849 3 2658. 7283 0.3788 NS 
Shocks Within groups 126331.633 18 7018.4241 
Total 134307.0 21 
Table A59: Experiment Thirteen. Extinction data 
Total avoidances Short avoidances Long avoidances 
Sal 2 llg 3 llg 4 IJg Sal 2 llg 3 IJg 4 llg Sal 2 llg 3 llg 4 llg 
Test 
SI 50 22 41 46 33 13 31 39 18 9 10 7 
S2 30 38 19 15 16 30 15 7 14 8 4 8 
S3 24 20 49 40 15 13 44 31 9 7 5 9 
S4 27 35 27 30 16 25 21 23 I I 10 6 7 
ss 32 15 30 23 21 10 13 15 I I 5 17 10 
S6 25 35 13 29 12 6 
l:x 188 130 166 189 114 91 124 144 
X 31.33 - 26.0 33.2 31.5 19.0 18.2 .24. 8 24.0 12.5 7.8 8.4 7.83 
SD 9.626 9. 975 I I • 84 11.327 7.348 8.757 12.814 11.576 3. 146 1.923 5.319 1.472 
SE 3.929 4.461 5.29 4.624 3.0 3.916 5.73 4.725 I. 284 0.86 2.379 0.6 
Test 2 
SI 35 36 39 45 27 16 29 40 8 20 10 5 
S2 37 32 8 6 25 21 7 I 12 I I I 5 
S3 7 20 18 37 3 16 I I 27 4 4 7 10 
S4 32 44 24 30 23 34 17 13 9 10 7 I 7 
ss 21 33 20 17 9 23 12 18 12 10 8 5 
S6 38 25 l3 
l:x 170 165 195 135 112 110 76 99 58 55 33 42 
X 28.33 33.0 21.8 2 7.0 18.66 22.0 15.2 19.8 9.66 11.0 6.6 8.4 
SD 12. 127 8.66 11.278 15.6 10.07 7.38 8.497 14.686 3.386 5.74 3.36 5. 272 
SE 4.95 3.87 5.044 6.978 4. 112 3.3 3.8 6.568 I. 382 2.56 I. 503 2. 358 
Table A59 (continued): Experiment Thirteen. Extinction data: Mean 
number of responses/subject on each trial block 
Total avoidances Short avoidances Long avoidances 
Sal 2 JJg 3 JJg 4 IJ8 Sal 2 \l8 3 JJg 4 JJg Sal 2 JJg 3 JJg 4 JJg 
0.999 1.0 
2 2.333 1.8 
3 3.666 3.0 
4 2.99 3.0 
5 3.666 2.8 
2.6 
3.6 
3.8 
3.0 
3.6 
6 3.166 2.6 3.8 
7 3.33 3.2 2.4 
8 3.5 2.2 4.0 
9 3.49 2.8 3.0 
10 2.666 3.6 3.4 
Test 
1.830 0.666 0.6 
2.49 1.5 1.0 
2. 66 I. 5 2. 2 
3. 0 I • 66 I • 8 
3.17 2.5 2.2 
3.166 1.5 1.8 
4.0 2.5 2.2 
4.0 2.5 2.0 
4.17 2.83 1.8 
3. 33 3 I • 833 2. 6 
2.4 
2.6 
2.8 
2.8 
2.6 
2.6 
I. 2 
3.0 
2.6 
2.2 
I. 5 
2. 16 
I. 16 
2.0 
2.5 
0.333 0.4 
0.833 0.8 
2. 166 0.8 
I. 33 I. 2 
1.1660.6 
2.166 1.666 0.8 
2.833 0.83 1.0 
3.0 1.0 0.2 
3.833 0.66 1.0 
2.833 0.833 1.0 
0.2 
1.0 
1.0 
0.2 
1.0 
1.2 
1.2 
I. 0 
0.4 
1.2 
0.33 
0.33 
1.5 
1.0 
0.666 
1.0 
I. 166 
1.0 
0.333 
0.5 
X 2.98 2.6 3.32 3.182 1.8991.82 2.48 2.398 1.08170.78 0.84 0.782 
SD 0.82 0.754 0.543 0.741 0.667 0.599 0.5 0.776 0.528 0.304 0.408 0.409 
SE 0.26 0.238 0.172 0.234 0.21 I 0.189 0.158 0.245 0.167 0.096 0.129 0.129 
3. 166 3.0 4.0 3.6 
2 3.326 3.2 2.8 3.6 
3 2.833 3.6 3.8 3.2 
4 2.993 3.0 
5 3.0 4.8 
6 3.16 3.4 
7 3.16 3.2 
8 2.5 4.4 
9 2.5 2.0 
I 0 I . 66 2. 8 
2.0 2.8 
I. 75 3.2 
2.0 3.2 
I .0 2. 8 
1.8 2.2 
2.2 2.0 
1.8 1.6 
Test 2 
1.666 2.0 2.8 2.8 
2.666 1.4 2.2 2.2 
1.333 2.6 2.6 2.0 
I . 833 I. 6 
2.0 3.8 
2.0 2.6 
1.83 2.0 
2.0 3.6 
2.0 1.6 
I. 33 I. 2 
1.0 1.8 
I. 5 2. 2 
1.5 1.8 
0.75 1.8 
1.4 2.0 
I. 4 I. 8 
1.0 1.4 
1.5 1.0 1.2 0.8 
0.66 1.8 0.6 1.4 
1.5 1.0 1.2 1.2 
1.16 1.4 
1.0 1.0 
1.16 0.8 
1.33 1.2 
0.5 0.8 
0.5 0.4 
0.33 1.6 
1.0 1.0 
0. 25 I. 0 
0.5 1.4 
0.25 1.0 
0.4 0.2 
0.8 0.2 
0.8 0.2 
X 2.829 3.34 2.315 2.82 1.866 2.24 1.615 1.98 0.964 1.1 0.7 0.84 
SD 0.496 0.794 0.946 0.683 0.384 0.898 0.694 0.37 0.436 0.41370.358 0.4789 
SE 0.157 0.251 0.299 0.215 0.121 0.284 0.219 0.117 0.138 0.131 0.113 0.1514 
Table A59 (continued): Exeeriment Thirteen. Outcomes of Freidman's 
analyses of variance on extinction data 
l:R~ 2 p 
J xr 
Test 2558.5 3.51 NS 
Total avoidances 
Test 2 2546.5 2. 79 NS 
Test I 2686.5 11. 19 < 0.02 
Short avoidances 
Test 2 2597.0 5. 82 NS 
Test 2563.5 3.81 NS 
Long avoidances 
Test 2 2602.0 6. 12 NS 
Table A60: Experiment Fourteen. Acquisition performance 
Sal LVP Sal LVP Sal LVP 
Sal Sal Seep Seep Phy Phy 
Avoidances 
-X 8.66 . 15,66 15.5 19.33 29.75 3.33 
so 11.64 12.801 16.28 26.23 17.29 3.44 
SE 4.75 5.23 6.647 10.71 8.64 I. 41 
Escapes 
-X 14.33 28.0 17. 16 9.5 28.0 4.5 
so 13.31 32.93 18.84 9.61 17.34 4.59 
SE 5.43 13.44 7.69 3.92 8.67 I. 87 
Failures 
X 77.66 56.5 67.5 67.66 41.5 82.0 
so 21.31 36.2 25.28 38. 18 22.52 20.57 
SE 8.29 14.78 10.32 15.58 11.26 8.39 
Shocks 
X 407.83 330. 16 365.33 355.66 256.25 470.33 
SD 82.35 139.63 108.73 178.91 98.73 18.24 
SE 33.62 57.0 44.39 73.04 49.36 7.45 
Table A60 (continued): Acguisition data: Anallsis of extinction 
performance 
Source ss df MS F p 
Between groups 2036.89 s 407.38 I.S8 NS 
Avoidances Within groups 7219 .sa 28 257.84 
Total 9256.47 33 
Between groups 2509.45 s SO I. 89 I. 47 NS 
Escapes Within groups 9551.17 28 341. I I 
Total 12060.62 33 
Between groups 5298.86 s IOS9.77 1.3 NS 
Failures Within groups 22740.67 28 812. 17 
Total 28039.53 33 
Between groups 131615.61 s 26323. 12 I. 93 NS 
Shocks Within groups 381466.42 28 13623.8 
Total Sl3082.03 33 
Table A61: Ex~eriment Fourteen. Extinction data: Res~onses in 
extinction 
Test I Test 2 
Sal LVP Sal LVP Sal LVP Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy Sal Sal Scop Scop Phy Phy 
Total avoidances 
-X 20.0 24.33 24.0 36.83 30.5 30.83 25.5 33.83 30.0 36.5 38.0 36.83 
SD 8.55 7.03 13.87 11.46 11 • I 5 10.34 9.31 13.0 I 11 .45 12.69 8. 48 . 7.65 
SE 3.49 2.87 5.66 4. 67 5.57 4.22 3.8 5.31 4.67 s. 18 4.24 3. 12 
Short avoidances 
X 10.33 14.0 18.83 26.66 22.0 22.0 IS. 16 25.66 22.0 28.33 30.25 27.66 
SD 6.62 5.73 13.04 I 0. 27 7.35 8.15 s. 77 11.34 12. 13 10.29 10.24 6.89 
SE 2.7 2.34 5.32 4. 19 3.67 3.33 2.36 4.63 4.95 4.2 5. 12 2.81 
Long avoidances 
X 9.66 10.33 5. 16 10.16 8.5 8.83 10.33 8. 16 8.0 8. 16 7.75 9. 16 
SD 3.56 3.01 2.64 3. 12 4. 12 3. 12 5.04 3.66 4.29 3. 97 4. 11 4.02 
SE 1.45 1.23 I. 07 I. 27 2.06 I. 27 2.06 I. 49 I. 75 I. 62 2.06 I. 64 
Table A62: Experiment Fourteen. Extinction data: Responses per block 
of five trials 
Test 
Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy 
Test 2 
Sal LVP Sal LVP Sal LVP 
Sal Sal Scop Scop Phy Phy 
Total avoidances 
I 0.833 1.999 2.5 2.999 3.0 
2 2.466 3.333 3.666 3.996 3.0 
3 1.499 2.993 2.333 3.999 3.5 
4 2.5 2.833 3.666 4.333 3.0 
5 2.3 1.666 3.166 4.333 3.5 
6 2.332 2.332 2.499 3.833 3.5 
7 2.166 2.999 1.666 3.833 2.5 
8 2.666 2.499 1.666 3.833 2.75 
9 2.166 2.333 1.332 3.332 3.0 
10 1.0 1.332 1.5 2.333 2.75 
X 1.993 2.432 2.399 3.682 3.05 
SD 0.648 0.634 0.872 0.626 0.349 
SE 0.205 0.2 0.276 0.178 D.lll 
I. 166 
3.333 
2.666 
3.666 
2.999 
3.666 
4. 166 
3.499 
3.0 
2.666 
3.083 
0.825 
D.261 
2.832 3.832 3.666 4.666 5.25 
3.666 3.5 4.166 4.166 4.25 
2.499 4.166 4.332 4.332 4.0 
4.166 3.666 3.8 4.332 4.5 
2.832 3.166 3.499 4.499 4.5 
3.333 3.933 2.832 3.833 5.D 
2.2 3.332 2.833 3.666 2.5 
1.0 2.999 1.666 1.999 2.5 
1.996 2.833 2.0 2.833 2.5 
1.499 2.499 1.833 2.166 3.0 
2.602 3.383 3.063 3.649 3.8 
0.974 0.515 0.979 0.976 1.079 
D.308 0.163 D.309 0.3D9 0.341 
3.666 
4.666 
3.666 
4.833 
3.832 
3.666 
3.499 
3.999 
2.832 
2.666 
3.732 
0.681 
D.215 
Short avoidances 
I 0.5 0.833 2.0 1.833 2.25 I .D 1.666 2.666 2.833 3.833 4.25 3.0 
2 I • 3 1.833 2.5 2. 166 I. 75 2.5 1.666 3.0 2.666 3.333 3.5 3.D 
3 D.666 2. 16 I. 833 2.333 3.0 2.D 1.833 3.0 3.166 3. 166 3.5 2.555 
4 1.0 1.833 3.0 3.5 I. 75 2.833 2.5 2.666 2.2 3.666 4.25 4.D 
5 1.3 D.666 2.333 3.833 2.25 1.666 I. 666 2. 833 2.166 3. 166 3. 75 3. 166 
6 1.166 1.166 1.833 3.0 2. 75 2.5 2.333 2.5 2.666 3.0 4.5 2.666 
7 1.0 I. 666 I • 666 3.5 I. 75 2.666 1.0 2. 166 2.5 2.666 2.5 2.666 
8 I. 666 I • 166 I • 5 2.5 2.25 2.833 D.6 2.666 I. 166 1.666 D.75 2.833 
9 1.166 1.5 1.166 2.166 2.5 2.0 I. 33 I. 833 1.5 2.0 1.5 2. 166 
10 0.5 1.166 1.0 1.833 1.75 2.0 D.833 2.333 1.5 I. 833 I. 75 1.5 
X 1.026 1.399 1.883 2.666 2.2 2. 199 I. 543 2.566 2.236 2.833 3.D25 2.766 
SD 0.377 0.478 0.609 0.737 D.453 D.581 D.615 0.37 D.658 D.766 1.315 0.649 
SE 0.119 0.151 0.193 D.233 0.143 o. 184 0.194 0.117 0.2D8 0.242 0.416 0.2DS 
Long avoidances 
I 0.333 I. 166 D.S 1.166 0.75 D. 166 I. 166 1.166 0.833 0.833 1.0 D.666 
2 I. 166 I. 5 I, 166 I. 83 2. IS D.833 2.D D.S 1.5 0.833 0.75 I .666 
3 0.833 D.833 0.5 1.666 o.s D.666 0.666 1.166 I. 166 1.166 D.5 1.0 
4 I. 5 1.0 0.666 0.833 1.25 D.833 1.666 1.0 1.6 0.666 D.25 0.833 
5 I. D 1.0 0.833 0.5 I. 25 1.333 I. 166 0.333 1.333 1.333 D.75 0.666 
6 I. 166 1.166 0.666 0.833 D.75 I. 166 I.D 1.333 o. 166 0.833 0.5 I.D 
7 I. 166 I .333 0 D.333 0.75 I. 5 1.2 I. 166 D. 333 I. 0 0 0.833 
8 1.0 1.333 0.166 1.333 0.5 D.666 0.4 0.333 D.S 0.333 1.75 I. 166 
9 1.0 0.833 0.166 I. 166 D.5 1.0 0.666 1.0 0.5 D.833 1.0 0.666 
ID 0.5 o. 166 0.5 0.5 1.0 D.666 D.666 0.166 0.333 0.333 1.25 I. 166 
X 0.966 I.D33 D.SI6 I.DI6 0.85 D.883 I .059 0.816 D.826 0.816 D. 775 D.966 
SD 0.341 0.375 D.346 D.SDS 0.316 0.385 0.494 0.433 0.533 D.319 D.506 0.312 
SE 0.107 0.119 D.ID9 D.IS9 0.1 0. 122 0.156 D.l37 0.168 D.l D. 16 0.988 
Table A62 (continued): E~eriment Fourteen. Analzsis of extinction 
data: Outcomes of Freidman's two waz 
analyses of variance 
I:R~ 2 p 
J xr 
Test 8330.0 27.988 < 0.001 
Total avoidances 
Test 2 8255.5 25.859 < 0.001 
Test 
Short avoidances 8339.5 28.252 < 0.001 
Test 2 8346.25 28.452 < 0.001 
Long avoidances Test 7757.5 11 • 631 < 0.05 
Test 2 7432.0 2.332 NS 
Table A63: Experiment Fourteen. Multiple comparisons tests on 
extinction data (Hollander and Wolfe 1973) 
Total avoidances 
Short avoidances 
Long avoidances 
Total avoidances 
Short avoidances 
Groups 
Test 
Sal Sal 
Sal Sal 
Sal Sal 
< LVP Scop 
< Sal Phy 
< LVP Phy 
LVP Sal < LVP Scop 
Sal Scop < LVP Scop 
Sal Sal < LVP Scop 
Sal Sal 
Sal Sal 
LVP Sal 
< Sal Phy 
< LVP Phy 
< LVP Scop 
Sal Sal > Sal Scop 
LVP Sal > Sal Seep 
LVP Scop > Sal Scop 
LVP Phy > Sal Scop 
Test 2 
Sal Sal < LVP Sal 
Sal Sal < Sal Phy 
Sal Sal < LVP Phy 
Sal Scop < Sal Phy 
Sal Sal 
Sal Sal 
Sal Sal 
Sal Sal 
< LVP Sal 
< LVP Scop 
< Sal Phy 
< LVP Phy 
d 
41.5 
24.5 
27.0 
26.5 
26.5 
38.0 
29.0 
29.5 
28.0 
22.0 
21.5 
22.0 
23.0 
29.5 
34.0 
30.5 
24.5 
22.5 
36.0 
37.0 
31.5 
p 
< 0.009 
< 0.047 
< 0.023 
< 0.023 
< 0.023 
< 0.009 
< 0.009 
< 0.009 
0.009 
[0.09] 
[0. I] 
[0. 09] 
[0.06] 
< 0.009 
< 0.009 
< 0.009 
< 0.047 
[0.075] 
< 0.009 
< 0.009 
< 0.009 
Reject H0 where d ~ r(a,k,n), k 6, n = 10 (Table AI7, 
Hollander and Wolfe 1973) 
Critical values of r; 24, a = 0.047; 26, a 0.023; 28, a = 0.009 
Table A64: Experiment Fifteen. Lever press data: Total number of responses per cell 
Days 
2 3 4 s 6 
SI ss S4 S2 S3 -S6 LX X SE 
Sal 1120 IS40 1640 1620 1840 1720 9480.0 IS80.0 100.94 
S2 SI S3 S4 S6 ss 
o.os IJg 1480 1840 1640 1740 1700 1920 10320.0 1720.0 63.0S 
~ 
""' <tl S3 S2 SI S6 ss S4 ,.. 
,.. I IJg 1600 IS40 1100 1700 1600 1960 9SOO.O IS83.3 114.26 IIJ 
p. 
Oil S4 S6 ss SI S2 S3 ;::1 
....., 
IIJ 2 IJg 960 1380 1380 IS20 1800 2000 9040.0 IS06.6 148.4 
., 
0 
t=l ss S4 S6 S3 SI S2 
3 IJg 1000 1360 1380 940 1260 460 6400.0 1066.6 142.6 
S6 S3 S2 ss S4 SI 
4 IJg 1080 1780 ISOO 1400 2000 960 8720.0 14S3.3 162.6 
LX 7239.9 9440.0 8640.0 8920.0 10200.0 9020.0 
-
X 1206.66 IS73.33 1440.0 1486.66 1700.0 IS03.33 
SE 109.0 81.4S 82.96 120.43 I 03. 79 262.0 
Table A65: Experiment Fifteen. Summary of analysis of variance on the 
number of lever responses per cell (Kirk 1968) 
Source ss df MS F pp 
Dose 7.086 5 I. 417 3. 311 < 0.05 
Days 3.786 5 o. 75 72 I. 769 NS 
Subjects 2.236 5 0.4472 1.045 NS 
Residual 8.558 20 0.4279 
Total 21.666 35 
Newman Keuls pairwise comparisons to locate significant differences 
between doses (Kirk 1968) 
Ordered means (mean number of responses per dose) 
K 
3 
4 
2 
Sal 
0.05 
3 
2.315 
Critical values of w 
4 
3 •. 153 
0.838* 
Dose (IJg) 
2 
3.273 
Sal 
3.43 
Differences (D) 
0.928* I. 115* 
o. 12 0.277 
0. 157 
0.5 
3.436 
I. 121 * 
o. 283 
o. 163 
0.006 
w6 = 1.188; w5 = 1.129;.w4 = 1.057; w3 = 0.956; w2 = 0.787 
When D ~ WR reject H0 at a (0.05) 
* p s; 0.05 
3.735 
1.42* 
0.582 
0.462 
0.305 
0.299 
Table A66: Experiment Fifteen. Lever press data 50% interquartile range per cell (50% IQR) 
Days 
2 3 4 5 6 
-SI ss S4 S2 S3 S6 LX X SE 
Sal 4. 77S 4. 918 4.266 4.234 3.74S 3.517 2S.455 4.242 0.225 
S2 SI S3 S4 S6 ss 
0.05 \lg 5.3S3 3.871 4. 11 3.832 3. 128 4. 13S 24.43 4.071 0.296 
~ S3 S2 SI S6 ss S4 
...... 
e 
Ll"' I IJg 5.73 4.84S 4.7S 3.776 4.617 4.077 27.79 4.632 0.277 
. 
0 
..._ 54 S6 ss SI S2 S3 00 
;;l. 
'-' 2 IJg 4.7S8 4.86 6.322 3.949 3.48 3.927 27.29 4.S49 0.415 
QJ 
"' 0 ss S4 S6 S3 SI S2 0 
3 IJg 6. 923 s. 166 4.838 3.336 6.02S 3. 773 30.06 S.OI o.ss 
S6 S3 S2 ss S4 SI 
4 \lg 7.6S2 4.S2 5.641 5. 102 4.20S 7.531 34.65 5.77S 0.608 
LX 35. 191 28. 18 29.927 24.229 2S.2 26.96 
X 5.865 4.696 4.987 4.038 4.2 4.49 
SE 0.483 o. 18S 0.34S 0.243 0.423 0.614 
Table A67: E~eriment Fifteen. Summary of analysis of variance on 50% 
interquartile range data (50% IQR) (Kirk 1968) 
Source ss df MS F p 
Dose 11.298 5 2.2596 3.457 < 0.05 
Days 13.021 5 2.6042 3.984 < 0.05 
Subjects 5.588 5 I. 1176 I. 709 NS 
Residual 13.073 20 0.6536 
Total 42.98 35 
Newman Keuls pairwise comparisons to locate significant differences 
between doses and days (Kirk 1968) 
Doses (ordered means) 
0.5 Sal 2 3 
4.0715 4.2425 4.5493 4.6325 5.0101 
Differences (D) 
0.5 o. 171 0.4778 0.561 0. 9386 
Sal 0.3068 0. 39 0. 76 76 
"' 2 0.083 0.4608 Qj 
"' 0 0. 3776 0 
3 
4 
Critical values of w (a = 0.05) 
w6 = 1.468; w5 = 1.396; w4 = 1.306; w3 = I. 181; w2 = 0.973 
Days (ordered means) 
4 5 6 2 3 
4.038 4.2 4.493 4.697 4.987 
Differences (D) 
4 0.162 0.455 0.659 o. 949 
5 0.293 0. 497 0.787 
"' 
6 0.204 0.494 
>. 
0.29 <11 2 0 
3 
Critical values of w (a= 0.01) 
w6 = 1.818; w5 = 1.745; w4 = 1.656; w3 = 1.531; w2 I. 326 
4 
5.7751 
1.7036* 
I. 5326* 
1.2258* 
I. 1426* 
0.765 
5.865 
I. 827** 
I. 665* 
I. 372* 
I. 168 
0. 878 
Table A68: E~eriment Sixteen. Summary of lever press res12onse data 
for DRL schedule 
Dose 
Sal 0.5 2 3 4 -X SD SE 
(I) Total responses 
SI 196 242 149 180 192 191.8 33.57 15.01 
S2 189 162 151 173 243 183.6 36.05 16. 12 
S3 167 245 149 181 199 170 185.16 33.63 13.73 
S4 201 210 164 157 143 175.0 29.02 12.98 
ss 215 163 179 229 193 250 204.83 32.51 13.27 
S6 168 202 181 185 222 163 186.83 22.03 8.99 
X 189.3 204.0 168.25 179.0 187.3 193.5 
SD 18.93 36.36 14.9 32.49 22.6 43.99 
SE 7.73 14.84 7.45 14.53 9.22 17.96 
(2) Rapid responses (latency S sec) 
SI IS 13 2 3 I 6.8 6.64 2.97 
S2 17 7 9 25 15 14.6 7. 12 3. 18 
S3 3 12 3 6 12 4 6.66 4.27 I. 74 
S4 17 IS 3 3 4 8.4 6.98 3. 12 
ss 31 7 5 25 37 33 23.0 13.74 5.6 
S6 0 4 2 3 7 I 2.83 2.48 I. 0 I 
X 13.83 9.66 3.25 9.0 14.5 9.66 
SD 11. 17 4.27 1.26 9.35 13.73 12.54 
SE 4.56 I. 74 0.63 4. 18 5.61 5. 12 
(3) Long responses (latency > 29 secs) 
SI 3 9 15 2 I 6.0 5.91 2.64 
S2 6 3 I 3 9 4.4 3. 13 I. 4 
S3 0 3 I 0 3 3 I. 66 I. 5 0. 61 
S4 5 4 0 2 0 2.2 2.28 I. 02 
ss 4 0 3 2 3 I 2. 16 I. 47 0.6 
S6 0 I 5 4 5 2.66 2.25 o. 91 
X 3. 16 3. 16 I. 25 4.6 2.83 3. 16 
SD 2.31 3.31 I .258 6. I 0.75 3.37 
SE 0.94 I. 35 0.63 2.73 0.31 I. 37 
(4) Total false alarms (latency 2 ~ s < 11 • 8) 
SI 83 172 85 78 114 106.4 39.3 17.56 
S2 75 40 18 71 159 72.6 53.65 23.99 
S3 46 145 33 49 65 66 67.3 40.0 16.33 
S4 67 83 42 58 25 55.0 22.39 10.01 
ss 70 31 53 132 63 133 80.33 42.5 17.35 
S6 41 118 91 85 154 52 90. 16 41.83 17.07 
X 63.66 98. 16 54.75 73.8 81.5 91.5 78.63 
SD 16.6 56.85 25.51 42.9 36. 18 51.8 18.05 
SE 6. 78 23.21 12.75 19. 19 14.77 21. 14 7.37 
Table A68 (continued) 
Dose 
-Sal 0.5 2 3 4 X so SE 
(5) Probability of a false alarm 
SI 0.458 0. 75 0.578 0.441 0.596 0.564 0. 124 0.055 
S2 0.436 0.258 0. 127 0.527 o. 697 0.409 0.233 0.1 
S3 0.28 0.622 0.228 0.28 o. 347 0.397 0. 358 0. 142 0.058 
S4 0.364 0.425 0.26 0.376 0. 179 0. 321 0.099 0.044 
ss 0.38 0. 198 0.304 0.647 0.404 0.613 0.424 0.175 0.071 
S6 0.244 0. 598 0.508 o. 467 0.716 0.322 0.475 0. 173 0.071 
X 0.36 0.475 0.324 0.419 0.468 0.467 
SD 0.084 0.218 o. 126 0.214 o. 136 o. 199 
SE 0.345 0.089 0.063 0.096 0.055 0.081 
(6) Total hits (latency > 12 secs) 
SI 95 48 44 92 76 71.0 23.97 10. 72 
S2 87 105 115 69 54 86;0 25.07 11.21 
S3 118 83 Ill 125 114 94 107.5 15.83 6.46 
S4 104 107 114 86 106 103.4 10.43 4.66 
ss 107 120 117 70 90 82 97.66 20.14 8.22 
S6 125 79 85 94 58 104 90.83 22.81 9.31 
X 106.0 90.33 106.75 89.6 84.83 86.0 92.64 
so 14.08 25.87 14.7 33.09 19.49 19.63 13.26 
SE 5. 75 10.56 7.35 14.8 7.96 8.01 5.4156 
(7) Probabi 1i ty of a hit 
SI 0.969 0.842 0.709 0.911 0.987 0.884 0. 112 0.05 
S2 0.897 0.800 o. 927 0. 896 0. 783 0.86 0.064 0.028 
S3 1.0 0. 943 0.982 0.99 0.934 0.94 0.964 0.029 0.011 
S4 0.888 0. 955 0.957 o. 895 0.929 0.924 0.032 0.014 
ss 0. 928 0.96 0.966 0.972 0.967 0.976 0.963 0.013 0.005 
S6 0.984 0. 987 0.966 0.969 0.951 0.045 0.968 0.014 0.006 
X 0.946 0.914 0.967 0.913 0.926 0.926 
SD 0.046 0.075 0.01 0. 116 0.029 0.073 
SE 0.018 0.03 0.005 0.052 0.012 0.03 
Table A69: Exeeriment Sixteen. Outcome of eaired "t" tests on lever 
press data (one tailed p) 
Sal v 0.5 Sal v Sal V 2 Sal v 3 Sal v 4 
t 0.747 I. 67 0.565 o. 132 0.264 
Total df 5 
responses 3 4 5 5 
p NS < 0. I NS NS NS 
t 0.877 I. 45 I. 332 0. I 53 I. 387 
Rapid df 5 3 4 5 5 responses 
p NS NS NS NS NS 
t 0 0.951 0.612 0.299 0 
Long latency 
responses df 5 3 4 5 5 
p NS NS NS NS NS 
t I. 353 0.072 0.525 0.915 I. 554 
False alarms df 5 3 4 5 5 
p NS NS NS NS < 0. I 
t I. 117 0.087 0.584 I. 453 1.696 
Probability of df 5 3 4 5 5 false alarm 
p NS NS NS NS < 0. I 
t I. 268 0.573 I. 139 2.206 4. I 52 
Total hits df 5 3 4 5 5 
p NS NS NS < 0.05 < 0.01 
t I .034 o. 728 0.806 I. 311 0. 762 
Probability of df 5 3 4 5 5 hit 
p NS NS NS NS NS 
